1	®	NNP	O	®	_	0	SENT_1	[p1l6t86r68b147],
2	Molecular	JJ	O	molecular	amod	3	SENT_1	[p1l170t81r281b106],
3	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_1	[p1l292t81r410b112],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l420t81r499b109],
5	2011	CD	DATE	2011	dep	1	SENT_1	[p1l420t81r499b109],
6	)	CD	NUMBER	)	number	7	SENT_1	[p1l420t81r499b109],
7	16	CD	NUMBER	16	dep	5	SENT_1	[p1l512t81r547b111],
8	,	,	O	,	_	0	SENT_1	[p1l512t81r547b111],
9	620-625	CD	NUMBER	620-625	appos	5	SENT_1	[p1l560t81r671b106],

1	©	RB	O	©	dep	2	SENT_2	[p1l169t125r185b144],
2	2011	CD	DATE	2011	dep	5	SENT_2	[p1l195t119r251b144],
3	Macmillan	NNP	ORGANIZATION	Macmillan	nn	5	SENT_2	[p1l264t119r371b144],
4	Publishers	NNPS	ORGANIZATION	Publishers	nn	5	SENT_2	[p1l383t119r489b144],
5	Limited	NNP	ORGANIZATION	Limited	_	0	SENT_2	[p1l500t119r575b144],
6	All	DT	ORGANIZATION	all	det	7	SENT_2	[p1l602t119r627b144],
7	rights	NNS	O	rights	nsubj	8	SENT_2	[p1l639t119r695b150],
8	reserved	VBD	O	reserve	rcmod	5	SENT_2	[p1l706t119r790b144],
9	1359-4184/11	CD	DURATION	1359-4184/11	num	10	SENT_2	[p1l804t119r962b147],
10	www.nature.com/mp	NN	O	www.nature.com/mp	dobj	8	SENT_2	[p1l169t176r428b205],

1	IMMEDIATE	JJ	O	immediate	amod	2	SENT_3	[p1l145t260r464b302],
2	COMMUNICATION	NN	O	communication	_	0	SENT_3	[p1l489t259r989b303],

1	Genetic	JJ	O	genetic	amod	2	SENT_4	[p1l129t367r398b424],
2	variation	NN	O	variation	nsubj	5	SENT_4	[p1l425t368r731b424],
3	in	IN	O	in	_	0	SENT_4	[p1l765t368r823b423],
4	CYP3A43	NN	O	cyp3a43	prep_in	2	SENT_4	[p1l855t367r1180b424],
5	explains	VBZ	O	explain	_	0	SENT_4	[p1l1210t368r1505b438],
6	racial	JJ	O	racial	amod	7	SENT_4	[p1l1536t368r1721b424],
7	difference	NN	O	difference	dobj	5	SENT_4	[p1l1754t368r2106b424],
8	in	IN	O	in	_	0	SENT_4	[p1l131t450r188b505],
9	olanzapine	NN	O	olanzapine	nn	10	SENT_4	[p1l220t450r602b520],
10	clearance	NN	O	clearance	prep_in	7	SENT_4	[p1l632t450r971b505],

1	KL	NNP	ORGANIZATION	KL	nn	3	SENT_5	[p1l129t554r181b588],
2	Bigos	NNP	ORGANIZATION	Bigos	nn	3	SENT_5	[p1l200t552r336b598],
3	‘	NNP	O	‘	_	0	SENT_5	[p1l200t552r336b598],
4	,	,	O	,	_	0	SENT_5	[p1l200t552r336b598],
5	RR	NNP	PERSON	RR	nn	6	SENT_5	[p1l359t554r420b588],
6	Biesz	NNP	PERSON	Biesz	conj_and	3	SENT_5	[p1l439t552r550b595],
7	,	,	O	,	_	0	SENT_5	[p1l439t552r550b595],
8	BG	NNP	ORGANIZATION	BG	nn	10	SENT_5	[p1l573t554r632b589],
9	Pollock	NNP	ORGANIZATION	Pollock	nn	10	SENT_5	[p1l654t552r848b595],
10	“	NN	O	“	conj_and	3	SENT_5	[p1l654t552r848b595],
11	,	,	O	,	_	0	SENT_5	[p1l654t552r848b595],
12	JJ	NN	PERSON	jj	nn	14	SENT_5	[p1l868t554r910b589],
13	Lowy	NNP	PERSON	Lowy	nn	14	SENT_5	[p1l932t552r1060b598],
14	‘	NNP	O	‘	conj_and	3	SENT_5	[p1l932t552r1060b598],
15	,	,	O	,	_	0	SENT_5	[p1l932t552r1060b598],
16	F	NN	O	f	nn	18	SENT_5	[p1l1083t554r1106b588],
17	Zhang	NNP	PERSON	Zhang	nn	18	SENT_5	[p1l1123t552r1262b598],
18	‘	NNP	O	‘	conj_and	3	SENT_5	[p1l1123t552r1262b598],
19	and	CC	O	and	_	0	SENT_5	[p1l1285t554r1357b589],
20	DR	NN	O	dr	conj_and	3	SENT_5	[p1l1377t554r1438b588],
21	Weinberger	NNP	PERSON	Weinberger	dep	3	SENT_5	[p1l1456t552r1731b598],
22	"	``	O	"	punct	21	SENT_5	[p1l1456t552r1731b598],
23	5	CD	NUMBER	5	dep	21	SENT_5	[p1l1456t552r1731b598],

1	‘	NN	O	‘	nn	2	SENT_6	[p1l86t633r215b668],
2	Genes	NNS	O	gene	_	0	SENT_6	[p1l86t633r215b668],
3	,	,	O	,	_	0	SENT_6	[p1l86t633r215b668],
4	Cognition	NNP	MISC	Cognition	appos	2	SENT_6	[p1l232t634r393b671],
5	,	,	O	,	_	0	SENT_6	[p1l232t634r393b671],
6	and	CC	O	and	_	0	SENT_6	[p1l407t635r471b663],
7	Psychosis	NNP	O	Psychosis	nn	8	SENT_6	[p1l480t635r646b671],
8	Program	NNP	O	Program	conj_and	4	SENT_6	[p1l658t635r806b671],
9	,	,	O	,	_	0	SENT_6	[p1l658t635r806b671],
10	National	NNP	ORGANIZATION	National	nn	11	SENT_6	[p1l822t635r958b663],
11	Institute	NNP	ORGANIZATION	Institute	appos	2	SENT_6	[p1l968t635r1097b663],
12	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1109t635r1142b663],
13	Mental	NNP	ORGANIZATION	Mental	nn	14	SENT_6	[p1l1150t635r1263b663],
14	Health	NNP	ORGANIZATION	Health	prep_of	11	SENT_6	[p1l1272t635r1385b668],
15	,	,	O	,	_	0	SENT_6	[p1l1272t635r1385b668],
16	NIH	NNP	ORGANIZATION	NIH	nn	22	SENT_6	[p1l1400t635r1470b668],
17	,	,	O	,	_	0	SENT_6	[p1l1400t635r1470b668],
18	Bethesda	NNP	LOCATION	Bethesda	appos	22	SENT_6	[p1l1485t635r1647b668],
19	,	,	O	,	_	0	SENT_6	[p1l1485t635r1647b668],
20	MD	NNP	O	MD	appos	22	SENT_6	[p1l1663t635r1726b668],
21	,	,	O	,	_	0	SENT_6	[p1l1663t635r1726b668],
22	USA	NNP	LOCATION	USA	appos	14	SENT_6	[p1l1743t634r1827b668],
23	;	:	O	;	_	0	SENT_6	[p1l1743t634r1827b668],
24	2Division	NN	O	2division	dep	11	SENT_6	[p1l1837t633r1981b663],
25	of	IN	O	of	_	0	SENT_6	[p1l1993t635r2026b663],
26	Clinical	JJ	O	clinical	amod	27	SENT_6	[p1l2035t634r2154b663],
27	Pharmacology	NN	O	pharmacology	prep_of	24	SENT_6	[p1l87t680r329b716],
28	,	,	O	,	_	0	SENT_6	[p1l87t680r329b716],
29	Department	NNP	ORGANIZATION	Department	appos	24	SENT_6	[p1l347t680r542b716],
30	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l554t680r588b709],
31	Medicine	NNP	ORGANIZATION	Medicine	nn	35	SENT_6	[p1l597t680r752b713],
32	,	,	O	,	_	0	SENT_6	[p1l597t680r752b713],
33	Indiana	NNP	ORGANIZATION	Indiana	appos	35	SENT_6	[p1l770t680r889b709],
34	University	NNP	ORGANIZATION	University	nn	35	SENT_6	[p1l905t680r1068b716],
35	School	NNP	ORGANIZATION	School	prep_of	29	SENT_6	[p1l1080t680r1194b709],
36	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1206t680r1239b709],
37	Medicine	NNP	ORGANIZATION	Medicine	prep_of	35	SENT_6	[p1l1249t680r1403b713],
38	,	,	O	,	_	0	SENT_6	[p1l1249t680r1403b713],
39	Indianapolis	NNP	LOCATION	Indianapolis	nn	43	SENT_6	[p1l1421t680r1624b716],
40	,	,	O	,	_	0	SENT_6	[p1l1421t680r1624b716],
41	IN	IN	O	in	dep	43	SENT_6	[p1l1642t680r1684b713],
42	,	,	O	,	_	0	SENT_6	[p1l1642t680r1684b713],
43	USA	NNP	LOCATION	USA	appos	24	SENT_6	[p1l1703t680r1787b713],
44	;	:	O	;	_	0	SENT_6	[p1l1703t680r1787b713],
45	3Rotman	NNP	O	3Rotman	nn	47	SENT_6	[p1l1799t678r1944b709],
46	Research	NNP	ORGANIZATION	Research	nn	47	SENT_6	[p1l1959t680r2115b709],
47	Institute	NNP	ORGANIZATION	Institute	dep	11	SENT_6	[p1l87t726r222b759],
48	,	,	O	,	_	0	SENT_6	[p1l87t726r222b759],
49	University	NNP	ORGANIZATION	University	appos	47	SENT_6	[p1l239t726r402b761],
50	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l411t726r445b754],
51	Toronto	NNP	ORGANIZATION	Toronto	nn	55	SENT_6	[p1l455t726r586b759],
52	,	,	O	,	_	0	SENT_6	[p1l455t726r586b759],
53	Toronto	NNP	LOCATION	Toronto	appos	55	SENT_6	[p1l604t726r735b759],
54	,	,	O	,	_	0	SENT_6	[p1l604t726r735b759],
55	ON	NNP	O	ON	prep_of	49	SENT_6	[p1l751t725r812b758],
56	,	,	O	,	_	0	SENT_6	[p1l751t725r812b758],
57	Canada	NNP	LOCATION	Canada	dep	49	SENT_6	[p1l828t725r965b759],
58	;	:	O	;	_	0	SENT_6	[p1l828t725r965b759],
59	“	CD	NUMBER	“	num	60	SENT_6	[p1l975t724r1101b754],
60	Centre	NNP	ORGANIZATION	Centre	dep	11	SENT_6	[p1l975t724r1101b754],
61	for	IN	ORGANIZATION	for	_	0	SENT_6	[p1l1113t726r1158b754],
62	Addiction	NN	ORGANIZATION	addiction	prep_for	60	SENT_6	[p1l1164t726r1318b754],
63	and	CC	ORGANIZATION	and	_	0	SENT_6	[p1l1329t726r1392b754],
64	Mental	NNP	ORGANIZATION	Mental	nn	65	SENT_6	[p1l1401t726r1514b754],
65	Health	NNP	ORGANIZATION	Health	prep_for	60	SENT_6	[p1l1523t726r1636b759],
66	,	,	O	,	_	0	SENT_6	[p1l1523t726r1636b759],
67	University	NNP	ORGANIZATION	University	appos	2	SENT_6	[p1l1653t726r1815b761],
68	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1825t726r1858b754],
69	Toronto	NNP	ORGANIZATION	Toronto	nn	75	SENT_6	[p1l1868t726r1999b759],
70	,	,	O	,	_	0	SENT_6	[p1l1868t726r1999b759],
71	Toronto	NNP	LOCATION	Toronto	nn	82	SENT_6	[p1l2017t726r2149b758],
72	,	,	O	,	_	0	SENT_6	[p1l2017t726r2149b758],
73	ON	NNP	O	ON	nn	82	SENT_6	[p1l87t770r148b804],
74	,	,	O	,	_	0	SENT_6	[p1l87t770r148b804],
75	Canada	NNP	LOCATION	Canada	nn	82	SENT_6	[p1l166t770r293b799],
76	and	CC	O	and	_	0	SENT_6	[p1l307t771r371b799],
77	5Clinical	JJ	O	5clinical	nn	82	SENT_6	[p1l380t769r516b799],
78	Brain	NN	O	brain	nn	82	SENT_6	[p1l528t771r613b799],
79	Disorders	NNS	O	disorder	nn	82	SENT_6	[p1l627t771r785b799],
80	Branch	NNP	O	Branch	nn	82	SENT_6	[p1l798t771r922b804],
81	,	,	O	,	_	0	SENT_6	[p1l798t771r922b804],
82	National	NNP	ORGANIZATION	National	prep_of	67	SENT_6	[p1l940t771r1076b799],
83	Institute	NNP	ORGANIZATION	Institute	dep	2	SENT_6	[p1l1089t771r1217b799],
84	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1231t771r1265b799],
85	Mental	NNP	ORGANIZATION	Mental	nn	86	SENT_6	[p1l1275t771r1387b799],
86	Health	NNP	ORGANIZATION	Health	prep_of	83	SENT_6	[p1l1399t771r1512b804],
87	,	,	O	,	_	0	SENT_6	[p1l1399t771r1512b804],
88	NIH	NNP	ORGANIZATION	NIH	nn	94	SENT_6	[p1l1529t771r1599b804],
89	,	,	O	,	_	0	SENT_6	[p1l1529t771r1599b804],
90	Bethesda	NNP	LOCATION	Bethesda	appos	94	SENT_6	[p1l1616t771r1779b804],
91	,	,	O	,	_	0	SENT_6	[p1l1616t771r1779b804],
92	MD	NNP	O	MD	appos	94	SENT_6	[p1l1796t771r1860b804],
93	,	,	O	,	_	0	SENT_6	[p1l1796t771r1860b804],
94	USA	NNP	LOCATION	USA	appos	86	SENT_6	[p1l1879t770r1951b799],

1	The	DT	O	the	det	3	SENT_7	[p1l325t879r391b907],
2	antipsychotic	JJ	O	antipsychotic	amod	3	SENT_7	[p1l406t879r645b915],
3	drug	NN	O	drug	nsubj	18	SENT_7	[p1l661t879r751b915],
4	,	,	O	,	_	0	SENT_7	[p1l661t879r751b915],
5	olanzapine	NN	O	olanzapine	appos	3	SENT_7	[p1l768t879r969b915],
6	,	,	O	,	_	0	SENT_7	[p1l768t879r969b915],
7	one	CD	NUMBER	one	appos	3	SENT_7	[p1l986t886r1051b907],
8	of	IN	O	of	_	0	SENT_7	[p1l1066t879r1100b907],
9	the	DT	O	the	det	13	SENT_7	[p1l1114t879r1170b907],
10	most	RBS	O	most	advmod	12	SENT_7	[p1l1186t881r1272b907],
11	widely	RB	O	widely	advmod	12	SENT_7	[p1l1287t879r1401b915],
12	used	VBN	O	use	amod	13	SENT_7	[p1l1417t879r1500b907],
13	drugs	NNS	O	drug	prep_of	7	SENT_7	[p1l1517t879r1619b915],
14	in	IN	O	in	_	0	SENT_7	[p1l1636t879r1665b907],
15	clinical	JJ	O	clinical	amod	16	SENT_7	[p1l1682t879r1805b907],
16	medicine	NN	O	medicine	prep_in	13	SENT_7	[p1l1823t879r1991b913],
17	,	,	O	,	_	0	SENT_7	[p1l1823t879r1991b913],
18	has	VBZ	O	have	_	0	SENT_7	[p1l327t921r388b948],
19	a	DT	O	a	det	21	SENT_7	[p1l406t927r425b948],
20	high	JJ	O	high	amod	21	SENT_7	[p1l443t920r518b956],
21	rate	NN	O	rate	dobj	18	SENT_7	[p1l538t922r603b948],
22	of	IN	O	of	_	0	SENT_7	[p1l621t920r655b948],
23	discontinuation	NN	O	discontinuation	prep_of	21	SENT_7	[p1l672t920r948b948],
24	due	JJ	O	due	_	0	SENT_7	[p1l967t921r1032b948],
25	to	TO	O	to	_	0	SENT_7	[p1l1048t922r1082b948],
26	inefficacy	NN	O	inefficacy	nn	29	SENT_7	[p1l1101t920r1270b956],
27	andlor	NN	O	andlor	nn	29	SENT_7	[p1l1288t920r1401b949],
28	adverse	JJ	O	adverse	amod	29	SENT_7	[p1l1418t921r1556b948],
29	effects	NNS	O	effect	prep_due_to	23	SENT_7	[p1l1574t920r1701b948],
30	.	.	O	.	_	0	SENT_7	[p1l1574t920r1701b948],

1	We	PRP	O	we	nsubj	2	SENT_8	[p1l1720t921r1774b948],
2	identified	VBD	O	identify	_	0	SENT_8	[p1l1793t920r1955b948],
3	a	DT	O	a	det	6	SENT_8	[p1l1974t927r1993b948],
4	single	JJ	O	single	amod	6	SENT_8	[p1l326t961r432b997],
5	nucleotide	NN	O	nucleotide	nn	6	SENT_8	[p1l453t961r637b989],
6	polymorphism	NN	O	polymorphism	dobj	2	SENT_8	[p1l658t961r912b997],
7	in	IN	O	in	_	0	SENT_8	[p1l934t961r963b989],
8	the	DT	O	the	det	11	SENT_8	[p1l984t961r1039b989],
9	drug	NN	O	drug	nn	11	SENT_8	[p1l1058t961r1139b997],
10	metabolizing	VBG	O	metabolize	amod	11	SENT_8	[p1l1161t961r1385b997],
11	enzyme	NN	O	enzyme	prep_in	6	SENT_8	[p1l1406t968r1550b997],
12	,	,	O	,	_	0	SENT_8	[p1l1406t968r1550b997],
13	cytochrome	NN	O	cytochrome	nn	15	SENT_8	[p1l1572t961r1781b997],
14	P450	NN	O	p450	nn	15	SENT_8	[p1l1803t961r1886b989],
15	3A43	NN	O	3a43	appos	6	SENT_8	[p1l1906t961r1992b989],
16	(	CD	NUMBER	(	num	17	SENT_8	[p1l326t1002r512b1038],
17	CYP3A43	NN	O	cyp3a43	dep	15	SENT_8	[p1l326t1002r512b1038],
18	;	:	O	;	_	0	SENT_8	[p1l326t1002r512b1038],
19	rs472660	NN	O	rs472660	nn	20	SENT_8	[p1l532t1002r709b1038],
20	)	NN	O	)	dep	15	SENT_8	[p1l532t1002r709b1038],
21	,	,	O	,	_	0	SENT_8	[p1l532t1002r709b1038],
22	that	WDT	O	that	nsubj	25	SENT_8	[p1l726t1003r793b1030],
23	highly	RB	O	highly	advmod	25	SENT_8	[p1l811t1002r919b1038],
24	significantly	RB	O	significantly	advmod	25	SENT_8	[p1l934t1002r1151b1038],
25	predicted	VBN	O	predict	rcmod	20	SENT_8	[p1l1168t1002r1332b1038],
26	olanzapine	NN	O	olanzapine	nn	27	SENT_8	[p1l1349t1002r1541b1038],
27	clearance	NN	O	clearance	npadvmod	25	SENT_8	[p1l1557t1003r1727b1030],
28	in	IN	O	in	_	0	SENT_8	[p1l1745t1002r1773b1030],
29	the	DT	O	the	det	32	SENT_8	[p1l1790t1003r1845b1030],
30	Clinical	JJ	O	clinical	amod	32	SENT_8	[p1l1862t1002r1991b1031],
31	Antipsychotic	JJ	O	antipsychotic	amod	32	SENT_8	[p1l326t1043r571b1079],
32	Trials	NNS	O	trial	prep_in	25	SENT_8	[p1l594t1043r692b1072],
33	of	IN	O	of	_	0	SENT_8	[p1l716t1043r750b1072],
34	Intervention	NN	O	intervention	nn	36	SENT_8	[p1l774t1043r984b1072],
35	Effectiveness	NN	O	effectiveness	nn	36	SENT_8	[p1l1010t1043r1247b1072],
36	trial	NN	O	trial	prep_of	32	SENT_8	[p1l1270t1043r1336b1072],
37	(	CD	NUMBER	(	num	38	SENT_8	[p1l1361t1042r1557b1079],
38	P	NN	O	p	dobj	25	SENT_8	[p1l1361t1042r1557b1079],
39	=	JJ	O	=	amod	38	SENT_8	[p1l1361t1042r1557b1079],
40	5.9	CD	NUMBER	5.9	number	39	SENT_8	[p1l1361t1042r1557b1079],
41	e	SYM	O	e	dep	42	SENT_8	[p1l1361t1042r1557b1079],
42	’	CD	NUMBER	’	dep	44	SENT_8	[p1l1361t1042r1557b1079],
43	7	CD	NUMBER	7	num	44	SENT_8	[p1l1361t1042r1557b1079],
44	)	NN	O	)	dep	38	SENT_8	[p1l1361t1042r1557b1079],
45	.	.	O	.	_	0	SENT_8	[p1l1361t1042r1557b1079],

1	Moreover	RB	O	moreover	advmod	20	SENT_9	[p1l1584t1044r1757b1077],
2	,	,	O	,	_	0	SENT_9	[p1l1584t1044r1757b1077],
3	at	IN	O	at	_	0	SENT_9	[p1l1782t1045r1814b1072],
4	standard	JJ	O	standard	amod	6	SENT_9	[p1l1837t1044r1991b1072],
5	antipsychotic	JJ	O	antipsychotic	amod	6	SENT_9	[p1l326t1084r565b1120],
6	doses	NNS	O	dose	prep_at	20	SENT_9	[p1l581t1085r696b1118],
7	,	,	O	,	_	0	SENT_9	[p1l581t1085r696b1118],
8	50	CD	PERCENT	50	num	9	SENT_9	[p1l714t1085r787b1113],
9	%	NN	PERCENT	%	nsubj	20	SENT_9	[p1l714t1085r787b1113],
10	of	IN	O	of	_	0	SENT_9	[p1l803t1084r837b1112],
11	individuals	NNS	O	individual	prep_of	9	SENT_9	[p1l854t1084r1046b1112],
12	with	IN	O	with	_	0	SENT_9	[p1l1062t1084r1135b1112],
13	the	DT	O	the	det	16	SENT_9	[p1l1152t1085r1207b1112],
14	high	JJ	O	high	amod	16	SENT_9	[p1l1224t1084r1299b1120],
15	clearance	NN	O	clearance	nn	16	SENT_9	[p1l1317t1085r1487b1112],
16	genotype	NN	O	genotype	prep_with	11	SENT_9	[p1l1503t1086r1667b1120],
17	(	CD	NUMBER	(	num	19	SENT_9	[p1l1684t1084r1760b1120],
18	AA	NN	O	aa	nn	19	SENT_9	[p1l1684t1084r1760b1120],
19	)	NN	O	)	dep	16	SENT_9	[p1l1684t1084r1760b1120],
20	have	VBP	O	have	_	0	SENT_9	[p1l1778t1085r1860b1112],
21	trough	NN	O	trough	nn	23	SENT_9	[p1l1875t1085r1991b1120],
22	blood	NN	O	blood	nn	23	SENT_9	[p1l327t1125r425b1153],
23	levels	NNS	O	level	dobj	20	SENT_9	[p1l443t1125r544b1153],
24	below	IN	O	below	_	0	SENT_9	[p1l561t1125r664b1153],
25	the	DT	O	the	det	27	SENT_9	[p1l679t1125r734b1153],
26	therapeutic	JJ	O	therapeutic	amod	27	SENT_9	[p1l749t1125r949b1161],
27	range	NN	O	range	prep_below	20	SENT_9	[p1l966t1132r1073b1161],
28	.	.	O	.	_	0	SENT_9	[p1l966t1132r1073b1161],

1	Interestingly	RB	O	interestingly	advmod	10	SENT_10	[p1l1092t1125r1320b1161],
2	,	,	O	,	_	0	SENT_10	[p1l1092t1125r1320b1161],
3	a	DT	O	a	det	6	SENT_10	[p1l1337t1132r1356b1153],
4	much	RB	O	much	advmod	5	SENT_10	[p1l1373t1125r1468b1153],
5	higher	JJR	O	higher	amod	6	SENT_10	[p1l1487t1125r1598b1161],
6	proportion	NN	O	proportion	nsubj	10	SENT_10	[p1l1615t1125r1800b1161],
7	of	IN	O	of	_	0	SENT_10	[p1l1817t1125r1851b1153],
8	African	JJ	MISC	african	amod	9	SENT_10	[p1l1866t1125r1991b1153],
9	Americans	NNPS	MISC	Americans	prep_of	6	SENT_10	[p1l326t1166r514b1195],
10	carry	VBP	O	carry	_	0	SENT_10	[p1l532t1173r621b1202],
11	the	DT	O	the	det	13	SENT_10	[p1l637t1167r692b1195],
12	A	NN	O	a	nn	13	SENT_10	[p1l709t1167r734b1194],
13	allele	NN	O	allele	dobj	10	SENT_10	[p1l751t1167r843b1195],
14	compared	VBN	O	compare	_	0	SENT_10	[p1l860t1167r1035b1202],
15	with	IN	O	with	prepc_compared_with	10	SENT_10	[p1l1053t1166r1126b1194],
16	Caucasians	NNPS	MISC	Caucasians	pobj	10	SENT_10	[p1l1145t1166r1349b1195],
17	(	CD	NUMBER	(	num	19	SENT_10	[p1l1367t1166r1471b1202],
18	allele	NN	O	allele	nn	19	SENT_10	[p1l1367t1166r1471b1202],
19	frequency	NN	O	frequency	dep	16	SENT_10	[p1l1487t1166r1665b1202],
20	67	CD	NUMBER	67	dep	19	SENT_10	[p1l1682t1167r1721b1195],
21	vs	CC	O	vs	_	0	SENT_10	[p1l1738t1173r1778b1195],
22	14	CD	PERCENT	14	num	23	SENT_10	[p1l1797t1166r1889b1202],
23	%	NN	PERCENT	%	conj_vs	19	SENT_10	[p1l1797t1166r1889b1202],
24	)	CD	NUMBER	)	dep	23	SENT_10	[p1l1797t1166r1889b1202],
25	.	.	O	.	_	0	SENT_10	[p1l1797t1166r1889b1202],

1	After	IN	O	after	_	0	SENT_11	[p1l1908t1166r1993b1195],
2	accounting	VBG	O	account	prepc_after	13	SENT_11	[p1l326t1207r522b1243],
3	for	IN	O	for	_	0	SENT_11	[p1l542t1207r592b1235],
4	CYP3A43	NN	O	cyp3a43	nn	5	SENT_11	[p1l611t1207r774b1236],
5	genotype	NN	O	genotype	prep_for	2	SENT_11	[p1l794t1209r967b1243],
6	,	,	O	,	_	0	SENT_11	[p1l794t1209r967b1243],
7	race	NN	O	race	nsubj	13	SENT_11	[p1l989t1214r1062b1235],
8	is	VBZ	O	be	cop	13	SENT_11	[p1l1083t1207r1111b1235],
9	no	RB	O	no	advmod	10	SENT_11	[p1l1131t1214r1174b1235],
10	longer	RB	O	longer	advmod	13	SENT_11	[p1l1195t1208r1307b1243],
11	a	DT	O	a	det	13	SENT_11	[p1l1326t1214r1345b1235],
12	significant	JJ	O	significant	amod	13	SENT_11	[p1l1364t1207r1550b1243],
13	predictor	NN	O	predictor	_	0	SENT_11	[p1l1570t1207r1729b1243],
14	of	IN	O	of	_	0	SENT_11	[p1l1748t1207r1782b1235],
15	olanzapine	NN	O	olanzapine	nn	16	SENT_11	[p1l1801t1207r1993b1243],
16	clearance	NN	O	clearance	prep_of	13	SENT_11	[p1l326t1249r505b1277],
17	.	.	O	.	_	0	SENT_11	[p1l326t1249r505b1277],

1	olanzapine	NN	O	olanzapine	nn	2	SENT_12	[p1l521t1248r718b1284],
2	clearance	NN	O	clearance	nsubjpass	4	SENT_12	[p1l732t1249r901b1277],
3	was	VBD	O	be	auxpass	4	SENT_12	[p1l915t1255r984b1277],
4	associated	VBN	O	associate	_	0	SENT_12	[p1l998t1248r1187b1277],
5	with	IN	O	with	_	0	SENT_12	[p1l1202t1248r1274b1277],
6	measures	NNS	O	measure	prep_with	4	SENT_12	[p1l1291t1255r1461b1277],
7	of	IN	O	of	_	0	SENT_12	[p1l1475t1248r1509b1277],
8	clinical	JJ	O	clinical	amod	9	SENT_12	[p1l1522t1248r1646b1277],
9	response	NN	O	response	prep_of	6	SENT_12	[p1l1662t1255r1834b1284],
10	.	.	O	.	_	0	SENT_12	[p1l1662t1255r1834b1284],

1	Patients	NNS	O	patient	nsubj	12	SENT_13	[p1l1851t1248r1992b1277],
2	with	IN	O	with	_	0	SENT_13	[p1l325t1290r398b1318],
3	greater	JJR	O	greater	amod	4	SENT_13	[p1l422t1292r546b1326],
4	clearance	NN	O	clearance	prep_with	1	SENT_13	[p1l568t1290r737b1318],
5	had	VBD	O	have	_	0	SENT_13	[p1l761t1290r823b1318],
6	higher	JJR	O	higher	amod	8	SENT_13	[p1l847t1290r959b1326],
7	symptom	NN	O	symptom	nn	8	SENT_13	[p1l981t1292r1144b1326],
8	ratings	NNS	O	rating	dobj	5	SENT_13	[p1l1168t1290r1289b1326],
9	and	CC	O	and	_	0	SENT_13	[p1l1312t1290r1375b1318],
10	were	VBD	O	be	cop	12	SENT_13	[p1l1398t1297r1482b1318],
11	more	RBR	O	more	advmod	12	SENT_13	[p1l1505t1297r1593b1318],
12	likely	JJ	O	likely	conj_and	5	SENT_13	[p1l1617t1290r1707b1326],
13	to	TO	O	to	aux	14	SENT_13	[p1l1728t1292r1762b1318],
14	discontinue	VB	O	discontinue	xcomp	12	SENT_13	[p1l1785t1290r1993b1318],
15	treatment	NN	O	treatment	nsubj	16	SENT_13	[p1l325t1333r494b1359],
16	due	JJ	O	due	xcomp	14	SENT_13	[p1l506t1332r571b1359],
17	to	TO	O	to	_	0	SENT_13	[p1l583t1333r617b1359],
18	an	DT	O	a	det	20	SENT_13	[p1l630t1338r670b1359],
19	inadequate	JJ	O	inadequate	amod	20	SENT_13	[p1l686t1331r880b1367],
20	response	NN	O	response	prep_to	16	SENT_13	[p1l894t1338r1066b1367],
21	.	.	O	.	_	0	SENT_13	[p1l894t1338r1066b1367],

1	Our	PRP$	O	we	poss	2	SENT_14	[p1l1081t1331r1145b1360],
2	data	NNS	O	datum	nsubj	13	SENT_14	[p1l1158t1332r1232b1359],
3	identify	VBP	O	identify	_	0	SENT_14	[p1l1246t1331r1377b1367],
4	a	DT	O	a	det	6	SENT_14	[p1l1389t1338r1408b1359],
5	genetic	JJ	O	genetic	amod	6	SENT_14	[p1l1421t1331r1549b1367],
6	mechanism	NN	O	mechanism	dobj	3	SENT_14	[p1l1563t1331r1764b1359],
7	for	IN	O	for	_	0	SENT_14	[p1l1777t1331r1827b1359],
8	variation	NN	O	variation	prep_for	3	SENT_14	[p1l1838t1331r1991b1359],
9	in	IN	O	in	_	0	SENT_14	[p1l327t1372r356b1400],
10	olanzapine	NN	O	olanzapine	nn	11	SENT_14	[p1l368t1372r560b1408],
11	response	NN	O	response	prep_in	8	SENT_14	[p1l572t1379r735b1408],
12	and	CC	O	and	_	0	SENT_14	[p1l745t1372r809b1400],
13	demonstrate	VBP	O	demonstrate	conj_and	3	SENT_14	[p1l821t1372r1043b1400],
14	that	IN	O	that	complm	22	SENT_14	[p1l1052t1372r1120b1400],
15	blood	NN	O	blood	nn	17	SENT_14	[p1l1132t1372r1230b1400],
16	level	NN	O	level	nn	17	SENT_14	[p1l1243t1372r1321b1400],
17	monitoring	NN	O	monitoring	nsubj	22	SENT_14	[p1l1335t1372r1526b1408],
18	of	IN	O	of	_	0	SENT_14	[p1l1538t1372r1572b1400],
19	olanzapine	NN	O	olanzapine	nn	20	SENT_14	[p1l1583t1372r1774b1408],
20	treatment	NN	O	treatment	prep_of	17	SENT_14	[p1l1784t1374r1953b1400],
21	is	VBZ	O	be	cop	22	SENT_14	[p1l1965t1372r1992b1400],
22	advisable	JJ	O	advisable	ccomp	13	SENT_14	[p1l326t1413r503b1441],
23	.	.	O	.	_	0	SENT_14	[p1l326t1413r503b1441],

1	Molecular	JJ	O	molecular	dep	6	SENT_15	[p1l327t1454r490b1482],
2	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_15	[p1l501t1454r674b1489],
3	(	NN	O	(	dep	6	SENT_15	[p1l685t1453r750b1489],
4	201	CD	NUMBER	201	num	3	SENT_15	[p1l685t1453r750b1489],
5	1	CD	NUMBER	1	num	6	SENT_15	[p1l761t1453r788b1489],
6	)	NN	O	)	dep	12	SENT_15	[p1l761t1453r788b1489],
7	16	CD	NUMBER	16	dep	6	SENT_15	[p1l805t1454r852b1487],
8	,	,	O	,	_	0	SENT_15	[p1l805t1454r852b1487],
9	620-625	CD	NUMBER	620-625	appos	7	SENT_15	[p1l868t1454r1018b1486],
10	;	:	O	;	_	0	SENT_15	[p1l868t1454r1018b1486],
11	doi	FW	O	doi	dep	7	SENT_15	[p1l1035t1453r1443b1489],
12	:10.1038	CD	NUMBER	:10.1038	_	0	SENT_15	[p1l1035t1453r1443b1489],
13	/	:	O	/	punct	14	SENT_15	[p1l1035t1453r1443b1489],
14	mp	NN	O	mp	dep	12	SENT_15	[p1l1035t1453r1443b1489],
15	.2011.38	CD	NUMBER	.2011.38	num	14	SENT_15	[p1l1035t1453r1443b1489],
16	;	:	O	;	_	0	SENT_15	[p1l1035t1453r1443b1489],
17	published	VBN	O	publish	partmod	12	SENT_15	[p1l1460t1454r1615b1489],
18	online	NN	O	online	prep	17	SENT_15	[p1l1631t1454r1727b1482],
19	26	CD	DATE	26	dep	18	SENT_15	[p1l1742t1454r1781b1482],
20	April	NNP	DATE	April	tmod	17	SENT_15	[p1l1795t1454r1867b1489],
21	2011	CD	DATE	2011	num	20	SENT_15	[p1l1882t1454r1957b1482],

1	Keywords	NNPS	O	Keywords	_	0	SENT_16	[p1l328t1525r507b1559],
2	:	:	O	:	_	0	SENT_16	[p1l328t1525r507b1559],
3	CYP450	NN	O	cyp450	dep	1	SENT_16	[p1l530t1522r682b1557],
4	;	:	O	;	_	0	SENT_16	[p1l530t1522r682b1557],
5	CYP3A43	NN	O	cyp3a43	dep	3	SENT_16	[p1l700t1522r879b1557],
6	;	:	O	;	_	0	SENT_16	[p1l700t1522r879b1557],
7	genetics	NNS	O	genetics	dep	3	SENT_16	[p1l897t1523r1049b1560],
8	;	:	O	;	_	0	SENT_16	[p1l897t1523r1049b1560],
9	olanzapine	NN	O	olanzapine	dep	7	SENT_16	[p1l1067t1523r1263b1560],
10	;	:	O	;	_	0	SENT_16	[p1l1067t1523r1263b1560],
11	pharmacogenetics	NNS	O	pharmacogenetic	dep	3	SENT_16	[p1l1282t1523r1608b1560],
12	;	:	O	;	_	0	SENT_16	[p1l1282t1523r1608b1560],
13	pharmacokinetics	NNS	O	pharmacokinetic	dep	11	SENT_16	[p1l1626t1523r1929b1560],

1	Introduction	NN	O	introduction	_	0	SENT_17	[p1l8t1721r532b1789],

1	The	DT	O	the	det	4	SENT_18	[p1l9t1882r158b1948],
2	Clinical	JJ	O	clinical	amod	4	SENT_18	[p1l226t1882r535b1948],
3	Antipsychotic	JJ	O	antipsychotic	amod	4	SENT_18	[p1l602t1882r1162b1969],
4	Trials	NNS	O	trial	nsubj	14	SENT_18	[p1l1232t1882r1449b1948],
5	of	IN	O	of	_	0	SENT_18	[p1l1520t1882r1598b1948],
6	Intervention	NN	O	intervention	nn	7	SENT_18	[p1l1658t1885r2147b1948],
7	Effectiveness	NN	O	effectiveness	prep_of	4	SENT_18	[p1l7t1979r524b2046],
8	(	CD	NUMBER	(	num	9	SENT_18	[p1l580t1979r885b2058],
9	CATIE	NNP	PERSON	CATIE	dep	7	SENT_18	[p1l580t1979r885b2058],
10	)	CD	NUMBER	)	num	9	SENT_18	[p1l580t1979r885b2058],
11	were	VBD	O	be	cop	14	SENT_18	[p1l937t2003r1126b2046],
12	a	DT	O	a	det	14	SENT_18	[p1l1178t2003r1217b2045],
13	systematic	JJ	O	systematic	amod	14	SENT_18	[p1l1267t1983r1679b2066],
14	evaluation	NN	O	evaluation	_	0	SENT_18	[p1l1732t1979r2147b2046],
15	of	IN	O	of	_	0	SENT_18	[p1l10t2077r88b2143],
16	the	DT	O	the	det	18	SENT_18	[p1l145t2076r266b2143],
17	clinical	JJ	O	clinical	amod	18	SENT_18	[p1l333t2076r626b2143],
18	response	NN	O	response	prep_of	14	SENT_18	[p1l690t2100r1039b2164],
19	to	TO	O	to	_	0	SENT_18	[p1l1103t2086r1176b2143],
20	antipsychotics	NNS	O	antipsychotic	prep_to	14	SENT_18	[p1l1243t2076r1815b2164],
21	in	IN	O	in	_	0	SENT_18	[p1l1883t2080r1960b2142],
22	the	DT	O	the	det	23	SENT_18	[p1l2024t2076r2145b2143],
23	treatment	NN	O	treatment	prep_in	20	SENT_18	[p1l7t2183r387b2239],
24	of	IN	O	of	_	0	SENT_18	[p1l426t2173r504b2239],
25	Alzheimer	NN	O	alzheimer	poss	27	SENT_18	[p1l535t2173r1008b2239],
26	’s	POS	O	’s	_	0	SENT_18	[p1l535t2173r1008b2239],
27	disease	NN	O	disease	prep_of	23	SENT_18	[p1l1052t2173r1335b2239],
28	and	CC	O	and	_	0	SENT_18	[p1l1376t2173r1521b2239],
29	schizophrenia	NN	O	schizophrenia	conj_and	27	SENT_18	[p1l1562t2173r2141b2260],
30	.	.	O	.	_	0	SENT_18	[p1l1562t2173r2141b2260],

1	In	IN	O	in	_	0	SENT_19	[p1l8t2275r87b2336],
2	the	DT	O	the	det	4	SENT_19	[p1l111t2270r232b2337],
3	schizophrenia	NN	O	schizophrenia	nn	4	SENT_19	[p1l261t2270r822b2357],
4	trial	NN	O	trial	prep_in	13	SENT_19	[p1l845t2270r1005b2337],
5	(	CD	NUMBER	(	num	7	SENT_19	[p1l1036t2270r1506b2349],
6	CATIE-SZ	NN	O	catie-sz	nn	7	SENT_19	[p1l1036t2270r1506b2349],
7	)	NN	O	)	dep	4	SENT_19	[p1l1036t2270r1506b2349],
8	,	,	O	,	_	0	SENT_19	[p1l1036t2270r1506b2349],
9	olanzapine	NN	O	olanzapine	nsubj	13	SENT_19	[p1l1537t2270r1969b2357],
10	was	VBD	O	be	cop	13	SENT_19	[p1l1995t2294r2144b2337],
11	the	DT	O	the	det	13	SENT_19	[p1l8t2367r129b2434],
12	most	RBS	O	most	advmod	13	SENT_19	[p1l185t2377r376b2434],
13	effective	JJ	O	effective	_	0	SENT_19	[p1l432t2368r763b2434],
14	antipsychotic	JJ	O	antipsychotic	amod	13	SENT_19	[p1l821t2367r1355b2455],
15	studied	VBN	O	study	partmod	13	SENT_19	[p1l1414t2367r1730b2444],
16	;	:	O	;	_	0	SENT_19	[p1l1414t2367r1730b2444],
17	with	IN	O	with	_	0	SENT_19	[p1l1788t2367r1969b2434],
18	the	DT	O	the	det	20	SENT_19	[p1l2024t2367r2145b2434],
19	lowest	JJS	O	lowest	amod	20	SENT_19	[p1l9t2464r266b2530],
20	rate	NN	O	rate	prep_with	30	SENT_19	[p1l315t2474r461b2530],
21	of	IN	O	of	_	0	SENT_19	[p1l515t2464r593b2530],
22	discontinuation	NN	O	discontinuation	prep_of	20	SENT_19	[p1l640t2464r1267b2530],
23	for	IN	O	for	_	0	SENT_19	[p1l1320t2464r1426b2530],
24	any	DT	O	any	det	26	SENT_19	[p1l1478t2487r1619b2551],
25	cause	NN	O	cause	nn	26	SENT_19	[p1l1670t2487r1886b2530],
26	(	NN	O	(	prep_for	22	SENT_19	[p1l1943t2464r2138b2543],
27	64	CD	PERCENT	64	num	28	SENT_19	[p1l1943t2464r2138b2543],
28	%	NN	PERCENT	%	dep	26	SENT_19	[p1l1943t2464r2138b2543],
29	discontinued	VBN	O	discontinue	amod	30	SENT_19	[p1l11t2560r532b2626],
30	treatment	NN	O	treatment	dep	13	SENT_19	[p1l591t2570r970b2626],
31	before	IN	O	before	_	0	SENT_19	[p1l1025t2560r1267b2626],
32	18	CD	DURATION	18	num	33	SENT_19	[p1l1332t2570r1417b2626],
33	months	NNS	NUMBER	month	prep_before	30	SENT_19	[p1l1478t2560r1857b2638],
34	)	RB	O	)	advmod	33	SENT_19	[p1l1478t2560r1857b2638],
35	?	.	O	?	_	0	SENT_19	[p1l1478t2560r1857b2638],

1	There	EX	O	there	expl	2	SENT_20	[p1l1919t2560r2145b2626],
2	was	VBD	O	be	_	0	SENT_20	[p1l7t2681r157b2724],
3	a	DT	O	a	det	5	SENT_20	[p1l194t2681r233b2724],
4	wide	JJ	O	wide	amod	5	SENT_20	[p1l264t2657r458b2724],
5	variability	NN	O	variability	nsubj	2	SENT_20	[p1l491t2657r899b2744],
6	in	IN	O	in	_	0	SENT_20	[p1l932t2661r1009b2723],
7	response	NN	O	response	prep_in	5	SENT_20	[p1l1041t2681r1390b2745],
8	to	TO	O	to	_	0	SENT_20	[p1l1424t2667r1496b2724],
9	olanzapine	NN	O	olanzapine	prep_to	7	SENT_20	[p1l1533t2657r1966b2745],
10	and	CC	O	and	_	0	SENT_20	[p1l2001t2657r2147b2724],
11	the	DT	O	the	det	13	SENT_20	[p1l7t2755r129b2821],
12	other	JJ	O	other	amod	13	SENT_20	[p1l165t2755r367b2821],
13	antipsychotics	NNS	O	antipsychotic	prep_in	5	SENT_20	[p1l399t2755r972b2842],
14	in	IN	O	in	_	0	SENT_20	[p1l1008t2758r1086b2820],
15	the	DT	O	the	det	16	SENT_20	[p1l1117t2755r1238b2821],
16	trial	NN	O	trial	prep_in	13	SENT_20	[p1l1271t2755r1431b2821],
17	and	CC	O	and	_	0	SENT_20	[p1l1466t2755r1610b2821],
18	although	IN	O	although	mark	26	SENT_20	[p1l1644t2755r1993b2842],
19	the	DT	O	the	det	20	SENT_20	[p1l2024t2755r2145b2821],
20	response	NN	O	response	nsubj	26	SENT_20	[p1l7t2877r356b2940],
21	to	TO	O	to	_	0	SENT_20	[p1l410t2863r482b2920],
22	olanzapine	NN	O	olanzapine	prep_to	20	SENT_20	[p1l539t2853r972b2940],
23	was	VBD	O	be	cop	26	SENT_20	[p1l1026t2877r1176b2920],
24	overall	RB	O	overall	advmod	26	SENT_20	[p1l1234t2853r1502b2920],
25	more	RBR	O	more	advmod	26	SENT_20	[p1l1555t2877r1752b2920],
26	positive	JJ	O	positive	advcl	33	SENT_20	[p1l1807t2857r2143b2940],
27	,	,	O	,	_	0	SENT_20	[p1l1807t2857r2143b2940],
28	treatment	NN	O	treatment	nsubjpass	33	SENT_20	[p1l8t2960r387b3017],
29	with	IN	O	with	_	0	SENT_20	[p1l427t2950r608b3017],
30	olanzapine	NN	O	olanzapine	prep_with	28	SENT_20	[p1l651t2950r1084b3037],
31	was	VBD	O	be	auxpass	33	SENT_20	[p1l1127t2974r1276b3017],
32	also	RB	O	also	advmod	33	SENT_20	[p1l1322t2950r1474b3017],
33	associated	VBN	O	associate	conj_and	2	SENT_20	[p1l1519t2950r1925b3017],
34	with	IN	O	with	_	0	SENT_20	[p1l1966t2950r2147b3017],
35	greater	JJR	O	greater	amod	37	SENT_20	[p1l8t3058r275b3135],
36	weight	NN	O	weight	nn	37	SENT_20	[p1l324t3048r593b3135],
37	gain	NN	O	gain	prep_with	33	SENT_20	[p1l642t3051r808b3135],
38	and	CC	O	and	_	0	SENT_20	[p1l861t3048r1006b3114],
39	alterations	NNS	O	alteration	conj_and	37	SENT_20	[p1l1058t3048r1470b3114],
40	in	IN	O	in	_	0	SENT_20	[p1l1524t3051r1602b3113],
41	glucose	NN	O	glucose	nn	44	SENT_20	[p1l1653t3048r1948b3135],
42	and	CC	O	and	_	0	SENT_20	[p1l2001t3048r2147b3114],
43	lipid	NN	O	lipid	conj_and	41	SENT_20	[p1l9t3144r198b3231],
44	metabolism	NN	O	metabolism	prep_in	33	SENT_20	[p1l242t3144r755b3211],
45	?	.	O	?	_	0	SENT_20	[p1l242t3144r755b3211],

1	One	CD	NUMBER	one	num	2	SENT_21	[p1l804t3148r962b3211],
2	reason	NN	O	reason	nsubj	10	SENT_21	[p1l1006t3168r1264b3211],
3	for	IN	O	for	_	0	SENT_21	[p1l1309t3144r1416b3211],
4	the	DT	O	the	det	6	SENT_21	[p1l1458t3144r1580b3211],
5	high	JJ	O	high	amod	6	SENT_21	[p1l1625t3144r1801b3231],
6	rates	NNS	O	rate	prep_for	2	SENT_21	[p1l1844t3154r2026b3211],
7	of	IN	O	of	_	0	SENT_21	[p1l2075t3144r2153b3211],
8	discontinuation	NN	O	discontinuation	prep_of	6	SENT_21	[p1l11t3241r638b3308],
9	may	MD	O	may	aux	10	SENT_21	[p1l674t3265r840b3328],
10	relate	VB	O	relate	_	0	SENT_21	[p1l874t3241r1092b3308],
11	to	TO	O	to	_	0	SENT_21	[p1l1128t3252r1201b3308],
12	the	DT	O	the	det	14	SENT_21	[p1l1238t3241r1359b3308],
13	wide	JJ	O	wide	amod	14	SENT_21	[p1l1395t3241r1589b3308],
14	variability	NN	O	variability	prep_to	10	SENT_21	[p1l1625t3241r2033b3328],
15	in	IN	O	in	_	0	SENT_21	[p1l2069t3245r2147b3307],
16	the	DT	O	the	det	17	SENT_21	[p1l7t3339r129b3405],
17	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	14	SENT_21	[p1l188t3339r891b3426],
18	of	IN	O	of	_	0	SENT_21	[p1l953t3339r1031b3405],
19	these	DT	O	these	det	20	SENT_21	[p1l1080t3339r1284b3405],
20	drugs	NNS	O	drug	prep_of	17	SENT_21	[p1l1345t3339r1582b3426],
21	,	,	O	,	_	0	SENT_21	[p1l1345t3339r1582b3426],
22	which	WDT	O	which	nsubj	24	SENT_21	[p1l1642t3339r1891b3405],
23	often	RB	O	often	advmod	24	SENT_21	[p1l1950t3339r2147b3405],
24	results	VBZ	O	result	rcmod	20	SENT_21	[p1l7t3435r268b3502],
25	in	IN	O	in	_	0	SENT_21	[p1l343t3439r421b3501],
26	differences	NNS	O	difference	prep_in	24	SENT_21	[p1l495t3435r926b3502],
27	in	IN	O	in	_	0	SENT_21	[p1l1001t3439r1079b3501],
28	the	DT	O	the	det	29	SENT_21	[p1l1149t3435r1271b3502],
29	pharmacodynamics	NNS	O	pharmacodynamic	prep_in	26	SENT_21	[p1l1344t3435r2143b3522],
30	,	,	O	,	_	0	SENT_21	[p1l1344t3435r2143b3522],
31	both	CC	O	both	dep	24	SENT_21	[p1l6t3532r183b3599],
32	in	IN	O	in	conj	24	SENT_21	[p1l223t3536r301b3598],
33	the	DT	O	the	det	34	SENT_21	[p1l339t3532r460b3599],
34	response	NN	O	response	pobj	32	SENT_21	[p1l500t3556r849b3620],
35	to	TO	O	to	dep	24	SENT_21	[p1l889t3543r961b3599],
36	a	DT	O	a	det	37	SENT_21	[p1l1003t3556r1042b3599],
37	drug	NN	O	drug	pobj	35	SENT_21	[p1l1083t3532r1260b3619],
38	and	CC	O	and	_	0	SENT_21	[p1l1300t3532r1446b3599],
39	the	DT	O	the	det	40	SENT_21	[p1l1484t3532r1605b3599],
40	incidence	NN	O	incidence	pobj	35	SENT_21	[p1l1647t3532r2033b3599],
41	of	IN	O	of	_	0	SENT_21	[p1l2075t3533r2153b3599],
42	adverse	JJ	O	adverse	amod	43	SENT_21	[p1l9t3630r307b3696],
43	effects	NNS	O	effect	prep_of	40	SENT_21	[p1l370t3630r639b3696],
44	.	.	O	.	_	0	SENT_21	[p1l370t3630r639b3696],

1	Sex	NN	O	sex	nsubjpass	9	SENT_22	[p1l707t3633r866b3706],
2	,	,	O	,	_	0	SENT_22	[p1l707t3633r866b3706],
3	smoking	NN	O	smoking	nsubjpass	9	SENT_22	[p1l931t3630r1263b3717],
4	and	CC	O	and	_	0	SENT_22	[p1l1323t3630r1468b3696],
5	race	NN	O	race	nsubjpass	9	SENT_22	[p1l1527t3653r1687b3696],
6	have	VBP	O	have	aux	9	SENT_22	[p1l1747t3630r1931b3696],
7	previously	RB	DATE	previously	advmod	9	SENT_22	[p1l1991t3653r2145b3717, p1l7t3726r300b3813],
8	been	VBN	O	be	auxpass	9	SENT_22	[p1l342t3726r530b3793],
9	shown	VBN	O	show	_	0	SENT_22	[p1l578t3726r838b3793],
10	to	TO	O	to	_	0	SENT_22	[p1l884t3736r956b3793],
11	impact	NN	O	impact	nn	12	SENT_22	[p1l1005t3730r1277b3813],
12	clearance	NN	O	clearance	prep_to	9	SENT_22	[p1l1324t3726r1694b3793],
13	of	IN	O	of	_	0	SENT_22	[p1l1743t3726r1821b3793],
14	olanzapine	NN	O	olanzapine	prep_of	12	SENT_22	[p1l1863t3726r2145b3793, p2l8t13r238b100],
15	,2	CD	NUMBER	,2	num	14	SENT_22	[p1l1863t3726r2145b3793, p2l8t13r238b100],

1	which	WDT	O	which	nsubj	3	SENT_23	[p2l320t12r568b79],
2	likely	JJ	O	likely	advmod	3	SENT_23	[p2l650t12r872b99],
3	contributes	VBZ	O	contribute	_	0	SENT_23	[p2l953t12r1394b79],
4	to	TO	O	to	_	0	SENT_23	[p2l1476t22r1548b79],
5	the	DT	O	the	det	6	SENT_23	[p2l1629t12r1751b79],
6	variable	NN	O	variable	prep_to	3	SENT_23	[p2l1831t12r2145b79],

1	Correspondence	NN	O	correspondence	_	0	SENT_24	[p2l8t234r551b305],
2	:	:	O	:	_	0	SENT_24	[p2l8t234r551b305],
3	Dr	VB	O	dr	dep	1	SENT_24	[p2l586t237r664b288],
4	DR	NN	O	dr	dep	3	SENT_24	[p2l694t237r792b288],
5	Weinberger	NNP	PERSON	Weinberger	nn	7	SENT_24	[p2l821t234r1204b305],
6	,	,	O	,	_	0	SENT_24	[p2l821t234r1204b305],
7	GCAP/DIRP/NIMH	NNP	O	GCAP/DIRP/NIMH	dep	4	SENT_24	[p2l1239t234r2037b297],
8	/	:	O	/	punct	4	SENT_24	[p2l1239t234r2037b297],
9	NIH	NNP	ORGANIZATION	NIH	dep	4	SENT_24	[p2l1239t234r2037b297],
10	,	,	O	,	_	0	SENT_24	[p2l1239t234r2037b297],
11	10	CD	NUMBER	10	num	13	SENT_24	[p2l2075t241r2145b288],
12	Center	NNP	O	Center	nn	13	SENT_24	[p2l8t317r219b368],
13	Drive	NNP	O	Drive	appos	9	SENT_24	[p2l245t317r437b377],
14	,	,	O	,	_	0	SENT_24	[p2l245t317r437b377],
15	MSC	NNP	O	MSC	appos	9	SENT_24	[p2l466t317r621b368],
16	1379	CD	DATE	1379	num	15	SENT_24	[p2l653t322r820b377],
17	,	,	O	,	_	0	SENT_24	[p2l653t322r820b377],
18	Bethesda	NNP	LOCATION	Bethesda	appos	9	SENT_24	[p2l850t314r1162b377],
19	,	,	O	,	_	0	SENT_24	[p2l850t314r1162b377],
20	MD	NNP	O	MD	appos	9	SENT_24	[p2l1191t318r1306b368],
21	20892	CD	NUMBER	20892	num	20	SENT_24	[p2l1336t322r1544b377],
22	,	,	O	,	_	0	SENT_24	[p2l1336t322r1544b377],
23	USA	NNP	LOCATION	USA	appos	9	SENT_24	[p2l1574t317r1742b368],
24	.	.	O	.	_	0	SENT_24	[p2l1574t317r1742b368],

1	E-mail	NN	O	e-mail	_	0	SENT_25	[p2l7t393r235b447],
2	:	:	O	:	_	0	SENT_25	[p2l7t393r235b447],
3	weinberd@mail.nih.gov	NNP	O	weinberd@mail.nih.gov	nsubj	4	SENT_25	[p2l264t393r1036b464],
4	Received	VBD	O	receive	dep	1	SENT_25	[p2l7t473r302b527],
5	14	CD	DATE	14	dobj	4	SENT_25	[p2l332t481r402b527],
6	February	NNP	DATE	February	tmod	5	SENT_25	[p2l431t473r721b544],
7	2011	CD	DATE	2011	num	6	SENT_25	[p2l750t480r918b536],
8	;	:	O	;	_	0	SENT_25	[p2l750t480r918b536],
9	accepted	VBN	O	accept	dep	5	SENT_25	[p2l949t473r1235b544],
10	15	CD	DATE	15	dobj	9	SENT_25	[p2l1265t481r1333b527],
11	February	NNP	DATE	February	tmod	9	SENT_25	[p2l1364t473r1654b544],
12	2011	CD	DATE	2011	num	11	SENT_25	[p2l1682t480r1851b536],
13	;	:	O	;	_	0	SENT_25	[p2l1682t480r1851b536],
14	published	VBN	O	publish	parataxis	9	SENT_25	[p2l8t553r334b625],
15	online	NN	O	online	prep	14	SENT_25	[p2l363t553r567b608],
16	26	CD	DATE	26	dep	15	SENT_25	[p2l598t561r668b608],
17	April	NNP	DATE	April	tmod	14	SENT_25	[p2l696t553r868b625],
18	2011	CD	DATE	2011	num	17	SENT_25	[p2l898t561r1045b608],

1	therapeutic	JJ	O	therapeutic	amod	2	SENT_26	[p2l8t786r457b873],
2	response	NN	O	response	_	0	SENT_26	[p2l507t810r876b873],
3	.	.	O	.	_	0	SENT_26	[p2l507t810r876b873],

1	This	DT	O	this	det	2	SENT_27	[p2l931t786r1103b853],
2	study	NN	O	study	nsubj	3	SENT_27	[p2l1157t786r1375b873],
3	aimed	VBN	O	aim	_	0	SENT_27	[p2l1424t786r1665b853],
4	to	TO	O	to	aux	5	SENT_27	[p2l1713t796r1785b853],
5	identify	VB	O	identify	xcomp	3	SENT_27	[p2l1837t786r2148b873],
6	genetic	JJ	O	genetic	amod	7	SENT_27	[p2l8t887r288b971],
7	predictors	NNS	O	predictor	dobj	5	SENT_27	[p2l375t884r774b971],
8	of	IN	O	of	_	0	SENT_27	[p2l864t884r942b950],
9	olanzapine	NN	O	olanzapine	nn	10	SENT_27	[p2l1023t884r1455b971],
10	clearance	NN	O	clearance	prep_of	7	SENT_27	[p2l1544t884r1913b950],
11	and	CC	O	and	_	0	SENT_27	[p2l2001t884r2146b950],
12	ultimately	RB	O	ultimately	advmod	13	SENT_27	[p2l7t982r416b1069],
13	response	NN	O	response	conj_and	3	SENT_27	[p2l447t1005r816b1069],
14	.	.	O	.	_	0	SENT_27	[p2l447t1005r816b1069],

1	Patients	NNS	O	patient	_	0	SENT_28	[p2l7t1223r337b1289],
2	and	CC	O	and	_	0	SENT_28	[p2l374t1221r526b1289],
3	methods	NNS	O	method	conj_and	1	SENT_28	[p2l560t1221r908b1289],

1	The	DT	O	the	det	4	SENT_29	[p2l9t1373r158b1440],
2	study	NN	O	study	nn	4	SENT_29	[p2l189t1373r407b1460],
3	design	NN	O	design	nn	4	SENT_29	[p2l436t1373r691b1460],
4	details	NNS	O	detail	nsubjpass	11	SENT_29	[p2l722t1373r978b1440],
5	for	IN	O	for	_	0	SENT_29	[p2l1010t1373r1116b1440],
6	the	DT	O	the	det	8	SENT_29	[p2l1142t1373r1263b1440],
7	CATIE-SZ	NN	MISC	catie-sz	nn	8	SENT_29	[p2l1293t1377r1686b1440],
8	study	NN	O	study	prep_for	4	SENT_29	[p2l1717t1373r1935b1460],
9	have	VBP	O	have	aux	11	SENT_29	[p2l1961t1373r2145b1440],
10	been	VBN	O	be	auxpass	11	SENT_29	[p2l6t1470r193b1537],
11	published	VBN	O	publish	_	0	SENT_29	[p2l253t1470r705b1558],
12	.3	NN	NUMBER	.3	dobj	11	SENT_29	[p2l253t1470r705b1558],
13	The	DT	O	the	det	14	SENT_29	[p2l768t1470r917b1537],
14	study	NN	O	study	nsubjpass	16	SENT_29	[p2l981t1470r1198b1557],
15	was	VBD	O	be	auxpass	16	SENT_29	[p2l1257t1494r1406b1537],
16	approved	VBN	O	approve	rcmod	12	SENT_29	[p2l1470t1470r1841b1558],
17	by	IN	O	by	_	0	SENT_29	[p2l1898t1470r1994b1557],
18	an	DT	O	a	det	21	SENT_29	[p2l2055t1494r2147b1537],
19	institutional	JJ	O	institutional	amod	21	SENT_29	[p2l9t1566r497b1632],
20	review	NN	O	review	nn	21	SENT_29	[p2l542t1569r810b1632],
21	board	NN	O	board	agent	16	SENT_29	[p2l852t1566r1077b1632],
22	at	IN	O	at	_	0	SENT_29	[p2l1124t1576r1193b1632],
23	each	DT	O	each	det	24	SENT_29	[p2l1239t1566r1417b1632],
24	site	NN	O	site	prep_at	21	SENT_29	[p2l1465t1569r1620b1642],
25	,	,	O	,	_	0	SENT_29	[p2l1465t1569r1620b1642],
26	and	CC	O	and	_	0	SENT_29	[p2l1670t1566r1815b1632],
27	written	VBN	O	write	amod	29	SENT_29	[p2l1859t1569r2147b1632],
28	informed	JJ	O	informed	amod	29	SENT_29	[p2l9t1663r371b1730],
29	consent	NN	O	consent	nsubjpass	31	SENT_29	[p2l410t1673r715b1730],
30	was	VBD	O	be	auxpass	31	SENT_29	[p2l749t1687r898b1730],
31	obtained	VBN	O	obtain	conj_and	11	SENT_29	[p2l940t1663r1282b1730],
32	from	IN	O	from	_	0	SENT_29	[p2l1320t1663r1503b1730],
33	each	DT	O	each	det	34	SENT_29	[p2l1540t1663r1719b1730],
34	patient	NN	O	patient	prep_from	31	SENT_29	[p2l1756t1667r2033b1750],
35	or	CC	O	or	_	0	SENT_29	[p2l2071t1687r2148b1730],
36	his	PRP$	O	he	amod	40	SENT_29	[p2l8t1760r123b1827],
37	or	CC	O	or	_	0	SENT_29	[p2l156t1784r233b1827],
38	her	PRP$	O	she	amod	40	SENT_29	[p2l260t1760r388b1827],
39	legal	JJ	O	legal	amod	40	SENT_29	[p2l416t1760r599b1847],
40	guardian	NN	O	guardian	prep_from	31	SENT_29	[p2l628t1760r997b1847],
41	.	.	O	.	_	0	SENT_29	[p2l628t1760r997b1847],

1	Patients	NNS	O	patient	nsubjpass	5	SENT_30	[p2l1030t1764r1344b1827],
2	with	IN	O	with	_	0	SENT_30	[p2l1375t1760r1555b1827],
3	schizophrenia	NN	O	schizophrenia	prep_with	1	SENT_30	[p2l1586t1760r2148b1848],
4	were	VBD	O	be	auxpass	5	SENT_30	[p2l7t1880r196b1923],
5	recruited	VBN	O	recruit	_	0	SENT_30	[p2l225t1857r585b1923],
6	from	IN	O	from	_	0	SENT_30	[p2l615t1857r798b1923],
7	multiple	JJ	O	multiple	amod	9	SENT_30	[p2l826t1857r1165b1944],
8	US	NNP	LOCATION	US	nn	9	SENT_30	[p2l1196t1860r1310b1923],
9	sites	NNS	O	site	prep_from	5	SENT_30	[p2l1344t1860r1515b1923],
10	and	CC	O	and	_	0	SENT_30	[p2l1549t1857r1693b1923],
11	patients	NNS	O	patient	nsubjpass	16	SENT_30	[p2l1723t1861r2036b1944],
12	in	IN	O	in	_	0	SENT_30	[p2l2068t1860r2146b1923],
13	this	DT	O	this	det	14	SENT_30	[p2l8t1954r152b2021],
14	analysis	NN	O	analysis	prep_in	11	SENT_30	[p2l192t1954r508b2041],
15	were	VBD	O	be	auxpass	16	SENT_30	[p2l547t1978r735b2021],
16	randomized	VBN	O	randomize	conj_and	5	SENT_30	[p2l772t1954r1247b2021],
17	to	TO	O	to	aux	18	SENT_30	[p2l1283t1964r1355b2021],
18	receive	VB	O	receive	xcomp	16	SENT_30	[p2l1392t1958r1672b2021],
19	olanzapine	NN	O	olanzapine	nn	20	SENT_30	[p2l1712t1954r2145b2041],
20	(	NN	O	(	dobj	18	SENT_30	[p2l13t2052r296b2130],
21	7.5	CD	NUMBER	7.5	number	22	SENT_30	[p2l13t2052r296b2130],
22	—	CD	NUMBER	—	num	24	SENT_30	[p2l13t2052r296b2130],
23	3O	NN	O	3o	nn	24	SENT_30	[p2l13t2052r296b2130],
24	mg	NN	O	mg	nsubj	27	SENT_30	[p2l316t2075r433b2138],
25	per	IN	O	per	_	0	SENT_30	[p2l463t2075r590b2139],
26	day	NN	DURATION	day	prep_per	24	SENT_30	[p2l621t2051r760b2138],
27	taken	VBN	O	take	rcmod	20	SENT_30	[p2l787t2051r1002b2118],
28	as	IN	O	as	_	0	SENT_30	[p2l1033t2075r1107b2118],
29	a	DT	O	a	det	31	SENT_30	[p2l1140t2075r1179b2118],
30	single	JJ	O	single	amod	31	SENT_30	[p2l1209t2051r1439b2138],
31	dose	NN	O	dose	prep_as	27	SENT_30	[p2l1473t2051r1649b2118],
32	or	CC	O	or	_	0	SENT_30	[p2l1681t2075r1758b2118],
33	split	NN	O	split	prep_as	27	SENT_30	[p2l1788t2051r1963b2139],
34	into	IN	O	into	_	0	SENT_30	[p2l1992t2055r2145b2118],
35	two	CD	NUMBER	two	num	36	SENT_30	[p2l8t2158r152b2215],
36	doses	NNS	O	dose	prep_into	31	SENT_30	[p2l181t2149r445b2227],
37	)	RB	O	)	advmod	27	SENT_30	[p2l181t2149r445b2227],
38	.	.	O	.	_	0	SENT_30	[p2l181t2149r445b2227],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_31	[p2l474t2149r1000b2236],
2	information	NN	O	information	nsubjpass	4	SENT_31	[p2l1027t2149r1495b2215],
3	was	VBD	O	be	auxpass	4	SENT_31	[p2l1519t2172r1668b2215],
4	collected	VBN	O	collect	_	0	SENT_31	[p2l1697t2149r2053b2215],
5	at	IN	O	at	_	0	SENT_31	[p2l2079t2159r2148b2215],
6	study	NN	O	study	nn	7	SENT_31	[p2l10t2245r228b2332],
7	visits	NNS	O	visit	prep_at	4	SENT_31	[p2l268t2249r476b2312],
8	and	CC	O	and	_	0	SENT_31	[p2l523t2245r667b2312],
9	race	NN	O	race	nsubj	11	SENT_31	[p2l709t2269r869b2312],
10	was	VBD	O	be	cop	11	SENT_31	[p2l912t2269r1061b2312],
11	self-reported	JJ	O	self-reported	conj_and	4	SENT_31	[p2l1108t2245r1628b2332],
12	.	.	O	.	_	0	SENT_31	[p2l1108t2245r1628b2332],

1	A	DT	O	a	det	2	SENT_32	[p2l1676t2250r1740b2311],
2	subset	NN	O	subset	nsubj	5	SENT_32	[p2l1785t2245r2032b2312],
3	of	IN	O	of	_	0	SENT_32	[p2l2075t2245r2153b2312],
4	patients	NNS	O	patient	prep_of	2	SENT_32	[p2l8t2346r321b2430],
5	provided	VBD	O	provide	_	0	SENT_32	[p2l376t2342r734b2430],
6	a	DT	O	a	det	7	SENT_32	[p2l786t2366r825b2409],
7	sample	NN	O	sample	dobj	5	SENT_32	[p2l877t2342r1155b2430],
8	to	TO	O	to	aux	10	SENT_32	[p2l1207t2353r1279b2409],
9	be	VB	O	be	auxpass	10	SENT_32	[p2l1329t2342r1418b2409],
10	used	VBN	O	use	infmod	7	SENT_32	[p2l1470t2342r1656b2409],
11	for	IN	O	for	_	0	SENT_32	[p2l1708t2343r1815b2409],
12	genetic	JJ	O	genetic	amod	13	SENT_32	[p2l1865t2346r2144b2429],
13	analysis	NN	O	analysis	prep_for	10	SENT_32	[p2l9t2440r326b2527],
14	(	CD	NUMBER	(	num	16	SENT_32	[p2l366t2440r643b2518],
15	CATIE	NNP	O	CATIE	nn	16	SENT_32	[p2l366t2440r643b2518],
16	genetics	NNS	O	genetics	dep	13	SENT_32	[p2l678t2443r996b2527],
17	distribution	NN	O	distribution	dep	13	SENT_32	[p2l1034t2440r1501b2506],
18	7	CD	NUMBER	7	num	17	SENT_32	[p2l1539t2450r1598b2516],
19	,	,	O	,	_	0	SENT_32	[p2l1539t2450r1598b2516],
20	n	NN	O	n	appos	13	SENT_32	[p2l1634t2463r1682b2505],
21	=	JJ	O	=	amod	23	SENT_32	[p2l1705t2471r1749b2494],
22	235	CD	NUMBER	235	tmod	21	SENT_32	[p2l1773t2440r1958b2518],
23	)	NN	O	)	dep	20	SENT_32	[p2l1773t2440r1958b2518],
24	.	.	O	.	_	0	SENT_32	[p2l1773t2440r1958b2518],

1	The	DT	O	the	det	2	SENT_33	[p2l1996t2440r2145b2506],
2	patients	NNS	O	patient	nsubj	22	SENT_33	[p2l8t2540r321b2623],
3	in	IN	O	in	_	0	SENT_33	[p2l377t2540r455b2602],
4	this	DT	O	this	det	5	SENT_33	[p2l506t2536r650b2603],
5	subset	NN	O	subset	prep_in	2	SENT_33	[p2l708t2536r954b2603],
6	who	WP	O	who	nsubj	7	SENT_33	[p2l1005t2536r1174b2603],
7	had	VBD	O	have	rcmod	5	SENT_33	[p2l1227t2536r1374b2603],
8	all	DT	O	all	det	10	SENT_33	[p2l1428t2536r1523b2602],
9	available	JJ	O	available	amod	10	SENT_33	[p2l1578t2536r1928b2603],
10	data	NNS	O	datum	nsubj	11	SENT_33	[p2l1984t2536r2148b2603],
11	pertinent	JJ	O	pertinent	xcomp	7	SENT_33	[p2l8t2637r373b2721],
12	to	TO	O	to	_	0	SENT_33	[p2l399t2643r472b2700],
13	this	DT	O	this	det	14	SENT_33	[p2l500t2633r645b2700],
14	study	NN	O	study	prep_to	11	SENT_33	[p2l678t2633r896b2720],
15	did	VBD	O	do	aux	17	SENT_33	[p2l926t2633r1054b2700],
16	not	RB	O	not	neg	17	SENT_33	[p2l1082t2643r1210b2700],
17	differ	VB	O	differ	rcmod	14	SENT_33	[p2l1240t2633r1452b2700],
18	demographically	RB	O	demographically	advmod	17	SENT_33	[p2l1482t2633r2148b2721],
19	from	IN	O	from	_	0	SENT_33	[p2l9t2731r192b2797],
20	all	DT	O	all	det	21	SENT_33	[p2l219t2731r314b2797],
21	subjects	NNS	O	subject	prep_from	17	SENT_33	[p2l343t2731r654b2817],
22	randomized	VBD	O	randomize	dep	32	SENT_33	[p2l682t2731r1157b2797],
23	to	TO	O	to	_	0	SENT_33	[p2l1182t2740r1254b2797],
24	olanzapine	NN	O	olanzapine	prep_to	22	SENT_33	[p2l1284t2731r1717b2818],
25	in	IN	O	in	_	0	SENT_33	[p2l1744t2734r1822b2796],
26	phase	NN	O	phase	prep_in	22	SENT_33	[p2l1848t2731r2075b2818],
27	1	CD	NUMBER	1	num	26	SENT_33	[p2l2107t2741r2141b2796],
28	of	IN	O	of	_	0	SENT_33	[p2l10t2826r88b2892],
29	the	DT	O	the	det	31	SENT_33	[p2l154t2826r276b2892],
30	CATIE	NNP	O	CATIE	nn	31	SENT_33	[p2l352t2830r603b2892],
31	trials	NNS	O	trial	prep_of	26	SENT_33	[p2l679t2826r876b2892],
32	(	VBP	O	(	_	0	SENT_33	[p2l957t2826r1096b2904],
33	11	CD	NUMBER	11	num	35	SENT_33	[p2l957t2826r1096b2904],
34	:	:	O	:	_	0	SENT_33	[p2l957t2826r1096b2904],
35	336	CD	NUMBER	336	nsubj	32	SENT_33	[p2l1120t2836r1277b2902],
36	,	,	O	,	_	0	SENT_33	[p2l1120t2836r1277b2902],
37	33	CD	PERCENT	33	number	38	SENT_33	[p2l1358t2826r1526b2898],
38	%	NN	PERCENT	%	amod	39	SENT_33	[p2l1358t2826r1526b2898],
39	female	NN	O	female	appos	35	SENT_33	[p2l1609t2826r1890b2903],
40	,	,	O	,	_	0	SENT_33	[p2l1609t2826r1890b2903],
41	60	CD	PERCENT	60	number	42	SENT_33	[p2l1970t2826r2138b2898],
42	%	NN	PERCENT	%	appos	39	SENT_33	[p2l1970t2826r2138b2898],
43	Caucasian	JJ	MISC	caucasian	amod	42	SENT_33	[p2l9t2926r432b3000],
44	,	,	O	,	_	0	SENT_33	[p2l9t2926r432b3000],
45	36	CD	PERCENT	36	number	46	SENT_33	[p2l483t2922r650b2995],
46	%	NN	PERCENT	%	amod	49	SENT_33	[p2l483t2922r650b2995],
47	African	JJ	MISC	african	amod	49	SENT_33	[p2l701t2923r997b2989],
48	American	JJ	MISC	american	amod	49	SENT_33	[p2l1040t2923r1477b3001],
49	)	NN	O	)	appos	39	SENT_33	[p2l1040t2923r1477b3001],
50	.	.	O	.	_	0	SENT_33	[p2l1040t2923r1477b3001],

1	Likewise	RB	O	likewise	advmod	15	SENT_34	[p2l1526t2922r1900b3000],
2	,	,	O	,	_	0	SENT_34	[p2l1526t2922r1900b3000],
3	baseline	NN	O	baseline	dep	4	SENT_34	[p2l1944t2922r2145b2989, p2l9t3021r158b3087],
4	Positive	JJ	O	positive	nsubj	15	SENT_34	[p2l196t3024r510b3087],
5	and	CC	O	and	_	0	SENT_34	[p2l550t3021r695b3087],
6	Negative	JJ	O	negative	amod	7	SENT_34	[p2l732t3024r1075b3108],
7	Syndrome	NN	O	syndrome	nsubj	15	SENT_34	[p2l1116t3021r1518b3108],
8	Scale	NNP	O	Scale	prep	4	SENT_34	[p2l1560t3021r1765b3087],
9	(	CD	NUMBER	(	num	12	SENT_34	[p2l1808t3021r2142b3099],
10	PANSS	NNP	O	PANSS	nn	12	SENT_34	[p2l1808t3021r2142b3099],
11	)	CD	NUMBER	)	num	12	SENT_34	[p2l1808t3021r2142b3099],
12	scores	NNS	O	score	dep	8	SENT_34	[p2l10t3141r248b3184],
13	did	VBD	O	do	aux	15	SENT_34	[p2l278t3117r407b3184],
14	not	RB	O	not	neg	15	SENT_34	[p2l432t3127r560b3184],
15	differ	VB	O	differ	_	0	SENT_34	[p2l586t3117r798b3184],
16	between	IN	O	between	prep	15	SENT_34	[p2l819t3117r1151b3184],
17	this	DT	O	this	det	18	SENT_34	[p2l1176t3117r1320b3184],
18	group	NN	O	group	dep	25	SENT_34	[p2l1347t3141r1572b3204],
19	and	CC	O	and	_	0	SENT_34	[p2l1602t3117r1747b3184],
20	the	DT	O	the	det	22	SENT_34	[p2l1771t3117r1892b3184],
21	entire	JJ	O	entire	amod	22	SENT_34	[p2l1920t3121r2145b3184],
22	sample	NN	O	sample	dep	25	SENT_34	[p2l10t3214r288b3302],
23	(	NN	O	(	dep	25	SENT_34	[p2l327t3215r562b3293],
24	74.84	CD	NUMBER	74.84	num	23	SENT_34	[p2l327t3215r562b3293],
25	i	FW	O	i	dep	29	SENT_34	[p2l587t3223r632b3282],
26	19.45	CD	NUMBER	19.45	dep	25	SENT_34	[p2l660t3224r863b3281],
27	vs	CC	O	vs	_	0	SENT_34	[p2l899t3238r981b3281],
28	76.13	CD	NUMBER	76.13	conj_vs	26	SENT_34	[p2l1022t3224r1224b3281],
29	i	FW	O	i	dep	35	SENT_34	[p2l1252t3223r1297b3282],
30	18.18	CD	NUMBER	18.18	dep	29	SENT_34	[p2l1325t3224r1553b3291],
31	,	,	O	,	_	0	SENT_34	[p2l1325t3224r1553b3291],
32	P	NN	O	p	appos	30	SENT_34	[p2l1589t3219r1705b3280],
33	:	:	O	:	_	0	SENT_34	[p2l1589t3219r1705b3280],
34	0.48	CD	NUMBER	0.48	num	35	SENT_34	[p2l1727t3215r1937b3293],
35	)	NN	O	)	dep	16	SENT_34	[p2l1727t3215r1937b3293],
36	.	.	O	.	_	0	SENT_34	[p2l1727t3215r1937b3293],

1	Plasma	NN	O	plasma	nn	2	SENT_35	[p2l94t3312r377b3378],
2	samples	NNS	O	sample	nsubjpass	4	SENT_35	[p2l428t3312r744b3399],
3	were	VBD	O	be	auxpass	4	SENT_35	[p2l796t3335r984b3378],
4	collected	VBN	O	collect	_	0	SENT_35	[p2l1037t3312r1393b3378],
5	during	IN	O	during	_	0	SENT_35	[p2l1446t3312r1706b3399],
6	the	DT	O	the	det	8	SENT_35	[p2l1755t3312r1877b3378],
7	study	NN	O	study	nn	8	SENT_35	[p2l1929t3312r2147b3399],
8	visits	NNS	O	visit	prep_during	4	SENT_35	[p2l7t3411r214b3474],
9	and	CC	O	and	_	0	SENT_35	[p2l269t3408r414b3474],
10	each	DT	O	each	det	11	SENT_35	[p2l466t3408r645b3474],
11	patient	NN	O	patient	nsubj	12	SENT_35	[p2l695t3411r973b3495],
12	provided	VBD	O	provide	conj_and	4	SENT_35	[p2l1023t3408r1381b3495],
13	between	IN	O	between	quantmod	14	SENT_35	[p2l1429t3408r1761b3474],
14	1	CD	NUMBER	1	num	17	SENT_35	[p2l1815t3418r1850b3473],
15	and	CC	NUMBER	and	_	0	SENT_35	[p2l1907t3408r2052b3474],
16	6	CD	NUMBER	6	num	17	SENT_35	[p2l2105t3417r2144b3474],
17	samples	NNS	O	sample	dobj	12	SENT_35	[p2l12t3505r328b3592],
18	for	IN	O	for	_	0	SENT_35	[p2l376t3505r483b3571],
19	determination	NN	O	determination	prep_for	12	SENT_35	[p2l530t3505r1089b3571],
20	of	IN	O	of	_	0	SENT_35	[p2l1136t3505r1214b3571],
21	olanzapine	NN	O	olanzapine	nn	22	SENT_35	[p2l1255t3505r1688b3592],
22	concentrations	NNS	O	concentration	prep_of	19	SENT_35	[p2l1736t3515r2150b3571, p2l9t3605r223b3668],
23	.	.	O	.	_	0	SENT_35	[p2l1736t3515r2150b3571, p2l9t3605r223b3668],

1	Data	NNS	O	datum	nsubjpass	3	SENT_36	[p2l278t3606r454b3668],
2	were	VBD	O	be	auxpass	3	SENT_36	[p2l502t3625r692b3668],
3	excluded	VBN	O	exclude	_	0	SENT_36	[p2l744t3602r1107b3668],
4	for	IN	O	for	_	0	SENT_36	[p2l1158t3602r1265b3668],
5	missing	VBG	O	miss	amod	8	SENT_36	[p2l1313t3605r1620b3689],
6	or	CC	O	or	_	0	SENT_36	[p2l1672t3625r1749b3668],
7	incorrect	JJ	O	incorrect	conj_or	5	SENT_36	[p2l1799t3605r2152b3668],
8	dose	NN	O	dose	prep_for	3	SENT_36	[p2l13t3699r211b3775],
9	,	,	O	,	_	0	SENT_36	[p2l13t3699r211b3775],
10	time	NN	O	time	appos	8	SENT_36	[p2l246t3702r420b3765],
11	of	IN	O	of	_	0	SENT_36	[p2l455t3699r534b3765],
12	dose	NN	O	dose	prep_of	10	SENT_36	[p2l561t3699r760b3775],
13	,	,	O	,	_	0	SENT_36	[p2l561t3699r760b3775],
14	sample	NN	O	sample	prep_of	10	SENT_36	[p2l797t3699r1076b3786],
15	or	CC	O	or	_	0	SENT_36	[p2l1112t3722r1188b3765],
16	time	NN	O	time	prep_of	10	SENT_36	[p2l1218t3702r1392b3765],
17	of	IN	O	of	_	0	SENT_36	[p2l1428t3699r1506b3765],
18	sample	NN	O	sample	prep_of	10	SENT_36	[p2l1533t3699r1832b3786],
19	.	.	O	.	_	0	SENT_36	[p2l1533t3699r1832b3786],

1	Plasma	NN	O	plasma	nn	2	SENT_37	[p2l1869t3699r2152b3765],
2	levels	NNS	O	level	nsubjpass	6	SENT_37	[p3l10t12r235b78],
3	of	IN	O	of	_	0	SENT_37	[p3l291t12r369b78],
4	olanzapine	NN	O	olanzapine	prep_of	2	SENT_37	[p3l415t12r848b99],
5	were	VBD	O	be	auxpass	6	SENT_37	[p3l900t35r1088b78],
6	determined	VBN	O	determine	_	0	SENT_37	[p3l1144t12r1596b78],
7	using	VBG	O	use	xcomp	6	SENT_37	[p3l1647t16r1862b99],
8	liquid	JJ	O	liquid	amod	9	SENT_37	[p3l1914t12r2151b99],
9	chromatography	NN	O	chromatography	dobj	7	SENT_37	[p3l11t109r659b196],
10	tandem	JJ	O	tandem	amod	12	SENT_37	[p3l704t109r1001b176],
11	mass	NN	O	mass	nn	12	SENT_37	[p3l1047t133r1239b176],
12	spectrometry	NN	O	spectrometry	tmod	7	SENT_37	[p3l1290t119r1820b196],
13	,	,	O	,	_	0	SENT_37	[p3l1290t119r1820b196],
14	as	IN	O	as	mark	16	SENT_37	[p3l1872t133r1946b176],
15	previously	RB	DATE	previously	advmod	16	SENT_37	[p3l1996t133r2150b196, p3l9t206r301b293],
16	described	VBN	O	describe	dep	12	SENT_37	[p3l336t206r821b272],
17	.	.	O	.	_	0	SENT_37	[p3l336t206r821b272],

1	“	NN	O	“	_	0	SENT_38	[p3l336t206r821b272],

1	Genotyping	VBG	O	genotype	_	0	SENT_39	[p3l98t306r557b390],
2	methods	NNS	O	method	dobj	1	SENT_39	[p3l613t303r951b369],
3	have	VBP	O	have	aux	6	SENT_39	[p3l1009t303r1194b369],
4	been	VBN	O	be	auxpass	6	SENT_39	[p3l1249t303r1436b369],
5	previously	RB	DATE	previously	advmod	6	SENT_39	[p3l1493t303r1915b390],
6	published	VBN	O	publish	dep	1	SENT_39	[p3l1971t303r2150b390, p3l10t400r308b467],
7	.5	CD	NUMBER	.5	dobj	6	SENT_39	[p3l1971t303r2150b390, p3l10t400r308b467],
8	We	PRP	O	we	nsubj	9	SENT_39	[p3l368t405r489b467],
9	used	VBD	O	use	rcmod	7	SENT_39	[p3l549t400r735b467],
10	a	DT	O	a	det	13	SENT_39	[p3l795t424r834b466],
11	candidate	NN	O	candidate	nn	13	SENT_39	[p3l893t400r1279b467],
12	gene	NN	O	gene	nn	13	SENT_39	[p3l1338t424r1518b487],
13	approach	NN	O	approach	nsubj	19	SENT_39	[p3l1579t400r1946b487],
14	and	CC	O	and	_	0	SENT_39	[p3l2006t400r2151b467],
15	selected	VBN	O	select	amod	18	SENT_39	[p3l12t497r330b563],
16	single	JJ	O	single	amod	18	SENT_39	[p3l400t497r631b584],
17	nucleotide	NN	O	nucleotide	nn	18	SENT_39	[p3l699t497r1121b563],
18	polymorphisms	NNS	O	polymorphism	nsubj	19	SENT_39	[p3l1190t497r1813b584],
19	(	VBP	O	(	ccomp	9	SENT_39	[p3l1888t497r2147b576],
20	SNPS	NN	O	snp	nn	21	SENT_39	[p3l1888t497r2147b576],
21	)	NN	O	)	dobj	19	SENT_39	[p3l1888t497r2147b576],
22	that	WDT	O	that	nsubj	23	SENT_39	[p3l9t594r162b660],
23	are	VBP	O	be	rcmod	21	SENT_39	[p3l209t617r323b660],
24	in	IN	O	in	prep	23	SENT_39	[p3l372t598r450b660],
25	or	CC	O	or	_	0	SENT_39	[p3l498t617r574b660],
26	near	IN	O	near	dep	27	SENT_39	[p3l619t617r791b660],
27	known	JJ	O	known	amod	30	SENT_39	[p3l836t594r1108b660],
28	olanzapine	NN	O	olanzapine	nn	30	SENT_39	[p3l1157t594r1590b681],
29	metabolizing	VBG	O	metabolize	amod	30	SENT_39	[p3l1637t594r2151b681],
30	enzymes	NNS	O	enzyme	conj_or	21	SENT_39	[p3l11t715r352b778],
31	(	CD	NUMBER	(	num	32	SENT_39	[p3l401t691r781b770],
32	CYP1A2	NN	O	cyp1a2	nsubj	1	SENT_39	[p3l401t691r781b770],
33	,	,	O	,	_	0	SENT_39	[p3l401t691r781b770],
34	CYPZDB	NN	O	cypzdb	appos	32	SENT_39	[p3l828t695r1154b758],
35	and	CC	O	and	_	0	SENT_39	[p3l1200t691r1345b758],
36	FMO3	NN	O	fmo3	appos	32	SENT_39	[p3l1387t691r1696b770],
37	)	CD	NUMBER	)	number	38	SENT_39	[p3l1387t691r1696b770],
38	6	CD	NUMBER	6	dep	34	SENT_39	[p3l1387t691r1696b770],
39	as	RB	O	as	_	0	SENT_39	[p3l1740t715r1815b758],
40	well	RB	O	well	_	0	SENT_39	[p3l1859t691r2030b758],
41	as	IN	O	as	_	0	SENT_39	[p3l2074t715r2149b758],
42	CYP3A	NN	O	cyp3a	appos	32	SENT_39	[p3l10t791r317b864],
43	,	,	O	,	_	0	SENT_39	[p3l10t791r317b864],
44	which	WDT	O	which	nsubjpass	58	SENT_39	[p3l351t788r601b854],
45	is	VBZ	O	be	auxpass	46	SENT_39	[p3l633t791r694b854],
46	involved	VBN	O	involve	rcmod	42	SENT_39	[p3l730t788r1077b854],
47	in	IN	O	in	_	0	SENT_39	[p3l1110t791r1188b854],
48	metabolism	NN	O	metabolism	prep_in	46	SENT_39	[p3l1220t788r1680b854],
49	of	IN	O	of	_	0	SENT_39	[p3l1714t788r1792b854],
50	approximately	RB	O	approximately	quantmod	51	SENT_39	[p3l1818t791r2150b875, p3l9t885r277b972],
51	half	DT	O	half	prep_of	48	SENT_39	[p3l313t885r472b951],
52	of	IN	O	of	_	0	SENT_39	[p3l505t885r583b952],
53	all	DT	O	all	det	54	SENT_39	[p3l614t885r709b951],
54	drugs	NNS	O	drug	prep_of	51	SENT_39	[p3l751t885r965b972],
55	and	CC	O	and	_	0	SENT_39	[p3l1006t885r1152b952],
56	has	VBZ	O	have	aux	58	SENT_39	[p3l1189t885r1319b952],
57	been	VBN	O	be	auxpass	58	SENT_39	[p3l1356t885r1544b952],
58	reported	VBN	O	report	conj_and	46	SENT_39	[p3l1580t885r1915b972],
59	to	TO	O	to	aux	61	SENT_39	[p3l1952t895r2024b952],
60	be	VB	O	be	auxpass	61	SENT_39	[p3l2061t885r2150b952],
61	altered	VBN	O	alter	xcomp	58	SENT_39	[p3l11t982r281b1049],
62	during	IN	O	during	_	0	SENT_39	[p3l355t982r614b1069],
63	olanzapine	NN	O	olanzapine	nn	64	SENT_39	[p3l685t982r1119b1069],
64	treatment	NN	O	treatment	prep_during	61	SENT_39	[p3l1189t984r1624b1049],
65	.7	CD	NUMBER	.7	num	64	SENT_39	[p3l1189t984r1624b1049],
66	All	DT	O	all	dobj	46	SENT_39	[p3l1694t982r1816b1048],
67	of	IN	O	of	_	0	SENT_39	[p3l1888t982r1966b1049],
68	the	DT	O	the	det	70	SENT_39	[p3l2029t982r2150b1049],
69	available	JJ	O	available	amod	70	SENT_39	[p3l11t1079r362b1145],
70	SNPs	NNS	O	snp	prep_of	66	SENT_39	[p3l427t1082r632b1145],
71	in	IN	O	in	_	0	SENT_39	[p3l695t1082r773b1145],
72	these	DT	O	these	det	73	SENT_39	[p3l834t1079r1038b1145],
73	genes	NNS	O	gene	prep_in	70	SENT_39	[p3l1099t1102r1316b1166],
74	on	IN	O	on	_	0	SENT_39	[p3l1382t1102r1477b1145],
75	the	DT	O	the	det	78	SENT_39	[p3l1537t1079r1659b1145],
76	Affymetrix	NNP	O	Affymetrix	nn	78	SENT_39	[p3l1720t1079r2153b1166],
77	500K	NNP	O	500K	nn	78	SENT_39	[p3l13t1181r229b1243],
78	chip	NN	O	chip	prep_on	46	SENT_39	[p3l283t1176r454b1263],
79	that	WDT	O	that	nsubjpass	81	SENT_39	[p3l511t1176r664b1243],
80	was	VBD	O	be	auxpass	81	SENT_39	[p3l715t1200r865b1243],
81	used	VBN	O	use	rcmod	78	SENT_39	[p3l921t1176r1108b1243],
82	for	IN	O	for	mark	88	SENT_39	[p3l1163t1176r1270b1243],
83	genotyping	NN	O	genotyping	nsubjpass	88	SENT_39	[p3l1323t1180r1764b1263],
84	of	IN	O	of	_	0	SENT_39	[p3l1821t1176r1899b1243],
85	these	DT	O	these	det	86	SENT_39	[p3l1946t1176r2150b1243],
86	patients	NNS	O	patient	prep_of	83	SENT_39	[p3l10t1277r323b1361],
87	were	VBD	O	be	auxpass	88	SENT_39	[p3l351t1297r540b1340],
88	tested	VBN	O	test	advcl	81	SENT_39	[p3l567t1273r820b1340],
89	.	.	O	.	_	0	SENT_39	[p3l567t1273r820b1340],

1	A	DT	O	a	det	2	SENT_40	[p3l851t1278r916b1339],
2	total	NN	O	total	nsubjpass	7	SENT_40	[p3l942t1273r1116b1340],
3	of	IN	O	of	_	0	SENT_40	[p3l1146t1274r1224b1340],
4	26	CD	NUMBER	26	num	5	SENT_40	[p3l1246t1283r1333b1340],
5	SNPs	NNS	O	snp	prep_of	2	SENT_40	[p3l1364t1277r1569b1340],
6	were	VBD	O	be	auxpass	7	SENT_40	[p3l1596t1297r1785b1340],
7	tested	VBN	O	test	conj_or	7	SENT_40	[p3l1812t1273r2047b1340],
8	in	IN	O	in	_	0	SENT_40	[p3l2074t1277r2151b1339],
9	or	CC	O	or	_	0	SENT_40	[p3l12t1393r88b1436],
10	near	IN	O	near	_	0	SENT_40	[p3l135t1393r307b1436],
11	CYP1A2	NN	O	cyp1a2	prep_in	7	SENT_40	[p3l355t1373r684b1436],
12	(	CD	NUMBER	(	num	11	SENT_40	[p3l741t1370r1192b1449],
13	rs2472300	NN	O	rs2472300	nn	22	SENT_40	[p3l741t1370r1192b1449],
14	,	,	O	,	_	0	SENT_40	[p3l741t1370r1192b1449],
15	rs2069522	NN	O	rs2069522	nn	22	SENT_40	[p3l1243t1379r1670b1447],
16	,	,	O	,	_	0	SENT_40	[p3l1243t1379r1670b1447],
17	rs2069526	NN	O	rs2069526	nn	22	SENT_40	[p3l1720t1379r2148b1447],
18	,	,	O	,	_	0	SENT_40	[p3l1720t1379r2148b1447],
19	rs4646425	NN	O	rs4646425	nn	22	SENT_40	[p3l9t1476r410b1533],
20	and	CC	O	and	_	0	SENT_40	[p3l451t1466r596b1533],
21	rs11631682	NN	O	rs11631682	nn	22	SENT_40	[p3l630t1466r1134b1545],
22	)	NN	O	)	dobj	7	SENT_40	[p3l630t1466r1134b1545],
23	,	,	O	,	_	0	SENT_40	[p3l630t1466r1134b1545],
24	CYPZDB	NN	O	cypzdb	nn	26	SENT_40	[p3l1173t1470r1498b1533],
25	(	CD	NUMBER	(	num	26	SENT_40	[p3l1540t1466r1968b1545],
26	rs6002616	NN	O	rs6002616	dobj	7	SENT_40	[p3l1540t1466r1968b1545],
27	and	CC	O	and	_	0	SENT_40	[p3l2006t1466r2151b1533],
28	189306356	CD	NUMBER	189306356	num	29	SENT_40	[p3l9t1564r465b1642],
29	)	NN	O	)	dobj	7	SENT_40	[p3l9t1564r465b1642],
30	,	,	O	,	_	0	SENT_40	[p3l9t1564r465b1642],
31	FMO3	NN	O	fmo3	appos	22	SENT_40	[p3l498t1567r741b1630],
32	(	CD	NUMBER	(	num	31	SENT_40	[p3l779t1564r1230b1642],
33	I	PRP	O	I	nsubj	34	SENT_40	[p3l779t1564r1230b1642],
34	‘	VBP	O	‘	rcmod	31	SENT_40	[p3l779t1564r1230b1642],
35	S2213712	NN	O	s2213712	dobj	34	SENT_40	[p3l779t1564r1230b1642],
36	,	,	O	,	_	0	SENT_40	[p3l779t1564r1230b1642],
37	182859228	CD	NUMBER	182859228	dobj	34	SENT_40	[p3l1261t1573r1689b1641],
38	,	,	O	,	_	0	SENT_40	[p3l1261t1573r1689b1641],
39	rs2859229	NN	O	rs2859229	nn	46	SENT_40	[p3l1720t1573r2148b1641],
40	,	,	O	,	_	0	SENT_40	[p3l1720t1573r2148b1641],
41	rs1492899	NN	O	rs1492899	conj_and	39	SENT_40	[p3l9t1670r436b1738],
42	,	,	O	,	_	0	SENT_40	[p3l9t1670r436b1738],
43	rs929087	NN	O	rs929087	conj_and	39	SENT_40	[p3l483t1670r838b1727],
44	and	CC	O	and	_	0	SENT_40	[p3l886t1661r1031b1727],
45	rs10458360	NN	O	rs10458360	conj_and	39	SENT_40	[p3l1074t1661r1553b1740],
46	)	NN	O	)	dobj	34	SENT_40	[p3l1074t1661r1553b1740],
47	and	CC	O	and	_	0	SENT_40	[p3l1603t1661r1748b1727],
48	CYP3A4	NN	O	cyp3a4	dobj	34	SENT_40	[p3l1793t1664r2147b1738],
49	,	,	O	,	_	0	SENT_40	[p3l1793t1664r2147b1738],
50	3A5	NN	O	3a5	conj_or	48	SENT_40	[p3l13t1762r191b1834],
51	,	,	O	,	_	0	SENT_40	[p3l13t1762r191b1834],
52	3A7	NN	O	3a7	conj_or	48	SENT_40	[p3l254t1762r409b1824],
53	or	CC	O	or	_	0	SENT_40	[p3l469t1781r546b1824],
54	3A43	NN	O	3a43	conj_or	48	SENT_40	[p3l604t1762r804b1824],
55	(	CD	NUMBER	(	num	56	SENT_40	[p3l870t1757r1320b1836],
56	rs2527894	NN	O	rs2527894	dep	48	SENT_40	[p3l870t1757r1320b1836],
57	,	,	O	,	_	0	SENT_40	[p3l870t1757r1320b1836],
58	rs2527887	NN	O	rs2527887	appos	56	SENT_40	[p3l1379t1767r1806b1834],
59	,	,	O	,	_	0	SENT_40	[p3l1379t1767r1806b1834],
60	rs4215	NN	O	rs4215	appos	58	SENT_40	[p3l1865t1767r2148b1835],
61	,	,	O	,	_	0	SENT_40	[p3l1865t1767r2148b1835],

1	rs2525557	NN	O	rs2525557	_	0	SENT_41	[p3l9t1864r416b1932],
2	,	,	O	,	_	0	SENT_41	[p3l9t1864r416b1932],
3	rs696054Z	NN	O	rs696054z	nn	9	SENT_41	[p3l441t1864r849b1932],
4	,	,	O	,	_	0	SENT_41	[p3l441t1864r849b1932],
5	rs47Z9562	NN	O	rs47z9562	dep	9	SENT_41	[p3l874t1864r1282b1932],
6	,	,	O	,	_	0	SENT_41	[p3l874t1864r1282b1932],
7	rs651430	NN	O	rs651430	dep	9	SENT_41	[p3l1307t1864r1669b1932],
8	,	,	O	,	_	0	SENT_41	[p3l1307t1864r1669b1932],
9	rs12535293	NN	O	rs12535293	appos	1	SENT_41	[p3l1694t1864r2147b1932],
10	,	,	O	,	_	0	SENT_41	[p3l1694t1864r2147b1932],

1	rs472660	NN	O	rs472660	_	0	SENT_42	[p3l9t1961r387b2028],
2	,	,	O	,	_	0	SENT_42	[p3l9t1961r387b2028],
3	rs17161981	NN	O	rs17161981	nn	10	SENT_42	[p3l454t1961r929b2028],
4	,	,	O	,	_	0	SENT_42	[p3l454t1961r929b2028],
5	rs17161983	NN	O	rs17161983	nn	10	SENT_42	[p3l994t1961r1469b2028],
6	,	,	O	,	_	0	SENT_42	[p3l994t1961r1469b2028],
7	rs2572023	NN	O	rs2572023	nn	10	SENT_42	[p3l1535t1961r1937b2017],
8	and	CC	O	and	_	0	SENT_42	[p3l2006t1952r2151b2017],
9	rs2527927	NN	O	rs2527927	conj_and	3	SENT_42	[p3l9t2047r463b2126],
10	)	NN	O	)	appos	1	SENT_42	[p3l9t2047r463b2126],
11	.	.	O	.	_	0	SENT_42	[p3l9t2047r463b2126],

1	Nonlinear	JJ	O	nonlinear	amod	4	SENT_43	[p3l96t2145r496b2212],
2	mixed	JJ	O	mixed	amod	4	SENT_43	[p3l562t2145r1093b2212],
3	—	NN	O	—	nn	4	SENT_43	[p3l562t2145r1093b2212],
4	effects	NNS	O	effect	_	0	SENT_43	[p3l562t2145r1093b2212],
5	modeling	NN	O	modeling	nsubjpass	7	SENT_43	[p3l1163t2145r1537b2232],
6	was	VBD	O	be	auxpass	7	SENT_43	[p3l1605t2169r1754b2212],
7	used	VBN	O	use	rcmod	4	SENT_43	[p3l1824t2145r2010b2212],
8	to	TO	O	to	aux	9	SENT_43	[p3l2077t2155r2149b2212],
9	determine	VB	O	determine	xcomp	7	SENT_43	[p3l13t2243r411b2309],
10	the	DT	O	the	det	11	SENT_43	[p3l478t2243r599b2309],
11	effects	NNS	O	effect	dobj	9	SENT_43	[p3l669t2243r917b2309],
12	of	IN	O	of	_	0	SENT_43	[p3l988t2243r1066b2309],
13	genotype	NN	O	genotype	prep_of	11	SENT_43	[p3l1125t2253r1483b2330],
14	on	IN	O	on	_	0	SENT_43	[p3l1553t2266r1648b2309],
15	olanzapine	NN	O	olanzapine	nn	16	SENT_43	[p3l1716t2243r2150b2330],
16	clearance	NN	O	clearance	prep_on	9	SENT_43	[p3l11t2339r382b2406],
17	using	VBG	O	use	partmod	16	SENT_43	[p3l452t2343r667b2426],
18	NONMEM	NNP	O	NONMEM	dobj	17	SENT_43	[p3l736t2343r1155b2406],
19	(	CD	NUMBER	(	num	18	SENT_43	[p3l1229t2339r1544b2418],
20	version	NN	O	version	dep	4	SENT_43	[p3l1229t2339r1544b2418],
21	5	CD	NUMBER	5	num	20	SENT_43	[p3l1617t2350r1678b2416],
22	,	,	O	,	_	0	SENT_43	[p3l1617t2350r1678b2416],
23	level	NN	O	level	appos	20	SENT_43	[p3l1752t2339r1940b2406],
24	1.1	CD	NUMBER	1.1	num	23	SENT_43	[p3l2015t2350r2147b2416],
25	;	:	O	;	_	0	SENT_43	[p3l2015t2350r2147b2416],
26	GloboMax	NNP	O	GloboMax	dep	4	SENT_43	[p3l10t2436r437b2513],
27	,	,	O	,	_	0	SENT_43	[p3l10t2436r437b2513],
28	Ellicott	NNP	LOCATION	Ellicott	nn	29	SENT_43	[p3l469t2436r757b2503],
29	City	NNP	LOCATION	City	conj_and	26	SENT_43	[p3l785t2440r960b2523],
30	,	,	O	,	_	0	SENT_43	[p3l785t2440r960b2523],
31	MD	NNP	O	MD	conj_and	26	SENT_43	[p3l992t2441r1154b2513],
32	,	,	O	,	_	0	SENT_43	[p3l992t2441r1154b2513],
33	USA	NNP	LOCATION	USA	conj_and	26	SENT_43	[p3l1187t2437r1397b2515],
34	)	CD	NUMBER	)	num	33	SENT_43	[p3l1187t2437r1397b2515],
35	and	CC	O	and	_	0	SENT_43	[p3l1432t2436r1577b2503],
36	the	DT	O	the	det	41	SENT_43	[p3l1606t2436r1728b2503],
37	first	JJ	ORDINAL	first	amod	41	SENT_43	[p3l1759t2437r1915b2503],
38	order	NN	O	order	nn	41	SENT_43	[p3l1945t2436r2152b2503],
39	conditional	JJ	O	conditional	amod	41	SENT_43	[p3l11t2533r465b2599],
40	estimation	NN	O	estimation	nn	41	SENT_43	[p3l504t2536r919b2599],
41	method	NN	O	method	dep	4	SENT_43	[p3l954t2533r1255b2599],
42	with	IN	O	with	_	0	SENT_43	[p3l1291t2533r1472b2599],
43	interaction	NN	O	interaction	prep_with	41	SENT_43	[p3l1509t2536r1958b2599],
44	.	.	O	.	_	0	SENT_43	[p3l1509t2536r1958b2599],

1	The	DT	O	the	det	3	SENT_44	[p3l2001t2533r2150b2599],
2	baseline	NN	O	baseline	nn	3	SENT_44	[p3l7t2630r333b2696],
3	population	NN	O	population	nsubjpass	9	SENT_44	[p3l365t2630r802b2717],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_44	[p3l831t2630r1497b2717],
5	model	NN	O	model	dep	3	SENT_44	[p3l1528t2630r1775b2696],
6	has	VBZ	O	have	aux	9	SENT_44	[p3l1805t2630r1935b2696],
7	been	VBN	O	be	auxpass	9	SENT_44	[p3l1964t2630r2151b2696],
8	previously	RB	DATE	previously	advmod	9	SENT_44	[p3l10t2727r432b2815],
9	published	VBN	O	publish	_	0	SENT_44	[p3l474t2727r927b2815],
10	?	.	O	?	_	0	SENT_44	[p3l474t2727r927b2815],

1	A	DT	O	a	det	4	SENT_45	[p3l970t2732r1035b2793],
2	one	CD	NUMBER	one	num	4	SENT_45	[p3l1079t2737r1780b2815],
3	—	NN	O	—	nn	4	SENT_45	[p3l1079t2737r1780b2815],
4	compartment	NN	O	compartment	nn	6	SENT_45	[p3l1079t2737r1780b2815],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_45	[p3l1822t2727r2150b2815, p3l11t2824r371b2890],
6	model	NN	O	model	nsubj	11	SENT_45	[p3l400t2824r647b2890],
7	with	IN	O	with	_	0	SENT_45	[p3l674t2824r855b2890],
8	additive	JJ	O	additive	amod	9	SENT_45	[p3l883t2824r1206b2890],
9	error	NN	O	error	prep_with	6	SENT_45	[p3l1236t2847r1424b2890],
10	best	JJS	O	best	advmod	11	SENT_45	[p3l1447t2824r1607b2890],
11	describes	VBZ	O	describe	_	0	SENT_45	[p3l1636t2824r1999b2890],
12	the	DT	O	the	det	13	SENT_45	[p3l2028t2824r2150b2890],
13	data	NNS	O	datum	dobj	11	SENT_45	[p3l13t2921r194b2987],
14	.	.	O	.	_	0	SENT_45	[p3l13t2921r194b2987],

1	In	IN	O	in	_	0	SENT_46	[p3l274t2925r352b2986],
2	a	DT	O	a	det	4	SENT_46	[p3l427t2944r466b2987],
3	previous	JJ	O	previous	amod	4	SENT_46	[p3l539t2924r880b3008],
4	analysis	NN	O	analysis	prep_in	36	SENT_46	[p3l958t2921r1274b3008],
5	of	IN	O	of	_	0	SENT_46	[p3l1353t2921r1431b2987],
6	these	DT	O	these	det	7	SENT_46	[p3l1496t2921r1700b2987],
7	data	NNS	O	datum	prep_of	4	SENT_46	[p3l1778t2921r1962b2997],
8	,	,	O	,	_	0	SENT_46	[p3l1778t2921r1962b2997],
9	We	PRP	O	we	nsubj	10	SENT_46	[p3l2038t2944r2150b2987],
10	identified	VBD	O	identify	parataxis	36	SENT_46	[p3l10t3018r398b3085],
11	sex	NN	O	sex	nn	16	SENT_46	[p3l443t3042r588b3095],
12	,	,	O	,	_	0	SENT_46	[p3l443t3042r588b3095],
13	race	NN	O	race	nn	16	SENT_46	[p3l634t3042r793b3085],
14	and	CC	O	and	_	0	SENT_46	[p3l839t3018r984b3085],
15	smoking	NN	O	smoking	nn	16	SENT_46	[p3l1029t3018r1361b3105],
16	status	NN	O	status	dobj	10	SENT_46	[p3l1406t3028r1630b3085],
17	as	IN	O	as	_	0	SENT_46	[p3l1676t3042r1751b3085],
18	independent	JJ	O	independent	amod	20	SENT_46	[p3l1797t3018r2150b3106, p3l13t3116r186b3182],
19	significant	JJ	O	significant	amod	20	SENT_46	[p3l212t3116r629b3203],
20	contributors	NNS	O	contributor	prep_as	10	SENT_46	[p3l654t3116r1134b3182],
21	to	TO	O	to	_	0	SENT_46	[p3l1161t3125r1233b3182],
22	olanzapine	JJ	O	olanzapine	amod	23	SENT_46	[p3l1261t3116r1695b3203],
23	clearance	NN	O	clearance	prep_to	10	SENT_46	[p3l1723t3116r2149b3192],
24	;	:	O	;	_	0	SENT_46	[p3l1723t3116r2149b3192],
25	2	CD	NUMBER	2	dep	23	SENT_46	[p3l1723t3116r2149b3192],
26	therefore	RB	O	therefore	advmod	23	SENT_46	[p3l9t3212r384b3288],
27	,	,	O	,	_	0	SENT_46	[p3l9t3212r384b3288],
28	the	DT	O	the	det	29	SENT_46	[p3l419t3212r541b3278],
29	model	NN	O	model	nsubj	36	SENT_46	[p3l574t3212r821b3278],
30	used	VBN	O	use	partmod	29	SENT_46	[p3l854t3212r1040b3278],
31	to	TO	O	to	aux	32	SENT_46	[p3l1072t3222r1144b3278],
32	test	VB	O	test	xcomp	30	SENT_46	[p3l1178t3222r1316b3278],
33	each	DT	O	each	det	35	SENT_46	[p3l1350t3212r1529b3278],
34	genetic	JJ	O	genetic	amod	35	SENT_46	[p3l1560t3215r1840b3299],
35	variant	NN	O	variant	dobj	32	SENT_46	[p3l1874t3215r2152b3278],
36	included	VBD	O	include	_	0	SENT_46	[p3l10t3309r365b3376],
37	sex	NN	O	sex	nn	42	SENT_46	[p3l405t3333r550b3386],
38	,	,	O	,	_	0	SENT_46	[p3l405t3333r550b3386],
39	race	NN	O	race	conj_and	37	SENT_46	[p3l590t3333r750b3376],
40	and	CC	O	and	_	0	SENT_46	[p3l791t3309r936b3376],
41	smoking	NN	O	smoking	conj_and	37	SENT_46	[p3l976t3309r1308b3396],
42	status	NN	O	status	dobj	36	SENT_46	[p3l1348t3319r1573b3376],
43	as	IN	O	as	_	0	SENT_46	[p3l1615t3333r1689b3376],
44	covariates	NNS	O	covariate	prep_as	36	SENT_46	[p3l1731t3313r2146b3376],
45	.	.	O	.	_	0	SENT_46	[p3l1731t3313r2146b3376],

1	Details	NNS	O	detail	nsubjpass	9	SENT_47	[p3l9t3407r279b3473],
2	on	IN	O	on	_	0	SENT_47	[p3l323t3430r419b3473],
3	the	DT	O	the	det	5	SENT_47	[p3l458t3407r580b3473],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_47	[p3l621t3407r1287b3494],
5	modeling	NN	O	modeling	prep_on	1	SENT_47	[p3l1328t3407r1702b3494],
6	have	VBP	O	have	aux	9	SENT_47	[p3l1742t3407r1926b3473],
7	been	VBN	O	be	auxpass	9	SENT_47	[p3l1964t3407r2151b3473],
8	previously	RB	DATE	previously	advmod	9	SENT_47	[p3l10t3503r432b3590],
9	published	VBN	O	publish	_	0	SENT_47	[p3l470t3503r922b3590],
10	?	.	O	?	_	0	SENT_47	[p3l470t3503r922b3590],

1	Smoking	NN	O	smoking	nn	2	SENT_48	[p3l966t3503r1312b3590],
2	status	NN	O	status	nsubjpass	4	SENT_48	[p3l1353t3513r1577b3569],
3	was	VBD	O	be	auxpass	4	SENT_48	[p3l1617t3526r1766b3569],
4	given	VBN	O	give	_	0	SENT_48	[p3l1806t3506r2021b3590],
5	by	IN	O	by	_	0	SENT_48	[p3l2056t3503r2152b3590],
6	patient	NN	O	patient	nn	7	SENT_48	[p3l10t3603r288b3687],
7	self	NN	O	self	agent	4	SENT_48	[p3l342t3600r748b3687],
8	—	CD	NUMBER	—	num	9	SENT_48	[p3l342t3600r748b3687],
9	report	NN	O	report	nsubj	20	SENT_48	[p3l342t3600r748b3687],
10	as	IN	O	as	_	0	SENT_48	[p3l803t3623r877b3666],
11	either	CC	O	either	preconj	13	SENT_48	[p3l935t3600r1162b3666],
12	active	JJ	O	active	amod	13	SENT_48	[p3l1216t3603r1446b3666],
13	smoker	NN	O	smoker	prep_as	9	SENT_48	[p3l1503t3600r1788b3666],
14	or	CC	O	or	_	0	SENT_48	[p3l1842t3623r1919b3666],
15	nonsmoker	NN	O	nonsmoker	prep_as	9	SENT_48	[p3l1971t3623r2150b3666, p3l11t3698r296b3764],
16	(	CD	NUMBER	(	num	15	SENT_48	[p3l339t3698r747b3785],
17	including	VBG	O	include	_	0	SENT_48	[p3l339t3698r747b3785],
18	past	JJ	DATE	past	amod	19	SENT_48	[p3l787t3707r949b3785],
19	smokers	NNS	O	smoker	prep_including	9	SENT_48	[p3l989t3698r1360b3776],
20	)	VBP	O	)	rcmod	7	SENT_48	[p3l989t3698r1360b3776],
21	.	.	O	.	_	0	SENT_48	[p3l989t3698r1360b3776],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_49	[p3l1405t3701r1914b3764],
2	medications	NNS	O	medication	_	0	SENT_49	[p3l1951t3698r2150b3764, p4l10t14r318b77],

1	that	WDT	O	that	nsubj	2	SENT_50	[p4l358t11r511b77],
2	had	VBD	O	have	csubjpass	13	SENT_50	[p4l549t11r696b77],
3	an	DT	O	a	det	4	SENT_50	[p4l736t34r828b77],
4	incidence	NN	O	incidence	dobj	2	SENT_50	[p4l867t11r1254b77],
5	of	IN	O	of	_	0	SENT_50	[p4l1296t11r1374b77],
6	approximately	RB	O	approximately	quantmod	7	SENT_50	[p4l1407t11r1982b98],
7	1	CD	PERCENT	1	num	8	SENT_50	[p4l2025t11r2143b82],
8	%	NN	PERCENT	%	prep_of	4	SENT_50	[p4l2025t11r2143b82],
9	or	CC	O	or	_	0	SENT_50	[p4l12t131r88b174],
10	greater	JJR	O	greater	prep_of	4	SENT_50	[p4l118t118r386b195],
11	were	VBD	O	be	auxpass	13	SENT_50	[p4l415t131r605b174],
12	individually	RB	O	individually	advmod	13	SENT_50	[p4l638t108r1133b195],
13	tested	VBN	O	test	_	0	SENT_50	[p4l1162t108r1397b174],
14	as	IN	O	as	_	0	SENT_50	[p4l1430t131r1504b174],
15	discrete	JJ	O	discrete	amod	16	SENT_50	[p4l1541t108r1847b174],
16	covariates	NNS	O	covariate	prep_as	13	SENT_50	[p4l1882t111r2150b174, p4l11t216r158b272],
17	in	IN	O	in	_	0	SENT_50	[p4l192t209r270b271],
18	the	DT	O	the	det	20	SENT_50	[p4l299t206r421b272],
19	original	JJ	O	original	amod	20	SENT_50	[p4l455t206r757b293],
20	characterization	NN	O	characterization	prep_in	16	SENT_50	[p4l790t206r1428b272],
21	of	IN	O	of	_	0	SENT_50	[p4l1460t206r1538b272],
22	the	DT	O	the	det	24	SENT_50	[p4l1561t206r1683b272],
23	population	NN	O	population	nn	24	SENT_50	[p4l1715t206r2151b293],
24	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	20	SENT_50	[p4l10t302r714b389],
25	of	IN	O	of	_	0	SENT_50	[p4l781t302r860b368],
26	olanzapine	NN	O	olanzapine	prep_of	24	SENT_50	[p4l916t302r1372b389],
27	,	,	O	,	_	0	SENT_50	[p4l916t302r1372b389],
28	and	CC	O	and	_	0	SENT_50	[p4l1439t302r1584b368],
29	none	NN	O	none	nsubj	30	SENT_50	[p4l1646t325r1839b368],
30	had	VBD	O	have	conj_and	13	SENT_50	[p4l1903t302r2049b368],
31	a	DT	O	a	det	33	SENT_50	[p4l2113t325r2152b368],
32	significant	JJ	O	significant	amod	33	SENT_50	[p4l12t399r428b486],
33	effect	NN	O	effect	dobj	30	SENT_50	[p4l461t399r728b465],
34	?	.	O	?	_	0	SENT_50	[p4l461t399r728b465],

1	Each	DT	O	each	det	2	SENT_51	[p4l762t399r953b465],
2	SNP	NN	O	snp	nsubjpass	4	SENT_51	[p4l988t402r1154b465],
3	was	VBD	O	be	auxpass	4	SENT_51	[p4l1187t422r1337b465],
4	tested	VBN	O	test	_	0	SENT_51	[p4l1371t399r1605b465],
5	separately	RB	O	separately	advmod	4	SENT_51	[p4l1640t399r2041b486],
6	as	IN	O	as	_	0	SENT_51	[p4l2074t422r2149b465],
7	a	DT	O	a	det	9	SENT_51	[p4l11t520r50b563],
8	categorical	JJ	O	categorical	amod	9	SENT_51	[p4l91t497r514b584],
9	covariate	NN	O	covariate	prep_as	4	SENT_51	[p4l556t500r911b563],
10	to	TO	O	to	aux	11	SENT_51	[p4l951t506r1023b563],
11	determine	VB	O	determine	xcomp	4	SENT_51	[p4l1067t497r1465b563],
12	its	PRP$	O	its	poss	13	SENT_51	[p4l1507t500r1597b563],
13	effect	NN	O	effect	dobj	11	SENT_51	[p4l1641t497r1854b563],
14	on	IN	O	on	_	0	SENT_51	[p4l1894t520r1989b563],
15	the	DT	O	the	det	18	SENT_51	[p4l2028t497r2150b563],
16	olanzapine	NN	O	olanzapine	nn	18	SENT_51	[p4l12t593r445b680],
17	population	NN	O	population	nn	18	SENT_51	[p4l480t593r916b680],
18	clearance	NN	O	clearance	prep_on	11	SENT_51	[p4l951t593r1342b659],
19	.	.	O	.	_	0	SENT_51	[p4l951t593r1342b659],

1	To	TO	O	to	aux	2	SENT_52	[p4l97t695r190b756],
2	determine	VB	O	determine	purpcl	14	SENT_52	[p4l244t690r641b756],
3	the	DT	O	the	det	4	SENT_52	[p4l692t690r813b756],
4	effect	NN	O	effect	dobj	2	SENT_52	[p4l865t690r1078b756],
5	of	IN	O	of	_	0	SENT_52	[p4l1129t690r1207b756],
6	olanzapine	NN	O	olanzapine	nn	7	SENT_52	[p4l1250t690r1684b777],
7	concentrations	NNS	O	concentration	prep_of	4	SENT_52	[p4l1736t700r2150b756, p4l9t792r202b855],
8	on	IN	O	on	_	0	SENT_52	[p4l242t812r337b855],
9	clinical	JJ	O	clinical	amod	11	SENT_52	[p4l374t789r668b855],
10	response	NN	O	response	nn	11	SENT_52	[p4l703t812r1052b876],
11	measures	NNS	O	measure	prep_on	2	SENT_52	[p4l1089t812r1479b865],
12	,	,	O	,	_	0	SENT_52	[p4l1089t812r1479b865],
13	we	PRP	O	we	nsubj	14	SENT_52	[p4l1516t812r1628b855],
14	performed	VBD	O	perform	_	0	SENT_52	[p4l1665t789r2076b876],
15	a	DT	O	a	det	16	SENT_52	[p4l2113t812r2152b855],
16	series	NN	O	series	dobj	14	SENT_52	[p4l12t888r231b951],
17	of	IN	O	of	_	0	SENT_52	[p4l317t885r396b951],
18	linear	JJ	O	linear	amod	19	SENT_52	[p4l471t885r699b951],
19	regressions	NNS	O	regression	prep_of	16	SENT_52	[p4l779t888r1219b972],
20	between	IN	O	between	_	0	SENT_52	[p4l1300t885r1633b951],
21	olanzapine	NN	O	olanzapine	nn	22	SENT_52	[p4l1716t885r2150b972],
22	clearance	NN	O	clearance	prep_between	19	SENT_52	[p4l11t982r382b1048],
23	estimated	VBN	O	estimate	partmod	22	SENT_52	[p4l434t982r816b1048],
24	using	VBG	O	use	xcomp	23	SENT_52	[p4l864t985r1079b1069],
25	the	DT	O	the	det	27	SENT_52	[p4l1128t982r1249b1048],
26	final	JJ	O	final	amod	27	SENT_52	[p4l1300t982r1478b1048],
27	model	NN	O	model	dobj	24	SENT_52	[p4l1527t982r1774b1048],
28	with	IN	O	with	_	0	SENT_52	[p4l1824t982r2005b1048],
29	all	DT	O	all	det	31	SENT_52	[p4l2055t982r2150b1048],
30	significant	JJ	O	significant	amod	31	SENT_52	[p4l12t1079r428b1166],
31	covariates	NNS	O	covariate	prep_with	24	SENT_52	[p4l480t1083r873b1146],
32	including	VBG	O	include	_	0	SENT_52	[p4l926t1079r1309b1166],
33	CYP3A43	NN	O	cyp3a43	nn	34	SENT_52	[p4l1360t1083r1737b1146],
34	genotype	NN	O	genotype	prep_including	31	SENT_52	[p4l1792t1089r2150b1166],
35	and	CC	O	and	_	0	SENT_52	[p4l11t1176r156b1242],
36	several	JJ	O	several	amod	37	SENT_52	[p4l197t1176r471b1242],
37	measures	NNS	O	measure	conj_and	34	SENT_52	[p4l510t1199r876b1242],
38	of	IN	O	of	_	0	SENT_52	[p4l920t1176r998b1242],
39	clinical	JJ	O	clinical	amod	40	SENT_52	[p4l1031t1176r1325b1242],
40	response	NN	O	response	prep_of	37	SENT_52	[p4l1364t1199r1713b1263],
41	to	TO	O	to	_	0	SENT_52	[p4l1752t1186r1824b1242],
42	olanzapine	NN	O	olanzapine	prep_to	14	SENT_52	[p4l1867t1176r2150b1242, p4l10t1276r184b1360],
43	for	IN	O	for	_	0	SENT_52	[p4l221t1273r328b1339],
44	patients	NNS	O	patient	prep_for	14	SENT_52	[p4l361t1276r675b1360],
45	in	IN	O	in	_	0	SENT_52	[p4l713t1276r791b1339],
46	phase	NN	O	phase	prep_in	44	SENT_52	[p4l825t1273r1053b1360],
47	1	CD	NUMBER	1	num	46	SENT_52	[p4l1094t1283r1128b1339],
48	or	CC	O	or	_	0	SENT_52	[p4l1170t1296r1246b1339],
49	1A	NN	O	1a	conj_or	46	SENT_52	[p4l1285t1278r1411b1339],
50	.	.	O	.	_	0	SENT_52	[p4l1285t1278r1411b1339],

1	We	PRP	O	we	nsubj	2	SENT_53	[p4l1450t1277r1572b1339],
2	chose	VBD	O	choose	_	0	SENT_53	[p4l1609t1273r1830b1339],
3	PANSS	NNP	O	PANSS	nn	4	SENT_53	[p4l1865t1276r2148b1339],
4	ratings	NNS	O	rating	dobj	2	SENT_53	[p4l9t1374r274b1457],
5	as	IN	O	as	_	0	SENT_53	[p4l329t1394r404b1437],
6	a	DT	O	a	det	7	SENT_53	[p4l459t1394r498b1436],
7	measure	NN	O	measure	prep_as	4	SENT_53	[p4l548t1394r877b1437],
8	of	IN	O	of	_	0	SENT_53	[p4l932t1370r1010b1437],
9	symptom	NN	O	symptom	nn	10	SENT_53	[p4l1056t1380r1422b1457],
10	severity	NN	O	severity	prep_of	7	SENT_53	[p4l1475t1374r1797b1457],
11	,	,	O	,	_	0	SENT_53	[p4l1475t1374r1797b1457],
12	time	NN	O	time	dobj	2	SENT_53	[p4l1851t1374r2025b1437],
13	to	TO	O	to	_	0	SENT_53	[p4l2077t1380r2149b1437],
14	discontinuation	NN	O	discontinuation	prep_to	12	SENT_53	[p4l13t1466r640b1532],
15	for	IN	O	for	_	0	SENT_53	[p4l688t1466r795b1532],
16	all	DT	O	all	det	17	SENT_53	[p4l841t1466r937b1532],
17	cause	NN	O	cause	prep_for	14	SENT_53	[p4l986t1489r1224b1542],
18	,	,	O	,	_	0	SENT_53	[p4l986t1489r1224b1542],
19	as	RB	O	as	_	0	SENT_53	[p4l1275t1489r1350b1532],
20	well	RB	O	well	_	0	SENT_53	[p4l1398t1466r1569b1532],
21	as	IN	O	as	_	0	SENT_53	[p4l1618t1489r1692b1532],
22	reason	NN	O	reason	conj_and	4	SENT_53	[p4l1739t1489r1998b1532],
23	for	IN	O	for	_	0	SENT_53	[p4l2045t1466r2152b1532],
24	discontinuation	NN	O	discontinuation	prep_for	22	SENT_53	[p4l13t1563r640b1629],
25	as	IN	O	as	_	0	SENT_53	[p4l687t1586r762b1629],
26	measures	NNS	O	measure	prep_as	2	SENT_53	[p4l809t1586r1176b1629],
27	of	IN	O	of	_	0	SENT_53	[p4l1226t1563r1304b1629],
28	clinical	JJ	O	clinical	amod	29	SENT_53	[p4l1343t1563r1637b1629],
29	response	NN	O	response	prep_of	26	SENT_53	[p4l1682t1586r2032b1650],
30	to	TO	O	to	_	0	SENT_53	[p4l2077t1573r2149b1629],
31	olanzapine	NN	O	olanzapine	prep_to	2	SENT_53	[p4l12t1660r466b1747],
32	.	.	O	.	_	0	SENT_53	[p4l12t1660r466b1747],

1	There	EX	O	there	expl	2	SENT_54	[p4l518t1660r744b1727],
2	were	VBD	O	be	_	0	SENT_54	[p4l791t1684r980b1727],
3	a	DT	O	a	det	4	SENT_54	[p4l1028t1684r1067b1726],
4	total	NN	O	total	nsubj	2	SENT_54	[p4l1111t1660r1286b1727],
5	of	IN	O	of	_	0	SENT_54	[p4l1335t1660r1413b1727],
6	153	CD	NUMBER	153	num	7	SENT_54	[p4l1456t1670r1587b1727],
7	patients	NNS	O	patient	prep_of	4	SENT_54	[p4l1638t1664r1952b1747],
8	that	WDT	O	that	nsubjpass	10	SENT_54	[p4l1999t1660r2152b1727],
9	were	VBD	O	be	auxpass	10	SENT_54	[p4l9t1780r198b1823],
10	randomized	VBN	O	randomize	rcmod	7	SENT_54	[p4l231t1757r706b1823],
11	to	TO	O	to	_	0	SENT_54	[p4l738t1766r810b1823],
12	olanzapine	NN	O	olanzapine	prep_to	10	SENT_54	[p4l846t1757r1280b1844],
13	for	IN	O	for	_	0	SENT_54	[p4l1314t1757r1421b1823],
14	phase	NN	O	phase	prep_for	12	SENT_54	[p4l1453t1757r1680b1844],
15	1	CD	NUMBER	1	num	14	SENT_54	[p4l1719t1767r1753b1822],
16	or	CC	O	or	_	0	SENT_54	[p4l1792t1780r1869b1823],
17	1A	NN	O	1a	conj_or	14	SENT_54	[p4l1904t1761r2012b1822],
18	for	IN	O	for	prep	10	SENT_54	[p4l2045t1757r2152b1823],

1	CYP3A43	NN	O	cyp3a43	_	0	SENT_55	[p4l14t1984r204b2027],
2	and	CC	O	and	_	0	SENT_55	[p4l224t1985r294b2027],
3	olanzapine	NN	O	olanzapine	conj_and	1	SENT_55	[p4l313t1985r524b2038],
4	metabolism	NN	O	metabolism	dep	1	SENT_55	[p4l543t1985r768b2027],
5	@	IN	O	@	_	0	SENT_55	[p4l2036t1982r2151b2094],
6	KL	NNP	ORGANIZATION	KL	nn	7	SENT_55	[p4l17t2048r65b2090],
7	Bigos	NNP	ORGANIZATION	Bigos	prep_@	4	SENT_55	[p4l85t2048r186b2101],
8	et	FW	O	et	nn	9	SENT_55	[p4l203t2050r240b2091],
9	al	FW	O	al	dep	7	SENT_55	[p4l256t2048r291b2090],
10	'	''	O	'	_	0	SENT_55	[p4l2119t2053r2143b2069],

1	which	WDT	O	which	dep	3	SENT_56	[p4l10t2207r224b2264],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_56	[p4l267t2207r839b2282],
3	data	NNS	O	datum	dep	14	SENT_56	[p4l886t2207r1043b2273],
4	,	,	O	,	_	0	SENT_56	[p4l886t2207r1043b2273],
5	genetic	JJ	O	genetic	amod	6	SENT_56	[p4l1089t2210r1330b2282],
6	data	NNS	O	datum	nsubj	14	SENT_56	[p4l1377t2207r1518b2264],
7	and	CC	O	and	_	0	SENT_56	[p4l1561t2207r1686b2264],
8	any	DT	O	any	det	12	SENT_56	[p4l1730t2227r1851b2282],
9	621	CD	NUMBER	621	num	12	SENT_56	[p4l2060t2165r2144b2217],
10	clinical	JJ	O	clinical	amod	12	SENT_56	[p4l12t2291r264b2348],
11	response	NN	O	response	nn	12	SENT_56	[p4l301t2311r601b2366],
12	data	NNS	O	datum	nsubj	14	SENT_56	[p4l643t2291r784b2348],
13	were	VBD	O	be	cop	14	SENT_56	[p4l819t2311r981b2348],
14	available	JJ	O	available	_	0	SENT_56	[p4l1021t2291r1340b2348],
15	.	.	O	.	_	0	SENT_56	[p4l1021t2291r1340b2348],

1	Four	CD	NUMBER	four	num	2	SENT_57	[p4l1382t2295r1542b2348],
2	patients	NNS	O	patient	nsubjpass	4	SENT_57	[p4l1578t2294r1848b2366],
3	were	VBD	O	be	auxpass	4	SENT_57	[p4l10t2393r172b2430],
4	excluded	VBN	O	exclude	_	0	SENT_57	[p4l197t2373r509b2430],
5	after	IN	O	after	mark	9	SENT_57	[p4l532t2373r682b2430],
6	blood	NN	O	blood	nn	8	SENT_57	[p4l701t2373r895b2430],
7	level	NN	O	level	nn	8	SENT_57	[p4l918t2373r1079b2430],
8	analysis	NN	O	analysis	nsubj	9	SENT_57	[p4l1104t2373r1376b2448],
9	indicated	VBD	O	indicate	advcl	4	SENT_57	[p4l1401t2373r1722b2430],
10	the	DT	O	the	det	11	SENT_57	[p4l1745t2373r1849b2430],
11	use	NN	O	use	dobj	9	SENT_57	[p4l10t2476r122b2513],
12	of	IN	O	of	_	0	SENT_57	[p4l154t2456r221b2513],
13	an	DT	O	a	det	15	SENT_57	[p4l245t2476r324b2513],
14	antipsychotic	JJ	O	antipsychotic	amod	15	SENT_57	[p4l353t2456r812b2531],
15	drug	NN	O	drug	prep_of	11	SENT_57	[p4l845t2456r997b2531],
16	outside	IN	O	outside	advmod	15	SENT_57	[p4l1028t2456r1275b2513],
17	of	IN	O	of	_	0	SENT_57	[p4l1307t2456r1374b2513],
18	the	DT	O	the	det	19	SENT_57	[p4l1396t2456r1500b2513],
19	study	NN	O	study	prep_of	11	SENT_57	[p4l1531t2456r1728b2531],
20	.	.	O	.	_	0	SENT_57	[p4l1531t2456r1728b2531],

1	The	DT	O	the	det	4	SENT_58	[p4l85t2540r214b2597],
2	likelihood	NN	O	likelihood	nn	4	SENT_58	[p4l242t2540r591b2597],
3	ratio	NN	O	ratio	nn	4	SENT_58	[p4l616t2543r770b2597],
4	test	NN	O	test	nsubjpass	6	SENT_58	[p4l797t2549r916b2597],
5	was	VBD	O	be	auxpass	6	SENT_58	[p4l941t2560r1069b2597],
6	used	VBN	O	use	_	0	SENT_58	[p4l1097t2540r1257b2597],
7	to	TO	O	to	aux	8	SENT_58	[p4l1283t2549r1345b2597],
8	determine	VB	O	determine	xcomp	6	SENT_58	[p4l1375t2540r1717b2597],
9	the	DT	O	the	det	10	SENT_58	[p4l1745t2540r1849b2597],
10	effect	NN	O	effect	dobj	8	SENT_58	[p4l12t2623r195b2679],
11	of	IN	O	of	_	0	SENT_58	[p4l222t2623r289b2679],
12	each	DT	O	each	det	13	SENT_58	[p4l311t2623r464b2679],
13	SNP	NN	ORGANIZATION	snp	prep_of	10	SENT_58	[p4l493t2626r635b2679],
14	on	IN	O	on	_	0	SENT_58	[p4l665t2643r747b2679],
15	the	DT	O	the	det	16	SENT_58	[p4l773t2623r877b2679],
16	model	NN	O	model	prep_on	13	SENT_58	[p4l904t2623r1133b2679],
17	.	.	O	.	_	0	SENT_58	[p4l904t2623r1133b2679],

1	The	DT	O	the	det	4	SENT_59	[p4l1164t2623r1292b2679],
2	likelihood	NN	O	likelihood	nn	4	SENT_59	[p4l1320t2623r1669b2679],
3	ratio	NN	O	ratio	nn	4	SENT_59	[p4l1695t2626r1848b2679],
4	test	NN	O	test	nsubjpass	6	SENT_59	[p4l10t2713r128b2762],
5	is	VBZ	O	be	auxpass	6	SENT_59	[p4l172t2708r224b2762],
6	based	VBN	O	base	_	0	SENT_59	[p4l268t2705r462b2762],
7	on	IN	O	on	_	0	SENT_59	[p4l508t2725r591b2762],
8	the	DT	O	the	det	9	SENT_59	[p4l634t2705r738b2762],
9	property	NN	O	property	prep_on	6	SENT_59	[p4l783t2713r1075b2780],
10	that	IN	O	that	complm	19	SENT_59	[p4l1117t2705r1249b2762],
11	the	DT	O	the	det	12	SENT_59	[p4l1291t2705r1395b2762],
12	ratio	NN	O	ratio	nsubj	19	SENT_59	[p4l1440t2708r1593b2762],
13	of	IN	O	of	_	0	SENT_59	[p4l1640t2705r1707b2762],
14	the	DT	O	the	det	18	SENT_59	[p4l1744t2705r1849b2762],
15	NONMEM	NNP	O	NONMEM	nn	18	SENT_59	[p4l10t2791r370b2845],
16	objective	NN	O	objective	nn	18	SENT_59	[p4l426t2788r727b2863],
17	function	NN	O	function	nn	18	SENT_59	[p4l783t2788r1070b2845],
18	values	NNS	O	value	prep_of	12	SENT_59	[p4l1124t2788r1340b2845],
19	(	VBP	O	(	ccomp	6	SENT_59	[p4l1400t2788r1513b2856],
20	-2	CD	NUMBER	-2	num	22	SENT_59	[p4l1400t2788r1513b2856],
21	loglikelihood	JJ	O	loglikelihood	amod	22	SENT_59	[p4l1572t2788r1849b2863, p4l11t2871r252b2939],
22	)	NN	O	)	nsubj	25	SENT_59	[p4l1572t2788r1849b2863, p4l11t2871r252b2939],
23	is	VBZ	O	be	cop	25	SENT_59	[p4l298t2874r350b2928],
24	asymptotically	RB	O	asymptotically	advmod	25	SENT_59	[p4l395t2871r898b2946],
25	X2	NN	O	x2	ccomp	19	SENT_59	[p4l938t2871r998b2943],
26	distributed	VBN	O	distribute	partmod	25	SENT_59	[p4l1044t2871r1432b2928],
27	.	.	O	.	_	0	SENT_59	[p4l1044t2871r1432b2928],

1	The	DT	O	the	det	4	SENT_60	[p4l1479t2871r1607b2928],
2	objective	JJ	O	objective	amod	4	SENT_60	[p4l1652t2871r1849b2946, p4l10t2957r134b3011],
3	function	NN	O	function	nn	4	SENT_60	[p4l168t2954r456b3011],
4	value	NN	O	value	nsubj	7	SENT_60	[p4l486t2954r670b3011],
5	is	VBZ	O	be	cop	7	SENT_60	[p4l704t2957r756b3011],
6	the	DT	O	the	det	7	SENT_60	[p4l789t2954r894b3011],
7	sum	NN	O	sum	_	0	SENT_60	[p4l929t2974r1070b3011],
8	of	IN	O	of	_	0	SENT_60	[p4l1104t2954r1171b3011],
9	squared	VBN	O	square	amod	10	SENT_60	[p4l1198t2954r1463b3029],
10	deviations	NNS	O	deviation	prep_of	7	SENT_60	[p4l1498t2954r1848b3011],
11	between	IN	O	between	_	0	SENT_60	[p4l8t3037r294b3094],
12	the	DT	O	the	det	13	SENT_60	[p4l340t3037r444b3094],
13	predictions	NNS	O	prediction	prep_between	10	SENT_60	[p4l493t3037r878b3112],
14	and	CC	O	and	_	0	SENT_60	[p4l929t3037r1053b3094],
15	the	DT	O	the	det	16	SENT_60	[p4l1100t3037r1204b3094],
16	observations	NNS	O	observation	prep_between	10	SENT_60	[p4l1254t3037r1697b3094],
17	.	.	O	.	_	0	SENT_60	[p4l1254t3037r1697b3094],

1	An	DT	O	a	det	4	SENT_61	[p4l1748t3041r1850b3094],
2	objective	JJ	O	objective	amod	4	SENT_61	[p4l12t3120r313b3195],
3	function	NN	O	function	nn	4	SENT_61	[p4l358t3120r645b3177],
4	decrease	NN	O	decrease	nsubjpass	9	SENT_61	[p4l691t3120r980b3177],
5	of	IN	O	of	_	0	SENT_61	[p4l1026t3120r1093b3177],
6	3.84	CD	NUMBER	3.84	num	7	SENT_61	[p4l1133t3128r1270b3177],
7	units	NNS	O	unit	prep_of	4	SENT_61	[p4l1314t3123r1485b3177],
8	was	VBD	O	be	auxpass	9	SENT_61	[p4l1529t3140r1658b3177],
9	considered	VBN	O	consider	_	0	SENT_61	[p4l1705t3140r1849b3177, p4l12t3203r261b3260],
10	significant	JJ	O	significant	amod	12	SENT_61	[p4l287t3203r645b3278],
11	(	NN	O	(	nn	12	SENT_61	[p4l673t3203r773b3275],
12	X2	NN	O	x2	dobj	9	SENT_61	[p4l673t3203r773b3275],
13	,	,	O	,	_	0	SENT_61	[p4l673t3203r773b3275],
14	d.f.	NN	O	d.f.	appos	12	SENT_61	[p4l803t3203r905b3260],
15	=	JJ	O	=	amod	14	SENT_61	[p4l928t3230r966b3250],
16	1	CD	NUMBER	1	tmod	15	SENT_61	[p4l988t3212r1040b3269],
17	,	,	O	,	_	0	SENT_61	[p4l988t3212r1040b3269],
18	P	NN	O	p	appos	12	SENT_61	[p4l1066t3207r1166b3260],
19	:	:	O	:	_	0	SENT_61	[p4l1066t3207r1166b3260],
20	0.05	CD	NUMBER	0.05	num	21	SENT_61	[p4l1185t3203r1366b3271],
21	)	NN	O	)	dep	12	SENT_61	[p4l1185t3203r1366b3271],
22	.	.	O	.	_	0	SENT_61	[p4l1185t3203r1366b3271],

1	That	DT	O	that	nsubj	2	SENT_62	[p4l1395t3203r1551b3260],
2	is	VBZ	O	be	_	0	SENT_62	[p4l1575t3206r1627b3260],
3	to	TO	O	to	aux	4	SENT_62	[p4l1653t3212r1715b3260],
4	say	VB	O	say	xcomp	2	SENT_62	[p4l1743t3223r1851b3278],
5	that	IN	O	that	complm	8	SENT_62	[p4l10t3286r141b3343],
6	the	DT	O	the	det	7	SENT_62	[p4l170t3286r275b3343],
7	SNP	NN	ORGANIZATION	snp	nsubj	8	SENT_62	[p4l309t3289r452b3343],
8	had	VBD	O	have	ccomp	4	SENT_62	[p4l484t3286r610b3343],
9	a	DT	O	a	det	11	SENT_62	[p4l642t3306r676b3343],
10	significant	JJ	O	significant	amod	11	SENT_62	[p4l708t3286r1066b3361],
11	impact	NN	O	impact	dobj	8	SENT_62	[p4l1096t3289r1330b3361],
12	on	IN	O	on	_	0	SENT_62	[p4l1362t3306r1444b3343],
13	olanzapine	NN	O	olanzapine	nn	14	SENT_62	[p4l1477t3286r1849b3361],
14	clearance	NN	O	clearance	prep_on	11	SENT_62	[p4l12t3369r330b3426],
15	if	IN	O	if	mark	20	SENT_62	[p4l359t3369r411b3426],
16	the	DT	O	the	det	19	SENT_62	[p4l432t3369r537b3426],
17	objective	JJ	O	objective	amod	19	SENT_62	[p4l568t3369r869b3444],
18	function	NN	O	function	nn	19	SENT_62	[p4l899t3369r1186b3426],
19	value	NN	O	value	nsubj	20	SENT_62	[p4l1213t3369r1396b3426],
20	decreased	VBD	O	decrease	advcl	4	SENT_62	[p4l1428t3369r1763b3426],
21	at	IN	O	at	quantmod	23	SENT_62	[p4l1792t3377r1851b3426],
22	least	JJS	O	least	mwe	21	SENT_62	[p4l11t3452r166b3509],
23	3.84	CD	NUMBER	3.84	num	24	SENT_62	[p4l197t3460r333b3509],
24	points	NNS	O	point	dobj	20	SENT_62	[p4l364t3455r593b3527],
25	.	.	O	.	_	0	SENT_62	[p4l364t3455r593b3527],

1	Post-processing	NN	O	post-processing	nsubjpass	9	SENT_63	[p4l84t3538r618b3611],
2	of	IN	O	of	_	0	SENT_63	[p4l649t3535r716b3593],
3	NONMEM	NNP	O	NONMEM	nn	4	SENT_63	[p4l739t3538r1099b3593],
4	outputs	NNS	O	output	prep_of	1	SENT_63	[p4l1129t3544r1384b3611],
5	and	CC	O	and	_	0	SENT_63	[p4l1417t3535r1541b3593],
6	all	DT	O	all	det	7	SENT_63	[p4l1571t3535r1653b3593],
7	plots	NNS	O	plot	prep_of	1	SENT_63	[p4l1683t3535r1847b3611],
8	were	VBD	O	be	auxpass	9	SENT_63	[p4l10t3639r172b3676],
9	generated	VBN	O	generate	_	0	SENT_63	[p4l195t3618r524b3693],
10	using	VBG	O	use	xcomp	9	SENT_63	[p4l546t3621r731b3693],
11	GraphPad	NNP	O	GraphPad	nn	12	SENT_63	[p4l753t3618r1090b3694],
12	Prism	NNP	O	Prism	dobj	10	SENT_63	[p4l1112t3622r1309b3676],
13	5	CD	NUMBER	5	number	14	SENT_63	[p4l1334t3627r1365b3676],
14	(	CD	NUMBER	(	dep	12	SENT_63	[p4l1394t3619r1665b3686],
15	version	NN	O	version	dep	14	SENT_63	[p4l1394t3619r1665b3686],
16	5.02	CD	NUMBER	5.02	num	15	SENT_63	[p4l1690t3627r1847b3684],
17	,	,	O	,	_	0	SENT_63	[p4l1690t3627r1847b3684],
18	GraphPad	NNP	O	GraphPad	nn	19	SENT_63	[p4l11t3701r348b3776],
19	Software	NNP	O	Software	appos	12	SENT_63	[p4l400t3701r715b3767],
20	,	,	O	,	_	0	SENT_63	[p4l400t3701r715b3767],
21	San	NNP	LOCATION	San	nn	26	SENT_63	[p4l770t3704r893b3758],
22	Diego	NNP	LOCATION	Diego	nn	26	SENT_63	[p4l941t3704r1151b3776],
23	,	,	O	,	_	0	SENT_63	[p4l941t3704r1151b3776],
24	CA	NNP	LOCATION	CA	appos	26	SENT_63	[p4l1204t3704r1326b3767],
25	,	,	O	,	_	0	SENT_63	[p4l1204t3704r1326b3767],
26	USA	NNP	LOCATION	USA	appos	19	SENT_63	[p4l1379t3701r1579b3769],
27	)	CD	NUMBER	)	num	26	SENT_63	[p4l1379t3701r1579b3769],
28	.	.	O	.	_	0	SENT_63	[p4l1379t3701r1579b3769],

1	Linear	JJ	O	linear	amod	2	SENT_64	[p4l1633t3704r1851b3758],
2	regression	NN	O	regression	nsubjpass	4	SENT_64	[p5l9t14r356b86],
3	was	VBD	O	be	auxpass	4	SENT_64	[p5l378t32r506b69],
4	performed	VBN	O	perform	_	0	SENT_64	[p5l531t11r884b87],
5	to	TO	O	to	aux	6	SENT_64	[p5l906t20r968b69],
6	determine	VB	O	determine	xcomp	4	SENT_64	[p5l994t11r1336b69],
7	the	DT	O	the	det	8	SENT_64	[p5l1359t11r1463b69],
8	magnitude	NN	O	magnitude	dobj	6	SENT_64	[p5l1487t11r1849b86],
9	of	IN	O	of	_	0	SENT_64	[p5l12t95r79b152],
10	contribution	NN	O	contribution	prep_of	8	SENT_64	[p5l107t95r530b152],
11	to	TO	O	to	_	0	SENT_64	[p5l561t103r622b152],
12	the	DT	O	the	det	13	SENT_64	[p5l655t95r760b152],
13	Variability	NN	O	variability	prep_to	6	SENT_64	[p5l792t95r1143b170],
14	of	IN	O	of	_	0	SENT_64	[p5l1176t95r1243b152],
15	clearance	NN	O	clearance	prep_of	13	SENT_64	[p5l1270t95r1588b152],
16	for	IN	O	for	_	0	SENT_64	[p5l1622t95r1714b152],
17	the	DT	O	the	det	19	SENT_64	[p5l1745t95r1849b152],
18	significant	JJ	O	significant	amod	19	SENT_64	[p5l12t177r370b252],
19	covariates	NNS	O	covariate	prep_for	15	SENT_64	[p5l393t180r731b234],
20	(	VBP	O	(	rcmod	19	SENT_64	[p5l759t177r890b245],
21	sex	NN	O	sex	nn	24	SENT_64	[p5l759t177r890b245],
22	and	CC	O	and	_	0	SENT_64	[p5l912t177r1037b234],
23	smoking	NN	O	smoking	nn	24	SENT_64	[p5l1061t177r1347b252],
24	status	NN	O	status	dobj	20	SENT_64	[p5l1371t177r1588b245],
25	)	RB	O	)	advmod	20	SENT_64	[p5l1371t177r1588b245],
26	as	RB	O	as	_	0	SENT_64	[p5l1615t197r1679b234],
27	well	RB	O	well	_	0	SENT_64	[p5l1702t177r1849b234],
28	as	IN	O	as	_	0	SENT_64	[p5l11t281r76b318],
29	genotype	NN	O	genotype	nn	30	SENT_64	[p5l115t269r422b336],
30	effects	NNS	O	effect	conj_and	19	SENT_64	[p5l463t260r694b318],
31	.	.	O	.	_	0	SENT_64	[p5l463t260r694b318],

1	In	IN	O	in	mark	4	SENT_65	[p5l737t264r805b317],
2	order	NN	O	order	dep	4	SENT_65	[p5l844t260r1022b318],
3	to	TO	O	to	aux	4	SENT_65	[p5l1058t269r1119b318],
4	correct	VB	O	correct	dep	15	SENT_65	[p5l1160t269r1392b318],
5	for	IN	O	for	_	0	SENT_65	[p5l1429t260r1521b318],
6	multiple	JJ	O	multiple	amod	7	SENT_65	[p5l1558t260r1849b336],
7	comparisons	NNS	O	comparison	prep_for	4	SENT_65	[p5l12t347r441b419],
8	for	IN	O	for	_	0	SENT_65	[p5l468t344r559b401],
9	the	DT	O	the	det	11	SENT_65	[p5l581t344r685b401],
10	26	CD	NUMBER	26	num	11	SENT_65	[p5l713t352r787b401],
11	SNPs	NNS	O	snp	prep_for	4	SENT_65	[p5l815t347r991b401],
12	tested	VBN	O	test	partmod	11	SENT_65	[p5l1016t344r1235b410],
13	,	,	O	,	_	0	SENT_65	[p5l1016t344r1235b410],
14	we	PRP	O	we	nsubj	15	SENT_65	[p5l1261t364r1357b401],
15	set	VBD	O	set	_	0	SENT_65	[p5l1383t352r1474b401],
16	an	DT	O	a	det	37	SENT_65	[p5l1498t364r1577b401],
17	a	DT	O	a	det	19	SENT_65	[p5l1603t364r1638b401],
18	priori	FW	O	priori	nn	19	SENT_65	[p5l1659t347r1853b419],
19	threshold	NN	O	threshold	dep	37	SENT_65	[p5l10t427r336b484],
20	based	VBN	O	base	_	0	SENT_65	[p5l401t427r596b484],
21	on	IN	O	on	prepc_based_on	19	SENT_65	[p5l665t447r747b484],
22	the	DT	O	the	det	25	SENT_65	[p5l814t427r919b484],
23	conservative	JJ	O	conservative	amod	25	SENT_65	[p5l989t430r1415b484],
24	Bonferroni	NNP	PERSON	Bonferroni	nn	25	SENT_65	[p5l1484t427r1849b484],
25	correction	NN	O	correction	pobj	19	SENT_65	[p5l12t512r355b567],
26	of	IN	O	of	_	0	SENT_65	[p5l394t509r461b567],
27	P	NN	O	p	prep_of	25	SENT_65	[p5l492t513r787b567],
28	=	JJ	O	=	amod	19	SENT_65	[p5l492t513r787b567],
29	0.002	CD	NUMBER	0.002	tmod	28	SENT_65	[p5l492t513r787b567],
30	for	IN	O	for	_	0	SENT_65	[p5l829t509r921b567],
31	the	DT	O	the	det	32	SENT_65	[p5l957t509r1061b567],
32	effect	NN	O	effect	prep_for	19	SENT_65	[p5l1101t509r1284b567],
33	of	IN	O	of	_	0	SENT_65	[p5l1322t509r1389b567],
34	genotype	NN	O	genotype	prep_of	32	SENT_65	[p5l1420t518r1728b585],
35	on	IN	O	on	_	0	SENT_65	[p5l1768t530r1850b567],
36	olanzapine	NN	O	olanzapine	prep_on	19	SENT_65	[p5l12t593r384b668],
37	clearance	NN	O	clearance	dobj	15	SENT_65	[p5l410t593r745b650],
38	.	.	O	.	_	0	SENT_65	[p5l410t593r745b650],

1	Data	NNS	O	datum	nsubjpass	3	SENT_66	[p5l772t597r924b650],
2	are	VBP	O	be	auxpass	3	SENT_66	[p5l948t613r1045b650],
3	reported	VBN	O	report	_	0	SENT_66	[p5l1069t593r1357b668],
4	as	IN	O	as	_	0	SENT_66	[p5l1380t613r1445b650],
5	mean	JJ	O	mean	prep_as	3	SENT_66	[p5l1469t613r1653b650],
6	i	FW	O	i	nn	8	SENT_66	[p5l1673t601r1712b651],
7	s.d.	FW	O	s.d.	nn	8	SENT_66	[p5l1733t593r1845b650],
8	Data	NNS	O	datum	nsubjpass	13	SENT_66	[p5l10t679r161b732],
9	in	IN	O	in	_	0	SENT_66	[p5l213t678r280b732],
10	the	DT	O	the	det	11	SENT_66	[p5l331t675r435b732],
11	plots	NNS	O	plot	prep_in	8	SENT_66	[p5l488t675r653b750],
12	were	VBD	O	be	auxpass	13	SENT_66	[p5l706t695r868b732],
13	estimated	VBN	O	estimate	rcmod	5	SENT_66	[p5l923t675r1250b732],
14	using	VBG	O	use	xcomp	13	SENT_66	[p5l1302t678r1486b750],
15	the	DT	O	the	det	17	SENT_66	[p5l1538t675r1642b732],
16	final	JJ	O	final	amod	17	SENT_66	[p5l1696t675r1849b732],
17	model	NN	O	model	dobj	14	SENT_66	[p5l10t759r241b826],
18	,	,	O	,	_	0	SENT_66	[p5l10t759r241b826],
19	which	WDT	O	which	nsubj	20	SENT_66	[p5l307t759r521b817],
20	included	VBD	O	include	rcmod	17	SENT_66	[p5l585t759r890b817],
21	the	DT	O	the	det	22	SENT_66	[p5l952t759r1057b817],
22	covariates	NNS	O	covariate	nsubj	23	SENT_66	[p5l1123t763r1461b817],
23	(	VBP	O	(	ccomp	20	SENT_66	[p5l1530t760r1661b827],
24	sex	NN	O	sex	nn	28	SENT_66	[p5l1530t760r1661b827],
25	and	CC	O	and	_	0	SENT_66	[p5l1725t759r1850b817],
26	smoking	NN	O	smoking	nn	28	SENT_66	[p5l12t843r297b918],
27	status	NN	O	status	nn	28	SENT_66	[p5l328t843r544b910],
28	)	NN	O	)	dobj	23	SENT_66	[p5l328t843r544b910],
29	and	CC	O	and	_	0	SENT_66	[p5l577t843r702b900],
30	genotype	NN	O	genotype	dobj	23	SENT_66	[p5l730t851r1055b918],
31	.	.	O	.	_	0	SENT_66	[p5l730t851r1055b918],

1	To	TO	O	to	aux	2	SENT_67	[p5l85t929r165b982],
2	address	VB	O	address	purpcl	24	SENT_67	[p5l201t925r457b982],
3	the	DT	O	the	det	4	SENT_67	[p5l492t925r597b982],
4	possibility	NN	O	possibility	dobj	2	SENT_67	[p5l632t925r991b1000],
5	of	IN	O	of	_	0	SENT_67	[p5l1025t925r1092b982],
6	population	NN	O	population	nn	7	SENT_67	[p5l1120t925r1496b1000],
7	stratification	NN	O	stratification	prep_of	4	SENT_67	[p5l1531t925r1849b982, p5l10t1011r162b1075],
8	,	,	O	,	_	0	SENT_67	[p5l1531t925r1849b982, p5l10t1011r162b1075],
9	which	WDT	O	which	nsubj	11	SENT_67	[p5l214t1008r428b1066],
10	could	MD	O	could	aux	11	SENT_67	[p5l479t1008r669b1066],
11	result	VB	O	result	rcmod	7	SENT_67	[p5l718t1008r913b1066],
12	in	IN	O	in	_	0	SENT_67	[p5l962t1011r1029b1065],
13	finding	VBG	O	find	prepc_in	11	SENT_67	[p5l1079t1008r1325b1083],
14	false	JJ	O	false	amod	16	SENT_67	[p5l1375t1008r1528b1066],
15	positive	JJ	O	positive	amod	16	SENT_67	[p5l1579t1011r1849b1084],
16	associations	NNS	O	association	dobj	13	SENT_67	[p5l11t1095r421b1149],
17	in	IN	O	in	_	0	SENT_67	[p5l445t1095r512b1148],
18	this	DT	O	this	det	19	SENT_67	[p5l534t1092r658b1149],
19	subset	NN	O	subset	prep_in	13	SENT_67	[p5l684t1092r897b1149],
20	of	IN	O	of	_	0	SENT_67	[p5l920t1092r987b1149],
21	patients	NNS	O	patient	prep_of	19	SENT_67	[p5l1003t1095r1292b1167],
22	,	,	O	,	_	0	SENT_67	[p5l1003t1095r1292b1167],
23	we	PRP	O	we	nsubj	24	SENT_67	[p5l1316t1112r1412b1149],
24	completed	VBD	O	complete	_	0	SENT_67	[p5l1437t1092r1794b1167],
25	a	DT	O	a	det	31	SENT_67	[p5l1817t1112r1851b1149],
26	multidimensional	JJ	O	multidimensional	amod	31	SENT_67	[p5l10t1174r622b1231],
27	scaling	NN	O	scaling	nn	31	SENT_67	[p5l672t1174r908b1249],
28	(	CD	NUMBER	(	num	31	SENT_67	[p5l960t1174r1170b1242],
29	MDS	NN	O	md	nn	31	SENT_67	[p5l960t1174r1170b1242],
30	)	NN	O	)	nn	31	SENT_67	[p5l960t1174r1170b1242],
31	analysis	NN	O	analysis	dobj	24	SENT_67	[p5l1222t1174r1513b1249],
32	.	.	O	.	_	0	SENT_67	[p5l1222t1174r1513b1249],

1	We	PRP	O	we	nsubj	2	SENT_68	[p5l1565t1178r1669b1231],
2	performed	VBD	O	perform	_	0	SENT_68	[p5l1719t1194r1849b1249, p5l11t1257r251b1315],
3	the	DT	O	the	det	5	SENT_68	[p5l274t1257r379b1315],
4	MDS	NN	ORGANIZATION	md	nn	5	SENT_68	[p5l403t1260r568b1315],
5	analysis	NN	O	analysis	nsubjpass	27	SENT_68	[p5l595t1257r867b1332],
6	based	VBN	O	base	partmod	5	SENT_68	[p5l890t1257r1085b1315],
7	on	IN	O	on	_	0	SENT_68	[p5l1110t1278r1192b1315],
8	identify	VB	O	identify	prepc_on	6	SENT_68	[p5l1217t1257r1484b1332],
9	by	IN	O	by	_	0	SENT_68	[p5l1504t1257r1586b1332],
10	state	NN	O	state	prep_by	8	SENT_68	[p5l1611t1266r1762b1315],
11	of	IN	O	of	_	0	SENT_68	[p5l1789t1257r1856b1315],
12	the	DT	O	the	det	15	SENT_68	[p5l10t1341r114b1398],
13	genome-wide	JJ	O	genome-wide	amod	15	SENT_68	[p5l151t1341r609b1416],
14	SNP	NN	ORGANIZATION	snp	nn	15	SENT_68	[p5l649t1344r792b1398],
15	genotypes	NNS	O	genotype	prep_of	10	SENT_68	[p5l829t1349r1170b1416],
16	within	IN	O	within	_	0	SENT_68	[p5l1207t1341r1434b1398],
17	each	DT	O	each	det	19	SENT_68	[p5l1473t1341r1626b1398],
18	racial	JJ	O	racial	amod	19	SENT_68	[p5l1662t1341r1849b1398],
19	group	NN	O	group	prep_within	8	SENT_68	[p5l10t1443r203b1498],
20	and	CC	O	and	_	0	SENT_68	[p5l266t1423r390b1480],
21	the	DT	O	the	det	25	SENT_68	[p5l448t1423r552b1480],
22	first	JJ	ORDINAL	first	amod	25	SENT_68	[p5l613t1423r746b1480],
23	two	CD	NUMBER	two	num	25	SENT_68	[p5l803t1431r927b1480],
24	MDS	NN	ORGANIZATION	md	nn	25	SENT_68	[p5l986t1426r1151b1480],
25	components	NNS	O	component	conj_and	19	SENT_68	[p5l1214t1431r1627b1498],
26	were	VBD	O	be	auxpass	27	SENT_68	[p5l1687t1443r1849b1480],
27	extracted	VBN	O	extract	ccomp	2	SENT_68	[p5l12t1506r323b1564],
28	to	TO	O	to	aux	30	SENT_68	[p5l357t1515r419b1564],
29	be	VB	O	be	auxpass	30	SENT_68	[p5l453t1506r529b1564],
30	used	VBN	O	use	xcomp	27	SENT_68	[p5l564t1506r724b1564],
31	as	IN	O	as	_	0	SENT_68	[p5l761t1527r824b1564],
32	covariates	NNS	O	covariate	prep_as	30	SENT_68	[p5l863t1509r1200b1564],
33	in	IN	O	in	_	0	SENT_68	[p5l1238t1509r1305b1563],
34	drug	NN	O	drug	nn	36	SENT_68	[p5l1342t1506r1494b1581],
35	clearance	NN	O	clearance	nn	36	SENT_68	[p5l1531t1506r1849b1564],
36	analysis	NN	O	analysis	prep_in	32	SENT_68	[p5l11t1590r302b1665],
37	.	.	O	.	_	0	SENT_68	[p5l11t1590r302b1665],

1	The	DT	O	the	nsubj	2	SENT_69	[p5l328t1590r457b1647],
2	identify	VBP	O	identify	_	0	SENT_69	[p5l479t1590r746b1665],
3	by	IN	O	by	_	0	SENT_69	[p5l764t1590r847b1665],
4	state	NN	O	state	prep_by	2	SENT_69	[p5l869t1598r1021b1647],
5	and	CC	O	and	_	0	SENT_69	[p5l1044t1590r1169b1647],
6	MDS	NN	O	md	nn	7	SENT_69	[p5l1190t1593r1355b1647],
7	analyses	NNS	O	analysis	nsubjpass	9	SENT_69	[p5l1380t1590r1664b1665],
8	were	VBD	O	be	auxpass	9	SENT_69	[p5l1687t1610r1849b1647],
9	completed	VBN	O	complete	conj_and	2	SENT_69	[p5l12t1672r368b1747],
10	using	VBG	O	use	xcomp	9	SENT_69	[p5l428t1675r612b1747],
11	PLINK8	NN	O	plink8	nn	16	SENT_69	[p5l672t1672r925b1728],
12	and	CC	O	and	_	0	SENT_69	[p5l986t1672r1111b1729],
13	R	NN	O	r	nn	16	SENT_69	[p5l1170t1676r1219b1728],
14	package	NN	O	package	nn	16	SENT_69	[p5l1277t1672r1547b1747],
15	(	CD	NUMBER	(	num	16	SENT_69	[p5l1612t1672r1849b1747],
16	http	NN	O	http	dobj	10	SENT_69	[p5l1612t1672r1849b1747],
17	:	:	O	:	_	0	SENT_69	[p5l1612t1672r1849b1747],
18	/	:	O	/	punct	22	SENT_69	[p5l1612t1672r1849b1747],
19	/	:	O	/	punct	20	SENT_69	[p5l1612t1672r1849b1747],
20	www.r-project.org	JJ	O	www.r-project.org	dep	22	SENT_69	[p5l10t1755r697b1830],
21	/	:	O	/	punct	20	SENT_69	[p5l10t1755r697b1830],
22	)	NN	O	)	dobj	9	SENT_69	[p5l10t1755r697b1830],
23	.	.	O	.	_	0	SENT_69	[p5l10t1755r697b1830],

1	Results	NNS	O	result	_	0	SENT_70	[p5l11t1961r267b2019],

1	Patient	NN	O	patient	nn	2	SENT_71	[p5l10t2096r249b2150],
2	demographics	NNS	O	demographic	nsubjpass	4	SENT_71	[p5l276t2093r750b2168],
3	are	VBP	O	be	auxpass	4	SENT_71	[p5l779t2113r877b2150],
4	listed	VBN	O	list	_	0	SENT_71	[p5l904t2093r1091b2150],
5	in	IN	O	in	_	0	SENT_71	[p5l1117t2096r1184b2149],
6	Table	NNP	O	Table	prep_in	4	SENT_71	[p5l1209t2093r1389b2150],
7	1	CD	NUMBER	1	num	6	SENT_71	[p5l1419t2101r1469b2150],
8	.	.	O	.	_	0	SENT_71	[p5l1419t2101r1469b2150],

1	There	EX	O	there	expl	2	SENT_72	[p5l1499t2093r1694b2150],
2	was	VBD	O	be	_	0	SENT_72	[p5l1719t2113r1848b2150],
3	a	DT	O	a	det	5	SENT_72	[p5l11t2195r45b2232],
4	ninefold	RB	O	ninefold	amod	5	SENT_72	[p5l74t2175r362b2232],
5	difference	NN	O	difference	nsubj	2	SENT_72	[p5l395t2175r733b2232],
6	in	IN	O	in	prep	5	SENT_72	[p5l765t2178r832b2231],
7	clearance	NN	O	clearance	dep	16	SENT_72	[p5l864t2175r1182b2232],
8	across	IN	O	across	_	0	SENT_72	[p5l1214t2195r1420b2232],
9	the	DT	O	the	det	11	SENT_72	[p5l1451t2175r1556b2232],
10	population	NN	O	population	nn	11	SENT_72	[p5l1587t2175r1849b2250, p5l10t2261r144b2315],
11	(	NN	O	(	prep_across	7	SENT_72	[p5l186t2258r390b2333],
12	range	NN	O	range	dep	16	SENT_72	[p5l186t2258r390b2333],
13	6.941	CD	NUMBER	6.941	num	12	SENT_72	[p5l431t2266r838b2315],
14	—	CD	NUMBER	—	number	15	SENT_72	[p5l431t2266r838b2315],
15	60.09	CD	NUMBER	60.09	num	16	SENT_72	[p5l431t2266r838b2315],
16	litre	NN	O	litre	dep	26	SENT_72	[p5l857t2258r992b2315],
17	per	IN	O	per	_	0	SENT_72	[p5l1032t2278r1141b2333],
18	hour	NN	DURATION	hour	nn	19	SENT_72	[p5l1178t2258r1359b2326],
19	)	NN	O	)	prep_per	16	SENT_72	[p5l1178t2258r1359b2326],
20	with	IN	O	with	_	0	SENT_72	[p5l1400t2258r1556b2315],
21	a	DT	O	a	det	23	SENT_72	[p5l1595t2278r1629b2315],
22	mean	JJ	O	mean	amod	23	SENT_72	[p5l1666t2278r1850b2315],
23	clearance	NN	O	clearance	prep_with	19	SENT_72	[p5l12t2342r330b2399],
24	of	IN	O	of	_	0	SENT_72	[p5l355t2342r422b2399],
25	25.83	CD	NUMBER	25.83	prep_of	23	SENT_72	[p5l442t2350r617b2399],
26	i	FW	O	i	dep	6	SENT_72	[p5l641t2349r680b2400],
27	9.920	CD	NUMBER	9.920	num	28	SENT_72	[p5l702t2350r881b2399],
28	litre	NN	O	litre	dep	26	SENT_72	[p5l899t2342r1035b2399],
29	per	IN	O	per	_	0	SENT_72	[p5l1059t2362r1168b2417],
30	hour	NN	DURATION	hour	prep_per	28	SENT_72	[p5l1189t2342r1360b2399],
31	.	.	O	.	_	0	SENT_72	[p5l1189t2342r1360b2399],

1	Similar	JJ	O	similar	_	0	SENT_73	[p5l1390t2342r1639b2399],
2	to	TO	O	to	_	0	SENT_73	[p5l1659t2350r1721b2399],
3	the	DT	O	the	det	6	SENT_73	[p5l1745t2342r1849b2399],
4	original	JJ	O	original	amod	6	SENT_73	[p5l12t2424r272b2499],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_73	[p5l323t2424r895b2499],
6	analysis	NN	O	analysis	prep_to	1	SENT_73	[p5l949t2424r1270b2499],
7	?	.	O	?	_	0	SENT_73	[p5l949t2424r1270b2499],

1	men	NNS	O	man	nsubj	2	SENT_74	[p5l1322t2444r1469b2481],
2	had	VBD	O	have	dep	46	SENT_74	[p5l1519t2424r1645b2481],
3	25	CD	PERCENT	25	num	4	SENT_74	[p5l1699t2424r1843b2485],
4	%	NN	PERCENT	%	dobj	2	SENT_74	[p5l1699t2424r1843b2485],
5	higher	JJR	O	higher	amod	6	SENT_74	[p5l10t2507r228b2582],
6	clearance	NN	O	clearance	dep	9	SENT_74	[p5l301t2507r619b2564],
7	than	IN	O	than	dep	9	SENT_74	[p5l692t2507r843b2564],
8	women	NNS	O	woman	nsubj	9	SENT_74	[p5l915t2527r1165b2564],
9	(	VBP	O	(	dep	2	SENT_74	[p5l1241t2507r1441b2575],
10	27.31	CD	NUMBER	27.31	dep	14	SENT_74	[p5l1241t2507r1441b2575],
11	i	FW	O	i	dep	10	SENT_74	[p5l1465t2515r1504b2565],
12	9.975	CD	NUMBER	9.975	num	13	SENT_74	[p5l1526t2515r1702b2564],
13	VS	NN	O	v	dep	14	SENT_74	[p5l1777t2527r1847b2564],
14	21.77	CD	NUMBER	21.77	dep	23	SENT_74	[p5l13t2599r191b2648],
15	i	FW	O	i	dep	14	SENT_74	[p5l213t2598r251b2649],
16	8.613	CD	NUMBER	8.613	num	17	SENT_74	[p5l274t2599r450b2648],
17	litre	NN	O	litre	nsubj	23	SENT_74	[p5l471t2591r606b2648],
18	per	IN	O	per	_	0	SENT_74	[p5l633t2611r743b2666],
19	hour	NN	DURATION	hour	nn	20	SENT_74	[p5l767t2591r969b2659],
20	)	NN	O	)	prep_per	17	SENT_74	[p5l767t2591r969b2659],
21	,	,	O	,	_	0	SENT_74	[p5l767t2591r969b2659],
22	smokers	NNS	O	smoker	appos	20	SENT_74	[p5l999t2591r1274b2648],
23	had	VBD	O	have	csubj	31	SENT_74	[p5l1301t2591r1428b2648],
24	53	CD	PERCENT	53	num	25	SENT_74	[p5l1456t2591r1600b2652],
25	%	NN	PERCENT	%	npadvmod	26	SENT_74	[p5l1456t2591r1600b2652],
26	higher	JJR	O	higher	amod	27	SENT_74	[p5l1632t2591r1851b2666],
27	clearance	NN	O	clearance	dobj	23	SENT_74	[p5l12t2673r330b2730],
28	compared	VBN	O	compare	_	0	SENT_74	[p5l369t2673r705b2748],
29	with	IN	O	with	prepc_compared_with	23	SENT_74	[p5l740t2673r896b2730],
30	nonsmokers	NNS	O	nonsmoker	pobj	23	SENT_74	[p5l932t2673r1342b2730],
31	(	VBP	O	(	ccomp	9	SENT_74	[p5l1385t2673r1587b2741],
32	29.54	CD	NUMBER	29.54	dobj	31	SENT_74	[p5l1385t2673r1587b2741],
33	i	FW	O	i	dep	37	SENT_74	[p5l1609t2680r1647b2731],
34	9.361	CD	NUMBER	9.361	dep	33	SENT_74	[p5l1669t2681r1845b2730],
35	VS	NN	O	v	dep	37	SENT_74	[p5l9t2776r79b2813],
36	19.26	CD	NUMBER	19.26	num	35	SENT_74	[p5l108t2764r285b2813],
37	i	FW	O	i	dep	31	SENT_74	[p5l307t2764r345b2815],
38	7.103	CD	NUMBER	7.103	num	39	SENT_74	[p5l370t2764r544b2813],
39	litre	NN	O	litre	dep	37	SENT_74	[p5l564t2756r700b2813],
40	per	IN	O	per	_	0	SENT_74	[p5l723t2776r833b2831],
41	hour	NN	DURATION	hour	nn	42	SENT_74	[p5l853t2756r1034b2824],
42	)	NN	O	)	prep_per	31	SENT_74	[p5l853t2756r1034b2824],
43	and	CC	O	and	_	0	SENT_74	[p5l1060t2756r1185b2813],
44	African	JJ	MISC	african	amod	45	SENT_74	[p5l1206t2756r1461b2813],
45	Americans	NNPS	MISC	Americans	prep_per	31	SENT_74	[p5l1483t2759r1848b2813],
46	had	VBD	O	have	_	0	SENT_74	[p5l10t2839r136b2896],
47	a	DT	O	a	det	51	SENT_74	[p5l214t2859r248b2896],
48	17	CD	PERCENT	17	num	49	SENT_74	[p5l327t2839r470b2901],
49	%	NN	PERCENT	%	npadvmod	50	SENT_74	[p5l327t2839r470b2901],
50	higher	JJR	O	higher	amod	51	SENT_74	[p5l552t2839r771b2914],
51	clearance	NN	O	clearance	dobj	46	SENT_74	[p5l847t2839r1165b2896],
52	than	IN	O	than	mark	54	SENT_74	[p5l1242t2839r1394b2896],
53	Caucasians	NNPS	MISC	Caucasians	nsubj	54	SENT_74	[p5l1470t2842r1847b2896],
54	(	VBP	O	(	dep	51	SENT_74	[p5l14t2922r216b2990],
55	28.74	CD	NUMBER	28.74	dobj	54	SENT_74	[p5l14t2922r216b2990],
56	i	FW	O	i	dep	55	SENT_74	[p5l238t2929r277b2980],
57	10.08	CD	NUMBER	10.08	dep	55	SENT_74	[p5l300t2930r477b2979],
58	vs	CC	O	vs	_	0	SENT_74	[p5l506t2942r577b2979],
59	24.49	CD	NUMBER	24.49	conj_vs	55	SENT_74	[p5l610t2930r788b2979],
60	i	FW	O	i	dep	59	SENT_74	[p5l810t2929r849b2980],
61	9.584	CD	NUMBER	9.584	num	62	SENT_74	[p5l871t2930r1050b2979],
62	litre	NN	O	litre	nsubj	46	SENT_74	[p5l1068t2922r1204b2979],
63	per	IN	O	per	_	0	SENT_74	[p5l1233t2942r1343b2997],
64	hour	NN	DURATION	hour	nn	65	SENT_74	[p5l1370t2922r1570b2990],
65	)	NN	O	)	prep_per	62	SENT_74	[p5l1370t2922r1570b2990],
66	.	.	O	.	_	0	SENT_74	[p5l1370t2922r1570b2990],

1	We	PRP	O	we	nsubj	2	SENT_75	[p5l84t3009r189b3062],
2	identified	VBD	O	identify	_	0	SENT_75	[p5l235t3005r568b3062],
3	a	DT	O	a	det	5	SENT_75	[p5l614t3025r648b3062],
4	single	JJ	O	single	amod	5	SENT_75	[p5l693t3005r891b3080],
5	SNP	NN	O	snp	dobj	2	SENT_75	[p5l939t3008r1082b3062],
6	in	IN	O	in	_	0	SENT_75	[p5l1129t3008r1196b3062],
7	cytochrome	NN	O	cytochrome	nn	9	SENT_75	[p5l1242t3005r1638b3080],
8	P450	NN	O	p450	nn	9	SENT_75	[p5l1683t3009r1848b3062],
9	3A43	NN	O	3a43	prep_in	2	SENT_75	[p5l13t3092r185b3145],
10	(	CD	NUMBER	(	num	11	SENT_75	[p5l230t3088r597b3156],
11	CYP3A43	NN	O	cyp3a43	dep	9	SENT_75	[p5l230t3088r597b3156],
12	;	:	O	;	_	0	SENT_75	[p5l230t3088r597b3156],
13	rs472660	NN	O	rs472660	nn	14	SENT_75	[p5l636t3088r965b3156],
14	)	NN	O	)	dep	9	SENT_75	[p5l636t3088r965b3156],
15	that	WDT	O	that	nsubj	18	SENT_75	[p5l1004t3088r1136b3145],
16	highly	RB	O	highly	advmod	18	SENT_75	[p5l1170t3088r1389b3163],
17	significantly	RB	O	significantly	advmod	18	SENT_75	[p5l1427t3088r1851b3163],
18	predicted	VBN	O	predict	rcmod	14	SENT_75	[p5l11t3171r336b3246],
19	olanzapine	NN	O	olanzapine	nn	20	SENT_75	[p5l401t3171r773b3246],
20	clearance	NN	O	clearance	dobj	18	SENT_75	[p5l839t3171r1175b3228],
21	.	.	O	.	_	0	SENT_75	[p5l839t3171r1175b3228],

1	The	DT	O	the	det	2	SENT_76	[p5l1243t3171r1371b3228],
2	addition	NN	O	addition	nsubj	21	SENT_76	[p5l1437t3171r1724b3228],
3	of	IN	O	of	_	0	SENT_76	[p5l1789t3171r1856b3228],
4	CYP3A43	NN	O	cyp3a43	nn	5	SENT_76	[p5l11t3257r335b3311],
5	genotype	NN	O	genotype	prep_of	2	SENT_76	[p5l384t3262r692b3329],
6	to	TO	O	to	_	0	SENT_76	[p5l738t3262r800b3311],
7	the	DT	O	the	det	9	SENT_76	[p5l846t3254r950b3311],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_76	[p5l997t3254r1569b3329],
9	model	NN	O	model	prep_to	5	SENT_76	[p5l1616t3254r1847b3320],
10	,	,	O	,	_	0	SENT_76	[p5l1616t3254r1847b3320],
11	which	WDT	O	which	nsubj	13	SENT_76	[p5l10t3337r224b3394],
12	already	RB	O	already	advmod	13	SENT_76	[p5l249t3337r499b3412],
13	included	VBD	O	include	rcmod	2	SENT_76	[p5l524t3337r828b3394],
14	sex	NN	O	sex	dobj	13	SENT_76	[p5l854t3357r979b3403],
15	,	,	O	,	_	0	SENT_76	[p5l854t3357r979b3403],
16	smoking	NN	O	smoking	nn	17	SENT_76	[p5l1009t3337r1294b3412],
17	status	NN	O	status	conj_and	14	SENT_76	[p5l1321t3346r1514b3394],
18	and	CC	O	and	_	0	SENT_76	[p5l1542t3337r1666b3394],
19	race	NN	O	race	dobj	13	SENT_76	[p5l1690t3357r1847b3403],
20	,	,	O	,	_	0	SENT_76	[p5l1690t3357r1847b3403],
21	resulted	VBD	O	result	_	0	SENT_76	[p5l9t3420r286b3477],
22	in	IN	O	in	_	0	SENT_76	[p5l343t3423r410b3476],
23	a	DT	O	a	det	26	SENT_76	[p5l468t3440r501b3477],
24	10.261	CD	NUMBER	10.261	num	26	SENT_76	[p5l561t3428r777b3477],
25	point	NN	O	point	nn	26	SENT_76	[p5l837t3423r1018b3495],
26	decrease	NN	O	decrease	prep_in	21	SENT_76	[p5l1076t3420r1365b3477],
27	in	IN	O	in	_	0	SENT_76	[p5l1423t3423r1490b3476],
28	objective	NN	O	objective	prep_in	21	SENT_76	[p5l1548t3420r1849b3495],

1	@	SYM	O	@	dep	7	SENT_77	[p6l6t44r68b105],
2	CYP3A43	NN	O	cyp3a43	nn	7	SENT_77	[p6l753t45r856b69],
3	and	CC	O	and	_	0	SENT_77	[p6l867t45r905b69],
4	olanzapine	NN	O	olanzapine	nn	7	SENT_77	[p6l915t45r1029b75],
5	metabolism	NN	O	metabolism	nn	7	SENT_77	[p6l1039t45r1161b69],
6	KL	NNP	PERSON	KL	nn	7	SENT_77	[p6l1013t80r1039b103],
7	Bigos	NNP	PERSON	Bigos	_	0	SENT_77	[p6l1050t80r1105b109],
8	et	FW	O	et	nn	9	SENT_77	[p6l1114t81r1134b103],
9	al	FW	O	al	dep	7	SENT_77	[p6l1143t80r1162b103],

1	622	CD	NUMBER	622	num	5	SENT_78	[p6l6t146r53b174],
2	Table	NNP	O	Table	nn	5	SENT_78	[p6l167t170r260b198],
3	1	CD	NUMBER	1	num	5	SENT_78	[p6l275t174r291b197],
4	Patient	NN	O	patient	nn	5	SENT_78	[p6l330t172r443b198],
5	demographics	NNS	O	demographic	_	0	SENT_78	[p6l457t171r681b206],
6	by	IN	O	by	_	0	SENT_78	[p6l694t171r733b206],
7	CYP3A43	NN	O	cyp3a43	nn	8	SENT_78	[p6l746t172r899b198],
8	genotype	NN	O	genotype	prep_by	5	SENT_78	[p6l914t175r1059b206],

1	AI1	NN	O	ai1	nn	3	SENT_79	[p6l349t245r400b273],
2	patients	NNS	O	patient	nn	3	SENT_79	[p6l411t247r546b282],
3	GG	NNS	O	gg	_	0	SENT_79	[p6l819t246r869b273],
4	genotype	NN	O	genotype	nn	8	SENT_79	[p6l880t249r1030b282],
5	GA	NN	O	ga	nn	8	SENT_79	[p6l1303t246r1352b273],
6	genotype	NN	O	genotype	nn	8	SENT_79	[p6l1366t249r1516b282],
7	AA	NN	O	aa	nn	8	SENT_79	[p6l1786t247r1840b273],
8	genotype	NN	O	genotype	dep	3	SENT_79	[p6l1853t249r2003b282],
9	[	CD	NUMBER	[	num	10	SENT_79	[p6l2015t245r2074b278],
10	n	NN	O	n	dep	3	SENT_79	[p6l2015t245r2074b278],
11	=	JJ	O	=	quantmod	13	SENT_79	[p6l2015t245r2074b278],
12	235	CD	NUMBER	235	number	13	SENT_79	[p6l2083t245r2154b279],
13	)	CD	NUMBER	)	num	28	SENT_79	[p6l2083t245r2154b279],
14	(	NN	O	(	nn	28	SENT_79	[p6l1054t290r1192b323],
15	n	NN	O	n	nn	28	SENT_79	[p6l1054t290r1192b323],
16	=	JJ	O	=	amod	28	SENT_79	[p6l1054t290r1192b323],
17	124	CD	NUMBER	124	number	18	SENT_79	[p6l1054t290r1192b323],
18	}	CD	NUMBER	}	num	28	SENT_79	[p6l1054t290r1192b323],
19	[	NN	O	[	nn	28	SENT_79	[p6l1549t290r1668b323],
20	n	NN	O	n	nn	28	SENT_79	[p6l1549t290r1668b323],
21	=	JJ	O	=	amod	28	SENT_79	[p6l1549t290r1668b323],
22	76	CD	NUMBER	76	number	23	SENT_79	[p6l1549t290r1668b323],
23	]	CD	NUMBER	]	num	28	SENT_79	[p6l1549t290r1668b323],
24	[	NN	O	[	nn	28	SENT_79	[p6l2035t290r2154b323],
25	n	NN	O	n	nn	28	SENT_79	[p6l2035t290r2154b323],
26	=	JJ	O	=	amod	28	SENT_79	[p6l2035t290r2154b323],
27	35	CD	NUMBER	35	num	28	SENT_79	[p6l2035t290r2154b323],
28	)	NN	O	)	dep	10	SENT_79	[p6l2035t290r2154b323],

1	Sex	NN	O	sex	nn	3	SENT_80	[p6l170t378r228b405],
2	63	CD	NUMBER	63	num	3	SENT_80	[p6l588t381r623b405],
3	F	NN	O	f	dep	12	SENT_80	[p6l639t379r659b405],
4	(	CD	PERCENT	(	num	6	SENT_80	[p6l675t377r770b410],
5	27	CD	PERCENT	27	num	6	SENT_80	[p6l675t377r770b410],
6	%	NN	PERCENT	%	dep	3	SENT_80	[p6l675t377r770b410],
7	)	CD	NUMBER	)	number	8	SENT_80	[p6l675t377r770b410],
8	31	CD	NUMBER	31	dep	6	SENT_80	[p6l1064t381r1099b405],
9	F	NN	O	f	dep	12	SENT_80	[p6l1114t379r1135b405],
10	(	CD	PERCENT	(	num	9	SENT_80	[p6l1151t377r1246b410],
11	25	CD	PERCENT	25	num	12	SENT_80	[p6l1151t377r1246b410],
12	%	NN	PERCENT	%	dep	19	SENT_80	[p6l1151t377r1246b410],
13	)	CD	NUMBER	)	number	14	SENT_80	[p6l1151t377r1246b410],
14	18	CD	NUMBER	18	num	15	SENT_80	[p6l1549t381r1585b405],
15	F	NN	O	f	dep	12	SENT_80	[p6l1599t379r1620b405],
16	(	CD	PERCENT	(	num	18	SENT_80	[p6l1636t377r1731b410],
17	24	CD	PERCENT	24	num	18	SENT_80	[p6l1636t377r1731b410],
18	%	NN	PERCENT	%	dep	15	SENT_80	[p6l1636t377r1731b410],
19	)	CD	NUMBER	)	dep	21	SENT_80	[p6l1636t377r1731b410],
20	14	CD	NUMBER	14	num	21	SENT_80	[p6l2036t381r2071b405],
21	F	NN	O	f	_	0	SENT_80	[p6l2086t379r2106b405],

1	Smokers	NNS	O	smoker	dep	8	SENT_81	[p6l170t472r309b500],
2	150	CD	PERCENT	150	number	3	SENT_81	[p6l603t476r659b500],
3	(	CD	PERCENT	(	dep	1	SENT_81	[p6l675t472r771b505],
4	64	CD	PERCENT	64	num	5	SENT_81	[p6l675t472r771b505],
5	%	NN	PERCENT	%	dep	3	SENT_81	[p6l675t472r771b505],
6	)	CD	NUMBER	)	dep	8	SENT_81	[p6l675t472r771b505],
7	76	CD	NUMBER	76	num	8	SENT_81	[p6l1099t476r1135b500],
8	(	NN	O	(	dep	13	SENT_81	[p6l1151t472r1246b505],
9	61	CD	PERCENT	61	num	10	SENT_81	[p6l1151t472r1246b505],
10	%	NN	PERCENT	%	dep	8	SENT_81	[p6l1151t472r1246b505],
11	)	CD	NUMBER	)	num	13	SENT_81	[p6l1151t472r1246b505],
12	51	CD	NUMBER	51	num	13	SENT_81	[p6l1583t476r1618b500],
13	(	NN	O	(	dep	17	SENT_81	[p6l1636t472r1732b505],
14	67	CD	PERCENT	67	num	15	SENT_81	[p6l1636t472r1732b505],
15	%	NN	PERCENT	%	dep	13	SENT_81	[p6l1636t472r1732b505],
16	)	CD	NUMBER	)	num	17	SENT_81	[p6l1636t472r1732b505],
17	23	CD	NUMBER	23	_	0	SENT_81	[p6l2070t476r2105b500],

1	Table	NNP	O	Table	dep	7	SENT_82	[p6l87t659r180b687],
2	2	CD	NUMBER	2	num	5	SENT_82	[p6l195t663r211b687],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_82	[p6l250t660r520b687],
4	model	NN	O	model	nn	5	SENT_82	[p6l534t660r635b687],
5	statistics	NNS	O	statistics	dep	1	SENT_82	[p6l649t661r787b687],
6	Model	NNP	O	Model	dep	7	SENT_82	[p6l87t731r191b759],
7	parameters	NNS	O	parameter	dep	14	SENT_82	[p6l202t735r390b768],
8	Objective	NNP	O	Objective	nn	9	SENT_82	[p6l633t731r785b768],
9	Change	NNP	O	Change	dep	7	SENT_82	[p6l918t731r1040b768],
10	from	IN	O	from	_	0	SENT_82	[p6l1050t731r1130b768],
11	Change	NNP	O	Change	prep_from	9	SENT_82	[p6l1285t731r1408b768],
12	from	IN	O	from	_	0	SENT_82	[p6l1417t731r1497b768],
13	P-Value	NNP	O	P-Value	prep_from	11	SENT_82	[p6l1665t731r1790b759],
14	based	VBN	O	base	_	0	SENT_82	[p6l1804t731r1900b759],
15	Total	JJ	O	total	amod	20	SENT_82	[p6l2060t731r2142b759],
16	function	NN	O	function	nn	20	SENT_82	[p6l635t772r776b809],
17	base	NN	O	base	nn	20	SENT_82	[p6l930t772r1002b800],
18	model	NN	O	model	nn	20	SENT_82	[p6l1015t772r1119b800],
19	previous	JJ	O	previous	amod	20	SENT_82	[p6l1260t774r1404b809],
20	model	NN	O	model	dep	14	SENT_82	[p6l1417t772r1521b800],
21	on	IN	O	on	_	0	SENT_82	[p6l1652t782r1690b800],
22	change	NN	O	change	prep_on	20	SENT_82	[p6l1706t772r1823b809],
23	from	IN	O	from	_	0	SENT_82	[p6l1833t772r1912b809],
24	R2	NN	O	r2	prep_from	22	SENT_82	[p6l2080t772r2117b800],

1	base	NN	O	base	nn	2	SENT_83	[p6l1688t814r1761b842],
2	model	NN	O	model	_	0	SENT_83	[p6l1773t814r1878b842],

1	Smoking	NN	O	smoking	dep	43	SENT_84	[p6l89t904r233b941],
2	and	CC	O	and	_	0	SENT_84	[p6l247t904r308b932],
3	sex	NN	O	sex	dep	43	SENT_84	[p6l322t914r375b932],
4	5814.858	CD	NUMBER	5814.858	dep	1	SENT_84	[p6l635t908r781b932],
5	NA	NNP	O	NA	nn	9	SENT_84	[p6l995t906r1051b932],
6	NA	NNP	O	NA	nn	9	SENT_84	[p6l1362t906r1418b932],
7	NA	NNP	O	NA	nn	9	SENT_84	[p6l1754t906r1809b932],
8	0.3327	CD	NUMBER	0.3327	num	9	SENT_84	[p6l2045t908r2152b932],
9	Smoking	NNP	O	Smoking	rcmod	4	SENT_84	[p6l89t945r242b981],
10	,	,	O	,	_	0	SENT_84	[p6l89t945r242b981],
11	sex	NN	O	sex	appos	9	SENT_84	[p6l258t955r319b977],
12	,	,	O	,	_	0	SENT_84	[p6l258t955r319b977],
13	race	NN	O	race	appos	9	SENT_84	[p6l333t955r400b973],
14	5809.365	CD	NUMBER	5809.365	num	13	SENT_84	[p6l635t949r781b973],
15	-5.493	CD	NUMBER	-5.493	num	16	SENT_84	[p6l977t949r1090b973],
16	-5.493	CD	NUMBER	-5.493	dep	13	SENT_84	[p6l1344t949r1457b973],
17	0.019	CD	NUMBER	0.019	number	18	SENT_84	[p6l1738t949r1825b973],
18	0.3627	CD	NUMBER	0.3627	num	19	SENT_84	[p6l2045t949r2152b973],
19	Smoking	NN	O	smoking	dep	16	SENT_84	[p6l89t986r242b1023],
20	,	,	O	,	_	0	SENT_84	[p6l89t986r242b1023],
21	sex	NN	O	sex	appos	9	SENT_84	[p6l258t996r319b1018],
22	,	,	O	,	_	0	SENT_84	[p6l258t996r319b1018],
23	race	NN	O	race	appos	9	SENT_84	[p6l333t996r409b1018],
24	,	,	O	,	_	0	SENT_84	[p6l333t996r409b1018],
25	gene	NN	O	gene	appos	9	SENT_84	[p6l424t996r499b1023],
26	5799.104	CD	NUMBER	5799.104	num	25	SENT_84	[p6l635t990r781b1014],
27	—	CD	NUMBER	—	number	28	SENT_84	[p6l957t990r1090b1014],
28	15.754	CD	NUMBER	15.754	num	29	SENT_84	[p6l957t990r1090b1014],
29	—	NN	O	—	dep	25	SENT_84	[p6l1324t990r1457b1014],
30	10.261	CD	NUMBER	10.261	number	31	SENT_84	[p6l1324t990r1457b1014],
31	7.2	CD	NUMBER	7.2	num	34	SENT_84	[p6l1735t986r1830b1014],
32	e	SYM	O	e	dep	34	SENT_84	[p6l1735t986r1830b1014],
33	’	CD	NUMBER	’	number	34	SENT_84	[p6l1735t986r1830b1014],
34	5	CD	NUMBER	5	dep	25	SENT_84	[p6l1735t986r1830b1014],
35	0.4122	CD	NUMBER	0.4122	num	36	SENT_84	[p6l2045t990r2151b1014],
36	Smoking	NN	O	smoking	dep	34	SENT_84	[p6l89t1027r242b1064],
37	,	,	O	,	_	0	SENT_84	[p6l89t1027r242b1064],
38	sex	NN	O	sex	appos	9	SENT_84	[p6l258t1037r319b1059],
39	,	,	O	,	_	0	SENT_84	[p6l258t1037r319b1059],
40	gene	NN	O	gene	dep	43	SENT_84	[p6l333t1037r408b1064],
41	5799.104	CD	NUMBER	5799.104	num	40	SENT_84	[p6l635t1031r781b1055],
42	—	CD	NUMBER	—	num	43	SENT_84	[p6l957t1031r1090b1055],
43	15.754	CD	NUMBER	15.754	dep	49	SENT_84	[p6l957t1031r1090b1055],
44	o	NN	O	o	dep	43	SENT_84	[p6l1382t1031r1399b1055],
45	7.2	CD	NUMBER	7.2	num	44	SENT_84	[p6l1735t1027r1830b1055],
46	e	SYM	O	e	dep	48	SENT_84	[p6l1735t1027r1830b1055],
47	’	CD	NUMBER	’	number	48	SENT_84	[p6l1735t1027r1830b1055],
48	5	CD	NUMBER	5	dep	44	SENT_84	[p6l1735t1027r1830b1055],
49	0.4122	CD	NUMBER	0.4122	_	0	SENT_84	[p6l2045t1031r2151b1055],

1	Table	NNP	O	Table	_	0	SENT_85	[p6l307t1231r480b1283],
2	3	CD	NUMBER	3	num	3	SENT_85	[p6l507t1239r537b1283],
3	CYP3A43	NN	O	cyp3a43	dep	1	SENT_85	[p6l611t1235r894b1283],
4	genotype	NN	O	genotype	nn	5	SENT_85	[p6l922t1240r1190b1299],
5	frequency	NN	O	frequency	dep	1	SENT_85	[p6l1217t1233r1512b1299],

1	GG	NNS	O	gg	nsubj	2	SENT_86	[p6l1280t1384r1372b1432],
2	GA	VBP	O	ga	_	0	SENT_86	[p6l1632t1384r1723b1432],
3	AA	NN	O	aa	dobj	2	SENT_86	[p6l1960t1385r2060b1432],

1	Caucasian	JJ	MISC	caucasian	amod	3	SENT_87	[p6l309t1556r620b1604],
2	(	NN	O	(	nn	3	SENT_87	[p6l649t1553r900b1613],
3	n	NN	O	n	dep	8	SENT_87	[p6l649t1553r900b1613],
4	=	JJ	O	=	dep	3	SENT_87	[p6l649t1553r900b1613],
5	161	CD	NUMBER	161	num	6	SENT_87	[p6l649t1553r900b1613],
6	)	NN	O	)	dep	8	SENT_87	[p6l649t1553r900b1613],
7	118	CD	NUMBER	118	num	8	SENT_87	[p6l1167t1560r1269b1604],
8	(	NN	O	(	dep	15	SENT_87	[p6l1301t1553r1477b1613],
9	73	CD	PERCENT	73	num	10	SENT_87	[p6l1301t1553r1477b1613],
10	%	NN	PERCENT	%	dep	8	SENT_87	[p6l1301t1553r1477b1613],
11	)	CD	NUMBER	)	number	12	SENT_87	[p6l1301t1553r1477b1613],
12	39	CD	NUMBER	39	num	13	SENT_87	[p6l1539t1560r1605b1604],
13	(	NN	O	(	dep	10	SENT_87	[p6l1636t1553r1813b1613],
14	24	CD	PERCENT	24	num	15	SENT_87	[p6l1636t1553r1813b1613],
15	%	NN	PERCENT	%	dep	25	SENT_87	[p6l1636t1553r1813b1613],
16	)	CD	NUMBER	)	number	17	SENT_87	[p6l1636t1553r1813b1613],
17	4	CD	NUMBER	4	num	18	SENT_87	[p6l1908t1561r1941b1603],
18	(	NN	O	(	dep	15	SENT_87	[p6l1971t1553r2111b1613],
19	2	CD	PERCENT	2	number	20	SENT_87	[p6l1971t1553r2111b1613],
20	%	NN	PERCENT	%	amod	18	SENT_87	[p6l1971t1553r2111b1613],
21	)	CD	NUMBER	)	num	25	SENT_87	[p6l1971t1553r2111b1613],
22	African	JJ	MISC	african	amod	25	SENT_87	[p6l307t1629r537b1680],
23	American	JJ	MISC	american	amod	25	SENT_87	[p6l562t1632r862b1680],
24	(	NN	O	(	nn	25	SENT_87	[p6l891t1629r999b1690],
25	n	NN	O	n	dep	32	SENT_87	[p6l891t1629r999b1690],
26	=	JJ	O	=	quantmod	28	SENT_87	[p6l891t1629r999b1690],
27	74	CD	NUMBER	74	number	28	SENT_87	[p6l1019t1629r1105b1690],
28	)	CD	NUMBER	)	dep	25	SENT_87	[p6l1019t1629r1105b1690],
29	6	CD	NUMBER	6	num	30	SENT_87	[p6l1240t1636r1270b1680],
30	(	NN	O	(	dep	28	SENT_87	[p6l1301t1629r1440b1690],
31	8	CD	PERCENT	8	num	32	SENT_87	[p6l1301t1629r1440b1690],
32	%	NN	PERCENT	%	dep	40	SENT_87	[p6l1301t1629r1440b1690],
33	)	CD	PERCENT	)	number	34	SENT_87	[p6l1301t1629r1440b1690],
34	37	CD	PERCENT	37	dep	32	SENT_87	[p6l1539t1636r1605b1680],
35	(	CD	PERCENT	(	num	37	SENT_87	[p6l1636t1629r1813b1690],
36	50	CD	PERCENT	50	num	37	SENT_87	[p6l1636t1629r1813b1690],
37	%	NN	PERCENT	%	dep	34	SENT_87	[p6l1636t1629r1813b1690],
38	)	CD	NUMBER	)	num	40	SENT_87	[p6l1636t1629r1813b1690],
39	31	CD	NUMBER	31	num	40	SENT_87	[p6l1874t1636r1938b1680],
40	(	NN	O	(	dep	43	SENT_87	[p6l1971t1629r2148b1690],
41	42	CD	PERCENT	42	num	42	SENT_87	[p6l1971t1629r2148b1690],
42	%	NN	PERCENT	%	dep	40	SENT_87	[p6l1971t1629r2148b1690],
43	)	CD	NUMBER	)	_	0	SENT_87	[p6l1971t1629r2148b1690],

1	function	NN	O	function	nn	2	SENT_88	[p6l309t1887r597b1944],
2	Value	NN	O	value	_	0	SENT_88	[p6l660t1887r844b1944],
3	(	CD	NUMBER	(	num	4	SENT_88	[p6l914t1887r1019b1958],
4	X2	NN	O	x2	dep	2	SENT_88	[p6l914t1887r1019b1958],
5	,	,	O	,	_	0	SENT_88	[p6l914t1887r1019b1958],
6	d.f.	NN	O	d.f.	appos	2	SENT_88	[p6l1089t1887r1326b1953],
7	=	JJ	O	=	amod	6	SENT_88	[p6l1089t1887r1326b1953],
8	1	CD	NUMBER	1	tmod	7	SENT_88	[p6l1089t1887r1326b1953],
9	,	,	O	,	_	0	SENT_88	[p6l1089t1887r1326b1953],
10	P	NN	O	p	dep	2	SENT_88	[p6l1393t1891r1753b1953],
11	=	JJ	O	=	amod	10	SENT_88	[p6l1393t1891r1753b1953],
12	0.0014	CD	NUMBER	0.0014	tmod	11	SENT_88	[p6l1393t1891r1753b1953],
13	;	:	O	;	_	0	SENT_88	[p6l1393t1891r1753b1953],
14	Table	NNP	O	Table	dep	2	SENT_88	[p6l1821t1887r2001b1944],
15	2	CD	NUMBER	2	number	16	SENT_88	[p6l2070t1887r2146b1954],
16	)	CD	NUMBER	)	dep	14	SENT_88	[p6l2070t1887r2146b1954],
17	.	.	O	.	_	0	SENT_88	[p6l2070t1887r2146b1954],

1	Interestingly	RB	O	interestingly	advmod	18	SENT_89	[p6l308t1969r751b2044],
2	,	,	O	,	_	0	SENT_89	[p6l308t1969r751b2044],
3	when	WRB	O	when	advmod	7	SENT_89	[p6l790t1969r980b2027],
4	CYP3A43	NN	O	cyp3a43	nn	5	SENT_89	[p6l1018t1972r1342b2027],
5	genotype	NN	O	genotype	nsubjpass	7	SENT_89	[p6l1382t1978r1691b2045],
6	was	VBD	O	be	auxpass	7	SENT_89	[p6l1728t1990r1857b2027],
7	entered	VBN	O	enter	advcl	18	SENT_89	[p6l1897t1969r2151b2027],
8	into	IN	O	into	_	0	SENT_89	[p6l309t2056r441b2110],
9	the	DT	O	the	det	10	SENT_89	[p6l493t2053r597b2110],
10	model	NN	O	model	prep_into	7	SENT_89	[p6l650t2053r881b2119],
11	,	,	O	,	_	0	SENT_89	[p6l650t2053r881b2119],
12	race	NN	O	race	nsubj	18	SENT_89	[p6l934t2073r1072b2110],
13	was	VBD	O	be	cop	18	SENT_89	[p6l1124t2073r1253b2110],
14	no	RB	O	no	advmod	15	SENT_89	[p6l1306t2073r1389b2110],
15	longer	RB	O	longer	advmod	18	SENT_89	[p6l1443t2053r1656b2128],
16	a	DT	O	a	det	18	SENT_89	[p6l1707t2073r1741b2110],
17	significant	JJ	O	significant	amod	18	SENT_89	[p6l1793t2053r2152b2128],
18	predictor	NN	O	predictor	_	0	SENT_89	[p6l308t2135r622b2210],
19	of	IN	O	of	_	0	SENT_89	[p6l669t2135r736b2192],
20	olanzapine	NN	O	olanzapine	nn	21	SENT_89	[p6l779t2135r1152b2210],
21	clearance	NN	O	clearance	prep_of	18	SENT_89	[p6l1201t2135r1538b2192],
22	.	.	O	.	_	0	SENT_89	[p6l1201t2135r1538b2192],

1	When	WRB	O	when	advmod	4	SENT_90	[p6l1588t2135r1790b2192],
2	race	NN	O	race	nsubjpass	4	SENT_90	[p6l1835t2155r1973b2192],
3	was	VBD	O	be	auxpass	4	SENT_90	[p6l2020t2155r2149b2192],
4	removed	VBN	O	remove	advcl	14	SENT_90	[p6l307t2218r604b2276],
5	from	IN	O	from	_	0	SENT_90	[p6l639t2218r797b2276],
6	the	DT	O	the	det	7	SENT_90	[p6l830t2218r934b2276],
7	model	NN	O	model	prep_from	4	SENT_90	[p6l969t2218r1200b2284],
8	,	,	O	,	_	0	SENT_90	[p6l969t2218r1200b2284],
9	the	DT	O	the	det	11	SENT_90	[p6l1237t2218r1341b2276],
10	objective	JJ	O	objective	amod	11	SENT_90	[p6l1378t2218r1680b2293],
11	function	NN	O	function	nsubj	14	SENT_90	[p6l1715t2218r2003b2276],
12	did	VBD	O	do	aux	14	SENT_90	[p6l2040t2218r2151b2276],
13	not	RB	O	not	neg	14	SENT_90	[p6l308t2311r418b2360],
14	change	VB	O	change	_	0	SENT_90	[p6l473t2303r728b2378],
15	,	,	O	,	_	0	SENT_90	[p6l473t2303r728b2378],
16	again	RB	O	again	advmod	14	SENT_90	[p6l787t2306r966b2378],
17	indicating	VBG	O	indicate	xcomp	14	SENT_90	[p6l1021t2303r1367b2378],
18	that	IN	O	that	complm	22	SENT_90	[p6l1422t2303r1554b2360],
19	race	NN	O	race	nsubj	22	SENT_90	[p6l1606t2323r1744b2360],
20	no	RB	O	no	advmod	21	SENT_90	[p6l1799t2323r1882b2360],
21	longer	RB	O	longer	advmod	22	SENT_90	[p6l1939t2303r2152b2378],
22	contributed	VBD	O	contribute	ccomp	17	SENT_90	[p6l310t2385r704b2442],
23	to	TO	O	to	_	0	SENT_90	[p6l740t2393r801b2442],
24	the	DT	O	the	det	25	SENT_90	[p6l838t2385r943b2442],
25	estimate	NN	O	estimate	prep_to	22	SENT_90	[p6l981t2388r1262b2442],
26	of	IN	O	of	_	0	SENT_90	[p6l1300t2385r1368b2442],
27	olanzapine	NN	O	olanzapine	nn	28	SENT_90	[p6l1399t2385r1772b2460],
28	clearance	NN	O	clearance	prep_of	25	SENT_90	[p6l1810t2385r2146b2442],
29	.	.	O	.	_	0	SENT_90	[p6l1810t2385r2146b2442],

1	The	DT	O	the	det	2	SENT_91	[p6l309t2468r437b2525],
2	difference	NN	O	difference	nsubj	27	SENT_91	[p6l467t2468r806b2526],
3	between	IN	O	between	_	0	SENT_91	[p6l832t2468r1118b2526],
4	a	DT	O	a	det	6	SENT_91	[p6l1146t2489r1180b2525],
5	base	NN	O	base	nn	6	SENT_91	[p6l1203t2468r1351b2526],
6	model	NN	O	model	prep_between	2	SENT_91	[p6l1378t2468r1591b2526],
7	(	CD	NUMBER	(	dep	6	SENT_91	[p6l1622t2468r1974b2543],
8	including	VBG	O	include	_	0	SENT_91	[p6l1622t2468r1974b2543],
9	only	RB	O	only	advmod	10	SENT_91	[p6l2003t2468r2152b2543],
10	smoking	NN	O	smoking	prep_including	7	SENT_91	[p6l310t2552r596b2627],
11	and	CC	O	and	_	0	SENT_91	[p6l623t2552r748b2609],
12	sex	NN	O	sex	nn	13	SENT_91	[p6l776t2552r905b2619],
13	)	NN	O	)	conj_and	10	SENT_91	[p6l776t2552r905b2619],
14	and	CC	O	and	_	0	SENT_91	[p6l936t2552r1061b2609],
15	the	DT	O	the	det	16	SENT_91	[p6l1086t2552r1191b2609],
16	addition	NN	O	addition	conj_and	10	SENT_91	[p6l1219t2552r1507b2609],
17	of	IN	O	of	_	0	SENT_91	[p6l1535t2552r1602b2609],
18	genotype	NN	O	genotype	prep_of	16	SENT_91	[p6l1621t2560r1930b2627],
19	to	TO	O	to	_	0	SENT_91	[p6l1956t2560r2018b2609],
20	the	DT	O	the	det	22	SENT_91	[p6l2045t2552r2150b2609],
21	base	NN	O	base	nn	22	SENT_91	[p6l306t2634r453b2691],
22	model	NN	O	model	prep_to	18	SENT_91	[p6l488t2634r700b2691],
23	is	VBZ	O	be	cop	27	SENT_91	[p6l736t2637r788b2691],
24	a	DT	O	a	det	27	SENT_91	[p6l825t2654r859b2691],
25	highly	RB	O	highly	advmod	26	SENT_91	[p6l891t2634r1110b2709],
26	significant	JJ	O	significant	amod	27	SENT_91	[p6l1145t2634r1503b2709],
27	change	NN	O	change	_	0	SENT_91	[p6l1538t2634r1774b2709],
28	in	IN	O	in	_	0	SENT_91	[p6l1809t2637r1876b2690],
29	-15.75	CD	NUMBER	-15.75	num	30	SENT_91	[p6l1915t2643r2147b2691],
30	points	NNS	O	point	prep_in	27	SENT_91	[p6l308t2720r519b2792],
31	(	CD	NUMBER	(	num	32	SENT_91	[p6l583t2717r703b2785],
32	P	NN	O	p	dep	30	SENT_91	[p6l583t2717r703b2785],
33	=	JJ	O	=	amod	30	SENT_91	[p6l583t2717r703b2785],
34	7.2	CD	NUMBER	7.2	number	33	SENT_91	[p6l726t2717r968b2785],
35	e	SYM	O	e	dep	36	SENT_91	[p6l726t2717r968b2785],
36	‘	CD	NUMBER	‘	dep	38	SENT_91	[p6l726t2717r968b2785],
37	5	CD	NUMBER	5	num	38	SENT_91	[p6l726t2717r968b2785],
38	)	NN	O	)	dep	27	SENT_91	[p6l726t2717r968b2785],
39	,	,	O	,	_	0	SENT_91	[p6l726t2717r968b2785],
40	and	CC	O	and	_	0	SENT_91	[p6l1030t2717r1155b2774],
41	the	DT	O	the	det	42	SENT_91	[p6l1212t2717r1316b2774],
42	addition	NN	O	addition	nsubj	45	SENT_91	[p6l1376t2717r1664b2774],
43	of	IN	O	of	_	0	SENT_91	[p6l1724t2717r1791b2774],
44	genotype	NN	O	genotype	prep_of	42	SENT_91	[p6l1842t2725r2150b2792],
45	explained	VBD	O	explain	conj_and	27	SENT_91	[p6l310t2801r647b2876],
46	an	DT	O	a	det	49	SENT_91	[p6l705t2821r784b2858],
47	additional	JJ	O	additional	amod	49	SENT_91	[p6l841t2801r1190b2858],
48	5	CD	PERCENT	5	num	49	SENT_91	[p6l1250t2801r1353b2862],
49	%	NN	PERCENT	%	dobj	45	SENT_91	[p6l1250t2801r1353b2862],
50	of	IN	O	of	_	0	SENT_91	[p6l1419t2801r1486b2858],
51	the	DT	O	the	det	52	SENT_91	[p6l1535t2801r1640b2858],
52	variance	NN	O	variance	prep_of	49	SENT_91	[p6l1697t2804r1985b2858],
53	not	RB	O	not	neg	54	SENT_91	[p6l2042t2809r2152b2858],
54	explained	VBN	O	explain	partmod	52	SENT_91	[p6l310t2883r647b2958],
55	by	IN	O	by	_	0	SENT_91	[p6l680t2883r763b2958],
56	the	DT	O	the	det	57	SENT_91	[p6l798t2883r902b2940],
57	race	NN	O	race	agent	54	SENT_91	[p6l938t2903r1076b2940],
58	effect	NN	O	effect	nn	60	SENT_91	[p6l1115t2883r1299b2940],
59	(	CD	NUMBER	(	num	60	SENT_91	[p6l1338t2883r1539b2951],
60	Table	NNP	O	Table	dep	57	SENT_91	[p6l1338t2883r1539b2951],
61	2	CD	NUMBER	2	number	62	SENT_91	[p6l1579t2883r1656b2951],
62	)	CD	NUMBER	)	dep	60	SENT_91	[p6l1579t2883r1656b2951],
63	.	.	O	.	_	0	SENT_91	[p6l1579t2883r1656b2951],

1	As	IN	O	as	mark	2	SENT_92	[p6l1696t2887r1783b2940],
2	shown	VBN	O	show	advcl	14	SENT_92	[p6l1823t2883r2048b2940],
3	in	IN	O	in	_	0	SENT_92	[p6l2084t2886r2151b2939],
4	Table	NNP	O	Table	prep_in	2	SENT_92	[p6l309t2966r489b3023],
5	3	CD	NUMBER	3	num	4	SENT_92	[p6l520t2974r573b3032],
6	,	,	O	,	_	0	SENT_92	[p6l520t2974r573b3032],
7	95	CD	PERCENT	95	num	8	SENT_92	[p6l605t2966r750b3028],
8	%	NN	PERCENT	%	nsubj	14	SENT_92	[p6l605t2966r750b3028],
9	of	IN	O	of	_	0	SENT_92	[p6l786t2966r853b3023],
10	CG	NN	O	cg	nn	11	SENT_92	[p6l875t2969r980b3023],
11	carriers	NNS	O	carrier	prep_of	8	SENT_92	[p6l1007t2969r1257b3023],
12	are	VBP	O	be	cop	14	SENT_92	[p6l1288t2986r1386b3023],
13	Caucasian	JJ	MISC	caucasian	amod	14	SENT_92	[p6l1415t2969r1761b3023],
14	(	NN	O	(	_	0	SENT_92	[p6l1792t2966r2151b3041],
15	compared	VBN	O	compare	prep	14	SENT_92	[p6l1792t2966r2151b3041],
16	with	IN	O	with	pcomp	15	SENT_92	[p6l307t3050r463b3107],
17	only	RB	O	only	quantmod	18	SENT_92	[p6l491t3050r640b3125],
18	5	CD	PERCENT	5	num	19	SENT_92	[p6l668t3050r771b3111],
19	%	NN	PERCENT	%	npadvmod	20	SENT_92	[p6l668t3050r771b3111],
20	African	JJ	MISC	african	amod	22	SENT_92	[p6l803t3050r1058b3107],
21	American	JJ	MISC	american	amod	22	SENT_92	[p6l1083t3050r1460b3117],
22	)	NN	O	)	pobj	16	SENT_92	[p6l1083t3050r1460b3117],
23	,	,	O	,	_	0	SENT_92	[p6l1083t3050r1460b3117],
24	while	IN	O	while	mark	36	SENT_92	[p6l1488t3050r1680b3107],
25	the	DT	O	the	det	26	SENT_92	[p6l1706t3050r1811b3107],
26	opposite	JJ	O	opposite	nsubj	36	SENT_92	[p6l1840t3053r2148b3125],
27	,	,	O	,	_	0	SENT_92	[p6l1840t3053r2148b3125],
28	89	CD	PERCENT	89	num	29	SENT_92	[p6l310t3132r455b3193],
29	%	NN	PERCENT	%	appos	26	SENT_92	[p6l310t3132r455b3193],
30	of	IN	O	of	_	0	SENT_92	[p6l494t3132r561b3189],
31	AA	NN	O	aa	nn	32	SENT_92	[p6l584t3136r698b3188],
32	carriers	NNS	O	carrier	prep_of	29	SENT_92	[p6l729t3135r979b3189],
33	are	VBP	O	be	cop	36	SENT_92	[p6l1012t3152r1110b3189],
34	African	JJ	MISC	african	amod	36	SENT_92	[p6l1140t3132r1396b3189],
35	American	JJ	MISC	american	amod	36	SENT_92	[p6l1425t3135r1759b3189],
36	(	NN	O	(	dep	22	SENT_92	[p6l1792t3132r2151b3207],
37	compared	VBN	O	compare	_	0	SENT_92	[p6l1792t3132r2151b3207],
38	with	IN	O	with	prepc_compared_with	36	SENT_92	[p6l307t3215r463b3272],
39	only	RB	O	only	advmod	43	SENT_92	[p6l500t3215r650b3290],
40	11	CD	PERCENT	11	num	41	SENT_92	[p6l689t3215r832b3277],
41	%	NN	PERCENT	%	pobj	39	SENT_92	[p6l689t3215r832b3277],
42	Caucasian	JJ	MISC	caucasian	amod	43	SENT_92	[p6l875t3215r1262b3283],
43	)	NN	O	)	pobj	36	SENT_92	[p6l875t3215r1262b3283],
44	.	.	O	.	_	0	SENT_92	[p6l875t3215r1262b3283],

1	These	DT	O	these	det	3	SENT_93	[p6l1303t3215r1503b3272],
2	allele	NN	O	allele	nn	3	SENT_93	[p6l1540t3215r1722b3272],
3	frequencies	NNS	O	frequency	nsubj	5	SENT_93	[p6l1760t3215r2149b3290],
4	are	VBP	O	be	cop	5	SENT_93	[p6l309t3319r407b3356],
5	similar	JJ	O	similar	_	0	SENT_93	[p6l439t3299r676b3356],
6	to	TO	O	to	_	0	SENT_93	[p6l703t3307r765b3356],
7	those	DT	O	those	prep_to	5	SENT_93	[p6l794t3299r974b3356],
8	in	IN	O	in	_	0	SENT_93	[p6l1004t3302r1071b3355],
9	the	DT	O	the	det	11	SENT_93	[p6l1098t3299r1203b3356],
10	HapMap	NNP	O	HapMap	nn	11	SENT_93	[p6l1232t3303r1523b3374],
11	project	NN	O	project	prep_in	7	SENT_93	[p6l1555t3299r1836b3374],
12	.9	CD	NUMBER	.9	num	11	SENT_93	[p6l1555t3299r1836b3374],

1	CYP3A43	NN	O	cyp3a43	nn	2	SENT_94	[p6l384t3384r708b3438],
2	genotype	NN	O	genotype	nsubj	7	SENT_94	[p6l738t3389r1047b3456],
3	was	VBD	O	be	cop	7	SENT_94	[p6l1073t3401r1202b3438],
4	also	RB	O	also	advmod	7	SENT_94	[p6l1232t3381r1363b3438],
5	a	DT	O	a	det	7	SENT_94	[p6l1393t3401r1427b3438],
6	significant	JJ	O	significant	amod	7	SENT_94	[p6l1454t3381r1812b3456],
7	predictor	NN	O	predictor	_	0	SENT_94	[p6l1839t3381r2152b3456],
8	of	IN	O	of	_	0	SENT_94	[p6l310t3464r377b3521],
9	olanzapine	NN	O	olanzapine	nn	10	SENT_94	[p6l405t3464r778b3539],
10	clearance	NN	O	clearance	prep_of	7	SENT_94	[p6l814t3464r1133b3521],
11	within	IN	O	within	_	0	SENT_94	[p6l1165t3464r1392b3521],
12	each	DT	O	each	det	13	SENT_94	[p6l1426t3464r1580b3521],
13	race	NN	O	race	prep_within	10	SENT_94	[p6l1612t3484r1769b3530],
14	,	,	O	,	_	0	SENT_94	[p6l1612t3484r1769b3530],
15	indicating	VBG	O	indicate	partmod	7	SENT_94	[p6l1804t3464r2151b3539],
16	that	IN	O	that	complm	23	SENT_94	[p6l308t3549r439b3606],
17	the	DT	O	the	det	19	SENT_94	[p6l489t3549r593b3606],
18	overall	JJ	O	overall	amod	19	SENT_94	[p6l647t3549r878b3606],
19	effect	NN	O	effect	nsubj	23	SENT_94	[p6l931t3549r1114b3606],
20	is	VBZ	O	be	cop	23	SENT_94	[p6l1165t3552r1217b3606],
21	not	RB	O	not	neg	23	SENT_94	[p6l1270t3557r1380b3606],
22	an	DT	O	a	det	23	SENT_94	[p6l1431t3569r1510b3606],
23	artifact	NN	O	artifact	ccomp	15	SENT_94	[p6l1562t3549r1799b3606],
24	of	IN	O	of	_	0	SENT_94	[p6l1851t3549r1919b3606],
25	racial	JJ	O	racial	amod	26	SENT_94	[p6l1962t3549r2150b3606],
26	stratification	NN	O	stratification	prep_of	23	SENT_94	[p7l310t19r758b76],
27	.	.	O	.	_	0	SENT_94	[p7l310t19r758b76],

1	A	DT	O	a	det	3	SENT_95	[p7l803t23r859b75],
2	linear	JJ	O	linear	amod	3	SENT_95	[p7l900t19r1097b76],
3	regression	NN	O	regression	_	0	SENT_95	[p7l1135t22r1482b94],
4	in	IN	O	in	_	0	SENT_95	[p7l1524t22r1591b76],
5	the	DT	O	the	det	8	SENT_95	[p7l1630t19r1735b76],
6	74	CD	NUMBER	74	num	8	SENT_95	[p7l1781t28r1854b75],
7	African	NNP	MISC	African	nn	8	SENT_95	[p7l1895t19r2151b76],
8	Americans	NNPS	MISC	Americans	prep_in	3	SENT_95	[p7l308t105r673b159],
9	revealed	VBD	O	reveal	rcmod	8	SENT_95	[p7l732t102r1020b159],
10	that	IN	O	that	complm	13	SENT_95	[p7l1077t102r1209b159],
11	CYP3A43	NN	O	cyp3a43	nn	12	SENT_95	[p7l1265t105r1590b159],
12	genotype	NN	O	genotype	nsubj	13	SENT_95	[p7l1651t110r1959b177],
13	predicted	VBD	O	predict	ccomp	9	SENT_95	[p7l2017t122r2150b177, p7l311t185r521b242],
14	>	JJR	O	>	dobj	13	SENT_95	[p7l603t203r641b242],
15	10	CD	PERCENT	10	number	16	SENT_95	[p7l663t185r806b247],
16	%	NN	PERCENT	%	amod	14	SENT_95	[p7l663t185r806b247],
17	of	IN	O	of	_	0	SENT_95	[p7l882t185r949b242],
18	olanzapine	NN	O	olanzapine	nn	19	SENT_95	[p7l1011t185r1384b260],
19	clearance	NN	O	clearance	prep_of	14	SENT_95	[p7l1454t185r1773b242],
20	in	IN	O	in	_	0	SENT_95	[p7l1841t188r1908b242],
21	these	DT	O	these	det	22	SENT_95	[p7l1974t185r2150b242],
22	patients	NNS	O	patient	prep_in	13	SENT_95	[p7l308t271r578b343],
23	(	IN	O	(	_	0	SENT_95	[p7l650t268r1040b336],
24	rZ	NN	O	rz	prep_(	13	SENT_95	[p7l650t268r1040b336],
25	=	JJ	O	=	amod	3	SENT_95	[p7l650t268r1040b336],
26	0.1055	CD	NUMBER	0.1055	tmod	25	SENT_95	[p7l650t268r1040b336],
27	,	,	O	,	_	0	SENT_95	[p7l650t268r1040b336],
28	F	NN	O	f	appos	3	SENT_95	[p7l1108t272r1426b334],
29	=	JJ	O	=	amod	28	SENT_95	[p7l1108t272r1426b334],
30	8.495	CD	NUMBER	8.495	tmod	29	SENT_95	[p7l1108t272r1426b334],
31	,	,	O	,	_	0	SENT_95	[p7l1108t272r1426b334],
32	DFn	NN	O	dfn	appos	3	SENT_95	[p7l1493t272r1766b334],
33	=	JJ	O	=	amod	32	SENT_95	[p7l1493t272r1766b334],
34	1	CD	NUMBER	1	tmod	33	SENT_95	[p7l1493t272r1766b334],
35	,	,	O	,	_	0	SENT_95	[p7l1493t272r1766b334],
36	DFd	NN	O	dfd	appos	3	SENT_95	[p7l1833t268r2148b334],
37	=	JJ	O	=	amod	36	SENT_95	[p7l1833t268r2148b334],
38	72	CD	NUMBER	72	tmod	37	SENT_95	[p7l1833t268r2148b334],
39	,	,	O	,	_	0	SENT_95	[p7l1833t268r2148b334],
40	P	NN	O	p	appos	3	SENT_95	[p7l307t351r690b419],
41	=	JJ	O	=	amod	43	SENT_95	[p7l307t351r690b419],
42	0.0047	CD	NUMBER	0.0047	tmod	41	SENT_95	[p7l307t351r690b419],
43	)	NN	O	)	dep	40	SENT_95	[p7l307t351r690b419],
44	.	.	O	.	_	0	SENT_95	[p7l307t351r690b419],

1	A	DT	O	a	det	3	SENT_96	[p7l725t355r781b408],
2	similar	JJ	O	similar	amod	3	SENT_96	[p7l813t351r1050b408],
3	analysis	NN	O	analysis	nsubj	8	SENT_96	[p7l1081t351r1353b426],
4	in	IN	O	in	_	0	SENT_96	[p7l1386t354r1454b408],
5	the	DT	O	the	det	7	SENT_96	[p7l1483t351r1588b408],
6	161	CD	NUMBER	161	num	7	SENT_96	[p7l1623t359r1735b408],
7	Caucasians	NNS	MISC	caucasian	prep_in	3	SENT_96	[p7l1771t354r2149b408],
8	found	VBD	O	find	_	0	SENT_96	[p7l309t434r509b491],
9	that	IN	O	that	complm	12	SENT_96	[p7l543t434r675b491],
10	CYP3A43	NN	O	cyp3a43	nn	11	SENT_96	[p7l710t437r1034b491],
11	genotype	NN	O	genotype	nsubj	12	SENT_96	[p7l1073t443r1381b509],
12	predicted	VBD	O	predict	ccomp	8	SENT_96	[p7l1417t434r1743b509],
13	almost	RB	O	almost	quantmod	14	SENT_96	[p7l1779t434r2004b491],
14	5	CD	PERCENT	5	num	15	SENT_96	[p7l2041t434r2144b496],
15	%	NN	PERCENT	%	dobj	12	SENT_96	[p7l2041t434r2144b496],
16	of	IN	O	of	_	0	SENT_96	[p7l310t517r377b574],
17	olanzapine	NN	O	olanzapine	nn	18	SENT_96	[p7l415t517r788b592],
18	clearance	NN	O	clearance	prep_of	15	SENT_96	[p7l833t517r1152b574],
19	in	IN	O	in	_	0	SENT_96	[p7l1196t520r1263b573],
20	this	DT	O	this	det	21	SENT_96	[p7l1305t517r1429b574],
21	group	NN	O	group	prep_in	12	SENT_96	[p7l1473t537r1667b592],
22	(	CD	NUMBER	(	number	23	SENT_96	[p7l1716t517r2148b585],
23	1	CD	NUMBER	1	num	21	SENT_96	[p7l1716t517r2148b585],
24	‘	NN	O	‘	tmod	12	SENT_96	[p7l1716t517r2148b585],
25	2	CD	NUMBER	2	num	24	SENT_96	[p7l1716t517r2148b585],
26	=	JJ	O	=	amod	24	SENT_96	[p7l1716t517r2148b585],
27	0.04596	CD	NUMBER	0.04596	tmod	26	SENT_96	[p7l1716t517r2148b585],
28	,	,	O	,	_	0	SENT_96	[p7l1716t517r2148b585],
29	F	NN	O	f	appos	24	SENT_96	[p7l308t605r407b658],
30	=	JJ	O	=	amod	29	SENT_96	[p7l308t605r407b658],
31	7.660	CD	NUMBER	7.660	tmod	30	SENT_96	[p7l429t609r626b667],
32	,	,	O	,	_	0	SENT_96	[p7l429t609r626b667],
33	DFn	NN	O	dfn	appos	24	SENT_96	[p7l656t605r855b658],
34	=	JJ	O	=	amod	33	SENT_96	[p7l656t605r855b658],
35	1	CD	NUMBER	1	tmod	34	SENT_96	[p7l877t610r929b667],
36	,	,	O	,	_	0	SENT_96	[p7l877t610r929b667],
37	DFd	NN	O	dfd	appos	24	SENT_96	[p7l958t601r1158b658],
38	=	JJ	O	=	quantmod	39	SENT_96	[p7l958t601r1158b658],
39	159	CD	NUMBER	159	dep	37	SENT_96	[p7l1180t609r1315b668],
40	,	,	O	,	_	0	SENT_96	[p7l1180t609r1315b668],
41	P	NN	O	p	npadvmod	42	SENT_96	[p7l1345t601r1727b669],
42	=	JJ	O	=	amod	24	SENT_96	[p7l1345t601r1727b669],
43	0.0063	CD	NUMBER	0.0063	num	44	SENT_96	[p7l1345t601r1727b669],
44	)	NN	O	)	dep	24	SENT_96	[p7l1345t601r1727b669],
45	.	.	O	.	_	0	SENT_96	[p7l1345t601r1727b669],

1	The	DT	O	the	det	3	SENT_97	[p7l1761t601r1889b658],
2	overall	JJ	O	overall	amod	3	SENT_97	[p7l1919t601r2150b658],
3	effect	NN	O	effect	nsubj	9	SENT_97	[p7l310t684r493b741],
4	of	IN	O	of	_	0	SENT_97	[p7l532t684r599b741],
5	genotype	NN	O	genotype	prep_of	3	SENT_97	[p7l631t693r939b759],
6	in	IN	O	in	prep	3	SENT_97	[p7l979t687r1046b741],
7	both	CC	O	both	dep	6	SENT_97	[p7l1082t684r1235b741],
8	races	NNS	O	race	conj	6	SENT_97	[p7l1272t704r1443b741],
9	is	VBZ	O	be	_	0	SENT_97	[p7l1484t687r1536b741],
10	that	IN	O	that	complm	13	SENT_97	[p7l1576t684r1708b741],
11	AA	NN	O	aa	nn	12	SENT_97	[p7l1744t688r1859b741],
12	carriers	NNS	O	carrier	nsubj	13	SENT_97	[p7l1898t687r2149b741],
13	have	VBP	O	have	ccomp	9	SENT_97	[p7l307t767r466b824],
14	37	CD	PERCENT	37	num	15	SENT_97	[p7l505t767r650b828],
15	%	NN	PERCENT	%	npadvmod	16	SENT_97	[p7l505t767r650b828],
16	higher	JJR	O	higher	amod	17	SENT_97	[p7l691t767r911b842],
17	clearance	NN	O	clearance	dobj	13	SENT_97	[p7l946t767r1265b824],
18	than	IN	O	than	_	0	SENT_97	[p7l1300t767r1452b824],
19	GG	NNS	O	gg	nn	20	SENT_97	[p7l1488t770r1593b824],
20	carriers	NNS	O	carrier	prep_than	17	SENT_97	[p7l1628t770r1899b833],
21	,	,	O	,	_	0	SENT_97	[p7l1628t770r1899b833],
22	which	WDT	O	which	rcmod	17	SENT_97	[p7l1936t767r2151b824],

1	‘	NN	O	‘	_	0	SENT_98	[p7l189t1205r254b1252],
2	fun	NN	O	fun	rcmod	1	SENT_98	[p7l189t1205r254b1252],
3	1	CD	NUMBER	1	number	4	SENT_98	[p7l272t1226r274b1228],
4	Em	NN	O	em	dep	2	SENT_98	[p7l379t1200r582b1252],
5	:	:	O	:	_	0	SENT_98	[p7l379t1200r582b1252],
6	-	:	O	-	_	0	SENT_98	[p7l379t1200r582b1252],
7	lrirlgz	NN	O	lrirlgz	nn	8	SENT_98	[p7l379t1200r582b1252],
8	Han	NN	O	han	dep	1	SENT_98	[p7l616t1183r802b1248],
9	-.25	CD	NUMBER	-.25	dep	8	SENT_98	[p7l616t1183r802b1248],
10	.	.	O	.	_	0	SENT_98	[p7l616t1183r802b1248],

1	~	NN	O	~	nn	2	SENT_99	[p7l819t1200r974b1248],
2	D	NN	O	d	_	0	SENT_99	[p7l819t1200r974b1248],
3	§	CD	NUMBER	§	num	4	SENT_99	[p7l819t1200r974b1248],
4	3i	NNS	O	3us	dep	2	SENT_99	[p7l819t1200r974b1248],
5	.	.	O	.	_	0	SENT_99	[p7l819t1200r974b1248],

1	ﬂ	NN	O	ﬂ	_	0	SENT_100	[p7l819t1200r974b1248],
2	=	JJ	O	=	rcmod	1	SENT_100	[p7l819t1200r974b1248],
3	E	NN	O	e	dep	2	SENT_100	[p7l819t1200r974b1248],
4	-	:	O	-	_	0	SENT_100	[p7l819t1200r974b1248],
5	'	''	O	'	_	0	SENT_100	[p7l819t1200r974b1248],
6	-	:	O	-	_	0	SENT_100	[p7l819t1200r974b1248],
7	"	``	O	"	punct	8	SENT_100	[p7l987t1183r1044b1217],
8	5	CD	NUMBER	5	dep	1	SENT_100	[p7l987t1183r1044b1217],
9	+	CC	O	+	_	0	SENT_100	[p7l379t1278r599b1330],
10	rE	NN	O	re	dep	1	SENT_100	[p7l620t1265r810b1329],
11	=	JJ	O	=	amod	14	SENT_100	[p7l620t1265r810b1329],
12	D	NN	O	d	dep	11	SENT_100	[p7l620t1265r810b1329],
13	,1	CD	NUMBER	,1	num	12	SENT_100	[p7l620t1265r810b1329],
14	EI	NN	O	eus	dep	1	SENT_100	[p7l620t1265r810b1329],
15	,	,	O	,	_	0	SENT_100	[p7l620t1265r810b1329],
16	p	NN	O	p	appos	1	SENT_100	[p7l827t1278r979b1330],
17	=	JJ	O	=	amod	16	SENT_100	[p7l827t1278r979b1330],
18	5	CD	NUMBER	5	tmod	17	SENT_100	[p7l827t1278r979b1330],
19	.	.	O	.	_	0	SENT_100	[p7l827t1278r979b1330],

1	.9	NN	NUMBER	.9	_	0	SENT_101	[p7l827t1278r979b1330],
2	e	SYM	O	e	dep	4	SENT_101	[p7l827t1278r979b1330],
3	"	``	O	"	punct	4	SENT_101	[p7l992t1261r1026b1295],
4	1	CD	NUMBER	1	dep	1	SENT_101	[p7l992t1261r1026b1295],
5	'	''	O	'	_	0	SENT_101	[p7l992t1261r1026b1295],

1	5.1	CD	NUMBER	5.1	num	2	SENT_102	[p7l189t1377r274b1425],
2	Best	NN	O	best	_	0	SENT_102	[p7l379t1355r474b1399],
3	:	:	O	:	_	0	SENT_102	[p7l379t1355r474b1399],
4	r	NN	O	r	nn	5	SENT_102	[p7l491t1338r673b1403],
5	*	NN	O	*	dep	2	SENT_102	[p7l491t1338r673b1403],
6	=	JJ	O	=	amod	7	SENT_102	[p7l491t1338r673b1403],
7	n.	NN	O	n.	dep	5	SENT_102	[p7l491t1338r673b1403],
8	na	TO	O	na	infmod	7	SENT_102	[p7l491t1338r673b1403],
9	.	.	O	.	_	0	SENT_102	[p7l491t1338r673b1403],

1	p	NN	O	p	nsubj	7	SENT_103	[p7l690t1342r888b1407],
2	=	JJ	O	=	amod	1	SENT_103	[p7l690t1342r888b1407],
3	1.2	CD	NUMBER	1.2	tmod	2	SENT_103	[p7l690t1342r888b1407],
4	e	SYM	O	e	dep	7	SENT_103	[p7l690t1342r888b1407],
5	"	``	O	"	punct	7	SENT_103	[p7l690t1342r888b1407],
6	'	''	O	'	_	0	SENT_103	[p7l690t1342r888b1407],
7	__	RB	O	__	_	0	SENT_103	[p7l1627t1386r1674b1412],
8	,	,	O	,	_	0	SENT_103	[p7l1627t1386r1674b1412],

1	Eli	NNP	PERSON	Eli	_	0	SENT_104	[p7l189t1550r254b1597],

1	«	NN	O	«	nn	3	SENT_105	[p7l189t1886r254b1934],
2	EDI	NN	O	edus	nn	3	SENT_105	[p7l189t1886r254b1934],
3	ELEARAJWEE	NN	O	elearajwee	_	0	SENT_105	[p7l56t1705r108b2107],
4	[	CD	NUMBER	[	num	6	SENT_105	[p7l56t1549r121b1684],
5	Uh	NN	O	uh	nn	6	SENT_105	[p7l56t1549r121b1684],
6	]	NN	O	]	dep	3	SENT_105	[p7l56t1549r121b1684],

1	2n	NN	O	2n	_	0	SENT_106	[p7l189t2058r254b2106],
2	:	:	O	:	_	0	SENT_106	[p7l279t2072r293b2093],

1	GB	NNP	O	GB	nn	3	SENT_107	[p7l392t2482r509b2542],
2	GA.	NNP	O	GA.	nn	3	SENT_107	[p7l694t2482r806b2542],
3	_	NNP	O	_	_	0	SENT_107	[p7l996t2482r1101b2542],
4	i	FW	O	i	dep	3	SENT_107	[p7l996t2482r1101b2542],
5	+	CC	O	+	_	0	SENT_107	[p7l996t2482r1101b2542],
6	G13	FW	O	g13	conj_+	3	SENT_107	[p7l1290t2482r1407b2542],
7	EA	NN	O	ea	dep	6	SENT_107	[p7l1588t2482r1700b2542],
8	+	CC	O	+	_	0	SENT_107	[p7l1898t2482r2002b2542],
9	Ihlansrnaking	JJ	O	ihlansrnaking	amod	10	SENT_107	[p7l422t2611r854b2680],
10	women	NNS	O	woman	dep	6	SENT_107	[p7l875t2611r1140b2667],
11	Emrultiing	VBG	O	emrultie	partmod	3	SENT_107	[p7l1363t2611r1666b2680],
12	Men	NN	O	man	dobj	11	SENT_107	[p7l1687t2611r1829b2667],

1	Figure	NNP	O	Figure	_	0	SENT_108	[p7l7t2752r238b2829],
2	1	CD	NUMBER	1	num	1	SENT_108	[p7l309t2760r343b2810],
3	The	DT	O	the	det	5	SENT_108	[p7l429t2750r564b2810],
4	combined	JJ	O	combined	amod	5	SENT_108	[p7l634t2750r985b2810],
5	effect	NN	O	effect	dep	1	SENT_108	[p7l1055t2750r1247b2810],
6	of	IN	O	of	_	0	SENT_108	[p7l1316t2750r1386b2810],
7	smoking	NN	O	smoking	nn	12	SENT_108	[p7l1449t2750r1767b2829],
8	,	,	O	,	_	0	SENT_108	[p7l1449t2750r1767b2829],
9	sex	NN	O	sex	nn	12	SENT_108	[p7l1840t2771r1953b2810],
10	and	CC	O	and	_	0	SENT_108	[p7l2021t2750r2152b2810],
11	CYP3A43	NN	O	cyp3a43	nn	12	SENT_108	[p7l8t2842r347b2899],
12	genotype	NN	O	genotype	prep_of	5	SENT_108	[p7l398t2848r721b2918],
13	on	IN	O	on	_	0	SENT_108	[p7l772t2860r858b2899],
14	olanzapine	NN	O	olanzapine	nn	15	SENT_108	[p7l908t2839r1298b2918],
15	clearance	NN	O	clearance	prep_on	12	SENT_108	[p7l1349t2839r1700b2899],
16	.	.	O	.	_	0	SENT_108	[p7l1349t2839r1700b2899],

1	Caucasians	NNS	MISC	caucasian	nsubj	2	SENT_109	[p7l1755t2842r2150b2899],
2	are	VBP	O	be	_	0	SENT_109	[p7l8t2948r111b2987],
3	in	IN	O	in	_	0	SENT_109	[p7l144t2930r214b2986],
4	blue	JJ	O	blue	prep_in	2	SENT_109	[p7l243t2927r415b2987],
5	.	.	O	.	_	0	SENT_109	[p7l243t2927r415b2987],

1	African	JJ	MISC	african	amod	2	SENT_110	[p7l451t2927r718b2987],
2	Americans	NNS	MISC	american	nsubj	3	SENT_110	[p7l749t2931r1131b2987],
3	are	VBP	O	be	_	0	SENT_110	[p7l1166t2948r1269b2987],
4	in	IN	O	in	_	0	SENT_110	[p7l1302t2930r1372b2986],
5	red	JJ	O	red	prep_in	3	SENT_110	[p7l1402t2927r1534b2987],
6	.	.	O	.	_	0	SENT_110	[p7l1402t2927r1534b2987],

1	Horizontal	JJ	O	horizontal	amod	2	SENT_111	[p7l1570t2927r1949b2987],
2	lines	NNS	O	line	nsubj	3	SENT_111	[p7l1981t2927r2150b2987],
3	represent	VBP	O	represent	_	0	SENT_111	[p7l6t3025r339b3095],
4	median	NN	O	median	dobj	3	SENT_111	[p7l368t3016r652b3076],
5	.	.	O	.	_	0	SENT_111	[p7l368t3016r652b3076],

1	translates	NNS	O	translate	nsubj	15	SENT_112	[p8l6t80r384b146],
2	into	IN	O	into	_	0	SENT_112	[p8l418t83r571b146],
3	a	DT	O	a	det	9	SENT_112	[p8l603t103r643b146],
4	48	CD	PERCENT	48	num	5	SENT_112	[p8l672t80r843b151],
5	%	NN	PERCENT	%	npadvmod	6	SENT_112	[p8l672t80r843b151],
6	lower	JJR	O	lower	amod	9	SENT_112	[p8l882t80r1106b146],
7	trough	NN	O	trough	nn	9	SENT_112	[p8l1134t80r1392b167],
8	plasma	NN	O	plasma	nn	9	SENT_112	[p8l1422t80r1705b167],
9	concentration	NN	O	concentration	prep_into	1	SENT_112	[p8l1736t90r2150b146, p8l6t180r163b243],
10	(	CD	NUMBER	(	number	11	SENT_112	[p8l201t177r313b256],
11	25	CD	NUMBER	25	dep	9	SENT_112	[p8l201t177r313b256],
12	ng	NN	O	ng	nn	14	SENT_112	[p8l336t200r429b264],
13	ml	NN	O	ml	nn	14	SENT_112	[p8l447t177r612b243],
14	”	NN	O	”	dep	11	SENT_112	[p8l447t177r612b243],
15	compared	VBN	O	compare	_	0	SENT_112	[p8l649t177r1040b264],
16	with	IN	O	with	_	0	SENT_112	[p8l1073t177r1255b243],
17	37	CD	NUMBER	37	num	19	SENT_112	[p8l1291t187r1377b243],
18	ngml	NN	O	ngml	nn	19	SENT_112	[p8l1398t177r1724b264],
19	‘	NN	O	‘	prep_with	15	SENT_112	[p8l1398t177r1724b264],
20	1	CD	NUMBER	1	num	21	SENT_112	[p8l1398t177r1724b264],
21	)	NN	O	)	dep	19	SENT_112	[p8l1398t177r1724b264],
22	.	.	O	.	_	0	SENT_112	[p8l1398t177r1724b264],

1	Linear	JJ	O	linear	amod	3	SENT_113	[p8l95t278r348b341],
2	regression	NN	O	regression	nn	3	SENT_113	[p8l389t278r792b362],
3	analysis	NN	O	analysis	nsubj	7	SENT_113	[p8l836t275r1153b362],
4	in	IN	O	in	_	0	SENT_113	[p8l1198t278r1276b340],
5	all	DT	O	all	det	6	SENT_113	[p8l1320t275r1416b341],
6	subjects	NNS	O	subject	prep_in	3	SENT_113	[p8l1460t275r1772b361],
7	revealed	VBD	O	reveal	_	0	SENT_113	[p8l1815t275r2152b341],
8	that	IN	O	that	complm	14	SENT_113	[p8l6t371r159b437],
9	patients	NNS	O	patient	nsubj	14	SENT_113	[p8l193t374r507b458],
10	with	IN	O	with	_	0	SENT_113	[p8l543t371r724b437],
11	the	DT	O	the	det	13	SENT_113	[p8l758t371r880b437],
12	AA	NNP	O	AA	nn	13	SENT_113	[p8l914t375r1047b437],
13	genotype	NN	O	genotype	prep_with	9	SENT_113	[p8l1081t381r1439b458],
14	had	VBD	O	have	ccomp	7	SENT_113	[p8l1474t371r1622b437],
15	significantly	RB	O	significantly	advmod	16	SENT_113	[p8l1658t371r2153b458],
16	higher	JJR	O	higher	amod	18	SENT_113	[p8l7t468r261b555],
17	olanzapine	NN	O	olanzapine	nn	18	SENT_113	[p8l320t468r754b555],
18	clearance	NN	O	clearance	dobj	14	SENT_113	[p8l813t468r1184b534],
19	(	CD	NUMBER	(	number	20	SENT_113	[p8l1247t468r1483b547],
20	31.60	CD	NUMBER	31.60	dep	18	SENT_113	[p8l1247t468r1483b547],
21	i	FW	O	i	dep	20	SENT_113	[p8l1508t477r1553b536],
22	8.990	CD	NUMBER	8.990	num	23	SENT_113	[p8l1578t478r1787b534],
23	litre	NN	O	litre	dep	20	SENT_113	[p8l1809t468r1967b534],
24	per	IN	O	per	_	0	SENT_113	[p8l2025t491r2153b555],
25	hour	NN	DURATION	hour	nn	26	SENT_113	[p8l7t566r217b644],
26	)	NN	O	)	prep_per	20	SENT_113	[p8l7t566r217b644],
27	compared	VBN	O	compare	_	0	SENT_113	[p8l250t566r641b653],
28	with	IN	O	with	prepc_compared_with	26	SENT_113	[p8l668t566r849b632],
29	GA	NN	O	ga	pobj	26	SENT_113	[p8l878t569r1004b632],
30	(	CD	NUMBER	(	number	31	SENT_113	[p8l1035t566r1271b644],
31	27.64	CD	NUMBER	27.64	num	29	SENT_113	[p8l1035t566r1271b644],
32	i	FW	O	i	dep	20	SENT_113	[p8l1297t574r1341b633],
33	10.70	CD	NUMBER	10.70	num	34	SENT_113	[p8l1369t575r1575b632],
34	litre	NN	O	litre	nsubj	41	SENT_113	[p8l1597t566r1755b632],
35	per	IN	O	per	_	0	SENT_113	[p8l1784t589r1912b653],
36	hour	NN	DURATION	hour	nn	37	SENT_113	[p8l1937t566r2148b644],
37	)	NN	O	)	prep_per	34	SENT_113	[p8l1937t566r2148b644],
38	and	CC	O	and	_	0	SENT_113	[p8l8t662r154b728],
39	GG	NNS	O	gg	nn	40	SENT_113	[p8l238t665r360b728],
40	genotypes	NNS	O	genotype	conj_and	37	SENT_113	[p8l441t672r838b749],
41	(	VBP	O	(	rcmod	32	SENT_113	[p8l928t662r1164b740],
42	23.09	CD	NUMBER	23.09	dobj	41	SENT_113	[p8l928t662r1164b740],
43	i	LS	O	i	dep	42	SENT_113	[p8l1189t671r1234b729],
44	-	:	O	-	_	0	SENT_113	[p8l1189t671r1234b729],
45	8.716	CD	NUMBER	8.716	num	46	SENT_113	[p8l1259t671r1467b728],
46	litre	NN	O	litre	dep	32	SENT_113	[p8l1490t662r1647b728],
47	per	IN	O	per	_	0	SENT_113	[p8l1732t685r1860b749],
48	hour	NN	DURATION	hour	prep_per	46	SENT_113	[p8l1942t662r2148b738],
49	;	:	O	;	_	0	SENT_113	[p8l1942t662r2148b738],
50	F	NN	O	f	dep	32	SENT_113	[p8l7t764r56b825],
51	=	JJ	O	=	amod	50	SENT_113	[p8l77t790r122b814],
52	26.39	CD	NUMBER	26.39	tmod	51	SENT_113	[p8l146t769r377b836],
53	,	,	O	,	_	0	SENT_113	[p8l146t769r377b836],
54	DFn	NN	O	dfn	appos	32	SENT_113	[p8l427t763r594b825],
55	=	JJ	O	=	amod	54	SENT_113	[p8l614t790r659b814],
56	1	CD	NUMBER	1	tmod	55	SENT_113	[p8l684t770r745b836],
57	,	,	O	,	_	0	SENT_113	[p8l684t770r745b836],
58	DFd	NN	O	dfd	appos	32	SENT_113	[p8l795t759r961b825],
59	=	JJ	O	=	quantmod	60	SENT_113	[p8l982t790r1027b814],
60	233	CD	NUMBER	233	dep	58	SENT_113	[p8l1051t769r1209b836],
61	,	,	O	,	_	0	SENT_113	[p8l1051t769r1209b836],
62	P	NN	O	p	appos	32	SENT_113	[p8l1259t763r1375b825],
63	:	:	O	:	_	0	SENT_113	[p8l1259t763r1375b825],
64	5.89	CD	NUMBER	5.89	dep	62	SENT_113	[p8l1399t760r1702b835],
65	e	SYM	O	e	dep	62	SENT_113	[p8l1399t760r1702b835],
66	‘	CD	NUMBER	‘	number	67	SENT_113	[p8l1399t760r1702b835],
67	7	CD	NUMBER	7	amod	62	SENT_113	[p8l1399t760r1702b835],
68	;	:	O	;	_	0	SENT_113	[p8l1399t760r1702b835],
69	Figure	NNP	O	Figure	dep	32	SENT_113	[p8l1754t762r2005b846],
70	1	CD	NUMBER	1	number	71	SENT_113	[p8l2059t759r2146b838],
71	)	CD	NUMBER	)	dep	69	SENT_113	[p8l2059t759r2146b838],
72	.	.	O	.	_	0	SENT_113	[p8l2059t759r2146b838],

1	A	DT	O	a	det	3	SENT_114	[p8l7t861r71b922],
2	linear	JJ	O	linear	amod	3	SENT_114	[p8l110t856r339b923],
3	regression	NN	O	regression	nsubj	4	SENT_114	[p8l375t860r779b943],
4	estimated	VBD	O	estimate	_	0	SENT_114	[p8l819t856r1201b923],
5	that	IN	O	that	_	0	SENT_114	[p8l1238t856r1391b923],
6	smoking	NN	O	smoking	nn	7	SENT_114	[p8l1430t856r1763b943],
7	accounts	NNS	O	account	prep_that	4	SENT_114	[p8l1803t866r2149b923],
8	for	IN	O	for	_	0	SENT_114	[p8l8t953r115b1019],
9	25	CD	PERCENT	25	num	10	SENT_114	[p8l146t953r343b1029],
10	%	NN	PERCENT	%	prep_for	7	SENT_114	[p8l146t953r343b1029],
11	,	,	O	,	_	0	SENT_114	[p8l146t953r343b1029],
12	sex	NN	O	sex	nn	13	SENT_114	[p8l378t976r503b1019],
13	accounts	NNS	O	account	prep_that	4	SENT_114	[p8l532t963r879b1019],
14	for	IN	O	for	_	0	SENT_114	[p8l911t953r1018b1019],
15	6	CD	PERCENT	6	num	16	SENT_114	[p8l1048t953r1169b1024],
16	%	NN	PERCENT	%	prep_for	13	SENT_114	[p8l1048t953r1169b1024],
17	and	CC	O	and	_	0	SENT_114	[p8l1207t953r1352b1019],
18	CYP3A43	NN	O	cyp3a43	nn	20	SENT_114	[p8l1381t956r1759b1019],
19	genotype	NN	O	genotype	nn	20	SENT_114	[p8l1792t963r2150b1040],
20	accounts	NNS	O	account	conj_and	7	SENT_114	[p8l8t1060r355b1116],
21	for	IN	O	for	_	0	SENT_114	[p8l414t1050r521b1116],
22	10	CD	PERCENT	10	num	23	SENT_114	[p8l581t1050r747b1122],
23	%	NN	PERCENT	%	prep_for	20	SENT_114	[p8l581t1050r747b1122],
24	of	IN	O	of	_	0	SENT_114	[p8l813t1050r891b1116],
25	the	DT	O	the	det	26	SENT_114	[p8l939t1050r1061b1116],
26	variability	NN	O	variability	prep_of	23	SENT_114	[p8l1116t1050r1525b1137],
27	in	IN	O	in	_	0	SENT_114	[p8l1580t1053r1658b1116],
28	olanzapine	NN	O	olanzapine	nn	29	SENT_114	[p8l1716t1050r2151b1137],
29	clearance	NN	O	clearance	prep_in	4	SENT_114	[p8l9t1146r400b1213],
30	.	.	O	.	_	0	SENT_114	[p8l9t1146r400b1213],

1	The	DT	O	the	det	3	SENT_115	[p8l437t1146r587b1213],
2	combined	JJ	O	combined	amod	3	SENT_115	[p8l622t1146r1013b1213],
3	effect	NN	O	effect	nsubj	8	SENT_115	[p8l1046t1146r1259b1213],
4	of	IN	O	of	_	0	SENT_115	[p8l1291t1146r1370b1213],
5	all	DT	O	all	det	7	SENT_115	[p8l1396t1146r1491b1213],
6	three	CD	NUMBER	three	num	7	SENT_115	[p8l1523t1146r1722b1213],
7	covariates	NNS	O	covariate	prep_of	3	SENT_115	[p8l1756t1150r2149b1213],
8	is	VBZ	O	be	_	0	SENT_115	[p8l8t1247r69b1310],
9	that	IN	O	that	complm	47	SENT_115	[p8l106t1244r259b1310],
10	smoking	NN	O	smoking	nn	11	SENT_115	[p8l295t1244r627b1331],
11	men	NNS	O	man	nsubj	47	SENT_115	[p8l662t1267r833b1310],
12	with	IN	O	with	_	0	SENT_115	[p8l867t1244r1049b1310],
13	AA	NN	O	aa	nn	14	SENT_115	[p8l1083t1248r1216b1309],
14	genotype	NN	O	genotype	prep_with	11	SENT_115	[p8l1250t1254r1609b1331],
15	(	CD	NUMBER	(	num	16	SENT_115	[p8l1650t1244r1723b1322],
16	n	NN	O	n	nsubj	20	SENT_115	[p8l1650t1244r1723b1322],
17	=	JJ	O	=	amod	16	SENT_115	[p8l1745t1275r1790b1299],
18	16	CD	NUMBER	16	number	19	SENT_115	[p8l1815t1244r1928b1322],
19	)	CD	NUMBER	)	dep	17	SENT_115	[p8l1815t1244r1928b1322],
20	have	VBP	O	have	rcmod	14	SENT_115	[p8l1966t1244r2151b1310],
21	2.5	CD	NUMBER	2.5	number	22	SENT_115	[p8l11t1351r119b1407],
22	times	NNS	O	time	num	24	SENT_115	[p8l169t1344r381b1407],
23	higher	JJR	O	higher	amod	24	SENT_115	[p8l429t1341r683b1428],
24	clearance	NN	O	clearance	dobj	20	SENT_115	[p8l729t1341r1101b1407],
25	of	IN	O	of	_	0	SENT_115	[p8l1150t1341r1228b1407],
26	olanzapine	NN	O	olanzapine	prep_of	24	SENT_115	[p8l1269t1341r1703b1428],
27	than	IN	O	than	_	0	SENT_115	[p8l1749t1341r1926b1407],
28	nonsmoking	JJ	O	nonsmoking	amod	29	SENT_115	[p8l1971t1364r2151b1407, p8l9t1438r342b1525],
29	women	NNS	O	woman	prep_than	20	SENT_115	[p8l377t1462r669b1505],
30	who	WP	O	who	nsubj	31	SENT_115	[p8l704t1438r873b1505],
31	have	VBP	O	have	rcmod	29	SENT_115	[p8l910t1438r1094b1505],
32	the	DT	O	the	det	35	SENT_115	[p8l1131t1438r1252b1505],
33	GG	NNS	O	gg	nn	35	SENT_115	[p8l1290t1442r1412b1505],
34	genotype	NN	O	genotype	nn	35	SENT_115	[p8l1446t1448r1805b1525],
35	(	NN	O	(	dobj	31	SENT_115	[p8l1846t1438r1918b1517],
36	II	CD	NUMBER	ii	num	39	SENT_115	[p8l1846t1438r1918b1517],
37	=	JJ	O	=	amod	39	SENT_115	[p8l1940t1470r1985b1493],
38	13	CD	NUMBER	13	tmod	37	SENT_115	[p8l2010t1438r2148b1517],
39	)	NN	O	)	dep	35	SENT_115	[p8l2010t1438r2148b1517],
40	,	,	O	,	_	0	SENT_115	[p8l2010t1438r2148b1517],
41	37.37	CD	NUMBER	37.37	appos	35	SENT_115	[p8l11t1544r218b1601],
42	i	FW	O	i	dep	41	SENT_115	[p8l243t1544r288b1602],
43	8.175	CD	NUMBER	8.175	dep	41	SENT_115	[p8l314t1544r520b1601],
44	compared	VBN	O	compare	_	0	SENT_115	[p8l584t1535r975b1622],
45	with	IN	O	with	prepc_compared_with	31	SENT_115	[p8l1032t1535r1214b1601],
46	15.14	CD	NUMBER	15.14	pobj	31	SENT_115	[p8l1276t1545r1482b1601],
47	i	FW	O	i	ccomp	8	SENT_115	[p8l1507t1544r1552b1602],
48	3.870	CD	NUMBER	3.870	num	49	SENT_115	[p8l1579t1544r1787b1601],
49	litre	NN	O	litre	dobj	47	SENT_115	[p8l1808t1535r1966b1601],
50	per	IN	O	per	_	0	SENT_115	[p8l2025t1558r2153b1622],
51	hour	NN	DURATION	hour	prep_per	49	SENT_115	[p8l7t1632r193b1698],
52	(	CD	NUMBER	(	num	51	SENT_115	[p8l221t1632r497b1719],
53	Figure	NN	O	figure	prep	47	SENT_115	[p8l221t1632r497b1719],
54	1	CD	NUMBER	1	num	55	SENT_115	[p8l528t1632r615b1711],
55	)	NN	O	)	dep	53	SENT_115	[p8l528t1632r615b1711],
56	.	.	O	.	_	0	SENT_115	[p8l528t1632r615b1711],

1	None	NN	O	none	nsubjpass	10	SENT_116	[p8l645t1636r854b1698],
2	of	IN	O	of	_	0	SENT_116	[p8l881t1632r959b1698],
3	the	DT	O	the	det	6	SENT_116	[p8l976t1632r1098b1698],
4	other	JJ	O	other	amod	6	SENT_116	[p8l1126t1632r1329b1698],
5	25	CD	NUMBER	25	num	6	SENT_116	[p8l1356t1642r1439b1698],
6	SNPs	NNS	O	snp	prep_of	1	SENT_116	[p8l1472t1635r1677b1698],
7	tested	VBN	O	test	partmod	1	SENT_116	[p8l1703t1632r1937b1698],
8	were	VBD	O	be	auxpass	10	SENT_116	[p8l1961t1655r2151b1698],
9	significantly	RB	O	significantly	advmod	10	SENT_116	[p8l9t1729r504b1816],
10	associated	VBN	O	associate	_	0	SENT_116	[p8l533t1729r940b1796],
11	with	IN	O	with	_	0	SENT_116	[p8l969t1729r1150b1796],
12	olanzapine	NN	O	olanzapine	nn	13	SENT_116	[p8l1181t1729r1615b1816],
13	clearance	NN	O	clearance	prep_with	10	SENT_116	[p8l1647t1729r2039b1796],
14	.	.	O	.	_	0	SENT_116	[p8l1647t1729r2039b1796],

1	In	IN	O	in	_	0	SENT_117	[p8l2073t1734r2152b1795],
2	addition	NN	O	addition	prep_in	29	SENT_117	[p8l8t1826r364b1902],
3	,	,	O	,	_	0	SENT_117	[p8l8t1826r364b1902],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_117	[p8l413t1826r1080b1913],
5	analysis	NN	O	analysis	appos	2	SENT_117	[p8l1127t1826r1445b1913],
6	of	IN	O	of	_	0	SENT_117	[p8l1495t1826r1573b1892],
7	the	DT	O	the	det	18	SENT_117	[p8l1610t1826r1732b1892],
8	clearance	NN	O	clearance	nn	9	SENT_117	[p8l1780t1826r2151b1892],
9	data	NNS	O	datum	nn	18	SENT_117	[p8l11t1923r175b1989],
10	from	IN	O	from	_	0	SENT_117	[p8l222t1923r405b1989],
11	another	DT	O	another	det	12	SENT_117	[p8l452t1923r752b1989],
12	drug	NN	O	drug	prep_from	9	SENT_117	[p8l801t1923r977b2010],
13	in	IN	O	in	_	0	SENT_117	[p8l1025t1926r1103b1989],
14	the	DT	O	the	det	16	SENT_117	[p8l1149t1923r1270b1989],
15	CATIE	NNP	MISC	CATIE	nn	16	SENT_117	[p8l1319t1926r1570b1989],
16	trial	NN	O	trial	prep_in	12	SENT_117	[p8l1619t1923r1801b2000],
17	,	,	O	,	_	0	SENT_117	[p8l1619t1923r1801b2000],
18	ziprasidone	NN	O	ziprasidone	prep_of	5	SENT_117	[p8l1852t1926r2145b2010, p8l11t2020r224b2096],
19	,	,	O	,	_	0	SENT_117	[p8l1852t1926r2145b2010, p8l11t2020r224b2096],
20	in	IN	O	in	_	0	SENT_117	[p8l255t2023r332b2085],
21	which	WDT	O	which	rel	26	SENT_117	[p8l358t2020r607b2086],
22	race	NN	O	race	nsubj	26	SENT_117	[p8l632t2043r792b2086],
23	was	VBD	O	be	cop	26	SENT_117	[p8l819t2043r968b2086],
24	not	RB	O	not	neg	26	SENT_117	[p8l996t2030r1124b2086],
25	a	DT	O	a	det	26	SENT_117	[p8l1151t2043r1190b2086],
26	predictor	NN	O	predictor	rcmod	18	SENT_117	[p8l1216t2020r1662b2107],
27	,	,	O	,	_	0	SENT_117	[p8l1216t2020r1662b2107],
28	”	NN	O	”	nsubj	29	SENT_117	[p8l1216t2020r1662b2107],
29	revealed	VBD	O	reveal	_	0	SENT_117	[p8l1688t2020r2023b2086],
30	no	DT	O	no	det	31	SENT_117	[p8l2049t2043r2145b2086],
31	effect	NN	O	effect	nn	39	SENT_117	[p8l10t2117r223b2183],
32	of	IN	O	of	_	0	SENT_117	[p8l260t2117r337b2183],
33	rs472660	NN	O	rs472660	nn	34	SENT_117	[p8l365t2126r720b2183],
34	genotype	NN	O	genotype	prep_of	31	SENT_117	[p8l757t2127r1115b2204],
35	(	CD	NUMBER	(	num	36	SENT_117	[p8l1156t2117r1578b2196],
36	P	NN	O	p	dep	31	SENT_117	[p8l1156t2117r1578b2196],
37	=	JJ	O	=	amod	39	SENT_117	[p8l1156t2117r1578b2196],
38	0.176	CD	NUMBER	0.176	tmod	37	SENT_117	[p8l1156t2117r1578b2196],
39	)	NN	O	)	dobj	29	SENT_117	[p8l1156t2117r1578b2196],
40	,	,	O	,	_	0	SENT_117	[p8l1156t2117r1578b2196],
41	implicating	VBG	O	implicate	partmod	29	SENT_117	[p8l1617t2117r2071b2204],
42	a	DT	O	a	det	45	SENT_117	[p8l2109t2140r2148b2183],
43	relatively	RB	O	relatively	advmod	44	SENT_117	[p8l8t2214r381b2301],
44	specific	JJ	O	specific	amod	45	SENT_117	[p8l416t2214r718b2301],
45	effect	NN	O	effect	dobj	41	SENT_117	[p8l754t2214r967b2280],
46	of	IN	O	of	_	0	SENT_117	[p8l1001t2214r1079b2280],
47	this	DT	O	this	det	48	SENT_117	[p8l1105t2214r1249b2280],
48	SNP	NN	O	snp	prep_of	45	SENT_117	[p8l1287t2217r1453b2280],
49	on	IN	O	on	_	0	SENT_117	[p8l1490t2237r1585b2280],
50	olanzapine	NN	O	olanzapine	prep_on	48	SENT_117	[p8l1621t2214r2074b2301],
51	.	.	O	.	_	0	SENT_117	[p8l1621t2214r2074b2301],

1	In	IN	O	in	_	0	SENT_118	[p8l96t2316r174b2377],
2	the	DT	O	the	det	6	SENT_118	[p8l215t2311r336b2378],
3	CATIE	NNP	O	CATIE	nn	6	SENT_118	[p8l380t2315r632b2378],
4	olanzapine	NN	O	olanzapine	nn	6	SENT_118	[p8l679t2311r1111b2398],
5	data	NN	O	datum	nn	6	SENT_118	[p8l1157t2311r1321b2378],
6	set	NN	O	set	prep_in	9	SENT_118	[p8l1364t2321r1490b2388],
7	,	,	O	,	_	0	SENT_118	[p8l1364t2321r1490b2388],
8	there	EX	O	there	expl	9	SENT_118	[p8l1535t2311r1733b2378],
9	were	VBD	O	be	_	0	SENT_118	[p8l1775t2335r1964b2378],
10	150	CD	NUMBER	150	num	11	SENT_118	[p8l2011t2321r2145b2378],
11	subjects	NNS	O	subject	nsubj	9	SENT_118	[p8l11t2408r322b2495],
12	treated	VBN	O	treat	partmod	11	SENT_118	[p8l352t2408r624b2474],
13	with	IN	O	with	_	0	SENT_118	[p8l652t2408r833b2474],
14	15-25	CD	NUMBER	15-25	num	15	SENT_118	[p8l866t2418r1093b2474],
15	mg	NN	O	mg	prep_with	12	SENT_118	[p8l1115t2431r1232b2495],
16	per	IN	O	per	_	0	SENT_118	[p8l1261t2431r1389b2495],
17	day	NN	DURATION	day	prep_per	15	SENT_118	[p8l1419t2408r1558b2495],
18	(	CD	NUMBER	(	num	17	SENT_118	[p8l1590t2408r1797b2487],
19	once	RB	DATE	once	advmod	23	SENT_118	[p8l1590t2408r1797b2487],
20	or	CC	O	or	_	0	SENT_118	[p8l1829t2431r1906b2474],
21	twice	RB	O	twice	conj_or	19	SENT_118	[p8l1933t2412r2146b2474],
22	a	DT	DURATION	a	det	23	SENT_118	[p8l10t2528r49b2571],
23	day	NN	DURATION	day	tmod	12	SENT_118	[p8l125t2505r283b2592],
24	;	:	O	;	_	0	SENT_118	[p8l125t2505r283b2592],
25	median	NN	O	median	nn	26	SENT_118	[p8l361t2505r657b2571],
26	dose	NN	O	dose	dep	11	SENT_118	[p8l734t2505r909b2571],
27	20mg	JJ	O	20mg	amod	26	SENT_118	[p8l987t2515r1211b2592],
28	per	IN	O	per	_	0	SENT_118	[p8l1285t2528r1412b2592],
29	day	NN	DURATION	day	prep_per	27	SENT_118	[p8l1488t2505r1676b2592],
30	)	CD	NUMBER	)	num	29	SENT_118	[p8l1488t2505r1676b2592],
31	,	,	O	,	_	0	SENT_118	[p8l1488t2505r1676b2592],
32	with	IN	O	with	_	0	SENT_118	[p8l1752t2505r1933b2571],
33	474	CD	NUMBER	474	num	34	SENT_118	[p8l2007t2515r2144b2571],
34	measurements	NNS	O	measurement	prep_with	11	SENT_118	[p8l8t2613r577b2670],
35	of	IN	O	of	_	0	SENT_118	[p8l624t2603r702b2670],
36	olanzapine	NN	O	olanzapine	nn	38	SENT_118	[p8l738t2603r1171b2690],
37	plasma	NN	O	plasma	nn	38	SENT_118	[p8l1214t2603r1496b2690],
38	concentrations	NNS	O	concentration	prep_of	34	SENT_118	[p8l1539t2607r2141b2670],
39	.	.	O	.	_	0	SENT_118	[p8l1539t2607r2141b2670],

1	The	DT	O	the	det	4	SENT_119	[p8l9t2700r158b2766],
2	mean	NN	O	mean	nn	4	SENT_119	[p8l219t2723r433b2766],
3	olanzapine	NN	O	olanzapine	nn	4	SENT_119	[p8l494t2700r927b2787],
4	clearance	NN	O	clearance	nsubj	6	SENT_119	[p8l990t2700r1360b2766],
5	was	VBD	O	be	cop	6	SENT_119	[p8l1420t2723r1569b2766],
6	25.63	CD	NUMBER	25.63	_	0	SENT_119	[p8l1634t2710r1838b2766],
7	i	FW	O	i	dep	6	SENT_119	[p8l1867t2709r1911b2767],
8	9.934	CD	NUMBER	9.934	num	10	SENT_119	[p8l1937t2710r2145b2766],
9	(	NN	O	(	nn	10	SENT_119	[p8l13t2797r249b2884],
10	range	NN	O	range	dep	6	SENT_119	[p8l13t2797r249b2884],
11	6.940	CD	NUMBER	6.940	number	12	SENT_119	[p8l280t2797r780b2876],
12	—	CD	NUMBER	—	dep	6	SENT_119	[p8l280t2797r780b2876],
13	50.87	CD	NUMBER	50.87	num	15	SENT_119	[p8l280t2797r780b2876],
14	)	NN	O	)	nn	15	SENT_119	[p8l280t2797r780b2876],
15	litre	NN	O	litre	dep	12	SENT_119	[p8l811t2797r969b2863],
16	per	IN	O	per	_	0	SENT_119	[p8l997t2820r1124b2884],
17	hour	NN	DURATION	hour	prep_per	6	SENT_119	[p8l1149t2797r1351b2874],
18	,	,	O	,	_	0	SENT_119	[p8l1149t2797r1351b2874],
19	which	WDT	O	which	nsubj	20	SENT_119	[p8l1380t2797r1629b2863],
20	resulted	VBD	O	result	rcmod	17	SENT_119	[p8l1654t2797r1975b2863],
21	in	IN	O	in	_	0	SENT_119	[p8l2003t2801r2080b2863],
22	a	DT	O	a	det	25	SENT_119	[p8l2109t2820r2148b2863],
23	mean	JJ	O	mean	amod	25	SENT_119	[p8l8t2918r222b2961],
24	steady-state	JJ	O	steady-state	amod	25	SENT_119	[p8l305t2894r767b2981],
25	concentration	NN	O	concentration	prep_in	20	SENT_119	[p8l851t2898r1396b2961],
26	of	IN	O	of	_	0	SENT_119	[p8l1479t2894r1557b2961],
27	36.67	CD	NUMBER	36.67	prep_of	25	SENT_119	[p8l1635t2904r1841b2961],
28	i	FW	O	i	nn	30	SENT_119	[p8l1867t2904r1911b2962],
29	24.71	FW	NUMBER	24.71	nn	30	SENT_119	[p8l1938t2904r2142b2960],
30	(	FW	O	(	dobj	20	SENT_119	[p8l13t2991r249b3078],
31	range	NN	O	range	dep	6	SENT_119	[p8l13t2991r249b3078],
32	0.09	CD	NUMBER	0.09	num	31	SENT_119	[p8l295t2991r746b3070],
33	—	CD	NUMBER	—	number	34	SENT_119	[p8l295t2991r746b3070],
34	178.5	CD	NUMBER	178.5	num	36	SENT_119	[p8l295t2991r746b3070],
35	)	NN	O	)	nn	36	SENT_119	[p8l295t2991r746b3070],
36	ngml	NN	O	ngml	dep	31	SENT_119	[p8l792t2991r1088b3078],
37	‘	NN	O	‘	dep	31	SENT_119	[p8l792t2991r1088b3078],
38	1	CD	NUMBER	1	num	37	SENT_119	[p8l792t2991r1088b3078],
39	.	.	O	.	_	0	SENT_119	[p8l792t2991r1088b3078],

1	Based	VBN	O	base	_	0	SENT_120	[p8l1136t2991r1368b3057],
2	on	IN	O	on	prepc_based_on	14	SENT_120	[p8l1412t3014r1507b3057],
3	these	DT	O	these	det	4	SENT_120	[p8l1547t2991r1751b3057],
4	data	NNS	O	datum	pobj	14	SENT_120	[p8l1797t2991r1980b3068],
5	,	,	O	,	_	0	SENT_120	[p8l1797t2991r1980b3068],
6	the	DT	O	the	det	7	SENT_120	[p8l2024t2991r2146b3057],
7	mean	NN	O	mean	nsubj	14	SENT_120	[p8l8t3112r222b3155],
8	individual	JJ	O	individual	amod	7	SENT_120	[p8l305t3088r720b3155],
9	predicted	VBN	O	predict	partmod	7	SENT_120	[p8l802t3088r1180b3175],
10	trough	NN	O	trough	nn	11	SENT_120	[p8l1261t3088r1519b3175],
11	concentration	NN	O	concentration	dobj	9	SENT_120	[p8l1601t3092r2147b3155],
12	would	MD	O	would	aux	14	SENT_120	[p8l8t3185r261b3252],
13	be	VB	O	be	cop	14	SENT_120	[p8l319t3185r407b3252],
14	31.74	CD	NUMBER	31.74	_	0	SENT_120	[p8l473t3195r680b3252],
15	i	FW	O	i	dep	14	SENT_120	[p8l705t3195r750b3253],
16	19.20	CD	NUMBER	19.20	dep	23	SENT_120	[p8l778t3195r983b3252],
17	(	NN	O	(	dep	16	SENT_120	[p8l1051t3185r1287b3272],
18	range	NN	O	range	dep	23	SENT_120	[p8l1051t3185r1287b3272],
19	7.760	CD	NUMBER	7.760	num	18	SENT_120	[p8l1355t3185r2143b3272],
20	—	CD	NUMBER	—	number	21	SENT_120	[p8l1355t3185r2143b3272],
21	132.0	CD	NUMBER	132.0	num	23	SENT_120	[p8l1355t3185r2143b3272],
22	ngm1	NN	O	ngm1	nn	23	SENT_120	[p8l1355t3185r2143b3272],
23	‘	NN	O	‘	dep	14	SENT_120	[p8l1355t3185r2143b3272],
24	1	CD	NUMBER	1	dep	23	SENT_120	[p8l1355t3185r2143b3272],
25	,	,	O	,	_	0	SENT_120	[p8l1355t3185r2143b3272],
26	which	WDT	O	which	nsubj	31	SENT_120	[p8l8t3282r257b3348],
27	is	VBZ	O	be	cop	31	SENT_120	[p8l293t3285r353b3348],
28	a	DT	O	a	det	31	SENT_120	[p8l393t3305r432b3348],
29	17-fold	JJ	O	17-fold	amod	31	SENT_120	[p8l471t3282r747b3348],
30	difference	NN	O	difference	nn	31	SENT_120	[p8l785t3282r1228b3361],
31	)	NN	O	)	dep	14	SENT_120	[p8l785t3282r1228b3361],
32	.	.	O	.	_	0	SENT_120	[p8l785t3282r1228b3361],

1	If	IN	O	if	mark	3	SENT_121	[p8l1269t3282r1330b3348],
2	we	PRP	O	we	nsubj	3	SENT_121	[p8l1357t3305r1469b3348],
3	compare	VBP	O	compare	advcl	12	SENT_121	[p8l1508t3305r1843b3369],
4	groups	NNS	O	group	dobj	3	SENT_121	[p8l1880t3305r2144b3369],
5	based	VBN	O	base	partmod	4	SENT_121	[p8l6t3379r232b3446],
6	solely	RB	O	solely	advmod	5	SENT_121	[p8l278t3379r509b3466],
7	on	IN	O	on	_	0	SENT_121	[p8l554t3403r649b3446],
8	genotype	NN	O	genotype	prep_on	5	SENT_121	[p8l692t3389r1072b3466],
9	,	,	O	,	_	0	SENT_121	[p8l692t3389r1072b3466],
10	GG	NNS	O	gg	nn	11	SENT_121	[p8l1121t3383r1242b3446],
11	carriers	NNS	O	carrier	nsubj	12	SENT_121	[p8l1285t3383r1576b3446],
12	have	VBP	O	have	_	0	SENT_121	[p8l1622t3379r1805b3446],
13	a	DT	O	a	det	15	SENT_121	[p8l1852t3403r1891b3445],
14	mean	JJ	O	mean	amod	15	SENT_121	[p8l1933t3403r2147b3446],
15	individual	JJ	O	individual	dobj	12	SENT_121	[p8l9t3476r425b3543],
16	predicted	VBN	O	predict	partmod	15	SENT_121	[p8l542t3476r921b3564],
17	trough	NN	O	trough	nn	18	SENT_121	[p8l1036t3476r1294b3563],
18	concentration	NN	O	concentration	dobj	16	SENT_121	[p8l1412t3480r1957b3543],
19	of	IN	O	of	_	0	SENT_121	[p8l2076t3477r2154b3543],
20	34.84	CD	NUMBER	34.84	prep_of	18	SENT_121	[p8l12t3582r219b3638],
21	i	FW	O	i	dep	27	SENT_121	[p8l244t3582r289b3640],
22	18.99	CD	NUMBER	18.99	dep	21	SENT_121	[p8l317t3582r546b3649],
23	,	,	O	,	_	0	SENT_121	[p8l317t3582r546b3649],
24	GA	NN	O	ga	nn	25	SENT_121	[p8l627t3576r752b3638],
25	carriers	NNS	O	carrier	appos	22	SENT_121	[p8l830t3576r1121b3638],
26	31.17	CD	NUMBER	31.17	dep	27	SENT_121	[p8l1203t3582r1410b3638],
27	i	FW	O	i	dep	18	SENT_121	[p8l1436t3582r1480b3640],
28	21.07	CD	NUMBER	21.07	dep	27	SENT_121	[p8l1507t3582r1713b3638],
29	and	CC	O	and	_	0	SENT_121	[p8l1794t3573r1938b3638],
30	AA	NN	O	aa	conj_and	28	SENT_121	[p8l2014t3577r2147b3638],

1	carriers	NNS	O	carrier	_	0	SENT_122	[p8l10t3673r301b3736],
2	23.47	CD	NUMBER	23.47	num	3	SENT_122	[p8l352t3678r976b3756],
3	i13	NN	O	i13	dep	1	SENT_122	[p8l352t3678r976b3756],
4	.59	CD	NUMBER	.59	num	7	SENT_122	[p8l352t3678r976b3756],
5	ng	NN	O	ng	nn	7	SENT_122	[p8l352t3678r976b3756],
6	ml	NN	O	ml	nn	7	SENT_122	[p8l995t3669r1180b3735],
7	”	NN	O	”	dep	3	SENT_122	[p8l995t3669r1180b3735],
8	.	.	O	.	_	0	SENT_122	[p8l995t3669r1180b3735],

1	Moreover	RB	O	moreover	_	0	SENT_123	[p8l1230t3674r1624b3746],
2	,	,	O	,	_	0	SENT_123	[p8l1230t3674r1624b3746],
3	50	CD	PERCENT	50	num	4	SENT_123	[p8l1676t3669r1843b3741],
4	%	NN	PERCENT	%	dep	5	SENT_123	[p8l1676t3669r1843b3741],
5	of	IN	O	of	dep	1	SENT_123	[p8l1899t3669r1977b3736],
6	AA	NN	O	aa	pobj	5	SENT_123	[p8l2014t3674r2147b3735],

1	carriers	NNS	O	carrier	nsubj	2	SENT_124	[p9l10t15r301b78],
2	(	VBP	O	(	ccomp	43	SENT_124	[p9l342t12r453b90],
3	13	CD	NUMBER	13	dobj	2	SENT_124	[p9l342t12r453b90],
4	of	IN	O	of	_	0	SENT_124	[p9l494t12r572b78],
5	26	CD	NUMBER	26	num	6	SENT_124	[p9l601t12r740b91],
6	)	CD	NUMBER	)	prep_of	3	SENT_124	[p9l601t12r740b91],
7	,	,	O	,	_	0	SENT_124	[p9l601t12r740b91],
8	33	CD	PERCENT	33	num	9	SENT_124	[p9l781t11r949b84],
9	%	NN	PERCENT	%	nsubj	13	SENT_124	[p9l781t11r949b84],
10	of	IN	O	of	_	0	SENT_124	[p9l992t12r1070b78],
11	GA	NN	O	ga	nn	12	SENT_124	[p9l1097t15r1223b78],
12	carriers	NNS	O	carrier	prep_of	9	SENT_124	[p9l1258t15r1549b78],
13	(	VBP	O	(	conj_and	2	SENT_124	[p9l1589t12r1701b91],
14	15	CD	NUMBER	15	dobj	13	SENT_124	[p9l1589t12r1701b91],
15	of	IN	O	of	_	0	SENT_124	[p9l1742t12r1820b78],
16	46	CD	NUMBER	46	num	17	SENT_124	[p9l1846t12r1962b90],
17	)	NN	O	)	prep_of	14	SENT_124	[p9l1846t12r1962b90],
18	and	CC	O	and	_	0	SENT_124	[p9l2002t11r2147b78],
19	18	CD	PERCENT	18	num	20	SENT_124	[p9l13t109r179b180],
20	%	NN	PERCENT	%	nsubj	24	SENT_124	[p9l13t109r179b180],
21	of	IN	O	of	_	0	SENT_124	[p9l259t109r337b174],
22	GG	NNS	O	gg	nn	23	SENT_124	[p9l400t112r522b174],
23	carriers	NNS	O	carrier	prep_of	20	SENT_124	[p9l591t112r881b174],
24	(	VBP	O	(	ccomp	43	SENT_124	[p9l958t109r1072b187],
25	14	CD	NUMBER	14	nsubj	29	SENT_124	[p9l958t109r1072b187],
26	of	IN	O	of	_	0	SENT_124	[p9l1146t109r1224b174],
27	78	CD	NUMBER	78	num	28	SENT_124	[p9l1292t109r1403b187],
28	)	CD	NUMBER	)	prep_of	25	SENT_124	[p9l1292t109r1403b187],
29	have	VBP	O	have	ccomp	24	SENT_124	[p9l1475t109r1659b174],
30	individual	JJ	O	individual	dobj	29	SENT_124	[p9l1730t109r2146b174],
31	predicted	VBN	O	predict	partmod	30	SENT_124	[p9l9t205r387b292],
32	trough	NN	O	trough	nn	33	SENT_124	[p9l419t205r676b292],
33	concentrations	NNS	O	concentration	nsubj	34	SENT_124	[p9l710t209r1292b272],
34	<	JJR	O	<	xcomp	31	SENT_124	[p9l1343t225r1388b271],
35	20	CD	NUMBER	20	num	36	SENT_124	[p9l1411t215r1498b272],
36	ngml	NN	O	ngml	dep	34	SENT_124	[p9l1518t205r1817b292],
37	'	''	O	'	_	0	SENT_124	[p9l1518t205r1817b292],
38	1	CD	NUMBER	1	tmod	31	SENT_124	[p9l1518t205r1817b292],
39	,	,	O	,	_	0	SENT_124	[p9l1518t205r1817b292],
40	a	DT	O	a	det	42	SENT_124	[p9l1854t229r1893b271],
41	blood	NN	O	blood	nn	42	SENT_124	[p9l1922t205r2147b272],
42	level	NN	O	level	nsubj	43	SENT_124	[p9l9t302r197b369],
43	thought	VBD	O	think	_	0	SENT_124	[p9l225t302r532b389],
44	to	TO	O	to	aux	45	SENT_124	[p9l558t312r630b369],
45	represent	VB	O	represent	xcomp	43	SENT_124	[p9l658t312r1029b390],
46	the	DT	O	the	det	49	SENT_124	[p9l1055t302r1176b369],
47	lower	JJR	O	lower	amod	49	SENT_124	[p9l1206t302r1429b369],
48	therapeutic	JJ	O	therapeutic	amod	49	SENT_124	[p9l1454t302r1904b390],
49	limit	NN	O	limit	dobj	45	SENT_124	[p9l1934t302r2141b369],
50	.	.	O	.	_	0	SENT_124	[p9l1934t302r2141b369],

1	The	DT	O	the	det	4	SENT_125	[p9l96t400r246b466],
2	olanzapine	NN	O	olanzapine	nn	4	SENT_125	[p9l276t400r709b487],
3	clearance	NN	O	clearance	nn	4	SENT_125	[p9l740t400r1109b466],
4	model	NN	O	model	nsubjpass	11	SENT_125	[p9l1138t400r1384b466],
5	based	VBN	O	base	_	0	SENT_125	[p9l1410t400r1636b466],
6	on	IN	O	on	prepc_based_on	4	SENT_125	[p9l1666t423r1761b466],
7	genotype	NN	O	genotype	pobj	4	SENT_125	[p9l1788t410r2145b487],
8	was	VBD	O	be	auxpass	11	SENT_125	[p9l8t520r157b563],
9	also	RB	O	also	advmod	11	SENT_125	[p9l212t496r365b563],
10	significantly	RB	O	significantly	advmod	11	SENT_125	[p9l420t496r913b583],
11	associated	VBN	O	associate	_	0	SENT_125	[p9l965t496r1371b563],
12	with	IN	O	with	_	0	SENT_125	[p9l1422t496r1603b563],
13	measures	NNS	O	measure	prep_with	11	SENT_125	[p9l1654t520r2020b563],
14	of	IN	O	of	_	0	SENT_125	[p9l2076t496r2154b563],
15	clinical	JJ	O	clinical	amod	16	SENT_125	[p9l10t593r304b660],
16	response	NN	O	response	prep_of	13	SENT_125	[p9l355t617r724b681],
17	.	.	O	.	_	0	SENT_125	[p9l355t617r724b681],

1	Patients	NNS	O	patient	dep	122	SENT_126	[p9l780t597r1094b660],
2	with	IN	O	with	dep	122	SENT_126	[p9l1147t593r1328b660],
3	a	DT	O	a	dep	122	SENT_126	[p9l1381t617r1420b660],
4	higher	JJR	O	higher	dep	122	SENT_126	[p9l1470t593r1724b680],
5	clearance	NN	O	clearance	dep	122	SENT_126	[p9l1775t593r2146b660],
6	(	NN	O	(	dep	122	SENT_126	[p9l13t691r190b769],
7	that	WDT	O	that	dep	122	SENT_126	[p9l13t691r190b769],
8	is	VBZ	O	be	dep	122	SENT_126	[p9l241t694r302b757],
9	lower	JJR	O	lower	dep	122	SENT_126	[p9l357t691r579b757],
10	concentrations	NNS	O	concentration	dep	122	SENT_126	[p9l632t694r1213b757],
11	of	IN	O	of	dep	122	SENT_126	[p9l1270t691r1348b757],
12	olanzapine	NN	O	olanzapine	dep	122	SENT_126	[p9l1394t691r1853b778],
13	)	NN	O	)	dep	122	SENT_126	[p9l1394t691r1853b778],
14	had	VBD	O	have	dep	122	SENT_126	[p9l1909t691r2055b757],
15	a	DT	O	a	dep	122	SENT_126	[p9l2109t714r2148b757],
16	higher	JJR	O	higher	dep	122	SENT_126	[p9l8t787r262b874],
17	total	JJ	O	total	dep	122	SENT_126	[p9l304t787r478b854],
18	PANSS	NN	O	panss	dep	122	SENT_126	[p9l522t791r805b854],
19	score	NN	NUMBER	score	dep	122	SENT_126	[p9l853t811r1053b854],
20	at	IN	O	at	dep	122	SENT_126	[p9l1099t797r1167b854],
21	the	DT	O	the	dep	122	SENT_126	[p9l1209t787r1330b854],
22	end	NN	O	end	dep	122	SENT_126	[p9l1377t787r1521b854],
23	of	IN	O	of	dep	122	SENT_126	[p9l1567t787r1645b854],
24	phase	NN	O	phase	dep	122	SENT_126	[p9l1681t787r1908b874],
25	1/1A	NN	O	1/1a	dep	122	SENT_126	[p9l1958t787r2147b854],
26	(	CD	NUMBER	(	dep	122	SENT_126	[p9l13t885r85b963],
27	n	NN	O	n	dep	122	SENT_126	[p9l13t885r85b963],
28	=	JJ	O	=	dep	122	SENT_126	[p9l108t916r152b939],
29	131	CD	NUMBER	131	dep	122	SENT_126	[p9l178t894r334b961],
30	,	,	O	,	_	0	SENT_126	[p9l178t894r334b961],
31	F	NN	O	f	dep	122	SENT_126	[p9l385t889r433b950],
32	=	JJ	O	=	dep	122	SENT_126	[p9l454t916r499b939],
33	11.39	CD	NUMBER	11.39	dep	122	SENT_126	[p9l524t894r753b961],
34	,	,	O	,	_	0	SENT_126	[p9l524t894r753b961],
35	12	CD	NUMBER	12	dep	122	SENT_126	[p9l802t885r863b950],
36	=	JJ	O	=	dep	122	SENT_126	[p9l886t916r931b939],
37	0.0811	CD	NUMBER	0.0811	dep	122	SENT_126	[p9l953t894r1232b961],
38	,	,	O	,	_	0	SENT_126	[p9l953t894r1232b961],
39	P	NN	O	p	dep	122	SENT_126	[p9l1282t889r1397b950],
40	:	:	O	:	_	0	SENT_126	[p9l1282t889r1397b950],
41	0.0010	CD	NUMBER	0.0010	dep	122	SENT_126	[p9l1420t894r1698b961],
42	;	:	O	;	_	0	SENT_126	[p9l1420t894r1698b961],
43	Figure	NNP	O	Figure	dep	122	SENT_126	[p9l1750t888r2000b971],
44	2	CD	NUMBER	2	dep	122	SENT_126	[p9l2053t885r2143b963],
45	)	CD	NUMBER	)	dep	122	SENT_126	[p9l2053t885r2143b963],
46	,	,	O	,	_	0	SENT_126	[p9l2053t885r2143b963],
47	meaning	VBG	O	mean	dep	122	SENT_126	[p9l8t985r348b1069],
48	that	IN	O	that	dep	122	SENT_126	[p9l387t982r540b1048],
49	they	PRP	O	they	dep	122	SENT_126	[p9l578t982r749b1068],
50	had	VBD	O	have	dep	122	SENT_126	[p9l788t982r934b1048],
51	more	RBR	O	more	dep	122	SENT_126	[p9l973t1005r1171b1048],
52	symptoms	NNS	O	symptom	dep	122	SENT_126	[p9l1214t992r1639b1069],
53	,	,	O	,	_	0	SENT_126	[p9l1214t992r1639b1069],
54	particularly	RB	O	particularly	dep	122	SENT_126	[p9l1683t982r2148b1069],
55	positive	JJ	O	positive	dep	122	SENT_126	[p9l9t1081r322b1165],
56	symptoms	NNS	O	symptom	dep	122	SENT_126	[p9l366t1088r767b1165],
57	(	VBP	O	(	dep	122	SENT_126	[p9l814t1078r887b1156],
58	F	NN	O	f	dep	122	SENT_126	[p9l814t1078r887b1156],
59	=	JJ	O	=	dep	122	SENT_126	[p9l909t1109r953b1133],
60	11.48	CD	NUMBER	11.48	dep	122	SENT_126	[p9l978t1087r1207b1154],
61	,	,	O	,	_	0	SENT_126	[p9l978t1087r1207b1154],
62	I2	NN	O	i2	dep	122	SENT_126	[p9l1250t1079r1310b1144],
63	=	JJ	O	=	dep	122	SENT_126	[p9l1333t1109r1377b1133],
64	0.0817	CD	NUMBER	0.0817	dep	122	SENT_126	[p9l1400t1087r1679b1154],
65	,	,	O	,	_	0	SENT_126	[p9l1400t1087r1679b1154],
66	P	NN	O	p	dep	122	SENT_126	[p9l1721t1082r1837b1143],
67	:	:	O	:	_	0	SENT_126	[p9l1721t1082r1837b1143],
68	0.0009	CD	NUMBER	0.0009	dep	122	SENT_126	[p9l1859t1078r2143b1157],
69	)	NN	O	)	dep	122	SENT_126	[p9l1859t1078r2143b1157],
70	and	CC	O	and	dep	122	SENT_126	[p9l10t1175r155b1242],
71	general	JJ	O	general	dep	122	SENT_126	[p9l245t1175r531b1262],
72	psychopathology	NN	O	psychopathology	dep	122	SENT_126	[p9l622t1175r1300b1263],
73	ratings	NNS	O	rating	dep	122	SENT_126	[p9l1388t1179r1653b1262],
74	(	VBP	O	(	dep	122	SENT_126	[p9l1750t1176r1889b1254],
75	F	NN	O	f	dep	122	SENT_126	[p9l1750t1176r1889b1254],
76	:	:	O	:	_	0	SENT_126	[p9l1750t1176r1889b1254],
77	11.24	CD	NUMBER	11.24	dep	122	SENT_126	[p9l1914t1185r2143b1252],
78	,	,	O	,	_	0	SENT_126	[p9l1914t1185r2143b1252],
79	I2	NN	O	i2	dep	122	SENT_126	[p9l8t1273r68b1338],
80	=	JJ	O	=	dep	122	SENT_126	[p9l91t1304r135b1327],
81	0.0801	CD	NUMBER	0.0801	dep	122	SENT_126	[p9l158t1282r437b1349],
82	,	,	O	,	_	0	SENT_126	[p9l158t1282r437b1349],
83	P	NN	O	p	dep	122	SENT_126	[p9l467t1277r583b1338],
84	:	:	O	:	_	0	SENT_126	[p9l467t1277r583b1338],
85	0.0011	CD	NUMBER	0.0011	dep	122	SENT_126	[p9l606t1273r889b1351],
86	)	NN	O	)	dep	122	SENT_126	[p9l606t1273r889b1351],
87	rather	RB	O	rather	dep	122	SENT_126	[p9l920t1273r1154b1339],
88	than	IN	O	than	dep	122	SENT_126	[p9l1180t1273r1356b1339],
89	negative	JJ	O	negative	dep	122	SENT_126	[p9l1383t1276r1711b1360],
90	symptoms	NNS	O	symptom	dep	122	SENT_126	[p9l1742t1282r2144b1360],
91	(	VBP	O	(	dep	122	SENT_126	[p9l13t1368r86b1446],
92	F	NN	O	f	dep	122	SENT_126	[p9l13t1368r86b1446],
93	=	JJ	O	=	dep	122	SENT_126	[p9l108t1399r152b1422],
94	2.774	CD	NUMBER	2.774	dep	122	SENT_126	[p9l176t1377r406b1444],
95	,	,	O	,	_	0	SENT_126	[p9l176t1377r406b1444],
96	I2	NN	O	i2	dep	122	SENT_126	[p9l449t1369r509b1433],
97	=	JJ	O	=	dep	122	SENT_126	[p9l532t1399r576b1422],
98	0.0211	CD	NUMBER	0.0211	dep	122	SENT_126	[p9l599t1377r878b1444],
99	,	,	O	,	_	0	SENT_126	[p9l599t1377r878b1444],
100	P	NN	O	p	dep	122	SENT_126	[p9l921t1372r1036b1433],
101	:	:	O	:	_	0	SENT_126	[p9l921t1372r1036b1433],
102	0.098	CD	NUMBER	0.098	dep	122	SENT_126	[p9l1059t1368r1319b1446],
103	)	NN	O	)	dep	122	SENT_126	[p9l1059t1368r1319b1446],
104	,	,	O	,	_	0	SENT_126	[p9l1059t1368r1319b1446],
105	consistent	JJ	O	consistent	dep	122	SENT_126	[p9l1364t1371r1767b1433],
106	with	IN	O	with	dep	122	SENT_126	[p9l1804t1368r1985b1433],
107	the	DT	O	the	dep	122	SENT_126	[p9l2024t1368r2146b1433],
108	fact	NN	O	fact	dep	122	SENT_126	[p9l10t1466r150b1532],
109	that	IN	O	that	dep	122	SENT_126	[p9l188t1465r340b1532],
110	antipsychotic	JJ	O	antipsychotic	dep	122	SENT_126	[p9l379t1465r913b1553],
111	drugs	NNS	O	drug	dep	122	SENT_126	[p9l957t1465r1170b1552],
112	are	VBP	O	be	dep	122	SENT_126	[p9l1213t1489r1327b1532],
113	more	RBR	O	more	dep	122	SENT_126	[p9l1366t1489r1563b1532],
114	efficacious	JJ	O	efficacious	dep	122	SENT_126	[p9l1605t1466r2027b1532],
115	in	IN	O	in	dep	122	SENT_126	[p9l2069t1469r2147b1531],
116	ameliorating	VBG	O	ameliorate	dep	122	SENT_126	[p9l10t1564r506b1651],
117	positive	JJ	O	positive	dep	122	SENT_126	[p9l537t1567r850b1651],
118	psychotic	JJ	O	psychotic	dep	122	SENT_126	[p9l882t1564r1263b1651],
119	symptoms	NNS	O	symptom	dep	122	SENT_126	[p9l1297t1573r1699b1651],
120	than	IN	O	than	dep	122	SENT_126	[p9l1732t1564r1908b1630],
121	negative	JJ	O	negative	dep	122	SENT_126	[p9l1938t1587r2146b1651, p9l8t1663r153b1726],
122	symptoms	NNS	O	symptom	_	0	SENT_126	[p9l199t1670r622b1747],
123	.	.	O	.	_	0	SENT_126	[p9l199t1670r622b1747],

1	While	IN	O	while	mark	6	SENT_127	[p9l669t1660r907b1726],
2	olanzapine	NN	O	olanzapine	nn	3	SENT_127	[p9l953t1660r1386b1747],
3	clearance	NN	O	clearance	nsubj	6	SENT_127	[p9l1432t1660r1802b1726],
4	did	VBD	O	do	aux	6	SENT_127	[p9l1849t1660r1977b1726],
5	not	RB	O	not	neg	6	SENT_127	[p9l2020t1670r2148b1726],
6	predict	VB	O	predict	advcl	37	SENT_127	[p9l9t1757r291b1845],
7	time	NN	O	time	dobj	6	SENT_127	[p9l321t1761r494b1824],
8	to	TO	O	to	_	0	SENT_127	[p9l526t1767r598b1824],
9	discontinuation	NN	O	discontinuation	prep_to	6	SENT_127	[p9l634t1757r1261b1824],
10	for	IN	O	for	_	0	SENT_127	[p9l1293t1758r1400b1824],
11	all	DT	O	all	det	12	SENT_127	[p9l1431t1757r1526b1824],
12	cause	NN	O	cause	prep_for	9	SENT_127	[p9l1560t1781r1776b1824],
13	in	IN	O	in	_	0	SENT_127	[p9l1809t1761r1887b1823],
14	phase	NN	O	phase	nn	15	SENT_127	[p9l1918t1757r2146b1845],
15	1/1A	NN	O	1/1a	prep_in	12	SENT_127	[p9l13t1854r202b1919],
16	(	CD	NUMBER	(	number	17	SENT_127	[p9l252t1854r324b1932],
17	11	CD	NUMBER	11	num	19	SENT_127	[p9l252t1854r324b1932],
18	=	JJ	O	=	quantmod	19	SENT_127	[p9l347t1885r391b1908],
19	149	CD	NUMBER	149	dep	15	SENT_127	[p9l417t1863r573b1930],
20	,	,	O	,	_	0	SENT_127	[p9l417t1863r573b1930],
21	F	NN	O	f	appos	15	SENT_127	[p9l622t1858r670b1919],
22	=	JJ	O	=	amod	21	SENT_127	[p9l692t1885r736b1908],
23	1.620	CD	NUMBER	1.620	tmod	22	SENT_127	[p9l762t1863r990b1930],
24	,	,	O	,	_	0	SENT_127	[p9l762t1863r990b1930],
25	I2	NN	O	i2	appos	15	SENT_127	[p9l1038t1854r1098b1919],
26	=	JJ	O	=	amod	25	SENT_127	[p9l1122t1885r1166b1908],
27	0.011	CD	NUMBER	0.011	tmod	26	SENT_127	[p9l1189t1863r1420b1930],
28	,	,	O	,	_	0	SENT_127	[p9l1189t1863r1420b1930],
29	P	NN	O	p	appos	15	SENT_127	[p9l1468t1858r1583b1919],
30	:	:	O	:	_	0	SENT_127	[p9l1468t1858r1583b1919],
31	0.205	CD	NUMBER	0.205	num	32	SENT_127	[p9l1606t1854r1866b1932],
32	)	NN	O	)	dep	29	SENT_127	[p9l1606t1854r1866b1932],
33	,	,	O	,	_	0	SENT_127	[p9l1606t1854r1866b1932],
34	it	PRP	O	it	nsubj	37	SENT_127	[p9l1916t1857r1970b1919],
35	did	VBD	O	do	aux	37	SENT_127	[p9l2018t1854r2147b1919],
36	significantly	RB	O	significantly	advmod	37	SENT_127	[p9l11t1950r504b2037],
37	predict	VB	O	predict	_	0	SENT_127	[p9l548t1950r830b2037],
38	the	DT	O	the	det	39	SENT_127	[p9l873t1950r994b2016],
39	reason	NN	O	reason	dobj	37	SENT_127	[p9l1039t1973r1296b2016],
40	for	IN	O	for	_	0	SENT_127	[p9l1342t1950r1449b2016],
41	discontinuation	NN	O	discontinuation	prep_for	39	SENT_127	[p9l1495t1950r2141b2016],
42	.	.	O	.	_	0	SENT_127	[p9l1495t1950r2141b2016],

1	Patients	NNS	O	patient	nsubj	10	SENT_128	[p9l8t2050r322b2113],
2	who	WP	O	who	nsubj	3	SENT_128	[p9l366t2047r535b2113],
3	discontinued	VBD	O	discontinue	rcmod	1	SENT_128	[p9l582t2047r1103b2113],
4	olanzapine	NN	O	olanzapine	iobj	3	SENT_128	[p9l1147t2047r1580b2134],
5	due	JJ	O	due	amod	7	SENT_128	[p9l1627t2047r1769b2113],
6	to	TO	O	to	dep	7	SENT_128	[p9l1812t2057r1884b2113],
7	unacceptable	JJ	O	unacceptable	amod	9	SENT_128	[p9l1927t2070r2145b2113, p9l10t2145r336b2232],
8	side	JJ	O	side	amod	9	SENT_128	[p9l370t2145r528b2211],
9	effects	NNS	O	effect	dobj	3	SENT_128	[p9l562t2145r809b2211],
10	(	VBP	O	(	_	0	SENT_128	[p9l847t2145r919b2223],
11	n	NN	O	n	dobj	10	SENT_128	[p9l847t2145r919b2223],
12	=	JJ	O	=	amod	14	SENT_128	[p9l941t2176r986b2199],
13	34	CD	NUMBER	34	num	14	SENT_128	[p9l1010t2145r1123b2223],
14	)	NN	O	)	nsubj	15	SENT_128	[p9l1010t2145r1123b2223],
15	had	VBD	O	have	rcmod	11	SENT_128	[p9l1157t2145r1304b2211],
16	the	DT	O	the	det	18	SENT_128	[p9l1334t2145r1455b2211],
17	lowest	JJS	O	lowest	amod	18	SENT_128	[p9l1487t2145r1745b2211],
18	clearance	NN	O	clearance	dobj	15	SENT_128	[p9l1776t2145r2146b2211],

1	125	CD	NUMBER	125	number	2	SENT_129	[p9l156t2398r268b2453],
2	8	CD	NUMBER	8	_	0	SENT_129	[p9l316t2435r327b2436],
3	r2	NN	O	r2	nn	5	SENT_129	[p9l444t2393r698b2487],
4	=	JJ	O	=	amod	5	SENT_129	[p9l444t2393r698b2487],
5	o	NN	O	o	dep	2	SENT_129	[p9l444t2393r698b2487],
6	-.103	CD	NUMBER	-.103	dep	2	SENT_129	[p9l444t2393r698b2487],
7	,	,	O	,	_	0	SENT_129	[p9l444t2393r698b2487],
8	p	NN	O	p	appos	6	SENT_129	[p9l732t2418r982b2488],
9	=	JJ	O	=	amod	12	SENT_129	[p9l732t2418r982b2488],
10	~	CD	NUMBER	~	tmod	9	SENT_129	[p9l732t2418r982b2488],
11	u.	NN	O	u.	nn	12	SENT_129	[p9l732t2418r982b2488],
12	m1	NN	O	m1	dep	8	SENT_129	[p9l732t2418r982b2488],

1	ion	NN	O	ion	_	0	SENT_130	[p9l156t2634r264b2690],

1	Total	JJ	O	total	amod	2	SENT_131	[p9l27t3196r83b3372],
2	PANSS	NNS	O	panss	_	0	SENT_131	[p9l23t2917r84b3170],
3	scare	NN	O	scare	dep	2	SENT_131	[p9l40t2694r84b2895],

1	ELEA	NNP	O	ELEA	_	0	SENT_132	[p10l892t37r1358b97],
2	.	.	O	.	_	0	SENT_132	[p10l892t37r1358b97],

1	RANCE	NNP	O	RANCE	_	0	SENT_133	[p10l892t37r1358b97],
2	(	CD	NUMBER	(	num	4	SENT_133	[p10l1383t37r1542b110],
3	Lfl1	NN	O	lfl1	nn	4	SENT_133	[p10l1383t37r1542b110],
4	}	NN	O	}	dep	1	SENT_133	[p10l1383t37r1542b110],

1	Figure	NN	O	figure	nsubj	5	SENT_134	[p10l8t144r239b219],
2	2	CD	NUMBER	2	num	4	SENT_134	[p10l268t150r303b200],
3	Olanzapine	JJ	O	olanzapine	amod	4	SENT_134	[p10l389t141r796b219],
4	clearance	NN	O	clearance	dep	1	SENT_134	[p10l825t141r1157b201],
5	predicts	VBZ	O	predict	_	0	SENT_134	[p10l1185t141r1470b219],
6	total	JJ	O	total	amod	8	SENT_134	[p10l1498t141r1655b201],
7	PANSS	NN	O	panss	nn	8	SENT_134	[p10l1681t144r1935b201],
8	score	NN	NUMBER	score	dobj	5	SENT_134	[p10l1966t162r2146b201],
9	at	IN	O	at	_	0	SENT_134	[p10l10t238r71b289],
10	end	NN	O	end	prep_at	5	SENT_134	[p10l101t230r231b289],
11	of	IN	O	of	_	0	SENT_134	[p10l263t230r333b289],
12	phase	NN	O	phase	nn	13	SENT_134	[p10l356t230r560b307],
13	1/1A	NN	O	1/1a	prep_of	10	SENT_134	[p10l595t230r781b289],
14	.	.	O	.	_	0	SENT_134	[p10l595t230r781b289],

1	CYP3A43	NN	O	cyp3a43	nn	4	SENT_135	[p10l14t411r204b454],
2	and	CC	O	and	_	0	SENT_135	[p10l224t412r294b454],
3	olanzapine	NN	O	olanzapine	nn	4	SENT_135	[p10l313t412r524b465],
4	metabolism	NN	O	metabolism	_	0	SENT_135	[p10l543t412r768b454],
5	KL	NNP	PERSON	KL	nn	6	SENT_135	[p10l17t475r65b517],
6	Bigos	NNP	PERSON	Bigos	dep	4	SENT_135	[p10l85t475r186b528],
7	et	FW	O	et	nn	8	SENT_135	[p10l203t477r240b518],
8	al	FW	O	al	dep	4	SENT_135	[p10l256t475r291b517],

1	(	NN	O	(	_	0	SENT_136	[p10l14t634r214b702],
2	24.41	CD	NUMBER	24.41	num	1	SENT_136	[p10l14t634r214b702],
3	i	FW	O	i	dep	1	SENT_136	[p10l238t642r277b693],
4	8.900	CD	NUMBER	8.900	num	5	SENT_136	[p10l299t643r478b691],
5	litre	NN	O	litre	dep	1	SENT_136	[p10l496t634r632b691],
6	per	IN	O	per	_	0	SENT_136	[p10l661t654r770b709],
7	hour	NN	DURATION	hour	nn	8	SENT_136	[p10l797t634r999b702],
8	)	NN	O	)	prep_per	5	SENT_136	[p10l797t634r999b702],
9	;	:	O	;	_	0	SENT_136	[p10l797t634r999b702],
10	patients	NNS	O	patient	dep	1	SENT_136	[p10l1030t637r1299b709],
11	who	WP	O	who	nsubj	12	SENT_136	[p10l1329t634r1474b691],
12	discontinued	VBD	O	discontinue	rcmod	10	SENT_136	[p10l1506t634r1849b691, p10l10t717r136b774],
13	due	JJ	O	due	_	0	SENT_136	[p10l175t717r298b774],
14	to	TO	O	to	_	0	SENT_136	[p10l335t725r397b774],
15	an	DT	O	a	det	19	SENT_136	[p10l436t737r515b774],
16	inadequate	JJ	O	inadequate	amod	19	SENT_136	[p10l552t717r926b792],
17	response	NN	O	response	nn	19	SENT_136	[p10l962t737r1262b792],
18	(	NN	O	(	nn	19	SENT_136	[p10l1305t717r1424b785],
19	n	NN	O	n	prep_due_to	22	SENT_136	[p10l1305t717r1424b785],
20	=	JJ	O	=	amod	22	SENT_136	[p10l1305t717r1424b785],
21	19	CD	NUMBER	19	num	22	SENT_136	[p10l1446t717r1542b785],
22	)	NN	O	)	nsubj	23	SENT_136	[p10l1446t717r1542b785],
23	had	VBD	O	have	ccomp	12	SENT_136	[p10l1582t717r1708b774],
24	the	DT	O	the	det	26	SENT_136	[p10l1745t717r1849b774],
25	highest	JJS	O	highest	amod	26	SENT_136	[p10l10t800r258b875],
26	clearance	NN	O	clearance	nsubj	29	SENT_136	[p10l300t800r619b857],
27	(	CD	NUMBER	(	number	28	SENT_136	[p10l666t800r1127b868],
28	30.97	CD	NUMBER	30.97	num	29	SENT_136	[p10l666t800r1127b868],
29	i9	NN	O	i9	xcomp	23	SENT_136	[p10l666t800r1127b868],
30	.192	CD	NUMBER	.192	num	31	SENT_136	[p10l666t800r1127b868],
31	litre	NN	O	litre	nsubj	43	SENT_136	[p10l1147t800r1283b857],
32	per	IN	O	per	_	0	SENT_136	[p10l1327t820r1436b875],
33	hour	NN	DURATION	hour	nn	34	SENT_136	[p10l1477t800r1679b868],
34	)	NN	O	)	prep_per	31	SENT_136	[p10l1477t800r1679b868],
35	;	:	O	;	_	0	SENT_136	[p10l1477t800r1679b868],
36	and	CC	O	and	_	0	SENT_136	[p10l1725t800r1850b857],
37	those	DT	O	those	nsubj	43	SENT_136	[p10l10t884r189b941],
38	who	WP	O	who	nsubj	39	SENT_136	[p10l213t884r359b941],
39	discontinued	VBD	O	discontinue	rcmod	37	SENT_136	[p10l387t884r836b941],
40	for	IN	O	for	_	0	SENT_136	[p10l861t884r953b941],
41	other	JJ	O	other	amod	42	SENT_136	[p10l978t884r1152b941],
42	reasons	NNS	O	reason	prep_for	39	SENT_136	[p10l1175t904r1428b941],
43	(	VBP	O	(	rcmod	29	SENT_136	[p10l1458t884r1520b952],
44	11	CD	NUMBER	11	dobj	43	SENT_136	[p10l1458t884r1520b952],
45	=	JJ	O	=	amod	47	SENT_136	[p10l1540t911r1578b932],
46	15	CD	NUMBER	15	num	47	SENT_136	[p10l1600t884r1696b952],
47	)	NN	O	)	nsubj	48	SENT_136	[p10l1600t884r1696b952],
48	had	VBD	O	have	rcmod	44	SENT_136	[p10l1724t884r1850b941],
49	an	DT	O	a	det	51	SENT_136	[p10l11t987r90b1024],
50	intermediate	JJ	O	intermediate	amod	51	SENT_136	[p10l159t967r591b1024],
51	clearance	NN	O	clearance	dobj	48	SENT_136	[p10l662t967r980b1024],
52	(	CD	NUMBER	(	number	53	SENT_136	[p10l1054t967r1253b1035],
53	29.91	CD	NUMBER	29.91	dep	51	SENT_136	[p10l1054t967r1253b1035],
54	i	FW	O	i	dep	53	SENT_136	[p10l1278t975r1316b1026],
55	6.687	CD	NUMBER	6.687	num	56	SENT_136	[p10l1338t967r1671b1024],
56	litre	NN	O	litre	tmod	23	SENT_136	[p10l1338t967r1671b1024],
57	per	IN	O	per	_	0	SENT_136	[p10l1741t987r1851b1042],
58	hour	NN	DURATION	hour	prep_per	56	SENT_136	[p10l10t1050r187b1116],
59	;	:	O	;	_	0	SENT_136	[p10l10t1050r187b1116],
60	analysis	NN	O	analysis	dep	10	SENT_136	[p10l257t1050r529b1125],
61	of	IN	O	of	_	0	SENT_136	[p10l599t1050r666b1107],
62	variance	NN	O	variance	nn	63	SENT_136	[p10l724t1053r1011b1107],
63	F	NN	O	f	prep_of	60	SENT_136	[p10l1078t1054r1395b1116],
64	=	JJ	O	=	amod	60	SENT_136	[p10l1078t1054r1395b1116],
65	4.361	CD	NUMBER	4.361	tmod	64	SENT_136	[p10l1078t1054r1395b1116],
66	,	,	O	,	_	0	SENT_136	[p10l1078t1054r1395b1116],
67	P	NN	O	p	appos	60	SENT_136	[p10l1463t1050r1845b1118],
68	=	JJ	O	=	amod	70	SENT_136	[p10l1463t1050r1845b1118],
69	0.0167	CD	NUMBER	0.0167	tmod	68	SENT_136	[p10l1463t1050r1845b1118],
70	)	NN	O	)	dep	67	SENT_136	[p10l1463t1050r1845b1118],
71	.	.	O	.	_	0	SENT_136	[p10l1463t1050r1845b1118],

1	Patients	NNS	O	patient	nsubj	6	SENT_137	[p10l10t1136r280b1190],
2	with	IN	O	with	_	0	SENT_137	[p10l336t1133r492b1190],
3	unacceptable	JJ	O	unacceptable	amod	5	SENT_137	[p10l545t1133r995b1208],
4	side	JJ	O	side	amod	5	SENT_137	[p10l1052t1133r1188b1190],
5	effects	NNS	O	effect	prep_with	1	SENT_137	[p10l1245t1133r1458b1190],
6	had	VBD	O	have	_	0	SENT_137	[p10l1515t1133r1641b1190],
7	27	CD	PERCENT	27	num	8	SENT_137	[p10l1699t1133r1843b1195],
8	%	NN	PERCENT	%	npadvmod	9	SENT_137	[p10l1699t1133r1843b1195],
9	lower	JJR	O	lower	amod	10	SENT_137	[p10l11t1216r203b1273],
10	clearance	NN	O	clearance	dobj	6	SENT_137	[p10l242t1216r560b1273],
11	than	IN	O	than	_	0	SENT_137	[p10l599t1216r750b1273],
12	those	DT	O	those	prep_than	6	SENT_137	[p10l788t1216r967b1273],
13	who	WP	O	who	nsubj	14	SENT_137	[p10l1006t1216r1152b1273],
14	had	VBD	O	have	rcmod	12	SENT_137	[p10l1191t1216r1318b1273],
15	an	DT	O	a	det	19	SENT_137	[p10l1357t1236r1436b1273],
16	inadequate	JJ	O	inadequate	amod	19	SENT_137	[p10l1475t1216r1849b1291],
17	response	NN	O	response	nn	19	SENT_137	[p10l9t1319r310b1374],
18	(	NN	O	(	nn	19	SENT_137	[p10l338t1299r725b1367],
19	Bonferroni	NNS	PERSON	bonferronus	dobj	14	SENT_137	[p10l338t1299r725b1367],
20	corrected	VBN	O	correct	partmod	19	SENT_137	[p10l751t1299r1065b1356],
21	P	NN	O	p	dobj	20	SENT_137	[p10l1088t1303r1188b1356],
22	=	JJ	O	=	advmod	20	SENT_137	[p10l1088t1303r1188b1356],
23	0.031	CD	NUMBER	0.031	num	24	SENT_137	[p10l1207t1299r1430b1367],
24	)	NN	O	)	dep	22	SENT_137	[p10l1207t1299r1430b1367],
25	.	.	O	.	_	0	SENT_137	[p10l1207t1299r1430b1367],

1	This	DT	O	this	nsubj	2	SENT_138	[p10l1458t1299r1606b1356],
2	means	VBZ	O	mean	_	0	SENT_138	[p10l1632t1319r1848b1356],
3	that	IN	O	that	complm	58	SENT_138	[p10l10t1382r141b1439],
4	patients	NNS	O	patient	nsubj	58	SENT_138	[p10l167t1385r436b1457],
5	who	WP	O	who	nsubj	6	SENT_138	[p10l465t1382r611b1439],
6	had	VBD	O	have	rcmod	4	SENT_138	[p10l639t1382r765b1439],
7	a	DT	O	a	det	10	SENT_138	[p10l794t1402r827b1439],
8	higher	JJR	O	higher	amod	10	SENT_138	[p10l853t1382r1072b1457],
9	olanzapine	NN	O	olanzapine	nn	10	SENT_138	[p10l1100t1382r1472b1457],
10	clearance	NN	O	clearance	dobj	6	SENT_138	[p10l1502t1382r1849b1439],
11	/	:	O	/	punct	17	SENT_138	[p10l1502t1382r1849b1439],
12	lower	JJR	O	lower	amod	14	SENT_138	[p10l11t1465r202b1522],
13	olanzapine	NN	O	olanzapine	nn	14	SENT_138	[p10l234t1465r606b1540],
14	concentrations	NNS	O	concentration	nsubj	17	SENT_138	[p10l639t1468r1139b1522],
15	were	VBD	O	be	cop	17	SENT_138	[p10l1171t1485r1333b1522],
16	more	RBR	O	more	advmod	17	SENT_138	[p10l1365t1485r1534b1522],
17	likely	JJ	O	likely	dep	10	SENT_138	[p10l1566t1465r1758b1540],
18	to	TO	O	to	aux	19	SENT_138	[p10l1786t1474r1848b1522],
19	discontinue	VB	O	discontinue	xcomp	17	SENT_138	[p10l13t1548r414b1605],
20	due	JJ	O	due	_	0	SENT_138	[p10l456t1548r578b1605],
21	to	TO	O	to	_	0	SENT_138	[p10l617t1557r679b1605],
22	an	DT	O	a	det	25	SENT_138	[p10l720t1568r799b1605],
23	inadequate	JJ	O	inadequate	amod	25	SENT_138	[p10l837t1548r1207b1623],
24	therapeutic	JJ	O	therapeutic	amod	25	SENT_138	[p10l1245t1548r1629b1623],
25	effect	NN	O	effect	prep_due_to	27	SENT_138	[p10l1670t1548r1852b1605],
26	(	CD	NUMBER	(	tmod	25	SENT_138	[p10l14t1632r77b1700],
27	F	NN	O	f	dobj	19	SENT_138	[p10l14t1632r77b1700],
28	=	JJ	O	=	amod	27	SENT_138	[p10l95t1660r133b1680],
29	3.981	CD	NUMBER	3.981	tmod	28	SENT_138	[p10l153t1640r349b1699],
30	,	,	O	,	_	0	SENT_138	[p10l153t1640r349b1699],
31	12	CD	NUMBER	12	dep	17	SENT_138	[p10l375t1633r426b1689],
32	=	JJ	O	=	amod	31	SENT_138	[p10l445t1660r484b1680],
33	0.0569	CD	NUMBER	0.0569	tmod	32	SENT_138	[p10l503t1640r741b1699],
34	,	,	O	,	_	0	SENT_138	[p10l503t1640r741b1699],
35	P	NN	O	p	dep	17	SENT_138	[p10l766t1636r866b1689],
36	=	JJ	O	=	amod	38	SENT_138	[p10l766t1636r866b1689],
37	0.050	CD	NUMBER	0.050	tmod	36	SENT_138	[p10l885t1632r1107b1700],
38	)	NN	O	)	dep	35	SENT_138	[p10l885t1632r1107b1700],
39	,	,	O	,	_	0	SENT_138	[p10l885t1632r1107b1700],
40	and	CC	O	and	_	0	SENT_138	[p10l1134t1632r1259b1690],
41	those	DT	O	those	dep	17	SENT_138	[p10l1281t1632r1459b1690],
42	with	IN	O	with	_	0	SENT_138	[p10l1482t1632r1636b1690],
43	lower	JJR	O	lower	amod	45	SENT_138	[p10l1661t1632r1851b1690],
44	olanzapine	NN	O	olanzapine	nn	45	SENT_138	[p10l12t1715r381b1790],
45	clearance/higher	NN	O	clearance/higher	prep_with	41	SENT_138	[p10l439t1715r1006b1790],
46	olanzapine	NN	O	olanzapine	nn	47	SENT_138	[p10l1062t1715r1434b1790],
47	concentrations	NNS	O	concentration	nsubj	50	SENT_138	[p10l1493t1724r1849b1772, p10l10t1801r175b1855],
48	were	VBD	O	be	cop	50	SENT_138	[p10l217t1818r379b1855],
49	more	RBR	O	more	advmod	50	SENT_138	[p10l419t1818r589b1855],
50	likely	JJ	O	likely	rcmod	10	SENT_138	[p10l630t1798r822b1873],
51	to	TO	O	to	aux	52	SENT_138	[p10l860t1806r922b1855],
52	discontinue	VB	O	discontinue	xcomp	50	SENT_138	[p10l966t1798r1360b1855],
53	due	JJ	O	due	amod	55	SENT_138	[p10l1403t1798r1523b1855],
54	to	TO	O	to	dep	55	SENT_138	[p10l1563t1806r1625b1855],
55	unacceptable	JJ	O	unacceptable	amod	57	SENT_138	[p10l1664t1818r1850b1855, p10l12t1881r287b1956],
56	side	JJ	O	side	amod	57	SENT_138	[p10l318t1881r452b1938],
57	effects	NNS	O	effect	dobj	52	SENT_138	[p10l481t1881r691b1938],
58	(	VBP	O	(	ccomp	2	SENT_138	[p10l724t1881r786b1949],
59	F	NN	O	f	dobj	58	SENT_138	[p10l724t1881r786b1949],
60	=	JJ	O	=	amod	59	SENT_138	[p10l804t1908r842b1928],
61	8.705	CD	NUMBER	8.705	tmod	60	SENT_138	[p10l861t1889r1056b1947],
62	,	,	O	,	_	0	SENT_138	[p10l861t1889r1056b1947],
63	I2	NN	O	i2	appos	59	SENT_138	[p10l1086t1882r1137b1938],
64	=	JJ	O	=	amod	63	SENT_138	[p10l1156t1908r1194b1928],
65	0.117	CD	NUMBER	0.117	tmod	64	SENT_138	[p10l1213t1889r1409b1947],
66	,	,	O	,	_	0	SENT_138	[p10l1213t1889r1409b1947],
67	P	NN	O	p	appos	59	SENT_138	[p10l1438t1885r1537b1938],
68	:	:	O	:	_	0	SENT_138	[p10l1438t1885r1537b1938],
69	0.0044	CD	NUMBER	0.0044	num	70	SENT_138	[p10l1555t1881r1814b1949],
70	)	NN	O	)	dep	67	SENT_138	[p10l1555t1881r1814b1949],
71	.	.	O	.	_	0	SENT_138	[p10l1555t1881r1814b1949],

1	An	DT	O	a	det	3	SENT_139	[p10l85t1968r186b2021],
2	MDS	NN	O	md	nn	3	SENT_139	[p10l248t1967r413b2022],
3	analysis	NN	O	analysis	nsubj	29	SENT_139	[p10l480t1964r753b2039],
4	of	IN	O	of	_	0	SENT_139	[p10l819t1964r886b2022],
5	the	DT	O	the	det	7	SENT_139	[p10l943t1964r1047b2022],
6	whole	JJ	O	whole	amod	7	SENT_139	[p10l1110t1964r1318b2022],
7	genome	NN	O	genome	prep_of	3	SENT_139	[p10l1382t1985r1644b2039],
8	data	NNS	O	datum	nsubj	9	SENT_139	[p10l1710t1964r1851b2022],
9	revealed	VBD	O	reveal	conj_and	9	SENT_139	[p10l9t2047r298b2105],
10	no	DT	O	no	det	11	SENT_139	[p10l330t2068r412b2105],
11	evidence	NN	O	evidence	dobj	9	SENT_139	[p10l448t2047r750b2105],
12	of	IN	O	of	_	0	SENT_139	[p10l786t2047r853b2105],
13	stratification	NN	O	stratification	prep_of	11	SENT_139	[p10l881t2047r1312b2105],
14	as	IN	O	as	_	0	SENT_139	[p10l1346t2068r1410b2105],
15	an	DT	O	a	det	16	SENT_139	[p10l1446t2068r1525b2104],
16	explanation	NN	O	explanation	prep_as	9	SENT_139	[p10l1560t2047r1849b2123, p10l10t2133r144b2187],
17	of	IN	O	of	_	0	SENT_139	[p10l191t2130r258b2187],
18	these	DT	O	these	det	20	SENT_139	[p10l296t2130r472b2187],
19	genotype	NN	O	genotype	nn	20	SENT_139	[p10l518t2139r825b2205],
20	associations	NNS	O	association	prep_of	16	SENT_139	[p10l873t2133r1282b2187],
21	with	IN	O	with	_	0	SENT_139	[p10l1328t2130r1484b2187],
22	clearance	NN	O	clearance	prep_with	9	SENT_139	[p10l1531t2130r1849b2187],
23	both	CC	O	both	preconj	9	SENT_139	[p10l8t2213r161b2271],
24	within	IN	O	within	_	0	SENT_139	[p10l187t2213r413b2271],
25	and	CC	O	and	_	0	SENT_139	[p10l441t2213r566b2271],
26	across	IN	O	across	_	0	SENT_139	[p10l594t2234r800b2271],
27	racial	JJ	O	racial	amod	28	SENT_139	[p10l828t2213r1016b2271],
28	groups	NNS	O	group	prep_across	9	SENT_139	[p10l1043t2234r1271b2289],
29	(	VBP	O	(	_	0	SENT_139	[p10l1304t2213r1851b2289],
30	Supplementary	NNP	O	Supplementary	nn	31	SENT_139	[p10l1304t2213r1851b2289],
31	Figure	NNP	O	Figure	nsubj	33	SENT_139	[p10l11t2300r226b2372],
32	1	CD	NUMBER	1	num	33	SENT_139	[p10l264t2297r339b2365],
33	)	CD	NUMBER	)	xcomp	29	SENT_139	[p10l264t2297r339b2365],
34	.	.	O	.	_	0	SENT_139	[p10l264t2297r339b2365],

1	While	IN	O	while	mark	3	SENT_140	[p10l375t2297r580b2354],
2	there	EX	O	there	expl	3	SENT_140	[p10l613t2297r783b2354],
3	were	VBD	O	be	advcl	22	SENT_140	[p10l816t2317r979b2354],
4	some	DT	O	some	det	5	SENT_140	[p10l1014t2317r1186b2354],
5	individuals	NNS	O	individual	nsubj	3	SENT_140	[p10l1220t2297r1610b2354],
6	in	IN	O	in	_	0	SENT_140	[p10l1646t2300r1712b2353],
7	the	DT	O	the	det	9	SENT_140	[p10l1745t2297r1849b2354],
8	Caucasian	JJ	MISC	caucasian	amod	9	SENT_140	[p10l11t2382r357b2436],
9	group	NN	O	group	prep_in	5	SENT_140	[p10l390t2399r583b2454],
10	that	WDT	O	that	nsubj	11	SENT_140	[p10l618t2379r750b2436],
11	were	VBD	O	be	rcmod	9	SENT_140	[p10l781t2399r943b2436],
12	outside	IN	O	outside	_	0	SENT_140	[p10l979t2379r1227b2436],
13	the	DT	O	the	det	15	SENT_140	[p10l1260t2379r1365b2436],
14	main	JJ	O	main	amod	15	SENT_140	[p10l1399t2382r1570b2436],
15	cluster	NN	O	cluster	prep_outside	11	SENT_140	[p10l1604t2379r1847b2445],
16	,	,	O	,	_	0	SENT_140	[p10l1604t2379r1847b2445],
17	the	DT	O	the	det	18	SENT_140	[p10l10t2462r114b2520],
18	proportion	NN	O	proportion	nsubj	22	SENT_140	[p10l148t2465r514b2538],
19	of	IN	O	of	_	0	SENT_140	[p10l549t2462r616b2520],
20	outlier	NN	O	outlier	nn	21	SENT_140	[p10l644t2462r868b2520],
21	individuals	NNS	O	individual	prep_of	18	SENT_140	[p10l900t2462r1290b2520],
22	was	VBD	O	be	_	0	SENT_140	[p10l1325t2483r1453b2520],
23	similar	JJ	O	similar	acomp	22	SENT_140	[p10l1490t2462r1726b2520],
24	for	IN	O	for	_	0	SENT_140	[p10l1759t2462r1851b2520],
25	each	DT	O	each	det	26	SENT_140	[p10l12t2546r165b2603],
26	genotype	NN	O	genotype	prep_for	23	SENT_140	[p10l189t2554r514b2621],
27	.	.	O	.	_	0	SENT_140	[p10l189t2554r514b2621],

1	In	IN	O	in	_	0	SENT_141	[p10l544t2550r612b2602],
2	addition	NN	O	addition	prep_in	5	SENT_141	[p10l638t2546r942b2612],
3	,	,	O	,	_	0	SENT_141	[p10l638t2546r942b2612],
4	we	PRP	O	we	nsubj	5	SENT_141	[p10l970t2566r1065b2603],
5	performed	VBD	O	perform	_	0	SENT_141	[p10l1092t2546r1445b2621],
6	an	DT	O	a	det	7	SENT_141	[p10l1471t2566r1550b2603],
7	analysis	NN	O	analysis	dobj	5	SENT_141	[p10l1575t2546r1847b2621],
8	controlling	VBG	O	control	partmod	7	SENT_141	[p10l12t2628r385b2703],
9	for	IN	O	for	_	0	SENT_141	[p10l411t2628r503b2685],
10	sex	NN	O	sex	prep_for	8	SENT_141	[p10l529t2648r654b2694],
11	,	,	O	,	_	0	SENT_141	[p10l529t2648r654b2694],
12	smoking	NN	O	smoking	prep_for	8	SENT_141	[p10l683t2628r968b2703],
13	and	CC	O	and	_	0	SENT_141	[p10l995t2628r1119b2685],
14	first	JJ	ORDINAL	first	amod	16	SENT_141	[p10l1145t2628r1279b2685],
15	two	CD	NUMBER	two	num	16	SENT_141	[p10l1303t2636r1427b2685],
16	dimensions	NNS	O	dimension	prep_for	8	SENT_141	[p10l1456t2628r1848b2685],
17	of	IN	O	of	_	0	SENT_141	[p10l12t2711r79b2769],
18	the	DT	O	the	det	20	SENT_141	[p10l99t2711r203b2769],
19	MDS	NN	ORGANIZATION	md	nn	20	SENT_141	[p10l230t2714r395b2769],
20	data	NNS	O	datum	prep_of	16	SENT_141	[p10l426t2711r584b2778],
21	,	,	O	,	_	0	SENT_141	[p10l426t2711r584b2778],
22	and	CC	O	and	_	0	SENT_141	[p10l614t2711r739b2769],
23	the	DT	O	the	det	24	SENT_141	[p10l764t2711r869b2769],
24	effect	NN	O	effect	nsubj	40	SENT_141	[p10l898t2711r1080b2769],
25	of	IN	O	of	_	0	SENT_141	[p10l1108t2711r1175b2769],
26	genotype	NN	O	genotype	prep_of	24	SENT_141	[p10l1194t2720r1502b2787],
27	remained	VBD	O	remain	cop	40	SENT_141	[p10l1528t2711r1850b2769],
28	in	IN	O	in	_	0	SENT_141	[p10l11t2799r78b2852],
29	both	CC	O	both	preconj	30	SENT_141	[p10l119t2796r272b2853],
30	Caucasians	NNPS	MISC	Caucasians	prep_in	40	SENT_141	[p10l315t2799r693b2853],
31	(	CD	NUMBER	(	num	32	SENT_141	[p10l743t2796r1125b2864],
32	P	NN	O	p	dep	30	SENT_141	[p10l743t2796r1125b2864],
33	=	JJ	O	=	amod	35	SENT_141	[p10l743t2796r1125b2864],
34	0.0131	CD	NUMBER	0.0131	tmod	33	SENT_141	[p10l743t2796r1125b2864],
35	)	NN	O	)	dep	32	SENT_141	[p10l743t2796r1125b2864],
36	and	CC	O	and	_	0	SENT_141	[p10l1173t2796r1298b2853],
37	African	JJ	MISC	african	amod	38	SENT_141	[p10l1341t2796r1596b2853],
38	Americans	NNPS	MISC	Americans	conj_and	30	SENT_141	[p10l1639t2800r1849b2853, p10l11t2881r184b2935],
39	(	CD	NUMBER	(	num	40	SENT_141	[p10l219t2878r287b2946],
40	P	NN	O	p	conj_and	5	SENT_141	[p10l219t2878r287b2946],
41	=	JJ	O	=	advmod	44	SENT_141	[p10l299t2905r338b2925],
42	0.0018	CD	NUMBER	0.0018	num	43	SENT_141	[p10l357t2878r601b2946],
43	)	NN	O	)	dep	41	SENT_141	[p10l357t2878r601b2946],
44	using	VBG	O	use	partmod	40	SENT_141	[p10l632t2881r817b2953],
45	a	DT	O	a	det	48	SENT_141	[p10l847t2898r880b2935],
46	general	JJ	O	general	amod	48	SENT_141	[p10l908t2878r1153b2953],
47	linear	JJ	O	linear	amod	48	SENT_141	[p10l1183t2878r1380b2935],
48	model	NN	O	model	dobj	44	SENT_141	[p10l1406t2878r1635b2935],
49	.	.	O	.	_	0	SENT_141	[p10l1406t2878r1635b2935],

1	Discussion	NN	O	discussion	_	0	SENT_142	[p10l10t3086r392b3142],

1	Approximately	RB	O	approximately	quantmod	2	SENT_143	[p11l10t43r527b119],
2	half	NN	O	half	nsubjpass	7	SENT_143	[p11l563t43r699b101],
3	of	IN	O	of	_	0	SENT_143	[p11l733t43r800b101],
4	all	DT	O	all	det	5	SENT_143	[p11l833t43r915b101],
5	drugs	NNS	O	drug	prep_of	2	SENT_143	[p11l956t43r1139b118],
6	are	VBP	O	be	auxpass	7	SENT_143	[p11l1180t64r1278b101],
7	metabolized	VBN	O	metabolize	_	0	SENT_143	[p11l1317t43r1733b101],
8	by	IN	O	by	_	0	SENT_143	[p11l1768t43r1851b118],
9	the	DT	O	the	det	11	SENT_143	[p11l10t127r114b184],
10	CYP3A	NN	O	cyp3a	nn	11	SENT_143	[p11l147t130r392b184],
11	family	NN	O	family	agent	7	SENT_143	[p11l424t127r640b202],
12	of	IN	O	of	_	0	SENT_143	[p11l672t127r739b184],
13	enzymes	NNS	O	enzyme	prep_of	11	SENT_143	[p11l765t127r1133b202],
14	,	,	O	,	_	0	SENT_143	[p11l765t127r1133b202],
15	“	NN	O	“	appos	11	SENT_143	[p11l765t127r1133b202],
16	which	WDT	O	which	nsubj	17	SENT_143	[p11l1166t127r1380b184],
17	spans	VBZ	O	span	rcmod	15	SENT_143	[p11l1412t147r1601b202],
18	220kb	NN	O	220kb	dobj	17	SENT_143	[p11l1638t127r1849b184],
19	on	IN	O	on	_	0	SENT_143	[p11l12t229r94b266],
20	chromosome	NN	O	chromosome	nn	22	SENT_143	[p11l136t209r570b266],
21	7q21	CD	NUMBER	7q21	num	22	SENT_143	[p11l617t217r832b284],
22	.1	NN	NUMBER	.1	prep_on	17	SENT_143	[p11l617t217r832b284],
23	and	CC	O	and	_	0	SENT_143	[p11l879t209r1004b266],
24	consists	VBZ	O	consist	rcmod	15	SENT_143	[p11l1046t212r1314b266],
25	of	IN	O	of	_	0	SENT_143	[p11l1360t209r1427b266],
26	four	CD	NUMBER	four	num	27	SENT_143	[p11l1463t209r1601b266],
27	genes	NNS	O	gene	prep_of	24	SENT_143	[p11l1640t229r1846b284],
28	:	:	O	:	_	0	SENT_143	[p11l1640t229r1846b284],
29	CYP3A4	NN	O	cyp3a4	dep	11	SENT_143	[p11l11t295r315b359],
30	,	,	O	,	_	0	SENT_143	[p11l11t295r315b359],
31	CYP3A5	NN	O	cyp3a5	dep	11	SENT_143	[p11l364t295r669b359],
32	,	,	O	,	_	0	SENT_143	[p11l364t295r669b359],
33	CYP3A7	NN	O	cyp3a7	dep	11	SENT_143	[p11l717t295r1001b350],
34	and	CC	O	and	_	0	SENT_143	[p11l1049t292r1174b349],
35	the	DT	O	the	det	39	SENT_143	[p11l1218t292r1322b350],
36	most	RBS	O	most	advmod	38	SENT_143	[p11l1367t301r1532b350],
37	recently	RB	DATE	recently	advmod	38	SENT_143	[p11l1574t292r1851b367],
38	identified	VBN	O	identify	amod	39	SENT_143	[p11l11t376r344b433],
39	CYP3A43	NN	O	cyp3a43	dep	11	SENT_143	[p11l371t376r856b433],
40	.12	CD	NUMBER	.12	dep	39	SENT_143	[p11l371t376r856b433],
41	‘	CD	NUMBER	‘	number	42	SENT_143	[p11l371t376r856b433],
42	15	CD	NUMBER	15	num	45	SENT_143	[p11l371t376r856b433],
43	The	DT	O	the	det	45	SENT_143	[p11l884t376r1013b433],
44	amino-acid	JJ	O	amino-acid	amod	45	SENT_143	[p11l1041t376r1422b433],
45	sequence	NN	O	sequence	nsubj	51	SENT_143	[p11l1450t396r1760b451],
46	of	IN	O	of	_	0	SENT_143	[p11l1789t376r1856b433],
47	CYP3A43	NN	O	cyp3a43	prep_of	45	SENT_143	[p11l11t462r335b516],
48	is	VBZ	O	be	cop	51	SENT_143	[p11l363t462r415b516],
49	75	CD	PERCENT	75	num	50	SENT_143	[p11l445t459r587b521],
50	%	NN	PERCENT	%	npadvmod	51	SENT_143	[p11l445t459r587b521],
51	identical	JJ	O	identical	rcmod	40	SENT_143	[p11l618t459r917b516],
52	to	TO	O	to	_	0	SENT_143	[p11l940t467r1002b516],
53	CYP3A4	NN	O	cyp3a4	prep_to	51	SENT_143	[p11l1027t462r1312b516],
54	and	CC	O	and	_	0	SENT_143	[p11l1339t459r1463b516],
55	CYP3A5	NN	O	cyp3a5	prep_to	51	SENT_143	[p11l1487t460r1848b525],
56	,	,	O	,	_	0	SENT_143	[p11l1487t460r1848b525],
57	”	NN	O	”	appos	11	SENT_143	[p11l1487t460r1848b525],
58	which	WDT	O	which	nsubj	59	SENT_143	[p11l10t542r224b600],
59	results	VBZ	O	result	rcmod	57	SENT_143	[p11l246t542r470b600],
60	in	IN	O	in	mark	62	SENT_143	[p11l496t546r563b599],
61	some	DT	O	some	nsubj	62	SENT_143	[p11l588t563r760b600],
62	overlap	VBP	O	overlap	advcl	59	SENT_143	[p11l787t542r1036b618],
63	in	IN	O	in	_	0	SENT_143	[p11l1062t546r1129b599],
64	substrate	JJ	O	substrate	amod	65	SENT_143	[p11l1154t542r1456b600],
65	specificity	NN	O	specificity	prep_in	62	SENT_143	[p11l1481t542r1845b618],
66	.	.	O	.	_	0	SENT_143	[p11l1481t542r1845b618],

1	The	DT	O	the	det	2	SENT_144	[p11l11t626r139b683],
2	SNP	NN	ORGANIZATION	snp	nsubjpass	16	SENT_144	[p11l200t629r343b683],
3	in	IN	O	in	_	0	SENT_144	[p11l403t629r470b682],
4	CYP3A43	NN	O	cyp3a43	prep_in	2	SENT_144	[p11l527t629r851b683],
5	showing	VBG	O	show	partmod	4	SENT_144	[p11l915t626r1201b701],
6	association	NN	O	association	dobj	5	SENT_144	[p11l1259t629r1637b683],
7	with	IN	O	with	_	0	SENT_144	[p11l1694t626r1850b683],
8	olanzapine	NN	O	olanzapine	nn	9	SENT_144	[p11l12t708r384b783],
9	clearance	NN	O	clearance	prep_with	5	SENT_144	[p11l432t708r750b765],
10	is	VBZ	O	be	cop	11	SENT_144	[p11l796t711r848b765],
11	intronic	JJ	O	intronic	_	0	SENT_144	[p11l895t711r1164b765],
12	and	CC	O	and	_	0	SENT_144	[p11l1211t708r1336b765],
13	has	VBZ	O	have	aux	16	SENT_144	[p11l1380t708r1491b765],
14	not	RB	O	not	neg	16	SENT_144	[p11l1538t716r1648b765],
15	been	VBN	O	be	auxpass	16	SENT_144	[p11l1689t708r1850b765],
16	established	VBN	O	establish	conj_and	11	SENT_144	[p11l12t792r394b849],
17	as	IN	O	as	_	0	SENT_144	[p11l455t812r519b849],
18	a	DT	O	a	det	20	SENT_144	[p11l582t812r616b849],
19	functional	JJ	O	functional	amod	20	SENT_144	[p11l675t792r1024b849],
20	variant	NN	O	variant	prep_as	16	SENT_144	[p11l1083t795r1337b849],
21	.	.	O	.	_	0	SENT_144	[p11l1083t795r1337b849],

1	However	RB	O	however	advmod	16	SENT_145	[p11l1402t796r1720b858],
2	,	,	O	,	_	0	SENT_145	[p11l1402t796r1720b858],
3	as	IN	O	as	mark	4	SENT_145	[p11l1783t812r1847b849],
4	illustrated	VBN	O	illustrate	advcl	16	SENT_145	[p11l11t876r361b933],
5	in	IN	O	in	_	0	SENT_145	[p11l393t879r460b932],
6	Supplementary	NNP	O	Supplementary	nn	7	SENT_145	[p11l493t876r1016b951],
7	Figure	NNP	O	Figure	prep_in	4	SENT_145	[p11l1047t879r1263b951],
8	2	CD	NUMBER	2	num	7	SENT_145	[p11l1298t884r1351b942],
9	,	,	O	,	_	0	SENT_145	[p11l1298t884r1351b942],
10	in	IN	O	in	_	0	SENT_145	[p11l1386t879r1453b932],
11	the	DT	O	the	det	13	SENT_145	[p11l1483t876r1588b933],
12	Caucasian	JJ	LOCATION	caucasian	amod	13	SENT_145	[p11l1621t879r1848b933, p11l12t961r149b1015],
13	sample	NN	O	sample	prep_in	4	SENT_145	[p11l193t958r451b1033],
14	,	,	O	,	_	0	SENT_145	[p11l193t958r451b1033],
15	it	PRP	O	it	nsubj	16	SENT_145	[p11l499t961r545b1015],
16	is	VBZ	O	be	_	0	SENT_145	[p11l588t961r640b1015],
17	only	RB	O	only	advmod	18	SENT_145	[p11l687t958r836b1033],
18	in	IN	O	in	dep	16	SENT_145	[p11l879t961r946b1014],
19	minor	JJ	O	minor	amod	21	SENT_145	[p11l988t961r1194b1015],
20	linkage	NN	O	linkage	nn	21	SENT_145	[p11l1236t958r1481b1033],
21	disequilibrium	NN	O	disequilibrium	pobj	18	SENT_145	[p11l1527t958r1849b1033, p11l8t1041r214b1098],
22	with	IN	O	with	_	0	SENT_145	[p11l282t1041r438b1098],
23	other	JJ	O	other	amod	25	SENT_145	[p11l509t1041r683b1098],
24	CYP3A43	NN	O	cyp3a43	nn	25	SENT_145	[p11l752t1044r1076b1098],
25	SNPS	NNS	O	snp	prep_with	21	SENT_145	[p11l1152t1044r1328b1098],
26	in	IN	O	in	_	0	SENT_145	[p11l1400t1044r1467b1098],
27	HapMap	NNP	ORGANIZATION	HapMap	prep_in	25	SENT_145	[p11l1536t1045r1847b1116],
28	,	,	O	,	_	0	SENT_145	[p11l1536t1045r1847b1116],
29	suggesting	VBG	O	suggest	dep	16	SENT_145	[p11l12t1128r365b1200],
30	that	IN	O	that	complm	34	SENT_145	[p11l406t1125r537b1182],
31	it	PRP	O	it	nsubj	34	SENT_145	[p11l578t1128r624b1182],
32	is	VBZ	O	be	cop	34	SENT_145	[p11l665t1128r717b1182],
33	either	CC	O	either	advmod	34	SENT_145	[p11l762t1125r957b1182],
34	functional	JJ	O	functional	ccomp	29	SENT_145	[p11l998t1125r1347b1182],
35	or	CC	O	or	_	0	SENT_145	[p11l1390t1145r1456b1182],
36	in	IN	O	in	conj_or	18	SENT_145	[p11l1496t1128r1563b1181],
37	linkage	NN	O	linkage	nn	38	SENT_145	[p11l1604t1125r1849b1200],
38	disequilibrium	NN	O	disequilibrium	pobj	36	SENT_145	[p11l13t1207r519b1282],
39	with	IN	O	with	_	0	SENT_145	[p11l551t1207r707b1264],
40	a	DT	O	a	det	44	SENT_145	[p11l741t1227r775b1264],
41	previously	RB	DATE	previously	advmod	42	SENT_145	[p11l808t1207r1171b1282],
42	untyped	JJ	O	untyped	amod	44	SENT_145	[p11l1203t1207r1488b1282],
43	CYP3A43	NN	O	cyp3a43	nn	44	SENT_145	[p11l1522t1210r1846b1264],
44	variant	NN	O	variant	prep_with	38	SENT_145	[p11l9t1293r249b1347],
45	in	IN	O	in	_	0	SENT_145	[p11l270t1293r337b1347],
46	this	DT	O	this	det	47	SENT_145	[p11l357t1290r482b1347],
47	population	NN	O	population	prep_in	44	SENT_145	[p11l506t1290r897b1365],
48	.	.	O	.	_	0	SENT_145	[p11l506t1290r897b1365],

1	In	IN	O	in	_	0	SENT_146	[p11l923t1294r991b1347],
2	the	DT	O	the	det	4	SENT_146	[p11l1012t1290r1116b1347],
3	Yurubi	NNP	LOCATION	Yurubi	nn	4	SENT_146	[p11l1138t1290r1372b1347],
4	sample	NN	O	sample	prep_in	61	SENT_146	[p11l1396t1290r1654b1365],
5	,	,	O	,	_	0	SENT_146	[p11l1396t1290r1654b1365],
6	there	EX	O	there	expl	7	SENT_146	[p11l1678t1290r1849b1347],
7	is	VBZ	O	be	parataxis	61	SENT_146	[p11l11t1377r63b1431],
8	more	JJR	O	more	amod	11	SENT_146	[p11l92t1394r262b1431],
9	significant	JJ	O	significant	amod	11	SENT_146	[p11l293t1374r651b1449],
10	linkage	NN	O	linkage	nn	11	SENT_146	[p11l678t1374r923b1449],
11	disequilibrium	NN	O	disequilibrium	nsubj	7	SENT_146	[p11l954t1374r1460b1449],
12	with	IN	O	with	_	0	SENT_146	[p11l1486t1374r1642b1431],
13	SNPs	NNS	O	snp	prep_with	11	SENT_146	[p11l1672t1377r1848b1431],
14	(	CD	NUMBER	(	num	15	SENT_146	[p11l14t1457r360b1524],
15	rs667660	NN	O	rs667660	nsubj	51	SENT_146	[p11l14t1457r360b1524],
16	,	,	O	,	_	0	SENT_146	[p11l14t1457r360b1524],
17	rs585071	NN	O	rs585071	appos	15	SENT_146	[p11l400t1465r726b1522],
18	,	,	O	,	_	0	SENT_146	[p11l400t1465r726b1522],
19	rs620020	NN	O	rs620020	appos	17	SENT_146	[p11l766t1465r1092b1522],
20	,	,	O	,	_	0	SENT_146	[p11l766t1465r1092b1522],
21	rs2740566	NN	O	rs2740566	nn	22	SENT_146	[p11l1133t1457r1503b1524],
22	)	NN	O	)	appos	17	SENT_146	[p11l1133t1457r1503b1524],
23	in	IN	O	in	_	0	SENT_146	[p11l1546t1460r1612b1513],
24	the	DT	O	the	det	27	SENT_146	[p11l1650t1457r1754b1513],
25	5	CD	NUMBER	5	num	27	SENT_146	[p11l1797t1456r1847b1513],
26	’	NN	O	’	nn	27	SENT_146	[p11l1797t1456r1847b1513],
27	domain	NN	O	domain	prep_in	22	SENT_146	[p11l13t1539r269b1596],
28	of	IN	O	of	_	0	SENT_146	[p11l299t1539r366b1596],
29	the	DT	O	the	det	30	SENT_146	[p11l388t1539r492b1596],
30	gene	NN	O	gene	prep_of	27	SENT_146	[p11l521t1559r694b1614],
31	,	,	O	,	_	0	SENT_146	[p11l521t1559r694b1614],
32	which	WDT	O	which	nsubjpass	35	SENT_146	[p11l725t1539r939b1596],
33	were	VBD	O	be	auxpass	35	SENT_146	[p11l966t1559r1128b1596],
34	neither	DT	O	neither	advmod	35	SENT_146	[p11l1158t1539r1401b1596],
35	typed	VBN	O	type	rcmod	30	SENT_146	[p11l1428t1539r1620b1614],
36	in	IN	O	in	_	0	SENT_146	[p11l1650t1542r1716b1596],
37	the	DT	O	the	det	39	SENT_146	[p11l1744t1539r1849b1596],
38	data	NN	O	datum	nn	39	SENT_146	[p11l13t1623r153b1680],
39	set	NN	O	set	prep_in	35	SENT_146	[p11l177t1631r286b1689],
40	,	,	O	,	_	0	SENT_146	[p11l177t1631r286b1689],
41	nor	CC	O	nor	_	0	SENT_146	[p11l312t1643r426b1680],
42	were	VBD	O	be	cop	44	SENT_146	[p11l448t1643r610b1680],
43	any	DT	O	any	det	44	SENT_146	[p11l635t1643r756b1698],
44	SNPs	NNS	O	snp	rcmod	30	SENT_146	[p11l781t1626r957b1680],
45	in	IN	O	in	_	0	SENT_146	[p11l983t1626r1050b1679],
46	linkage	NN	O	linkage	nn	47	SENT_146	[p11l1074t1623r1318b1698],
47	disequilibrium	NN	O	disequilibrium	prep_in	44	SENT_146	[p11l1345t1623r1851b1698],
48	with	IN	O	with	_	0	SENT_146	[p11l10t1705r165b1762],
49	these	DT	O	these	det	50	SENT_146	[p11l224t1705r399b1762],
50	SNPs	NNS	O	snp	prep_with	44	SENT_146	[p11l462t1708r638b1762],
51	(	VBP	O	(	rcmod	13	SENT_146	[p11l703t1705r1250b1780],
52	Supplementary	NNP	O	Supplementary	nn	53	SENT_146	[p11l703t1705r1250b1780],
53	Figure	NNP	O	Figure	dobj	51	SENT_146	[p11l1309t1708r1524b1780],
54	2	CD	NUMBER	2	dep	53	SENT_146	[p11l1588t1713r1640b1771],
55	;	:	O	;	_	0	SENT_146	[p11l1588t1713r1640b1771],
56	SNP	NN	O	snp	nn	57	SENT_146	[p11l1705t1708r1848b1762],
57	version	NN	O	version	dep	53	SENT_146	[p11l9t1791r260b1845],
58	2.1	CD	NUMBER	2.1	dep	57	SENT_146	[p11l378t1796r493b1854],
59	,	,	O	,	_	0	SENT_146	[p11l378t1796r493b1854],
60	http://www.broadinstitute.org/mpg/	NN	O	http://www.broadinstitute.org/mpg/	nsubj	61	SENT_146	[p11l611t1788r1849b1863],
61	snap	VBP	O	snap	_	0	SENT_146	[p11l12t1871r211b1946],
62	)	RB	O	)	advmod	61	SENT_146	[p11l12t1871r211b1946],
63	.	.	O	.	_	0	SENT_146	[p11l12t1871r211b1946],

1	Further	JJ	O	further	amod	2	SENT_147	[p11l259t1871r515b1928],
2	investigation	NN	O	investigation	nsubjpass	9	SENT_147	[p11l558t1874r1000b1946],
3	of	IN	O	of	_	0	SENT_147	[p11l1045t1871r1112b1928],
4	genetic	JJ	O	genetic	amod	5	SENT_147	[p11l1149t1874r1390b1946],
5	variation	NN	O	variation	prep_of	2	SENT_147	[p11l1434t1874r1739b1928],
6	in	IN	O	in	_	0	SENT_147	[p11l1783t1874r1850b1928],
7	CYP3A43	NN	O	cyp3a43	prep_in	5	SENT_147	[p11l11t1957r335b2011],
8	is	VBZ	O	be	auxpass	9	SENT_147	[p11l361t1957r413b2011],
9	needed	VBN	O	need	_	0	SENT_147	[p11l437t1954r684b2011],
10	to	TO	O	to	aux	11	SENT_147	[p11l706t1962r768b2011],
11	identify	VB	O	identify	xcomp	9	SENT_147	[p11l792t1954r1059b2029],
12	the	DT	O	the	det	14	SENT_147	[p11l1079t1954r1184b2011],
13	functional	JJ	O	functional	amod	14	SENT_147	[p11l1207t1954r1556b2011],
14	variants	NNS	O	variant	nsubj	16	SENT_147	[p11l1578t1957r1848b2011],
15	likely	JJ	O	likely	dep	16	SENT_147	[p11l11t2037r202b2112],
16	monitored	VBN	O	monitor	xcomp	11	SENT_147	[p11l230t2037r583b2094],
17	by	IN	O	by	_	0	SENT_147	[p11l610t2037r692b2112],
18	this	DT	O	this	det	19	SENT_147	[p11l719t2037r843b2094],
19	SNP	NN	O	snp	prep_by	16	SENT_147	[p11l876t2040r1027b2094],
20	.	.	O	.	_	0	SENT_147	[p11l876t2040r1027b2094],

1	CYP3A43	NN	O	cyp3a43	nsubjpass	21	SENT_148	[p11l86t2123r410b2177],
2	is	VBZ	O	be	auxpass	3	SENT_148	[p11l463t2123r515b2177],
3	expressed	VBN	O	express	_	0	SENT_148	[p11l567t2120r903b2195],
4	at	IN	O	at	_	0	SENT_148	[p11l952t2129r1011b2177],
5	much	RB	O	much	advmod	6	SENT_148	[p11l1058t2120r1250b2177],
6	lower	JJR	O	lower	amod	7	SENT_148	[p11l1299t2120r1491b2177],
7	levels	NNS	O	level	prep_at	3	SENT_148	[p11l1539t2120r1732b2177],
8	in	IN	O	in	_	0	SENT_148	[p11l1783t2123r1850b2177],
9	human	JJ	O	human	amod	10	SENT_148	[p11l10t2203r249b2260],
10	liver	NN	O	liver	prep_in	7	SENT_148	[p11l273t2203r427b2260],
11	compared	VBN	O	compare	_	0	SENT_148	[p11l451t2203r787b2278],
12	with	IN	O	with	prepc_compared_with	3	SENT_148	[p11l810t2203r965b2260],
13	CYP3A415	NN	O	cyp3a415	pobj	3	SENT_148	[p11l989t2203r1330b2260],
14	and	CC	O	and	_	0	SENT_148	[p11l1356t2203r1499b2269],
15	,	,	O	,	_	0	SENT_148	[p11l1356t2203r1499b2269],
16	therefore	RB	O	therefore	dep	3	SENT_148	[p11l1525t2203r1847b2269],
17	,	,	O	,	_	0	SENT_148	[p11l1525t2203r1847b2269],
18	has	VBZ	O	have	aux	21	SENT_148	[p11l10t2286r122b2343],
19	previously	RB	DATE	previously	advmod	21	SENT_148	[p11l158t2286r521b2361],
20	been	VBN	O	be	auxpass	21	SENT_148	[p11l552t2286r713b2343],
21	thought	VBN	O	think	conj_and	3	SENT_148	[p11l746t2286r1011b2361],
22	to	TO	O	to	aux	25	SENT_148	[p11l1044t2294r1106b2343],
23	be	VB	O	be	cop	25	SENT_148	[p11l1139t2286r1216b2343],
24	less	RBR	O	less	advmod	25	SENT_148	[p11l1252t2286r1374b2343],
25	important	JJ	O	important	xcomp	21	SENT_148	[p11l1412t2289r1749b2361],
26	in	IN	O	in	_	0	SENT_148	[p11l1783t2289r1850b2343],
27	drug	NN	O	drug	nn	28	SENT_148	[p11l13t2369r165b2444],
28	metabolism	NN	O	metabolism	prep_in	25	SENT_148	[p11l199t2369r613b2435],
29	,	,	O	,	_	0	SENT_148	[p11l199t2369r613b2435],
30	although	IN	O	although	mark	37	SENT_148	[p11l652t2369r951b2444],
31	analogous	JJ	O	analogous	ccomp	37	SENT_148	[p11l987t2369r1325b2444],
32	to	TO	O	to	_	0	SENT_148	[p11l1362t2378r1424b2426],
33	CYP3A5	NN	O	cyp3a5	prep_to	31	SENT_148	[p11l1461t2372r1765b2435],
34	,	,	O	,	_	0	SENT_148	[p11l1461t2372r1765b2435],
35	it	PRP	O	it	nsubj	37	SENT_148	[p11l1804t2372r1851b2426],
36	may	MD	O	may	aux	37	SENT_148	[p11l10t2472r153b2527],
37	contribute	VB	O	contribute	advcl	25	SENT_148	[p11l199t2452r546b2509],
38	to	TO	O	to	_	0	SENT_148	[p11l592t2460r654b2509],
39	a	DT	O	a	det	41	SENT_148	[p11l702t2472r735b2509],
40	large	JJ	O	large	amod	41	SENT_148	[p11l780t2452r941b2527],
41	fraction	NN	O	fraction	prep_to	37	SENT_148	[p11l988t2452r1250b2509],
42	of	IN	O	of	_	0	SENT_148	[p11l1297t2452r1364b2509],
43	total	JJ	O	total	amod	44	SENT_148	[p11l1403t2452r1553b2509],
44	hepatic	JJ	O	hepatic	prep_of	41	SENT_148	[p11l1599t2452r1848b2527],

1	@	SYM	O	@	dep	2	SENT_149	[p11l6t2813r122b2925],
2	CYP3A43	NN	O	cyp3a43	_	0	SENT_149	[p11l1389t2815r1579b2858],
3	and	CC	O	and	_	0	SENT_149	[p11l1599t2816r1669b2858],
4	olanzapine	NN	O	olanzapine	nn	5	SENT_149	[p11l1688t2816r1899b2869],
5	metabolism	NN	O	metabolism	conj_and	2	SENT_149	[p11l1918t2816r2143b2858],

1	KL	NNP	PERSON	KL	nn	2	SENT_150	[p11l1870t2879r1918b2921],
2	Bigos	NNP	PERSON	Bigos	_	0	SENT_150	[p11l1937t2879r2039b2932],
3	et	FW	O	et	nn	4	SENT_150	[p11l2056t2881r2094b2922],
4	al	FW	O	al	dep	2	SENT_150	[p11l2109t2879r2145b2922],

1	CYP3A	NN	O	cyp3a	nn	3	SENT_151	[p11l308t3041r554b3095],
2	enzyme	NN	O	enzyme	nn	3	SENT_151	[p11l600t3058r859b3113],
3	activity	NN	O	activity	dep	4	SENT_151	[p11l906t3041r1160b3113],
4	due	JJ	O	due	_	0	SENT_151	[p11l1206t3038r1328b3095],
5	to	TO	O	to	_	0	SENT_151	[p11l1373t3047r1435b3095],
6	genetic	JJ	O	genetic	amod	7	SENT_151	[p11l1480t3041r1721b3113],
7	variation	NN	O	variation	prep_to	4	SENT_151	[p11l1767t3040r2147b3095],
8	.	.	O	.	_	0	SENT_151	[p11l1767t3040r2147b3095],

1	”	NN	O	”	ccomp	5	SENT_152	[p11l1767t3040r2147b3095],
2	Interestingly	RB	O	interestingly	advmod	1	SENT_152	[p11l307t3121r749b3196],
3	,	,	O	,	_	0	SENT_152	[p11l307t3121r749b3196],
4	CYP3A43	NN	O	cyp3a43	nsubj	5	SENT_152	[p11l801t3124r1125b3178],
5	has	VBZ	O	have	_	0	SENT_152	[p11l1176t3121r1287b3178],
6	higher	JJR	O	higher	amod	7	SENT_152	[p11l1337t3121r1555b3196],
7	levels	NNS	O	level	dobj	5	SENT_152	[p11l1602t3121r1796b3178],
8	of	IN	O	of	_	0	SENT_152	[p11l1847t3121r1914b3178],
9	extrahepatic	JJ	O	extrahepatic	amod	10	SENT_152	[p11l1958t3129r2146b3178, p11l307t3204r552b3279],
10	expression	NN	O	expression	prep_of	7	SENT_152	[p11l578t3207r936b3279],
11	with	IN	O	with	_	0	SENT_152	[p11l959t3204r1113b3261],
12	highest	JJS	O	highest	amod	13	SENT_152	[p11l1135t3204r1379b3279],
13	levels	NNS	O	level	prep_with	10	SENT_152	[p11l1402t3204r1592b3261],
14	in	IN	O	in	_	0	SENT_152	[p11l1617t3207r1683b3260],
15	the	DT	O	the	det	16	SENT_152	[p11l1706t3204r1810b3261],
16	brain	NN	O	brain	prep_in	7	SENT_152	[p11l1831t3204r2024b3270],
17	,	,	O	,	_	0	SENT_152	[p11l1831t3204r2024b3270],
18	which	WDT	O	which	nsubj	20	SENT_152	[p11l307t3287r521b3344],
19	could	MD	O	could	aux	20	SENT_152	[p11l577t3287r768b3344],
20	result	VB	O	result	rcmod	16	SENT_152	[p11l821t3287r1015b3344],
21	in	IN	O	in	_	0	SENT_152	[p11l1069t3290r1136b3344],
22	even	RB	O	even	advmod	23	SENT_152	[p11l1192t3307r1349b3344],
23	larger	JJR	O	larger	amod	24	SENT_152	[p11l1405t3287r1596b3362],
24	differences	NNS	O	difference	prep_in	20	SENT_152	[p11l1652t3287r2023b3344],
25	in	IN	O	in	_	0	SENT_152	[p11l2081t3290r2148b3344],
26	olanzapine	NN	O	olanzapine	nn	27	SENT_152	[p11l309t3370r682b3445],
27	levels	NNS	O	level	prep_in	24	SENT_152	[p11l712t3370r905b3427],
28	at	IN	O	at	_	0	SENT_152	[p11l937t3379r996b3427],
29	the	DT	O	the	det	30	SENT_152	[p11l1022t3370r1127b3427],
30	site	NN	O	site	prep_at	20	SENT_152	[p11l1158t3373r1272b3427],
31	of	IN	O	of	_	0	SENT_152	[p11l1304t3370r1371b3427],
32	its	PRP$	O	its	poss	34	SENT_152	[p11l1394t3373r1471b3427],
33	therapeutic	JJ	O	therapeutic	amod	34	SENT_152	[p11l1501t3370r1888b3445],
34	action	NN	O	action	prep_of	30	SENT_152	[p11l1919t3373r2143b3427],
35	.	.	O	.	_	0	SENT_152	[p11l1919t3373r2143b3427],

1	In	IN	O	in	_	0	SENT_153	[p11l307t3457r375b3510],
2	fact	NN	O	fact	prep_in	6	SENT_153	[p11l397t3453r534b3519],
3	,	,	O	,	_	0	SENT_153	[p11l397t3453r534b3519],
4	one	CD	NUMBER	one	num	5	SENT_153	[p11l560t3473r678b3510],
5	study	NN	O	study	nsubj	6	SENT_153	[p11l701t3453r888b3528],
6	showed	VBD	O	show	_	0	SENT_153	[p11l909t3453r1169b3510],
7	that	IN	O	that	complm	12	SENT_153	[p11l1189t3453r1320b3510],
8	differences	NNS	O	difference	nsubj	12	SENT_153	[p11l1342t3453r1710b3510],
9	in	IN	O	in	_	0	SENT_153	[p11l1733t3456r1800b3510],
10	CYP3A43	NN	O	cyp3a43	nn	11	SENT_153	[p11l1822t3456r2143b3510],
11	expression	NN	O	expression	prep_in	8	SENT_153	[p11l309t3539r664b3611],
12	resulted	VBD	O	result	ccomp	6	SENT_153	[p11l687t3536r956b3593],
13	in	IN	O	in	_	0	SENT_153	[p11l979t3539r1045b3593],
14	differences	NNS	O	difference	prep_in	12	SENT_153	[p11l1070t3536r1431b3593],
15	in	IN	O	in	_	0	SENT_153	[p11l1455t3539r1521b3593],
16	CYP3A43-specific	JJ	O	cyp3a43-specific	amod	17	SENT_153	[p11l1545t3536r2146b3611],
17	metabolism	NN	O	metabolism	prep_in	14	SENT_153	[p11l307t3619r703b3676],
18	of	IN	O	of	_	0	SENT_153	[p11l728t3619r795b3676],
19	alprazolam	NN	O	alprazolam	prep_of	17	SENT_153	[p11l815t3619r1193b3694],
20	to	TO	O	to	_	0	SENT_153	[p11l1216t3628r1278b3676],
21	oc-hydroxy	JJ	O	oc-hydroxy	amod	22	SENT_153	[p11l1305t3619r1654b3694],
22	alprazolam	NN	O	alprazolam	prep_to	12	SENT_153	[p11l1678t3619r2056b3694],
23	in	IN	O	in	_	0	SENT_153	[p11l2081t3622r2148b3676],
24	human	JJ	O	human	amod	25	SENT_153	[p11l307t3703r546b3760],
25	brain	NN	O	brain	prep_in	22	SENT_153	[p11l572t3703r825b3760],
26	.	.	O	.	_	0	SENT_153	[p11l572t3703r825b3760],

1	”	NN	O	”	_	0	SENT_154	[p11l572t3703r825b3760],

1	While	IN	O	while	mark	6	SENT_155	[p12l382t19r586b76],
2	rs472660	NN	O	rs472660	nsubj	6	SENT_155	[p12l616t27r922b76],
3	was	VBD	O	be	cop	6	SENT_155	[p12l952t39r1081b76],
4	the	DT	O	the	det	6	SENT_155	[p12l1111t19r1216b76],
5	only	JJ	O	only	amod	6	SENT_155	[p12l1248t19r1398b94],
6	SNP	NN	ORGANIZATION	snp	advcl	18	SENT_155	[p12l1429t22r1571b76],
7	tested	VBN	O	test	partmod	6	SENT_155	[p12l1602t19r1803b76],
8	to	TO	O	to	aux	9	SENT_155	[p12l1832t27r1894b76],
9	have	VB	O	have	xcomp	7	SENT_155	[p12l1925t19r2083b76],
10	a	DT	O	a	det	12	SENT_155	[p12l2114t39r2148b76],
11	significant	JJ	O	significant	amod	12	SENT_155	[p12l309t102r668b177],
12	effect	NN	O	effect	dobj	9	SENT_155	[p12l705t102r889b159],
13	on	IN	O	on	_	0	SENT_155	[p12l927t122r1009b159],
14	olanzapine	NN	O	olanzapine	nn	15	SENT_155	[p12l1048t102r1421b177],
15	clearance	NN	O	clearance	prep_on	12	SENT_155	[p12l1461t102r1798b168],
16	,	,	O	,	_	0	SENT_155	[p12l1461t102r1798b168],
17	there	EX	O	there	expl	18	SENT_155	[p12l1838t102r2008b159],
18	are	VBP	O	be	_	0	SENT_155	[p12l2048t122r2146b159],
19	likely	JJ	O	likely	amod	20	SENT_155	[p12l308t185r500b260],
20	SNPs	NNS	O	snp	nsubj	18	SENT_155	[p12l562t188r737b242],
21	in	IN	O	in	_	0	SENT_155	[p12l800t188r867b242],
22	other	JJ	O	other	amod	24	SENT_155	[p12l928t185r1102b242],
23	metabolizing	VBG	O	metabolize	amod	24	SENT_155	[p12l1161t185r1602b260],
24	enzymes	NNS	O	enzyme	prep_in	20	SENT_155	[p12l1663t205r1955b260],
25	that	WDT	O	that	nsubj	26	SENT_155	[p12l2017t185r2148b242],
26	contribute	VBP	O	contribute	rcmod	24	SENT_155	[p12l309t268r656b325],
27	to	TO	O	to	_	0	SENT_155	[p12l715t277r778b325],
28	variability	NN	O	variability	prep_to	26	SENT_155	[p12l837t268r1187b343],
29	in	IN	O	in	_	0	SENT_155	[p12l1246t271r1313b325],
30	olanzapine	NN	O	olanzapine	nn	31	SENT_155	[p12l1373t268r1745b343],
31	clearance	NN	O	clearance	prep_in	28	SENT_155	[p12l1807t268r2144b334],
32	,	,	O	,	_	0	SENT_155	[p12l1807t268r2144b334],
33	and	CC	O	and	_	0	SENT_155	[p12l309t351r433b408],
34	future	JJ	DATE	future	amod	35	SENT_155	[p12l476t351r679b408],
35	studies	NNS	O	study	nsubj	40	SENT_155	[p12l722t351r961b408],
36	should	MD	O	should	aux	37	SENT_155	[p12l1006t351r1238b408],
37	test	VB	O	test	conj_and	18	SENT_155	[p12l1279t360r1398b408],
38	known	JJ	O	known	acomp	37	SENT_155	[p12l1438t351r1672b408],
39	and	CC	O	and	_	0	SENT_155	[p12l1715t351r1839b408],
40	identify	VB	O	identify	conj_and	37	SENT_155	[p12l1881t351r2148b426],
41	novel	JJ	O	novel	amod	42	SENT_155	[p12l307t434r494b491],
42	functional	JJ	O	functional	amod	43	SENT_155	[p12l517t434r866b491],
43	polymorphism	NN	O	polymorphism	dobj	40	SENT_155	[p12l888t434r1392b509],
44	in	IN	O	in	_	0	SENT_155	[p12l1413t437r1479b491],
45	CYP450s	NNS	O	cyp450	prep_in	40	SENT_155	[p12l1501t437r1802b491],
46	and	CC	O	and	_	0	SENT_155	[p12l1826t434r1951b491],
47	other	JJ	O	other	amod	49	SENT_155	[p12l1974t434r2148b491],
48	metabolizing	VBG	O	metabolize	amod	49	SENT_155	[p12l307t517r748b592],
49	enzymes	NNS	O	enzyme	prep_in	40	SENT_155	[p12l772t537r1082b592],
50	.	.	O	.	_	0	SENT_155	[p12l772t537r1082b592],

1	For	IN	O	for	_	0	SENT_156	[p12l1109t521r1223b574],
2	example	NN	O	example	prep_for	5	SENT_156	[p12l1245t517r1548b592],
3	,	,	O	,	_	0	SENT_156	[p12l1245t517r1548b592],
4	there	EX	O	there	expl	5	SENT_156	[p12l1573t517r1743b574],
5	is	VBZ	O	be	_	0	SENT_156	[p12l1767t520r1819b574],
6	evidence	NN	O	evidence	nsubj	5	SENT_156	[p12l1844t517r2146b574],
7	that	IN	O	that	complm	32	SENT_156	[p12l307t600r438b657],
8	a	DT	O	a	det	10	SENT_156	[p12l465t621r498b657],
9	genetic	JJ	O	genetic	amod	10	SENT_156	[p12l523t604r764b675],
10	variant	NN	O	variant	nsubj	32	SENT_156	[p12l791t603r1030b657],
11	in	IN	O	in	_	0	SENT_156	[p12l1056t603r1123b657],
12	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	nn	13	SENT_156	[p12l1157t600r2146b675],
13	1A4	NN	O	1a4	prep_in	10	SENT_156	[p12l312t687r443b740],
14	(	CD	NUMBER	(	num	16	SENT_156	[p12l482t683r845b751],
15	UGT1A4	NN	O	ugt1a4	nn	16	SENT_156	[p12l482t683r845b751],
16	)	NN	O	)	dep	10	SENT_156	[p12l482t683r845b751],
17	,	,	O	,	_	0	SENT_156	[p12l482t683r845b751],
18	a	DT	O	a	det	19	SENT_156	[p12l883t704r916b741],
19	phase	NN	O	phase	appos	10	SENT_156	[p12l948t683r1144b759],
20	2	CD	NUMBER	2	num	19	SENT_156	[p12l1181t692r1212b740],
21	metabolizing	VBG	O	metabolize	partmod	19	SENT_156	[p12l1248t683r1690b758],
22	enzyme	NN	O	enzyme	dobj	21	SENT_156	[p12l1724t704r1984b758],
23	that	IN	O	that	nsubj	24	SENT_156	[p12l2017t683r2148b741],
24	catalyzes	VBZ	O	catalyze	rcmod	22	SENT_156	[p12l309t766r614b841],
25	the	DT	O	the	det	26	SENT_156	[p12l637t766r742b823],
26	conjugation	NN	O	conjugation	dobj	24	SENT_156	[p12l766t769r1165b841],
27	of	IN	O	of	_	0	SENT_156	[p12l1189t766r1256b823],
28	a	DT	O	a	det	30	SENT_156	[p12l1273t786r1306b823],
29	glucuronosyl	NN	O	glucuronosyl	nn	30	SENT_156	[p12l1327t766r1772b841],
30	group	NN	O	group	prep_of	26	SENT_156	[p12l1794t786r2009b841],
31	,	,	O	,	_	0	SENT_156	[p12l1794t786r2009b841],
32	has	VBZ	O	have	ccomp	5	SENT_156	[p12l2033t766r2145b823],
33	a	DT	O	a	det	35	SENT_156	[p12l309t870r343b907],
34	significant	JJ	O	significant	amod	35	SENT_156	[p12l372t849r730b924],
35	effect	NN	O	effect	dobj	32	SENT_156	[p12l759t849r942b907],
36	on	IN	O	on	_	0	SENT_156	[p12l971t870r1053b907],
37	olanzapine	NN	O	olanzapine	nn	38	SENT_156	[p12l1084t849r1456b925],
38	clearance	NN	O	clearance	prep_on	35	SENT_156	[p12l1487t849r1882b907],
39	.	.	O	.	_	0	SENT_156	[p12l1487t849r1882b907],

1	”	NN	O	”	_	0	SENT_157	[p12l1487t849r1882b907],

1	While	IN	O	while	mark	8	SENT_158	[p12l382t933r586b990],
2	further	JJ	O	further	amod	3	SENT_158	[p12l643t933r877b990],
3	research	NN	O	research	nsubjpass	8	SENT_158	[p12l931t933r1215b990],
4	into	IN	O	into	_	0	SENT_158	[p12l1271t936r1403b990],
5	CYP3A	NN	O	cyp3a	nn	6	SENT_158	[p12l1461t936r1706b990],
6	genetics	NNS	O	genetics	prep_into	3	SENT_158	[p12l1761t936r2035b1008],
7	is	VBZ	O	be	auxpass	8	SENT_158	[p12l2093t936r2145b990],
8	needed	VBN	O	need	advcl	12	SENT_158	[p12l307t1015r572b1081],
9	,	,	O	,	_	0	SENT_158	[p12l307t1015r572b1081],
10	these	DT	O	these	det	11	SENT_158	[p12l613t1015r788b1072],
11	data	NNS	O	datum	nsubj	12	SENT_158	[p12l829t1015r970b1072],
12	suggest	VBP	O	suggest	_	0	SENT_158	[p12l1009t1024r1254b1090],
13	that	IN	O	that	complm	18	SENT_158	[p12l1291t1015r1422b1072],
14	genetic	JJ	O	genetic	amod	15	SENT_158	[p12l1458t1018r1699b1090],
15	variation	NN	O	variation	nsubj	18	SENT_158	[p12l1737t1018r2042b1072],
16	in	IN	O	in	_	0	SENT_158	[p12l2081t1018r2148b1072],
17	CYP3A43	NN	O	cyp3a43	prep_in	15	SENT_158	[p12l308t1101r632b1156],
18	contributes	VBZ	O	contribute	ccomp	12	SENT_158	[p12l701t1098r1080b1156],
19	to	TO	O	to	_	0	SENT_158	[p12l1144t1107r1206b1156],
20	the	DT	O	the	det	22	SENT_158	[p12l1270t1098r1374b1156],
21	Wide	NN	O	wide	nn	22	SENT_158	[p12l1437t1098r1604b1156],
22	variability	NN	O	variability	prep_to	18	SENT_158	[p12l1667t1098r2018b1173],
23	in	IN	O	in	_	0	SENT_158	[p12l2080t1101r2147b1155],
24	olanzapine	NN	O	olanzapine	nn	25	SENT_158	[p12l309t1182r682b1257],
25	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	22	SENT_158	[p12l732t1182r1337b1257],
26	and	CC	O	and	dep	31	SENT_158	[p12l1389t1182r1531b1248],
27	,	,	O	,	_	0	SENT_158	[p12l1389t1182r1531b1248],
28	therefore	RB	O	therefore	dep	31	SENT_158	[p12l1582t1182r1904b1248],
29	,	,	O	,	_	0	SENT_158	[p12l1582t1182r1904b1248],
30	likely	JJ	O	likely	amod	31	SENT_158	[p12l1957t1182r2148b1257],
31	results	NNS	O	result	dep	18	SENT_158	[p12l307t1264r531b1321],
32	in	IN	O	in	_	0	SENT_158	[p12l588t1267r655b1321],
33	differences	NNS	O	difference	prep_in	31	SENT_158	[p12l711t1264r1081b1321],
34	in	IN	O	in	_	0	SENT_158	[p12l1139t1267r1205b1321],
35	clinical	JJ	O	clinical	amod	36	SENT_158	[p12l1260t1264r1513b1321],
36	response	NN	O	response	prep_in	33	SENT_158	[p12l1566t1284r1884b1339],
37	.	.	O	.	_	0	SENT_158	[p12l1566t1284r1884b1339],

1	While	IN	O	while	mark	6	SENT_159	[p12l1942t1264r2147b1321],
2	genotype	NN	O	genotype	nsubj	6	SENT_159	[p12l307t1356r615b1423],
3	alone	RB	O	alone	advmod	6	SENT_159	[p12l670t1347r852b1405],
4	did	VBD	O	do	aux	6	SENT_159	[p12l908t1347r1019b1405],
5	not	RB	O	not	neg	6	SENT_159	[p12l1071t1356r1181b1405],
6	predict	VB	O	predict	advcl	17	SENT_159	[p12l1233t1347r1476b1423],
7	clinical	JJ	O	clinical	amod	8	SENT_159	[p12l1529t1347r1782b1405],
8	outcome	NN	O	outcome	dobj	6	SENT_159	[p12l1837t1356r2145b1413],
9	,	,	O	,	_	0	SENT_159	[p12l1837t1356r2145b1413],
10	olanzapine	NN	O	olanzapine	nn	11	SENT_159	[p12l309t1431r682b1506],
11	clearance	NN	O	clearance	nsubj	17	SENT_159	[p12l716t1431r1035b1488],
12	estimated	VBN	O	estimate	partmod	11	SENT_159	[p12l1069t1431r1397b1488],
13	using	VBG	O	use	xcomp	12	SENT_159	[p12l1428t1434r1613b1506],
14	CYP3A43	NN	O	cyp3a43	nn	15	SENT_159	[p12l1645t1434r1969b1488],
15	genotype	NN	O	genotype	dobj	13	SENT_159	[p12l2004t1451r2146b1506, p12l309t1522r494b1588],
16	significantly	RB	O	significantly	advmod	17	SENT_159	[p12l531t1513r955b1588],
17	predicted	VBD	O	predict	_	0	SENT_159	[p12l988t1513r1314b1588],
18	PANSS	JJ	O	panss	amod	19	SENT_159	[p12l1347t1516r1591b1570],
19	score	NN	NUMBER	score	dobj	17	SENT_159	[p12l1629t1533r1820b1579],
20	,	,	O	,	_	0	SENT_159	[p12l1629t1533r1820b1579],
21	and	CC	O	and	_	0	SENT_159	[p12l1859t1513r1983b1570],
22	was	VBD	O	be	auxpass	24	SENT_159	[p12l2017t1533r2145b1570],
23	also	RB	O	also	advmod	24	SENT_159	[p12l309t1597r440b1654],
24	associated	VBN	O	associate	conj_and	17	SENT_159	[p12l507t1597r857b1654],
25	with	IN	O	with	_	0	SENT_159	[p12l921t1597r1077b1654],
26	reason	NN	O	reason	prep_with	24	SENT_159	[p12l1141t1617r1362b1654],
27	for	IN	O	for	_	0	SENT_159	[p12l1428t1597r1520b1654],
28	discontinuation	NN	O	discontinuation	prep_for	26	SENT_159	[p12l1587t1597r2142b1654],
29	.	.	O	.	_	0	SENT_159	[p12l1587t1597r2142b1654],

1	These	DT	O	these	det	2	SENT_160	[p12l308t1680r507b1737],
2	results	NNS	O	result	nsubj	3	SENT_160	[p12l562t1680r786b1737],
3	indicate	VBP	O	indicate	_	0	SENT_160	[p12l843t1680r1117b1737],
4	that	IN	O	that	complm	8	SENT_160	[p12l1171t1680r1302b1737],
5	olanzapine	NN	O	olanzapine	nn	6	SENT_160	[p12l1358t1680r1730b1755],
6	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	8	SENT_160	[p12l1785t1680r2146b1755, p12l307t1762r572b1819],
7	can	MD	O	can	aux	8	SENT_160	[p12l647t1782r763b1819],
8	have	VB	O	have	ccomp	3	SENT_160	[p12l833t1762r991b1819],
9	a	DT	O	a	det	11	SENT_160	[p12l1064t1782r1098b1819],
10	direct	JJ	O	direct	amod	11	SENT_160	[p12l1170t1762r1365b1819],
11	impact	NN	O	impact	dobj	8	SENT_160	[p12l1435t1765r1668b1837],
12	on	IN	O	on	_	0	SENT_160	[p12l1740t1782r1822b1819],
13	clinical	JJ	O	clinical	amod	14	SENT_160	[p12l1894t1762r2147b1819],
14	response	NN	O	response	prep_on	11	SENT_160	[p12l307t1866r607b1921],
15	and	CC	O	and	cc	3	SENT_160	[p12l642t1845r785b1911],
16	,	,	O	,	_	0	SENT_160	[p12l642t1845r785b1911],
17	therefore	RB	O	therefore	advmod	22	SENT_160	[p12l821t1845r1144b1911],
18	,	,	O	,	_	0	SENT_160	[p12l821t1845r1144b1911],
19	it	PRP	O	it	nsubj	22	SENT_160	[p12l1180t1849r1227b1903],
20	may	MD	O	may	aux	22	SENT_160	[p12l1259t1866r1402b1920],
21	be	VB	O	be	cop	22	SENT_160	[p12l1432t1845r1509b1903],
22	important	JJ	O	important	ccomp	3	SENT_160	[p12l1543t1848r1881b1921],
23	to	TO	O	to	aux	24	SENT_160	[p12l1913t1854r1975b1903],
24	take	VB	O	take	xcomp	22	SENT_160	[p12l2009t1845r2146b1903],
25	CYP3A43	NN	O	cyp3a43	nn	26	SENT_160	[p12l308t1932r632b1986],
26	genotype	NN	O	genotype	dobj	24	SENT_160	[p12l659t1937r967b2004],
27	and	CC	O	and	_	0	SENT_160	[p12l992t1929r1117b1986],
28	other	JJ	O	other	amod	29	SENT_160	[p12l1142t1929r1317b1986],
29	contributors	NNS	O	contributor	dobj	24	SENT_160	[p12l1340t1929r1753b1986],
30	to	TO	O	to	_	0	SENT_160	[p12l1777t1937r1839b1986],
31	pharmacokinetic	JJ	O	pharmacokinetic	amod	32	SENT_160	[p12l1864t1929r2146b2004, p12l309t2011r618b2068],
32	variability	NN	O	variability	prep_to	24	SENT_160	[p12l652t2011r1003b2086],
33	into	IN	O	into	_	0	SENT_160	[p12l1035t2014r1166b2068],
34	consideration	NN	O	consideration	prep_into	24	SENT_160	[p12l1203t2011r1668b2068],
35	when	WRB	O	when	advmod	37	SENT_160	[p12l1700t2011r1889b2068],
36	dosing	NN	O	dosing	dep	37	SENT_160	[p12l1924t2011r2147b2086],
37	olanzapine	NN	O	olanzapine	dep	34	SENT_160	[p12l309t2095r699b2171],
38	.	.	O	.	_	0	SENT_160	[p12l309t2095r699b2171],

1	Dose	NN	O	dose	nn	4	SENT_161	[p12l382t2183r889b2254],
2	—	NN	O	—	nn	4	SENT_161	[p12l382t2183r889b2254],
3	response	NN	O	response	nn	4	SENT_161	[p12l382t2183r889b2254],
4	curves	NNS	O	curve	nsubj	13	SENT_161	[p12l939t2179r1213b2236],
5	”	CD	NUMBER	”	dep	4	SENT_161	[p12l939t2179r1213b2236],
6	and	CC	O	and	_	0	SENT_161	[p12l1261t2179r1386b2236],
7	international	JJ	O	international	amod	9	SENT_161	[p12l1434t2179r1874b2236],
8	dosing	NN	O	dosing	nn	9	SENT_161	[p12l1924t2179r2147b2254],
9	recommendations	NNS	O	recommendation	nsubj	13	SENT_161	[p12l307t2261r917b2318],
10	of	IN	O	of	_	0	SENT_161	[p12l949t2261r1016b2318],
11	olanzapine	NN	O	olanzapine	nn	12	SENT_161	[p12l1041t2261r1468b2336],
12	“	NN	O	“	prep_of	9	SENT_161	[p12l1041t2261r1468b2336],
13	agree	VBP	O	agree	ccomp	52	SENT_161	[p12l1499t2281r1672b2336],
14	that	IN	O	that	complm	19	SENT_161	[p12l1701t2261r1832b2318],
15	effective	JJ	O	effective	amod	16	SENT_161	[p12l1862t2261r2147b2318],
16	doses	NNS	O	dose	nsubj	19	SENT_161	[p12l310t2344r494b2402],
17	of	IN	O	of	_	0	SENT_161	[p12l524t2344r591b2402],
18	olanzapine	NN	O	olanzapine	prep_of	16	SENT_161	[p12l613t2344r986b2420],
19	are	VBP	O	be	ccomp	13	SENT_161	[p12l1014t2365r1112b2402],
20	in	IN	O	in	_	0	SENT_161	[p12l1140t2348r1207b2401],
21	the	DT	O	the	det	23	SENT_161	[p12l1232t2344r1337b2402],
22	minimum	JJ	O	minimum	amod	23	SENT_161	[p12l1364t2348r1702b2402],
23	range	NN	O	range	prep_in	19	SENT_161	[p12l1727t2365r1910b2419],
24	of	IN	O	of	_	0	SENT_161	[p12l1939t2344r2007b2402],
25	1520	CD	DATE	1520	num	26	SENT_161	[p12l2031t2353r2150b2402, p12l310t2436r385b2485],
26	mg	NN	O	mg	prep_of	23	SENT_161	[p12l402t2448r503b2503],
27	per	IN	O	per	_	0	SENT_161	[p12l539t2448r648b2503],
28	day	NN	DURATION	day	prep_per	26	SENT_161	[p12l685t2428r816b2503],
29	,	,	O	,	_	0	SENT_161	[p12l685t2428r816b2503],
30	with	IN	O	with	_	0	SENT_161	[p12l854t2428r1010b2485],
31	target	NN	O	target	nn	33	SENT_161	[p12l1044t2436r1233b2503],
32	plasma	NN	O	plasma	nn	33	SENT_161	[p12l1268t2428r1511b2503],
33	concentrations	NNS	O	concentration	prep_with	19	SENT_161	[p12l1547t2431r2047b2485],
34	of	IN	O	of	_	0	SENT_161	[p12l2086t2428r2153b2485],
35	20-50	CD	NUMBER	20-50	num	38	SENT_161	[p12l310t2518r509b2567],
36	ng	NN	O	ng	nn	38	SENT_161	[p12l527t2530r607b2585],
37	ml	NN	O	ml	nn	38	SENT_161	[p12l622t2510r894b2566],
38	‘”	NN	O	‘”	prep_of	33	SENT_161	[p12l622t2510r894b2566],
39	2	CD	NUMBER	2	number	40	SENT_161	[p12l622t2510r894b2566],
40	’23	CD	NUMBER	’23	dep	38	SENT_161	[p12l622t2510r894b2566],
41	Based	VBN	O	base	_	0	SENT_161	[p12l918t2510r1119b2567],
42	on	IN	O	on	prepc_based_on	40	SENT_161	[p12l1143t2530r1225b2567],
43	our	PRP$	O	we	poss	45	SENT_161	[p12l1248t2530r1360b2567],
44	clearance	NN	O	clearance	nn	45	SENT_161	[p12l1382t2510r1701b2567],
45	data	NNS	O	datum	pobj	40	SENT_161	[p12l1726t2510r1884b2576],
46	,	,	O	,	_	0	SENT_161	[p12l1726t2510r1884b2576],
47	50	CD	PERCENT	50	num	48	SENT_161	[p12l1912t2510r2056b2571],
48	%	NN	PERCENT	%	nsubj	52	SENT_161	[p12l1912t2510r2056b2571],
49	of	IN	O	of	_	0	SENT_161	[p12l2086t2510r2153b2567],
50	AA	NN	O	aa	nn	51	SENT_161	[p12l307t2597r421b2650],
51	carriers	NNS	O	carrier	prep_of	48	SENT_161	[p12l466t2596r716b2650],
52	have	VBP	O	have	_	0	SENT_161	[p12l762t2593r920b2650],
53	individual	JJ	O	individual	dobj	52	SENT_161	[p12l965t2593r1323b2650],
54	predicted	VBN	O	predict	partmod	53	SENT_161	[p12l1367t2593r1693b2668],
55	trough	NN	O	trough	nn	56	SENT_161	[p12l1736t2593r1958b2668],
56	concentrations	NNS	O	concentration	nsubj	57	SENT_161	[p12l2002t2613r2146b2650, p12l309t2680r684b2734],
57	<	JJR	O	<	xcomp	54	SENT_161	[p12l748t2685r881b2734],
58	20	CD	NUMBER	20	num	60	SENT_161	[p12l748t2685r881b2734],
59	ngml	NN	O	ngml	nn	60	SENT_161	[p12l898t2677r1154b2752],
60	‘	NN	O	‘	dep	53	SENT_161	[p12l898t2677r1154b2752],
61	1	CD	NUMBER	1	dep	60	SENT_161	[p12l898t2677r1154b2752],
62	.	.	O	.	_	0	SENT_161	[p12l898t2677r1154b2752],

1	These	DT	O	these	det	2	SENT_162	[p12l1206t2677r1405b2734],
2	results	NNS	O	result	nsubj	3	SENT_162	[p12l1451t2677r1675b2734],
3	suggest	VBP	O	suggest	_	0	SENT_162	[p12l1726t2685r1972b2752],
4	that	IN	O	that	complm	39	SENT_162	[p12l2017t2677r2148b2734],
5	while	IN	O	while	mark	11	SENT_162	[p12l307t2759r498b2816],
6	CYP45O	NN	O	cyp45o	nn	8	SENT_162	[p12l544t2762r812b2816],
7	genetic	JJ	O	genetic	amod	8	SENT_162	[p12l856t2762r1097b2834],
8	testing	NN	O	testing	nsubj	11	SENT_162	[p12l1141t2762r1367b2834],
9	may	MD	O	may	aux	11	SENT_162	[p12l1411t2779r1554b2834],
10	ultimately	RB	O	ultimately	advmod	11	SENT_162	[p12l1595t2759r1946b2834],
11	have	VB	O	have	advcl	39	SENT_162	[p12l1988t2759r2146b2816],
12	utility	NN	O	utility	dobj	11	SENT_162	[p12l307t2842r517b2917],
13	in	IN	O	in	_	0	SENT_162	[p12l539t2845r605b2899],
14	clinical	JJ	O	clinical	amod	15	SENT_162	[p12l628t2842r881b2899],
15	monitoring	NN	O	monitoring	prep_in	12	SENT_162	[p12l902t2845r1281b2917],
16	of	IN	O	of	_	0	SENT_162	[p12l1305t2842r1372b2899],
17	olanzapine	NN	O	olanzapine	nn	18	SENT_162	[p12l1389t2842r1762b2917],
18	therapy	NN	O	therapy	prep_of	15	SENT_162	[p12l1784t2842r2055b2917],
19	,	,	O	,	_	0	SENT_162	[p12l1784t2842r2055b2917],
20	in	IN	O	in	_	0	SENT_162	[p12l2081t2845r2148b2899],
21	the	DT	O	the	det	22	SENT_162	[p12l307t2926r411b2983],
22	absence	NN	O	absence	prep_in	18	SENT_162	[p12l439t2926r703b2983],
23	of	IN	O	of	_	0	SENT_162	[p12l731t2926r798b2983],
24	more	RBR	O	more	advmod	25	SENT_162	[p12l817t2946r986b2983],
25	extensive	JJ	O	extensive	amod	27	SENT_162	[p12l1013t2929r1332b2983],
26	genetic	JJ	O	genetic	amod	27	SENT_162	[p12l1357t2929r1598b3001],
27	analyses	NNS	O	analysis	prep_of	22	SENT_162	[p12l1626t2926r1931b3001],
28	,	,	O	,	_	0	SENT_162	[p12l1626t2926r1931b3001],
29	at	IN	O	at	_	0	SENT_162	[p12l1960t2934r2018b2983],
30	the	DT	O	the	det	31	SENT_162	[p12l2042t2926r2146b2983],
31	minimum	NN	O	minimum	prep_at	11	SENT_162	[p12l307t3011r663b3074],
32	,	,	O	,	_	0	SENT_162	[p12l307t3011r663b3074],
33	monitoring	VBG	O	monitor	amod	35	SENT_162	[p12l702t3011r1081b3083],
34	blood	NN	O	blood	nn	35	SENT_162	[p12l1116t3008r1310b3065],
35	levels	NNS	O	level	nsubj	39	SENT_162	[p12l1347t3008r1541b3065],
36	of	IN	O	of	_	0	SENT_162	[p12l1582t3008r1649b3065],
37	olanzapine	NN	O	olanzapine	prep_of	35	SENT_162	[p12l1682t3008r2054b3083],
38	is	VBZ	O	be	cop	39	SENT_162	[p12l2093t3011r2145b3065],
39	advisable	JJ	O	advisable	ccomp	3	SENT_162	[p12l309t3092r644b3149],
40	.	.	O	.	_	0	SENT_162	[p12l309t3092r644b3149],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_163	[p12l308t3288r587b3346],
2	of	IN	O	of	_	0	SENT_163	[p12l617t3288r690b3346],
3	interest	NN	O	interest	prep_of	1	SENT_163	[p12l709t3290r976b3346],

1	The	DT	O	the	det	2	SENT_164	[p12l308t3420r436b3476],
2	authors	NNS	O	author	nsubj	3	SENT_164	[p12l467t3420r718b3476],
3	declare	VBP	O	declare	_	0	SENT_164	[p12l751t3420r994b3476],
4	no	DT	O	no	det	5	SENT_164	[p12l1023t3440r1106b3476],
5	conflict	NN	O	conflict	dobj	3	SENT_164	[p12l1137t3420r1395b3476],
6	of	IN	O	of	_	0	SENT_164	[p12l1424t3420r1491b3476],
7	interest	NN	O	interest	prep_of	5	SENT_164	[p12l1514t3423r1784b3476],
8	.	.	O	.	_	0	SENT_164	[p12l1514t3423r1784b3476],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_165	[p12l307t3615r967b3692],

1	This	DT	O	this	det	2	SENT_166	[p13l308t34r456b92],
2	research	NN	O	research	nsubjpass	4	SENT_166	[p13l483t34r768b92],
3	was	VBD	O	be	auxpass	4	SENT_166	[p13l793t55r921b92],
4	supported	VBN	O	support	_	0	SENT_166	[p13l951t34r1296b110],
5	(	RB	O	(	advmod	4	SENT_166	[p13l1325t35r1414b102],
6	in	IN	O	in	_	0	SENT_166	[p13l1325t35r1414b102],
7	part	NN	O	part	prep_in	4	SENT_166	[p13l1440t35r1595b110],
8	)	CD	NUMBER	)	num	7	SENT_166	[p13l1440t35r1595b110],
9	by	IN	O	by	_	0	SENT_166	[p13l1622t34r1704b109],
10	the	DT	O	the	det	11	SENT_166	[p13l1728t34r1833b92],
11	Division	NN	O	division	agent	4	SENT_166	[p13l1860t37r2148b92],
12	of	IN	O	of	_	0	SENT_166	[p13l309t117r376b174],
13	Intramural	NNP	ORGANIZATION	Intramural	nn	15	SENT_166	[p13l393t117r754b174],
14	Research	NNP	ORGANIZATION	Research	nn	15	SENT_166	[p13l777t117r1082b174],
15	Programs	NNP	ORGANIZATION	Programs	prep_of	11	SENT_166	[p13l1104t121r1438b192],
16	,	,	O	,	_	0	SENT_166	[p13l1104t121r1438b192],
17	National	NNP	ORGANIZATION	National	nn	18	SENT_166	[p13l1464t117r1755b174],
18	Institute	NNP	ORGANIZATION	Institute	appos	15	SENT_166	[p13l1778t120r2061b174],
19	of	IN	ORGANIZATION	of	_	0	SENT_166	[p13l2086t117r2153b174],
20	Mental	NNP	ORGANIZATION	Mental	nn	24	SENT_166	[p13l307t201r545b259],
21	Health	NNP	ORGANIZATION	Health	nn	24	SENT_166	[p13l597t201r841b268],
22	,	,	O	,	_	0	SENT_166	[p13l597t201r841b268],
23	National	NNP	ORGANIZATION	National	appos	24	SENT_166	[p13l894t201r1186b259],
24	Institutes	NNPS	ORGANIZATION	Institutes	prep_of	18	SENT_166	[p13l1237t204r1553b259],
25	of	IN	ORGANIZATION	of	_	0	SENT_166	[p13l1608t201r1675b259],
26	Health	NNP	ORGANIZATION	Health	prep_of	24	SENT_166	[p13l1720t201r1962b259],
27	.	.	O	.	_	0	SENT_166	[p13l1720t201r1962b259],

1	The	DT	O	the	det	3	SENT_167	[p13l2018t201r2146b259],
2	principal	JJ	O	principal	amod	3	SENT_167	[p13l308t284r620b360],
3	investigators	NNS	O	investigator	nsubj	19	SENT_167	[p13l661t288r1091b359],
4	of	IN	O	of	_	0	SENT_167	[p13l1135t284r1202b342],
5	the	DT	O	the	det	10	SENT_167	[p13l1235t284r1339b342],
6	CATIE	NNP	O	CATIE	nn	10	SENT_167	[p13l1381t287r1598b342],
7	(	NNP	O	(	nn	10	SENT_167	[p13l1644t284r1931b352],
8	Clinical	JJ	O	clinical	amod	10	SENT_167	[p13l1644t284r1931b352],
9	Antipsychotic	JJ	O	antipsychotic	amod	10	SENT_167	[p13l1971t288r2146b342, p13l308t367r635b442],
10	Trials	NNS	O	trial	prep_of	3	SENT_167	[p13l683t367r870b424],
11	of	IN	O	of	_	0	SENT_167	[p13l920t367r987b424],
12	Intervention	NN	O	intervention	nn	13	SENT_167	[p13l1026t370r1447b424],
13	Effectiveness	NN	O	effectiveness	prep_of	10	SENT_167	[p13l1492t367r1960b435],
14	)	CD	NUMBER	)	num	15	SENT_167	[p13l1492t367r1960b435],
15	trial	NN	O	trial	dep	13	SENT_167	[p13l2009t367r2147b424],
16	were	VBD	O	be	cop	19	SENT_167	[p13l307t470r469b507],
17	Jeffrey	NNP	PERSON	Jeffrey	nn	19	SENT_167	[p13l501t450r721b525],
18	A	NNP	PERSON	A	nn	19	SENT_167	[p13l754t454r809b507],
19	Lieberman	NNP	PERSON	Lieberman	_	0	SENT_167	[p13l843t450r1223b516],
20	,	,	O	,	_	0	SENT_167	[p13l843t450r1223b516],
21	MD	NNP	O	MD	conj_and	19	SENT_167	[p13l1259t454r1399b516],
22	,	,	O	,	_	0	SENT_167	[p13l1259t454r1399b516],
23	T	NN	O	t	nn	25	SENT_167	[p13l1436t454r1481b507],
24	Scott	NNP	PERSON	Scott	nn	25	SENT_167	[p13l1518t453r1688b507],
25	Stroup	NNP	PERSON	Stroup	conj_and	19	SENT_167	[p13l1724t453r1968b525],
26	,	,	O	,	_	0	SENT_167	[p13l1724t453r1968b525],
27	MD	NNP	O	MD	conj_and	19	SENT_167	[p13l2005t454r2144b516],
28	,	,	O	,	_	0	SENT_167	[p13l2005t454r2144b516],
29	MPH	NNP	O	MPH	conj_and	19	SENT_167	[p13l307t537r479b590],
30	and	CC	O	and	_	0	SENT_167	[p13l506t533r631b591],
31	Joseph	NNP	PERSON	Joseph	nn	35	SENT_167	[p13l652t533r881b609],
32	P	NN	PERSON	p	nn	35	SENT_167	[p13l905t537r947b590],
33	McEvoy	NNP	PERSON	McEvoy	nn	35	SENT_167	[p13l973t537r1261b608],
34	,	,	O	,	_	0	SENT_167	[p13l973t537r1261b608],
35	MD.	NNP	LOCATION	MD.	conj_and	19	SENT_167	[p13l1288t537r1426b591],
36	.	.	O	.	_	0	SENT_167	[p13l1288t537r1426b591],

1	The	DT	O	the	det	3	SENT_168	[p13l1456t533r1584b591],
2	CATIE	NNP	O	CATIE	nn	3	SENT_168	[p13l1612t536r1828b591],
3	trial	NN	O	trial	nsubjpass	5	SENT_168	[p13l1854t533r1992b591],
4	was	VBD	O	be	auxpass	5	SENT_168	[p13l2017t554r2145b591],
5	funded	VBN	O	fund	_	0	SENT_168	[p13l10t949r291b1015],
6	by	IN	O	by	_	0	SENT_168	[p13l348t949r443b1036],
7	a	DT	O	a	det	8	SENT_168	[p13l504t972r543b1015],
8	grant	NN	O	grant	agent	5	SENT_168	[p13l600t959r801b1036],
9	from	IN	O	from	_	0	SENT_168	[p13l860t949r1043b1015],
10	the	DT	O	the	det	18	SENT_168	[p13l1101t949r1222b1015],
11	National	NNP	ORGANIZATION	National	dep	18	SENT_168	[p13l1283t949r1622b1015],
12	Institute	NNP	ORGANIZATION	Institute	dep	11	SENT_168	[p13l1682t952r2010b1015],
13	of	IN	ORGANIZATION	of	_	0	SENT_168	[p13l2073t949r2151b1015],
14	Mental	NNP	ORGANIZATION	Mental	nn	15	SENT_168	[p13l9t1048r285b1114],
15	Health	NNP	ORGANIZATION	Health	prep_of	11	SENT_168	[p13l396t1048r658b1114],
16	[	CD	NUMBER	[	num	15	SENT_168	[p13l773t1048r952b1126],
17	N01	NN	O	n01	nn	18	SENT_168	[p13l773t1048r952b1126],
18	MH9000O1	NN	O	mh9000o1	prep_from	8	SENT_168	[p13l1067t1048r1526b1126],
19	)	CD	NUMBER	)	npadvmod	20	SENT_168	[p13l1067t1048r1526b1126],
20	along	IN	O	along	advmod	18	SENT_168	[p13l1643t1048r1854b1135],
21	with	IN	O	with	_	0	SENT_168	[p13l1964t1048r2145b1114],
22	MH0740Z7	NN	O	mh0740z7	nn	25	SENT_168	[p13l9t1149r441b1211],
23	(	CD	NUMBER	(	num	25	SENT_168	[p13l483t1145r586b1223],
24	PI	NN	O	pi	nn	25	SENT_168	[p13l483t1145r586b1223],
25	PF	NN	PERSON	pf	prep_with	5	SENT_168	[p13l620t1149r722b1211],
26	Sullivan	NNP	PERSON	Sullivan	tmod	5	SENT_168	[p13l762t1145r1141b1224],
27	)	CD	NUMBER	)	num	26	SENT_168	[p13l762t1145r1141b1224],
28	.	.	O	.	_	0	SENT_168	[p13l762t1145r1141b1224],

1	Genotyping	VBG	O	genotype	nsubjpass	3	SENT_169	[p13l1183t1148r1641b1232],
2	was	VBD	O	be	auxpass	3	SENT_169	[p13l1675t1168r1825b1211],
3	funded	VBN	O	fund	_	0	SENT_169	[p13l1863t1145r2144b1211],
4	by	IN	O	by	_	0	SENT_169	[p13l7t1243r102b1330],
5	Eli	NNP	PERSON	Eli	nn	6	SENT_169	[p13l140t1243r247b1309],
6	Lilly	NNP	PERSON	Lilly	agent	3	SENT_169	[p13l288t1243r473b1330],
7	and	CC	O	and	_	0	SENT_169	[p13l513t1243r658b1309],
8	Company	NNP	O	Company	agent	3	SENT_169	[p13l698t1246r1087b1330],
9	.	.	O	.	_	0	SENT_169	[p13l698t1246r1087b1330],

1	We	PRP	O	we	nsubj	2	SENT_170	[p13l1131t1247r1252b1309],
2	thank	VBP	O	thank	_	0	SENT_170	[p13l1293t1243r1519b1309],
3	Alette	NNP	PERSON	Alette	nn	4	SENT_170	[p13l1555t1243r1792b1309],
4	Wessels	NNP	PERSON	Wessels	dobj	2	SENT_170	[p13l1833t1243r2141b1309],
5	for	IN	O	for	_	0	SENT_170	[p13l10t1341r117b1408],
6	sharing	VBG	O	share	prepc_for	4	SENT_170	[p13l161t1341r450b1428],
7	the	DT	O	the	det	11	SENT_170	[p13l493t1341r614b1408],
8	ziprasidone	NN	O	ziprasidone	nn	11	SENT_170	[p13l660t1341r1123b1428],
9	population	NN	O	population	nn	11	SENT_170	[p13l1168t1341r1603b1428],
10	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_170	[p13l1647t1341r2143b1428, p13l9t1441r201b1503],
11	model	NN	O	model	dobj	6	SENT_170	[p13l236t1438r502b1503],
12	.	.	O	.	_	0	SENT_170	[p13l236t1438r502b1503],

1	References	NNS	O	reference	_	0	SENT_171	[p13l9t1664r457b1732],

1	1	CD	NUMBER	1	num	3	SENT_172	[p13l46t1845r72b1888],
2	Lieberman	NNP	O	Lieberman	nn	3	SENT_172	[p13l113t1837r436b1888],
3	JA	NNP	O	JA	_	0	SENT_172	[p13l459t1840r549b1901],
4	,	,	O	,	_	0	SENT_172	[p13l459t1840r549b1901],
5	Stroup	NNP	PERSON	Stroup	nn	6	SENT_172	[p13l579t1840r779b1904],
6	TS	NN	O	t	appos	3	SENT_172	[p13l807t1840r906b1897],
7	,	,	O	,	_	0	SENT_172	[p13l807t1840r906b1897],
8	McEvoy	NNP	PERSON	McEvoy	nn	9	SENT_172	[p13l933t1840r1180b1904],
9	JP	NNP	O	JP	appos	3	SENT_172	[p13l1202t1840r1272b1901],
10	,	,	O	,	_	0	SENT_172	[p13l1202t1840r1272b1901],
11	Swartz	NNP	PERSON	Swartz	nn	12	SENT_172	[p13l1302t1840r1508b1888],
12	MS	NN	O	m	appos	3	SENT_172	[p13l1533t1840r1651b1896],
13	,	,	O	,	_	0	SENT_172	[p13l1533t1840r1651b1896],
14	Rosenheck	NNP	PERSON	Rosenheck	nn	15	SENT_172	[p13l1679t1837r2009b1888],
15	RA	NN	O	ra	appos	3	SENT_172	[p13l2032t1840r2142b1896],
16	,	,	O	,	_	0	SENT_172	[p13l2032t1840r2142b1896],
17	Perkins	NNP	PERSON	Perkins	nn	18	SENT_172	[p13l112t1917r338b1968],
18	DO	NNP	O	DO	appos	3	SENT_172	[p13l400t1919r496b1968],
19	et	FW	O	et	nn	20	SENT_172	[p13l561t1924r615b1968],
20	aI	FW	O	ai	dep	18	SENT_172	[p13l674t1917r742b1968],
21	.	.	O	.	_	0	SENT_172	[p13l674t1917r742b1968],

1	Effectiveness	NN	O	effectiveness	_	0	SENT_173	[p13l805t1917r1202b1968],
2	of	IN	O	of	_	0	SENT_173	[p13l1266t1917r1327b1968],
3	antipsychotic	JJ	O	antipsychotic	amod	4	SENT_173	[p13l1383t1917r1793b1984],
4	drugs	NNS	O	drug	prep_of	1	SENT_173	[p13l1858t1917r2022b1984],
5	in	IN	O	in	_	0	SENT_173	[p13l2085t1919r2145b1968],
6	patients	NNS	O	patient	prep_in	1	SENT_173	[p13l113t2000r353b2065],
7	with	IN	O	with	_	0	SENT_173	[p13l384t1997r523b2049],
8	chronic	JJ	O	chronic	amod	9	SENT_173	[p13l553t1997r781b2049],
9	schizophrenia	NN	O	schizophrenia	prep_with	6	SENT_173	[p13l813t1997r1258b2065],
10	.	.	O	.	_	0	SENT_173	[p13l813t1997r1258b2065],

1	New	NNP	O	New	nn	3	SENT_174	[p13l1292t2001r1432b2049],
2	Engl	NNP	O	Engl	nn	3	SENT_174	[p13l1454t1997r1592b2065],
3	]	NNP	O	]	nsubj	4	SENT_174	[p13l1613t2001r1645b2062],
4	Med	VBD	O	med	_	0	SENT_174	[p13l1664t1997r1799b2049],
5	2005	CD	DATE	2005	dobj	4	SENT_174	[p13l1828t2005r1986b2057],
6	;	:	O	;	_	0	SENT_174	[p13l1828t2005r1986b2057],
7	353	CD	NUMBER	353	num	9	SENT_174	[p13l2020t2005r2141b2049],
8	:	:	O	:	_	0	SENT_174	[p13l2020t2005r2141b2049],
9	1209-1223	CD	DATE	1209-1223	dep	5	SENT_174	[p13l116t2085r456b2128],
10	.	.	O	.	_	0	SENT_174	[p13l116t2085r456b2128],

1	2	CD	NUMBER	2	_	0	SENT_175	[p13l45t2165r73b2208],
2	Bigos	NNP	ORGANIZATION	Bigos	nn	3	SENT_175	[p13l113t2160r275b2225],
3	KL	NNP	ORGANIZATION	KL	dep	1	SENT_175	[p13l302t2161r403b2217],
4	,	,	O	,	_	0	SENT_175	[p13l302t2161r403b2217],
5	Pollock	NNP	ORGANIZATION	Pollock	nn	6	SENT_175	[p13l430t2158r659b2209],
6	BG	NNP	ORGANIZATION	BG	appos	3	SENT_175	[p13l682t2160r788b2217],
7	,	,	O	,	_	0	SENT_175	[p13l682t2160r788b2217],
8	Coley	NNP	ORGANIZATION	Coley	nn	9	SENT_175	[p13l815t2158r987b2225],
9	KC	NNP	ORGANIZATION	KC	appos	3	SENT_175	[p13l1011t2160r1116b2217],
10	,	,	O	,	_	0	SENT_175	[p13l1011t2160r1116b2217],
11	Miller	NNP	PERSON	Miller	nn	12	SENT_175	[p13l1144t2158r1332b2209],
12	DD	NNP	O	DD	appos	3	SENT_175	[p13l1355t2161r1464b2217],
13	,	,	O	,	_	0	SENT_175	[p13l1355t2161r1464b2217],
14	Marder	NNP	PERSON	Marder	nn	15	SENT_175	[p13l1491t2158r1712b2209],
15	SR	NN	O	sr	appos	3	SENT_175	[p13l1738t2160r1835b2217],
16	,	,	O	,	_	0	SENT_175	[p13l1738t2160r1835b2217],
17	Aravagiri	NNP	O	Aravagiri	nn	20	SENT_175	[p13l1862t2160r2144b2225],
18	M	NNP	O	M	nn	20	SENT_175	[p13l112t2241r173b2288],
19	eta	NN	O	eta	nn	20	SENT_175	[p13l196t2237r337b2289],
20	]	NN	O	]	appos	3	SENT_175	[p13l196t2237r337b2289],
21	.	.	O	.	_	0	SENT_175	[p13l196t2237r337b2289],

1	Sex	NN	O	sex	_	0	SENT_176	[p13l362t2240r485b2297],
2	,	,	O	,	_	0	SENT_176	[p13l362t2240r485b2297],
3	race	NN	O	race	conj_and	1	SENT_176	[p13l507t2255r647b2297],
4	,	,	O	,	_	0	SENT_176	[p13l507t2255r647b2297],
5	and	CC	O	and	_	0	SENT_176	[p13l671t2237r782b2289],
6	smoking	NN	O	smoking	conj_and	1	SENT_176	[p13l805t2237r1060b2305],
7	impact	NN	O	impact	nn	9	SENT_176	[p13l1081t2240r1290b2305],
8	olanzapine	NN	O	olanzapine	nn	9	SENT_176	[p13l1311t2237r1644b2305],
9	exposure	NN	O	exposure	dep	1	SENT_176	[p13l1667t2255r1955b2305],
10	.	.	O	.	_	0	SENT_176	[p13l1667t2255r1955b2305],

1	I	PRP	O	I	nsubj	2	SENT_177	[p13l1976t2241r2008b2302],
2	Clin	VBP	O	clin	_	0	SENT_177	[p13l2024t2237r2143b2289],
3	Pharmacol	NNP	O	Pharmacol	dobj	2	SENT_177	[p13l112t2317r445b2368],
4	2008	CD	DATE	2008	num	3	SENT_177	[p13l470t2325r628b2376],
5	;	:	O	;	_	0	SENT_177	[p13l470t2325r628b2376],
6	48	CD	NUMBER	48	num	8	SENT_177	[p13l656t2325r742b2368],
7	:	:	O	:	_	0	SENT_177	[p13l656t2325r742b2368],
8	157-165	CD	NUMBER	157-165	dep	3	SENT_177	[p13l774t2325r1041b2369],
9	.	.	O	.	_	0	SENT_177	[p13l774t2325r1041b2369],

1	3	CD	NUMBER	3	num	3	SENT_178	[p13l45t2403r73b2447],
2	Stroup	NNP	ORGANIZATION	Stroup	nn	3	SENT_178	[p13l115t2399r315b2463],
3	TS	NN	O	t	_	0	SENT_178	[p13l340t2399r439b2456],
4	,	,	O	,	_	0	SENT_178	[p13l340t2399r439b2456],
5	McEvoy	NNP	PERSON	McEvoy	nn	6	SENT_178	[p13l463t2399r710b2463],
6	JP	NNP	O	JP	appos	3	SENT_178	[p13l729t2399r799b2460],
7	,	,	O	,	_	0	SENT_178	[p13l729t2399r799b2460],
8	Swartz	NNP	PERSON	Swartz	nn	9	SENT_178	[p13l827t2399r1032b2447],
9	MS	NN	O	m	appos	3	SENT_178	[p13l1055t2399r1173b2455],
10	,	,	O	,	_	0	SENT_178	[p13l1055t2399r1173b2455],
11	Byerly	NNP	PERSON	Byerly	nn	12	SENT_178	[p13l1198t2396r1395b2463],
12	MJ	NNP	PERSON	MJ	appos	3	SENT_178	[p13l1417t2399r1516b2460],
13	,	,	O	,	_	0	SENT_178	[p13l1417t2399r1516b2460],
14	Glick	NNP	PERSON	Glick	nn	15	SENT_178	[p13l1542t2396r1702b2447],
15	ID	NNP	O	ID	appos	3	SENT_178	[p13l1723t2399r1806b2455],
16	,	,	O	,	_	0	SENT_178	[p13l1723t2399r1806b2455],
17	Canive	NNP	O	Canive	appos	3	SENT_178	[p13l1832t2399r2038b2447],
18	JM	NN	O	jm	dep	17	SENT_178	[p13l2059t2399r2145b2460],
19	et	FW	O	et	nn	18	SENT_178	[p13l115t2483r169b2526],
20	a	FW	O	a	nn	18	SENT_178	[p13l213t2476r281b2526],
21	]	FW	O	]	dep	18	SENT_178	[p13l213t2476r281b2526],
22	.	.	O	.	_	0	SENT_178	[p13l213t2476r281b2526],

1	The	DT	O	the	det	3	SENT_179	[p13l330t2476r445b2526],
2	National	NNP	ORGANIZATION	National	nn	3	SENT_179	[p13l490t2476r751b2526],
3	Institute	NNP	ORGANIZATION	Institute	dep	14	SENT_179	[p13l797t2478r1050b2526],
4	of	IN	ORGANIZATION	of	_	0	SENT_179	[p13l1098t2476r1158b2526],
5	Mental	NNP	ORGANIZATION	Mental	nn	9	SENT_179	[p13l1197t2476r1410b2526],
6	Health	NNP	ORGANIZATION	Health	nn	9	SENT_179	[p13l1456t2476r1658b2526],
7	Clinical	JJ	ORGANIZATION	clinical	amod	9	SENT_179	[p13l1704t2476r1942b2526],
8	Antipsychotic	JJ	ORGANIZATION	antipsychotic	amod	9	SENT_179	[p13l1987t2478r2144b2526, p13l113t2555r405b2623],
9	Trials	NNS	ORGANIZATION	trial	prep_of	3	SENT_179	[p13l452t2555r620b2607],
10	of	IN	ORGANIZATION	of	_	0	SENT_179	[p13l668t2555r728b2607],
11	Intervention	NN	ORGANIZATION	intervention	prep_of	9	SENT_179	[p13l767t2558r1143b2607],
12	Effectiveness	NN	ORGANIZATION	effectiveness	dep	14	SENT_179	[p13l1187t2555r1584b2607],
13	(	CD	NUMBER	(	num	12	SENT_179	[p13l1635t2556r1869b2616],
14	CATIE	NNP	PERSON	CATIE	dep	20	SENT_179	[p13l1635t2556r1869b2616],
15	)	CD	NUMBER	)	num	16	SENT_179	[p13l1635t2556r1869b2616],
16	project	NN	O	project	dep	14	SENT_179	[p13l1917t2558r2141b2623],
17	:	:	O	:	_	0	SENT_179	[p13l1917t2558r2141b2623],
18	schizophrenia	NN	O	schizophrenia	nn	20	SENT_179	[p13l114t2635r545b2702],
19	trial	NN	O	trial	nn	20	SENT_179	[p13l575t2635r698b2686],
20	design	NN	O	design	_	0	SENT_179	[p13l731t2635r927b2702],
21	and	CC	O	and	_	0	SENT_179	[p13l959t2635r1071b2686],
22	protocol	NN	O	protocol	nn	23	SENT_179	[p13l1102t2635r1353b2702],
23	development	NN	O	development	conj_and	20	SENT_179	[p13l1387t2635r1797b2702],
24	.	.	O	.	_	0	SENT_179	[p13l1387t2635r1797b2702],

1	Schizophr	NNP	O	Schizophr	nn	2	SENT_180	[p13l1836t2635r2150b2702],
2	Bull	NNP	O	Bull	_	0	SENT_180	[p13l112t2717r239b2768],
3	2003	CD	DATE	2003	num	2	SENT_180	[p13l264t2724r422b2775],
4	;	:	O	;	_	0	SENT_180	[p13l264t2724r422b2775],
5	29	CD	NUMBER	29	num	7	SENT_180	[p13l451t2724r536b2768],
6	:	:	O	:	_	0	SENT_180	[p13l451t2724r536b2768],
7	15-31	CD	DATE	15-31	dep	2	SENT_180	[p13l568t2724r761b2768],
8	.	.	O	.	_	0	SENT_180	[p13l568t2724r761b2768],

1	4	CD	NUMBER	4	num	3	SENT_181	[p13l42t2803r74b2846],
2	Aravagiri	NN	O	aravagirus	nn	3	SENT_181	[p13l112t2798r394b2862],
3	M	NN	O	m	_	0	SENT_181	[p13l414t2799r490b2854],
4	,	,	O	,	_	0	SENT_181	[p13l414t2799r490b2854],
5	Marder	NNP	PERSON	Marder	nn	6	SENT_181	[p13l512t2795r733b2846],
6	SR.	NNP	O	SR.	appos	3	SENT_181	[p13l753t2798r848b2846],
7	.	.	O	.	_	0	SENT_181	[p13l753t2798r848b2846],

1	Determination	NN	O	determination	_	0	SENT_182	[p13l871t2798r1310b2846],
2	of	IN	O	of	_	0	SENT_182	[p13l1331t2795r1391b2846],
3	olanzapine	NN	O	olanzapine	prep_of	1	SENT_182	[p13l1406t2795r1739b2863],
4	in	IN	O	in	_	0	SENT_182	[p13l1760t2798r1819b2846],
5	plasma	NN	O	plasma	prep_in	1	SENT_182	[p13l1838t2795r2055b2863],
6	by	IN	O	by	_	0	SENT_182	[p13l2071t2795r2145b2862],
7	liquid	JJ	O	liquid	amod	11	SENT_182	[p13l113t2876r295b2944],
8	chromatography/electrospray	NN	O	chromatography/electrospray	nn	11	SENT_182	[p13l341t2876r1239b2944],
9	tandem	JJ	O	tandem	amod	11	SENT_182	[p13l1281t2876r1510b2928],
10	mass	NN	O	mass	nn	11	SENT_182	[p13l1553t2894r1701b2928],
11	spectrometry	NN	O	spectrometry	prep_by	5	SENT_182	[p13l1748t2884r2145b2944],
12	and	CC	O	and	_	0	SENT_182	[p13l114t2956r225b3007],
13	its	PRP$	O	its	poss	14	SENT_182	[p13l257t2959r326b3007],
14	application	NN	O	application	conj_and	5	SENT_182	[p13l360t2956r706b3023],
15	to	TO	O	to	_	0	SENT_182	[p13l737t2964r793b3007],
16	plasma	NN	O	plasma	nn	18	SENT_182	[p13l826t2956r1043b3023],
17	level	NN	O	level	nn	18	SENT_182	[p13l1074t2956r1218b3007],
18	monitoring	NN	O	monitoring	prep_to	14	SENT_182	[p13l1250t2959r1589b3023],
19	in	IN	O	in	_	0	SENT_182	[p13l1621t2959r1681b3007],
20	schizophrenic	JJ	O	schizophrenic	amod	21	SENT_182	[p13l1714t2956r2142b3023],
21	patients	NNS	O	patient	prep_in	18	SENT_182	[p13l113t3039r370b3104],
22	.	.	O	.	_	0	SENT_182	[p13l113t3039r370b3104],

1	AAPS	NN	O	aap	nn	2	SENT_183	[p13l398t3039r582b3088],
2	PharmSc1	NN	O	pharmsc1	_	0	SENT_183	[p13l605t3037r905b3088],
3	'	''	O	'	_	0	SENT_183	[p13l605t3037r905b3088],
4	2002	CD	DATE	2002	dep	2	SENT_183	[p13l931t3044r1088b3096],
5	;	:	O	;	_	0	SENT_183	[p13l931t3044r1088b3096],
6	4	CD	NUMBER	4	num	8	SENT_183	[p13l1117t3044r1150b3087],
7	Abstract	JJ	O	abstract	amod	8	SENT_183	[p13l1176t3037r1430b3088],
8	W5016	NN	O	w5016	dep	2	SENT_183	[p13l1454t3040r1681b3088],
9	.	.	O	.	_	0	SENT_183	[p13l1454t3040r1681b3088],

1	5	CD	NUMBER	5	num	3	SENT_184	[p13l45t3124r73b3168],
2	Sullivan	NNP	ORGANIZATION	Sullivan	nn	3	SENT_184	[p13l115t3116r370b3168],
3	PF	NNP	ORGANIZATION	PF	_	0	SENT_184	[p13l418t3120r507b3176],
4	,	,	O	,	_	0	SENT_184	[p13l418t3120r507b3176],
5	Lin	NNP	PERSON	Lin	nn	6	SENT_184	[p13l558t3119r659b3167],
6	D	NNP	PERSON	D	appos	3	SENT_184	[p13l707t3120r768b3176],
7	,	,	O	,	_	0	SENT_184	[p13l707t3120r768b3176],
8	T	NN	O	t	nn	10	SENT_184	[p13l820t3120r861b3167],
9	zeng	NN	O	zeng	nn	10	SENT_184	[p13l866t3134r1003b3184],
10	JY	NN	O	jy	appos	3	SENT_184	[p13l1049t3120r1129b3180],
11	,	,	O	,	_	0	SENT_184	[p13l1049t3120r1129b3180],
12	van	NN	O	van	nn	15	SENT_184	[p13l1179t3134r1289b3168],
13	den	NN	O	den	nn	15	SENT_184	[p13l1339t3116r1450b3168],
14	Oord	NN	O	oord	nn	15	SENT_184	[p13l1499t3116r1651b3168],
15	E	NN	O	e	appos	3	SENT_184	[p13l1699t3120r1754b3176],
16	,	,	O	,	_	0	SENT_184	[p13l1699t3120r1754b3176],
17	Perkins	NNP	ORGANIZATION	Perkins	nn	18	SENT_184	[p13l1804t3116r2030b3168],
18	D	NNP	ORGANIZATION	D	appos	3	SENT_184	[p13l2080t3120r2142b3176],
19	,	,	O	,	_	0	SENT_184	[p13l2080t3120r2142b3176],
20	Stroup	NNP	PERSON	Stroup	nn	21	SENT_184	[p13l115t3199r315b3263],
21	TS	NN	O	t	appos	3	SENT_184	[p13l370t3199r450b3247],
22	et	FW	O	et	nn	23	SENT_184	[p13l507t3203r560b3247],
23	a1	FW	O	a1	dep	21	SENT_184	[p13l611t3196r679b3247],
24	.	.	O	.	_	0	SENT_184	[p13l611t3196r679b3247],

1	Genomewide	JJ	O	genomewide	amod	2	SENT_185	[p13l735t3196r1134b3247],
2	association	NN	O	association	_	0	SENT_185	[p13l1188t3199r1526b3247],
3	for	IN	O	for	_	0	SENT_185	[p13l1579t3196r1661b3247],
4	schizophrenia	NN	O	schizophrenia	prep_for	2	SENT_185	[p13l1714t3196r2145b3263],
5	in	IN	O	in	_	0	SENT_185	[p13l113t3279r173b3327],
6	the	DT	O	the	det	8	SENT_185	[p13l204t3277r298b3328],
7	CATIE	NNP	O	CATIE	nn	8	SENT_185	[p13l331t3279r525b3328],
8	study	NN	O	study	prep_in	4	SENT_185	[p13l560t3277r742b3344],
9	:	:	O	:	_	0	SENT_185	[p13l560t3277r742b3344],
10	results	NNS	O	result	dep	2	SENT_185	[p13l776t3277r977b3328],
11	of	IN	O	of	_	0	SENT_185	[p13l1013t3277r1072b3328],
12	stage	NN	O	stage	prep_of	10	SENT_185	[p13l1100t3284r1247b3344],
13	1	CD	NUMBER	1	num	12	SENT_185	[p13l1283t3284r1328b3328],
14	.	.	O	.	_	0	SENT_185	[p13l1283t3284r1328b3328],

1	M01	NN	O	m01	_	0	SENT_186	[p13l1363t3277r1481b3328],
2	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_186	[p13l1509t3277r1834b3344],
3	2008	CD	DATE	2008	num	2	SENT_186	[p13l1863t3284r2020b3336],
4	;	:	O	;	_	0	SENT_186	[p13l1863t3284r2020b3336],
5	13	CD	NUMBER	13	num	7	SENT_186	[p13l2057t3284r2141b3328],
6	:	:	O	:	_	0	SENT_186	[p13l2057t3284r2141b3328],
7	570-584	CD	NUMBER	570-584	dep	1	SENT_186	[p13l115t3364r382b3407],
8	.	.	O	.	_	0	SENT_186	[p13l115t3364r382b3407],

1	Callaghan	NNP	PERSON	Callaghan	nn	2	SENT_187	[p14l113t21r415b89],
2	IT	NNP	O	IT	_	0	SENT_187	[p14l449t25r526b85],
3	,	,	O	,	_	0	SENT_187	[p14l449t25r526b85],
4	Bergstrom	NNP	PERSON	Bergstrom	nn	5	SENT_187	[p14l565t25r874b89],
5	RF	NNP	O	RF	appos	2	SENT_187	[p14l910t25r1002b81],
6	,	,	O	,	_	0	SENT_187	[p14l910t25r1002b81],
7	Ptak	NNP	PERSON	Ptak	nn	8	SENT_187	[p14l1041t21r1174b73],
8	LR	NNP	O	LR	appos	2	SENT_187	[p14l1209t25r1307b81],
9	,	,	O	,	_	0	SENT_187	[p14l1209t25r1307b81],
10	Beasley	NNP	PERSON	Beasley	nn	11	SENT_187	[p14l1347t21r1578b89],
11	CM	NN	O	cm	appos	2	SENT_187	[p14l1615t24r1733b73],
12	.	.	O	.	_	0	SENT_187	[p14l1615t24r1733b73],

1	Olanzapine	NNP	O	Olanzapine	_	0	SENT_188	[p14l1776t21r2141b89],
2	:	:	O	:	_	0	SENT_188	[p14l1776t21r2141b89],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_188	[p14l113t101r624b168],
4	and	CC	O	and	_	0	SENT_188	[p14l659t101r770b152],
5	pharmacodynamic	JJ	O	pharmacodynamic	amod	6	SENT_188	[p14l803t101r1370b168],
6	profile	NN	O	profile	dep	1	SENT_188	[p14l1405t101r1620b168],
7	.	.	O	.	_	0	SENT_188	[p14l1405t101r1620b168],

1	CI1	NN	O	ci1	_	0	SENT_189	[p14l1661t101r1780b152],
2	'n	CC	O	'n	_	0	SENT_189	[p14l1661t101r1780b152],
3	Pharmacokinet1999	NN	O	pharmacokinet1999	conj_'n	1	SENT_189	[p14l1813t101r2145b152, p14l112t183r863b241],
4	;	:	O	;	_	0	SENT_189	[p14l1813t101r2145b152, p14l112t183r863b241],
5	37:177	CD	NUMBER	37:177	num	6	SENT_189	[p14l1813t101r2145b152, p14l112t183r863b241],
6	-193	CD	NUMBER	-193	dep	1	SENT_189	[p14l1813t101r2145b152, p14l112t183r863b241],
7	.	.	O	.	_	0	SENT_189	[p14l1813t101r2145b152, p14l112t183r863b241],

1	Ring	NN	O	ring	nn	3	SENT_190	[p14l112t264r251b328],
2	B	NN	O	b	nn	3	SENT_190	[p14l286t265r366b325],
3	]	NN	O	]	_	0	SENT_190	[p14l286t265r366b325],
4	,	,	O	,	_	0	SENT_190	[p14l286t265r366b325],
5	Binkley	NNP	PERSON	Binkley	nn	6	SENT_190	[p14l403t261r638b328],
6	SN	NNP	O	SN	appos	3	SENT_190	[p14l675t264r779b320],
7	,	,	O	,	_	0	SENT_190	[p14l675t264r779b320],
8	Vandenbranden	NNP	O	Vandenbranden	nn	9	SENT_190	[p14l816t261r1300b312],
9	M	NNP	O	M	appos	3	SENT_190	[p14l1334t265r1411b320],
10	,	,	O	,	_	0	SENT_190	[p14l1334t265r1411b320],
11	Wrighton	NNP	PERSON	Wrighton	nn	12	SENT_190	[p14l1448t261r1733b328],
12	SA	NNP	O	SA	appos	3	SENT_190	[p14l1771t264r1873b312],
13	.	.	O	.	_	0	SENT_190	[p14l1771t264r1873b312],

1	In	IN	O	in	_	0	SENT_191	[p14l1911t265r1971b312],
2	Vitro	NNP	O	Vitro	nn	3	SENT_191	[p14l2009t264r2145b312],
3	interaction	NN	O	interaction	pobj	1	SENT_191	[p14l113t344r444b392],
4	of	IN	O	of	_	0	SENT_191	[p14l487t341r547b392],
5	the	DT	O	the	det	8	SENT_191	[p14l582t341r676b392],
6	antipsychotic	JJ	O	antipsychotic	amod	8	SENT_191	[p14l719t341r1130b408],
7	agent	NN	O	agent	nn	8	SENT_191	[p14l1174t349r1334b408],
8	olanzapine	NN	O	olanzapine	prep_of	3	SENT_191	[p14l1377t341r1709b408],
9	with	IN	O	with	_	0	SENT_191	[p14l1751t341r1890b392],
10	human	JJ	O	human	amod	13	SENT_191	[p14l1932t341r2145b392],
11	cytochromes	NNS	O	cytochrome	nn	13	SENT_191	[p14l114t422r497b489],
12	P450	NN	O	p450	nn	13	SENT_191	[p14l528t425r676b473],
13	CYP2C9	NN	O	cyp2c9	prep_with	8	SENT_191	[p14l707t424r972b481],
14	,	,	O	,	_	0	SENT_191	[p14l707t424r972b481],
15	CYP2C19	NN	O	cyp2c19	conj_and	13	SENT_191	[p14l1004t424r1306b481],
16	,	,	O	,	_	0	SENT_191	[p14l1004t424r1306b481],
17	CYP2D6	NN	O	cyp2d6	conj_and	13	SENT_191	[p14l1339t424r1589b473],
18	and	CC	O	and	_	0	SENT_191	[p14l1621t422r1733b473],
19	CYP3A	NN	O	cyp3a	conj_and	13	SENT_191	[p14l1762t424r1996b473],
20	.	.	O	.	_	0	SENT_191	[p14l1762t424r1996b473],

1	Br	NN	O	br	nn	3	SENT_192	[p14l2030t425r2153b486],
2	]	CD	NUMBER	]	num	3	SENT_192	[p14l2030t425r2153b486],
3	CHﬂ1Phanmac0I1996	NN	O	chﬂ1phanmac0i1996	_	0	SENT_192	[p14l116t501r1191b560],
4	;	:	O	;	_	0	SENT_192	[p14l116t501r1191b560],
5	41:181	CD	NUMBER	41:181	number	6	SENT_192	[p14l116t501r1191b560],
6	-186	CD	NUMBER	-186	dep	3	SENT_192	[p14l116t501r1191b560],
7	.	.	O	.	_	0	SENT_192	[p14l116t501r1191b560],

1	Purcell	NNP	PERSON	Purcell	nn	2	SENT_193	[p14l112t580r328b631],
2	S	NNP	O	S	_	0	SENT_193	[p14l350t583r402b639],
3	,	,	O	,	_	0	SENT_193	[p14l350t583r402b639],
4	Neale	NNP	PERSON	Neale	nn	5	SENT_193	[p14l424t580r596b631],
5	B	NNP	PERSON	B	appos	2	SENT_193	[p14l617t584r674b639],
6	,	,	O	,	_	0	SENT_193	[p14l617t584r674b639],
7	Todd-Brown	NNP	PERSON	Todd-Brown	nn	8	SENT_193	[p14l697t580r1078b631],
8	K	NNP	PERSON	K	appos	2	SENT_193	[p14l1098t584r1159b639],
9	,	,	O	,	_	0	SENT_193	[p14l1098t584r1159b639],
10	Thomas	NNP	PERSON	Thomas	nn	11	SENT_193	[p14l1181t580r1421b631],
11	L	NNP	PERSON	L	appos	2	SENT_193	[p14l1443t584r1497b639],
12	,	,	O	,	_	0	SENT_193	[p14l1443t584r1497b639],
13	Ferreira	NNP	PERSON	Ferreira	nn	14	SENT_193	[p14l1520t583r1758b631],
14	MA	NNP	PERSON	MA	appos	2	SENT_193	[p14l1777t584r1905b639],
15	,	,	O	,	_	0	SENT_193	[p14l1777t584r1905b639],
16	Bender	NNP	PERSON	Bender	nn	17	SENT_193	[p14l1928t580r2145b631],
17	D	NNP	O	D	appos	2	SENT_193	[p14l112t662r156b710],
18	et	FW	O	et	nn	19	SENT_193	[p14l203t666r257b710],
19	aI	FW	O	ai	dep	17	SENT_193	[p14l299t659r367b710],
20	.	.	O	.	_	0	SENT_193	[p14l299t659r367b710],

1	PLINK	NNP	O	PLINK	_	0	SENT_194	[p14l413t662r630b710],
2	:	:	O	:	_	0	SENT_194	[p14l413t662r630b710],
3	a	DT	O	a	det	4	SENT_194	[p14l678t677r708b710],
4	tool	NN	O	tool	dep	1	SENT_194	[p14l750t659r865b710],
5	set	VBN	O	set	partmod	4	SENT_194	[p14l911t667r993b710],
6	for	IN	O	for	_	0	SENT_194	[p14l1036t659r1118b710],
7	whole-genome	JJ	O	whole-genome	amod	8	SENT_194	[p14l1159t659r1606b726],
8	association	NN	O	association	prep_for	5	SENT_194	[p14l1651t662r1989b710],
9	and	CC	O	and	_	0	SENT_194	[p14l2033t659r2145b710],
10	population-based	JJ	O	population-based	amod	12	SENT_194	[p14l113t740r646b807],
11	linkage	NN	O	linkage	nn	12	SENT_194	[p14l683t740r901b807],
12	analyses	NNS	O	analysis	prep_for	5	SENT_194	[p14l941t740r1212b807],
13	.	.	O	.	_	0	SENT_194	[p14l941t740r1212b807],

1	Am	VBP	O	be	dep	4	SENT_195	[p14l1252t743r1360b790],
2	]	CD	NUMBER	]	num	4	SENT_195	[p14l1394t743r1425b804],
3	Hum	NNP	O	Hum	nn	4	SENT_195	[p14l1454t743r1603b791],
4	Genet	NNP	O	Genet	_	0	SENT_195	[p14l1646t742r1820b791],
5	2007	CD	DATE	2007	num	4	SENT_195	[p14l1857t747r2015b799],
6	;	:	O	;	_	0	SENT_195	[p14l1857t747r2015b799],
7	81	CD	NUMBER	81	dep	4	SENT_195	[p14l2056t747r2141b791],
8	:	:	O	:	_	0	SENT_195	[p14l2056t747r2141b791],
9	559-575	CD	NUMBER	559-575	dep	7	SENT_195	[p14l115t826r382b870],
10	.	.	O	.	_	0	SENT_195	[p14l115t826r382b870],

1	Consortium	NNP	O	Consortium	nn	2	SENT_196	[p14l113t901r470b949],
2	TIH	NNP	O	TIH	_	0	SENT_196	[p14l494t901r624b949],
3	.	.	O	.	_	0	SENT_196	[p14l494t901r624b949],

1	The	DT	O	the	det	3	SENT_197	[p14l653t898r768b949],
2	international	JJ	O	international	amod	3	SENT_197	[p14l794t898r1186b949],
3	HapMap	NNP	O	HapMap	_	0	SENT_197	[p14l1211t901r1470b965],
4	project	NN	O	project	dep	3	SENT_197	[p14l1497t901r1720b965],
5	.	.	O	.	_	0	SENT_197	[p14l1497t901r1720b965],

1	Nature	NNP	O	Nature	_	0	SENT_198	[p14l1748t901r1959b949],
2	2003	CD	DATE	2003	num	1	SENT_198	[p14l1983t905r2141b957],
3	;	:	O	;	_	0	SENT_198	[p14l1983t905r2141b957],
4	426:789	CD	NUMBER	426:789	num	5	SENT_198	[p14l112t986r534b1029],
5	—	NN	O	—	dep	1	SENT_198	[p14l112t986r534b1029],
6	796	CD	NUMBER	796	dep	5	SENT_198	[p14l112t986r534b1029],
7	.	.	O	.	_	0	SENT_198	[p14l112t986r534b1029],

1	Wessels	NNP	ORGANIZATION	Wessels	nn	2	SENT_199	[p14l115t1059r353b1109],
2	AM	NNP	ORGANIZATION	AM	nsubj	20	SENT_199	[p14l385t1062r514b1117],
3	,	,	O	,	_	0	SENT_199	[p14l385t1062r514b1117],
4	Bies	NNP	ORGANIZATION	Bies	nn	5	SENT_199	[p14l547t1061r672b1109],
5	RR	NNP	ORGANIZATION	RR	appos	2	SENT_199	[p14l703t1062r806b1117],
6	,	,	O	,	_	0	SENT_199	[p14l703t1062r806b1117],
7	Pollock	NNP	ORGANIZATION	Pollock	nn	8	SENT_199	[p14l838t1059r1067b1109],
8	BG	NNP	ORGANIZATION	BG	appos	2	SENT_199	[p14l1095t1061r1201b1117],
9	,	,	O	,	_	0	SENT_199	[p14l1095t1061r1201b1117],
10	Schneider	NNP	ORGANIZATION	Schneider	nn	11	SENT_199	[p14l1236t1059r1544b1109],
11	LS	NN	ORGANIZATION	l	appos	2	SENT_199	[p14l1573t1061r1668b1117],
12	,	,	O	,	_	0	SENT_199	[p14l1573t1061r1668b1117],
13	Lieberman	NNP	LOCATION	Lieberman	nn	14	SENT_199	[p14l1701t1059r2025b1109],
14	IA	NNP	LOCATION	IA	appos	2	SENT_199	[p14l2052t1062r2142b1122],
15	,	,	O	,	_	0	SENT_199	[p14l2052t1062r2142b1122],
16	Stroup	NNP	PERSON	Stroup	appos	2	SENT_199	[p14l119t1140r319b1205],
17	S	NNP	O	S	dep	20	SENT_199	[p14l354t1140r387b1189],
18	et	FW	O	et	nn	20	SENT_199	[p14l422t1144r476b1189],
19	a	FW	O	a	nn	20	SENT_199	[p14l504t1137r572b1189],
20	]	FW	O	]	_	0	SENT_199	[p14l504t1137r572b1189],
21	.	.	O	.	_	0	SENT_199	[p14l504t1137r572b1189],

1	Population	NNP	O	Population	nn	3	SENT_200	[p14l605t1137r941b1205],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_200	[p14l971t1137r1482b1205],
3	modeling	NN	O	modeling	_	0	SENT_200	[p14l1514t1137r1801b1205],
4	of	IN	O	of	_	0	SENT_200	[p14l1833t1137r1892b1189],
5	ziprasidone	NN	O	ziprasidone	prep_of	3	SENT_200	[p14l1918t1140r2143b1205, p14l119t1217r265b1268],
6	in	IN	O	in	_	0	SENT_200	[p14l291t1220r351b1268],
7	patients	NNS	O	patient	prep_in	3	SENT_200	[p14l375t1220r616b1284],
8	with	IN	O	with	_	0	SENT_200	[p14l642t1217r781b1268],
9	schizophrenia	NN	O	schizophrenia	prep_with	7	SENT_200	[p14l808t1217r1239b1284],
10	from	IN	O	from	_	0	SENT_200	[p14l1264t1217r1405b1268],
11	the	DT	O	the	det	13	SENT_200	[p14l1429t1217r1522b1268],
12	CATIE	NNP	O	CATIE	nn	13	SENT_200	[p14l1548t1220r1742b1268],
13	study	NN	O	study	prep_from	3	SENT_200	[p14l1771t1217r1947b1284],
14	.	.	O	.	_	0	SENT_200	[p14l1771t1217r1947b1284],

1	I	PRP	O	I	nsubj	2	SENT_201	[p14l1972t1220r2004b1281],
2	Clin	VBP	O	clin	_	0	SENT_201	[p14l2024t1217r2143b1268],
3	Pharmacol	NNP	O	Pharmacol	dobj	2	SENT_201	[p14l115t1298r448b1349],
4	2011	CD	DATE	2011	num	3	SENT_201	[p14l468t1305r625b1357],
5	;	:	O	;	_	0	SENT_201	[p14l468t1305r625b1357],
6	advance	NN	O	advance	nn	8	SENT_201	[p14l649t1298r897b1349],
7	online	NN	O	online	nn	8	SENT_201	[p14l919t1298r1110b1349],
8	publication	NN	O	publication	dep	3	SENT_201	[p14l1132t1298r1497b1365],
9	,	,	O	,	_	0	SENT_201	[p14l1132t1298r1497b1365],
10	January	NNP	DATE	January	appos	8	SENT_201	[p14l1517t1301r1752b1365],
11	2011	CD	DATE	2011	num	10	SENT_201	[p14l1774t1305r1931b1357],
12	;	:	O	;	_	0	SENT_201	[p14l1774t1305r1931b1357],
13	PMID	NNP	O	PMID	dep	3	SENT_201	[p14l1953t1301r2141b1349],
14	:	:	O	:	_	0	SENT_201	[p14l1953t1301r2141b1349],
15	21209243	CD	NUMBER	21209243	num	16	SENT_201	[p14l119t1384r405b1429],
16	(	NN	O	(	dep	3	SENT_201	[p14l437t1377r516b1438],
17	in	IN	O	in	_	0	SENT_201	[p14l437t1377r516b1438],
18	press	NN	O	press	nn	19	SENT_201	[p14l542t1377r735b1445],
19	)	NN	O	)	prep_in	16	SENT_201	[p14l542t1377r735b1445],
20	.	.	O	.	_	0	SENT_201	[p14l542t1377r735b1445],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_202	[p14l115t1460r294b1508],
2	WE	NNP	O	WE	_	0	SENT_202	[p14l386t1460r507b1516],
3	,	,	O	,	_	0	SENT_202	[p14l386t1460r507b1516],
4	Relling	NNP	O	Relling	nn	5	SENT_202	[p14l601t1457r817b1524],
5	MV	NNP	O	MV	appos	2	SENT_202	[p14l908t1460r1024b1508],
6	.	.	O	.	_	0	SENT_202	[p14l908t1460r1024b1508],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_203	[p14l1118t1457r1725b1524],
2	:	:	O	:	_	0	SENT_203	[p14l1118t1457r1725b1524],
3	translating	VBG	O	translate	dep	1	SENT_203	[p14l1820t1457r2144b1524],
4	functional	JJ	O	functional	amod	5	SENT_203	[p14l117t1537r428b1588],
5	genomics	NNS	O	genomic	dobj	3	SENT_203	[p14l476t1540r761b1604],
6	into	IN	O	into	_	0	SENT_203	[p14l811t1540r928b1588],
7	rational	JJ	O	rational	amod	8	SENT_203	[p14l975t1537r1210b1588],
8	therapeutics	NNS	O	therapeutics	prep_into	3	SENT_203	[p14l1257t1537r1649b1604],
9	.	.	O	.	_	0	SENT_203	[p14l1257t1537r1649b1604],

1	Science	NN	O	science	_	0	SENT_204	[p14l1703t1540r1935b1588],
2	1999	CD	DATE	1999	num	1	SENT_204	[p14l1984t1544r2141b1596],
3	;	:	O	;	_	0	SENT_204	[p14l1984t1544r2141b1596],
4	286:487	CD	NUMBER	286:487	num	5	SENT_204	[p14l118t1624r538b1668],
5	—	NN	O	—	dep	1	SENT_204	[p14l118t1624r538b1668],
6	491	CD	NUMBER	491	dep	5	SENT_204	[p14l118t1624r538b1668],
7	.	.	O	.	_	0	SENT_204	[p14l118t1624r538b1668],

1	Gellner	NNP	PERSON	Gellner	nn	2	SENT_205	[p14l117t1696r340b1747],
2	K	NNP	PERSON	K	_	0	SENT_205	[p14l368t1700r429b1755],
3	,	,	O	,	_	0	SENT_205	[p14l368t1700r429b1755],
4	Eiselt	NNP	PERSON	Eiselt	nn	5	SENT_205	[p14l459t1696r629b1747],
5	R	NNP	PERSON	R	appos	2	SENT_205	[p14l655t1700r713b1755],
6	,	,	O	,	_	0	SENT_205	[p14l655t1700r713b1755],
7	Hustert	NNP	PERSON	Hustert	nn	8	SENT_205	[p14l744t1700r969b1747],
8	E	NNP	PERSON	E	appos	2	SENT_205	[p14l996t1700r1051b1755],
9	,	,	O	,	_	0	SENT_205	[p14l996t1700r1051b1755],
10	Arnold	NNP	PERSON	Arnold	nn	11	SENT_205	[p14l1081t1696r1297b1747],
11	H	NNP	PERSON	H	appos	2	SENT_205	[p14l1325t1700r1391b1755],
12	,	,	O	,	_	0	SENT_205	[p14l1325t1700r1391b1755],
13	Koch	NNP	O	Koch	nn	17	SENT_205	[p14l1423t1696r1579b1747],
14	I	PRP	O	I	dep	17	SENT_205	[p14l1607t1700r1642b1755],
15	,	,	O	,	_	0	SENT_205	[p14l1607t1700r1642b1755],
16	Haberl	NNP	PERSON	Haberl	dep	17	SENT_205	[p14l1672t1696r1873b1747],
17	M	NNP	O	M	appos	2	SENT_205	[p14l1902t1700r1962b1747],
18	et	FW	O	et	nn	19	SENT_205	[p14l1993t1703r2047b1747],
19	aI	FW	O	ai	dep	17	SENT_205	[p14l2073t1696r2141b1747],
20	.	.	O	.	_	0	SENT_205	[p14l2073t1696r2141b1747],

1	Genomic	JJ	MISC	genomic	amod	2	SENT_206	[p14l117t1778r386b1826],
2	organization	NN	O	organization	_	0	SENT_206	[p14l418t1778r795b1842],
3	of	IN	O	of	_	0	SENT_206	[p14l826t1775r886b1826],
4	the	DT	O	the	det	7	SENT_206	[p14l909t1775r1003b1826],
5	human	JJ	O	human	amod	7	SENT_206	[p14l1032t1775r1245b1826],
6	CYP3A	NN	O	cyp3a	nn	7	SENT_206	[p14l1275t1778r1494b1826],
7	locus	NN	O	locus	prep_of	2	SENT_206	[p14l1523t1775r1698b1826],
8	:	:	O	:	_	0	SENT_206	[p14l1523t1775r1698b1826],
9	identification	NN	O	identification	dep	2	SENT_206	[p14l1731t1775r2145b1826],
10	of	IN	O	of	_	0	SENT_206	[p14l118t1856r178b1907],
11	a	DT	O	a	det	16	SENT_206	[p14l214t1874r244b1907],
12	new	JJ	O	new	amod	16	SENT_206	[p14l283t1874r422b1915],
13	,	,	O	,	_	0	SENT_206	[p14l283t1874r422b1915],
14	inducible	JJ	O	inducible	amod	16	SENT_206	[p14l466t1856r755b1907],
15	CYP3A	NN	O	cyp3a	nn	16	SENT_206	[p14l797t1858r1016b1907],
16	gene	NN	O	gene	prep_of	9	SENT_206	[p14l1056t1874r1209b1923],
17	.	.	O	.	_	0	SENT_206	[p14l1056t1874r1209b1923],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_207	[p14l1253t1856r1812b1923],
2	2001	CD	DATE	2001	num	1	SENT_207	[p14l1854t1863r2011b1915],
3	;	:	O	;	_	0	SENT_207	[p14l1854t1863r2011b1915],
4	11	CD	NUMBER	11	num	6	SENT_207	[p14l2057t1863r2141b1907],
5	:	:	O	:	_	0	SENT_207	[p14l2057t1863r2141b1907],
6	111-121	CD	NUMBER	111-121	dep	1	SENT_207	[p14l120t1942r386b1985],
7	.	.	O	.	_	0	SENT_207	[p14l120t1942r386b1985],

1	Domanski	NNP	PERSON	Domanski	nn	2	SENT_208	[p14l115t2014r420b2066],
2	TL	NNP	O	TL	_	0	SENT_208	[p14l466t2018r564b2074],
3	,	,	O	,	_	0	SENT_208	[p14l466t2018r564b2074],
4	Finta	NNP	ORGANIZATION	Finta	nn	5	SENT_208	[p14l612t2017r769b2066],
5	C	NNP	ORGANIZATION	C	appos	2	SENT_208	[p14l814t2017r871b2074],
6	,	,	O	,	_	0	SENT_208	[p14l814t2017r871b2074],
7	Halpert	NNP	PERSON	Halpert	nn	8	SENT_208	[p14l918t2014r1146b2082],
8	IR	NNP	O	IR	appos	2	SENT_208	[p14l1188t2018r1270b2079],
9	,	,	O	,	_	0	SENT_208	[p14l1188t2018r1270b2079],
10	Zaphiropoulos	NNP	O	Zaphiropoulos	nn	11	SENT_208	[p14l1318t2014r1766b2082],
11	PG	NNP	O	PG	appos	2	SENT_208	[p14l1812t2017r1913b2066],
12	.	.	O	.	_	0	SENT_208	[p14l1812t2017r1913b2066],

1	cDNA	NN	O	cdna	nn	2	SENT_209	[p14l1963t2018r2145b2066],
2	cloning	NN	O	cloning	_	0	SENT_209	[p14l117t2094r343b2161],
3	and	CC	O	and	_	0	SENT_209	[p14l374t2094r485b2145],
4	initial	JJ	O	initial	amod	5	SENT_209	[p14l516t2094r697b2145],
5	characterization	NN	O	characterization	conj_and	2	SENT_209	[p14l728t2094r1218b2145],
6	of	IN	O	of	_	0	SENT_209	[p14l1249t2094r1309b2145],
7	CYP3A43	NN	O	cyp3a43	prep_of	2	SENT_209	[p14l1333t2097r1643b2153],
8	,	,	O	,	_	0	SENT_209	[p14l1333t2097r1643b2153],
9	a	DT	O	a	det	13	SENT_209	[p14l1676t2112r1707b2145],
10	novel	JJ	O	novel	amod	13	SENT_209	[p14l1734t2094r1901b2145],
11	human	JJ	O	human	amod	13	SENT_209	[p14l1932t2094r2145b2145],
12	cytochrome	NN	O	cytochrome	nn	13	SENT_209	[p14l117t2175r471b2242],
13	P450	NN	O	p450	appos	7	SENT_209	[p14l498t2178r661b2226],
14	.	.	O	.	_	0	SENT_209	[p14l498t2178r661b2226],

1	M01	NN	O	m01	nn	2	SENT_210	[p14l690t2175r808b2226],
2	Pharmacol	NN	O	pharmacol	_	0	SENT_210	[p14l829t2175r1163b2226],
3	2001	CD	DATE	2001	dep	2	SENT_210	[p14l1188t2182r1346b2234],
4	;	:	O	;	_	0	SENT_210	[p14l1188t2182r1346b2234],
5	59	CD	NUMBER	59	num	7	SENT_210	[p14l1376t2182r1461b2226],
6	:	:	O	:	_	0	SENT_210	[p14l1376t2182r1461b2226],
7	386-392	CD	NUMBER	386-392	dep	2	SENT_210	[p14l1492t2182r1759b2226],
8	.	.	O	.	_	0	SENT_210	[p14l1492t2182r1759b2226],

1	Westlind	NNP	MISC	Westlind	nn	2	SENT_211	[p14l115t2254r389b2305],
2	A	NNP	MISC	A	_	0	SENT_211	[p14l428t2258r493b2313],
3	,	,	O	,	_	0	SENT_211	[p14l428t2258r493b2313],
4	Malmebo	NNP	PERSON	Malmebo	nn	5	SENT_211	[p14l535t2254r817b2305],
5	S	NNP	PERSON	S	appos	2	SENT_211	[p14l860t2257r912b2313],
6	,	,	O	,	_	0	SENT_211	[p14l860t2257r912b2313],
7	Iohansson	NNP	O	Iohansson	nn	8	SENT_211	[p14l951t2254r1263b2318],
8	I	NNP	O	I	appos	2	SENT_211	[p14l1302t2258r1338b2313],
9	,	,	O	,	_	0	SENT_211	[p14l1302t2258r1338b2313],
10	Otter	NNP	O	Otter	nn	11	SENT_211	[p14l1381t2257r1534b2305],
11	C	NNP	O	C	appos	2	SENT_211	[p14l1573t2257r1630b2313],
12	,	,	O	,	_	0	SENT_211	[p14l1573t2257r1630b2313],
13	Andersson	NNP	PERSON	Andersson	nn	14	SENT_211	[p14l1671t2254r2000b2305],
14	TB	NN	O	tb	appos	2	SENT_211	[p14l2040t2258r2142b2313],
15	,	,	O	,	_	0	SENT_211	[p14l2040t2258r2142b2313],
16	Ingelman-Sundberg	NN	O	ingelman-sundberg	nn	17	SENT_211	[p14l116t2333r716b2400],
17	M	NN	O	m	appos	2	SENT_211	[p14l745t2336r806b2384],
18	et	FW	O	et	nn	19	SENT_211	[p14l838t2340r892b2384],
19	aI	FW	O	ai	dep	17	SENT_211	[p14l920t2333r988b2384],
20	.	.	O	.	_	0	SENT_211	[p14l920t2333r988b2384],

1	Cloning	NN	O	cloning	nn	4	SENT_212	[p14l1021t2333r1259b2400],
2	and	CC	O	and	_	0	SENT_212	[p14l1290t2333r1402b2384],
3	tissue	NN	O	tissue	nn	4	SENT_212	[p14l1431t2336r1607b2384],
4	distribution	NN	O	distribution	_	0	SENT_212	[p14l1640t2333r1999b2384],
5	of	IN	O	of	_	0	SENT_212	[p14l2030t2333r2090b2384],
6	a	DT	O	a	det	10	SENT_212	[p14l2115t2351r2146b2384],
7	novel	JJ	O	novel	amod	10	SENT_212	[p14l116t2414r283b2465],
8	human	JJ	O	human	amod	10	SENT_212	[p14l348t2414r562b2465],
9	cytochrome	NN	O	cytochrome	nn	10	SENT_212	[p14l629t2414r983b2481],
10	P450	NN	O	p450	prep_of	4	SENT_212	[p14l1049t2417r1197b2465],
11	of	IN	O	of	_	0	SENT_212	[p14l1265t2414r1325b2465],
12	the	DT	O	the	det	14	SENT_212	[p14l1384t2414r1478b2465],
13	CYP3A	NN	O	cyp3a	nn	14	SENT_212	[p14l1544t2416r1763b2465],
14	subfamily	NN	O	subfamily	prep_of	4	SENT_212	[p14l1831t2414r2142b2481],
15	,	,	O	,	_	0	SENT_212	[p14l1831t2414r2142b2481],
16	CYP3A43	NN	O	cyp3a43	appos	14	SENT_212	[p14l117t2496r424b2545],
17	.	.	O	.	_	0	SENT_212	[p14l117t2496r424b2545],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_213	[p14l453t2493r719b2545],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_213	[p14l744t2493r990b2561],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_213	[p14l1014t2497r1121b2545],
4	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_213	[p14l1149t2496r1423b2545],
5	2001	CD	DATE	2001	num	4	SENT_213	[p14l1453t2501r1611b2553],
6	;	:	O	;	_	0	SENT_213	[p14l1453t2501r1611b2553],
7	281	CD	NUMBER	281	num	9	SENT_213	[p14l1640t2501r1762b2545],
8	:	:	O	:	_	0	SENT_213	[p14l1640t2501r1762b2545],
9	1349-1355	CD	DATE	1349-1355	dep	4	SENT_213	[p14l1794t2501r2134b2545],
10	.	.	O	.	_	0	SENT_213	[p14l1794t2501r2134b2545],

1	Thompson	NNP	PERSON	Thompson	nn	2	SENT_214	[p14l116t2573r444b2641],
2	EE	NNP	O	EE	_	0	SENT_214	[p14l476t2577r572b2633],
3	,	,	O	,	_	0	SENT_214	[p14l476t2577r572b2633],
4	Kuttab-Boulos	NNP	O	Kuttab-Boulos	nn	5	SENT_214	[p14l607t2573r1041b2625],
5	H	NNP	O	H	appos	2	SENT_214	[p14l1075t2577r1141b2633],
6	,	,	O	,	_	0	SENT_214	[p14l1075t2577r1141b2633],
7	Yang	NNP	PERSON	Yang	nn	8	SENT_214	[p14l1175t2577r1323b2641],
8	L	NNP	PERSON	L	appos	2	SENT_214	[p14l1356t2577r1410b2633],
9	,	,	O	,	_	0	SENT_214	[p14l1356t2577r1410b2633],
10	Roe	NNP	PERSON	Roe	nn	11	SENT_214	[p14l1445t2577r1557b2625],
11	BA	NN	PERSON	ba	appos	2	SENT_214	[p14l1590t2577r1700b2633],
12	,	,	O	,	_	0	SENT_214	[p14l1590t2577r1700b2633],
13	Di	NNP	LOCATION	Di	nn	17	SENT_214	[p14l1735t2576r1802b2624],
14	Rienzo	NNP	LOCATION	Rienzo	nn	17	SENT_214	[p14l1835t2576r2043b2625],
15	A.	NNP	O	A.	nn	17	SENT_214	[p14l2076t2577r2141b2625],
16	Sequence	NN	O	sequence	nn	17	SENT_214	[p14l119t2656r406b2720],
17	diversity	NN	O	diversity	appos	2	SENT_214	[p14l434t2653r701b2720],
18	and	CC	O	and	_	0	SENT_214	[p14l726t2653r838b2704],
19	haplotype	NN	O	haplotype	nn	20	SENT_214	[p14l862t2653r1167b2720],
20	structure	NN	O	structure	appos	2	SENT_214	[p14l1195t2660r1464b2704],
21	at	IN	O	at	_	0	SENT_214	[p14l1492t2661r1544b2704],
22	the	DT	O	the	det	25	SENT_214	[p14l1568t2653r1661b2704],
23	human	JJ	O	human	amod	25	SENT_214	[p14l1686t2653r1900b2704],
24	CYP3A	NN	O	cyp3a	nn	25	SENT_214	[p14l1925t2656r2144b2704],
25	cluster	NN	O	cluster	prep_at	17	SENT_214	[p14l117t2733r332b2784],
26	.	.	O	.	_	0	SENT_214	[p14l117t2733r332b2784],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	_	0	SENT_215	[p14l361t2733r960b2800],
2	I	PRP	O	I	dep	1	SENT_215	[p14l980t2736r1012b2797],
3	2005	CD	DATE	2005	dep	1	SENT_215	[p14l1032t2740r1189b2792],
4	;	:	O	;	_	0	SENT_215	[p14l1032t2740r1189b2792],
5	6	CD	NUMBER	6	num	7	SENT_215	[p14l1219t2740r1267b2784],
6	:	:	O	:	_	0	SENT_215	[p14l1219t2740r1267b2784],
7	105-114	CD	NUMBER	105-114	dep	1	SENT_215	[p14l1299t2740r1566b2784],
8	.	.	O	.	_	0	SENT_215	[p14l1299t2740r1566b2784],

1	Westlind-Johnsson	NNP	MISC	Westlind-Johnsson	nn	2	SENT_216	[p14l115t2813r690b2877],
2	A	NNP	MISC	A	dep	19	SENT_216	[p14l717t2817r782b2872],
3	,	,	O	,	_	0	SENT_216	[p14l717t2817r782b2872],
4	Malmebo	NNP	PERSON	Malmebo	nn	5	SENT_216	[p14l812t2813r1093b2864],
5	S	NNP	PERSON	S	appos	2	SENT_216	[p14l1123t2816r1175b2872],
6	,	,	O	,	_	0	SENT_216	[p14l1123t2816r1175b2872],
7	Iohansson	NNP	O	Iohansson	nn	8	SENT_216	[p14l1202t2813r1514b2877],
8	A	NNP	O	A	appos	2	SENT_216	[p14l1540t2817r1606b2872],
9	,	,	O	,	_	0	SENT_216	[p14l1540t2817r1606b2872],
10	Otter	NNP	ORGANIZATION	Otter	nn	11	SENT_216	[p14l1636t2816r1789b2864],
11	C	NNP	ORGANIZATION	C	appos	2	SENT_216	[p14l1815t2816r1872b2872],
12	,	,	O	,	_	0	SENT_216	[p14l1815t2816r1872b2872],
13	Andersson	NNP	PERSON	Andersson	nn	14	SENT_216	[p14l1901t2813r2143b2864, p14l118t2910r221b2943],
14	TB	NN	O	tb	appos	2	SENT_216	[p14l272t2895r373b2951],
15	,	,	O	,	_	0	SENT_216	[p14l272t2895r373b2951],
16	Iohansson	NN	O	iohansson	appos	2	SENT_216	[p14l424t2892r737b2956],
17	I	PRP	O	I	dep	19	SENT_216	[p14l787t2895r807b2943],
18	et	FW	O	et	nn	19	SENT_216	[p14l859t2899r913b2943],
19	a	FW	O	a	_	0	SENT_216	[p14l962t2892r1030b2943],
20	]	FW	O	]	dep	19	SENT_216	[p14l962t2892r1030b2943],
21	.	.	O	.	_	0	SENT_216	[p14l962t2892r1030b2943],

1	Comparative	JJ	O	comparative	amod	2	SENT_217	[p14l1085t2895r1469b2959],
2	analysis	NN	O	analysis	nsubj	9	SENT_217	[p14l1522t2892r1765b2959],
3	of	IN	O	of	_	0	SENT_217	[p14l1819t2892r1879b2943],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_217	[p14l1925t2895r2145b2943],
5	expression	NN	O	expression	prep_of	2	SENT_217	[p14l117t2975r444b3040],
6	in	IN	O	in	_	0	SENT_217	[p14l468t2975r528b3023],
7	human	JJ	O	human	amod	8	SENT_217	[p14l551t2973r765b3024],
8	liver	NN	O	liver	prep_in	5	SENT_217	[p14l789t2973r927b3024],
9	suggests	VBZ	O	suggest	_	0	SENT_217	[p14l952t2980r1199b3040],
10	only	RB	O	only	advmod	13	SENT_217	[p14l1226t2973r1360b3040],
11	a	DT	O	a	det	13	SENT_217	[p14l1384t2991r1414b3024],
12	minor	JJ	O	minor	amod	13	SENT_217	[p14l1437t2975r1620b3024],
13	role	NN	O	role	dobj	9	SENT_217	[p14l1642t2973r1757b3024],
14	for	IN	O	for	_	0	SENT_217	[p14l1783t2973r1865b3024],
15	CYP3A5	NN	O	cyp3a5	prep_for	13	SENT_217	[p14l1888t2975r2140b3024],
16	in	IN	O	in	_	0	SENT_217	[p14l117t3054r177b3103],
17	drug	NN	O	drug	nn	18	SENT_217	[p14l204t3052r340b3119],
18	metabolism	NN	O	metabolism	prep_in	15	SENT_217	[p14l365t3052r733b3103],
19	.	.	O	.	_	0	SENT_217	[p14l365t3052r733b3103],

1	Drug	NN	O	drug	nn	3	SENT_218	[p14l762t3055r912b3119],
2	Metab	NNP	O	Metab	nn	3	SENT_218	[p14l932t3052r1120b3103],
3	Dispos	NNP	O	Dispos	_	0	SENT_218	[p14l1144t3055r1349b3119],
4	2003	CD	DATE	2003	num	3	SENT_218	[p14l1377t3059r1534b3111],
5	;	:	O	;	_	0	SENT_218	[p14l1377t3059r1534b3111],
6	31	CD	NUMBER	31	num	8	SENT_218	[p14l1564t3059r1649b3103],
7	:	:	O	:	_	0	SENT_218	[p14l1564t3059r1649b3103],
8	755-761	CD	NUMBER	755-761	dep	3	SENT_218	[p14l1682t3059r1948b3103],
9	.	.	O	.	_	0	SENT_218	[p14l1682t3059r1948b3103],

1	Kuehl	NNP	PERSON	Kuehl	nn	2	SENT_219	[p14l116t3132r298b3184],
2	P	NN	O	p	dep	17	SENT_219	[p14l336t3136r383b3192],
3	,	,	O	,	_	0	SENT_219	[p14l336t3136r383b3192],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_219	[p14l425t3132r615b3200],
5	J	NNP	PERSON	J	appos	2	SENT_219	[p14l651t3136r689b3197],
6	,	,	O	,	_	0	SENT_219	[p14l651t3136r689b3197],
7	Lin	NNP	O	Lin	nn	8	SENT_219	[p14l730t3135r832b3183],
8	Y	NN	O	y	appos	2	SENT_219	[p14l869t3136r925b3192],
9	,	,	O	,	_	0	SENT_219	[p14l869t3136r925b3192],
10	Lamba	NNP	PERSON	Lamba	nn	14	SENT_219	[p14l967t3132r1169b3184],
11	I	PRP	O	I	dep	14	SENT_219	[p14l1204t3136r1242b3197],
12	,	,	O	,	_	0	SENT_219	[p14l1204t3136r1242b3197],
13	Assem	NNP	PERSON	Assem	dep	14	SENT_219	[p14l1282t3136r1485b3184],
14	M	NNP	PERSON	M	appos	2	SENT_219	[p14l1523t3136r1599b3192],
15	,	,	O	,	_	0	SENT_219	[p14l1523t3136r1599b3192],
16	Schuetz	NNP	PERSON	Schuetz	appos	2	SENT_219	[p14l1643t3132r1883b3184],
17	I	PRP	O	I	_	0	SENT_219	[p14l1920t3136r1942b3197],
18	et	FW	O	et	nn	19	SENT_219	[p14l1982t3139r2036b3184],
19	aI	FW	O	ai	dep	17	SENT_219	[p14l2073t3132r2141b3184],
20	.	.	O	.	_	0	SENT_219	[p14l2073t3132r2141b3184],

1	Sequence	NN	O	sequence	nn	2	SENT_220	[p14l119t3215r406b3279],
2	diversity	NN	O	diversity	_	0	SENT_220	[p14l441t3212r707b3279],
3	in	IN	O	in	_	0	SENT_220	[p14l739t3215r799b3263],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_220	[p14l831t3215r1050b3263],
5	promoters	NNS	O	promoter	prep_in	2	SENT_220	[p14l1082t3219r1388b3279],
6	and	CC	O	and	_	0	SENT_220	[p14l1423t3212r1534b3263],
7	characterization	NN	O	characterization	prep_in	2	SENT_220	[p14l1567t3212r2057b3263],
8	of	IN	O	of	_	0	SENT_220	[p14l2090t3212r2150b3263],
9	the	DT	O	the	det	11	SENT_220	[p14l116t3293r209b3344],
10	genetic	JJ	O	genetic	amod	11	SENT_220	[p14l239t3295r454b3360],
11	basis	NN	O	basis	prep_of	2	SENT_220	[p14l481t3293r631b3344],
12	of	IN	O	of	_	0	SENT_220	[p14l664t3293r724b3344],
13	polymorphic	JJ	O	polymorphic	amod	15	SENT_220	[p14l748t3293r1140b3360],
14	CYP3A5	NN	O	cyp3a5	nn	15	SENT_220	[p14l1171t3295r1423b3344],
15	expression	NN	O	expression	prep_of	11	SENT_220	[p14l1457t3295r1798b3360],
16	.	.	O	.	_	0	SENT_220	[p14l1457t3295r1798b3360],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_221	[p14l1832t3296r1944b3344],
2	Genet	NNP	PERSON	Genet	_	0	SENT_221	[p14l1974t3295r2148b3344],
3	2001	CD	DATE	2001	num	2	SENT_221	[p14l119t3380r690b3430],
4	;	:	O	;	_	0	SENT_221	[p14l119t3380r690b3430],
5	27:383	CD	NUMBER	27:383	number	6	SENT_221	[p14l119t3380r690b3430],
6	-391	CD	NUMBER	-391	dep	2	SENT_221	[p14l119t3380r690b3430],
7	.	.	O	.	_	0	SENT_221	[p14l119t3380r690b3430],

1	CYP3A43	NN	O	cyp3a43	nn	4	SENT_222	[p15l998t45r1101b69],
2	and	CC	O	and	_	0	SENT_222	[p15l1112t45r1150b69],
3	olanzapine	NN	O	olanzapine	nn	4	SENT_222	[p15l1160t45r1274b75],
4	metabolism	NN	O	metabolism	_	0	SENT_222	[p15l1284t45r1406b69],
5	®	CD	NUMBER	®	num	7	SENT_222	[p15l2092t44r2154b105],
6	KL	NNP	ORGANIZATION	KL	nn	7	SENT_222	[p15l1000t80r1026b103],
7	Bigos	NNP	ORGANIZATION	Bigos	dep	4	SENT_222	[p15l1036t80r1091b109],
8	et	FW	O	et	nn	9	SENT_222	[p15l1100t81r1121b103],
9	al	FW	O	al	dep	4	SENT_222	[p15l1129t80r1148b103],

1	18	CD	NUMBER	18	num	3	SENT_223	[p15l6t163r36b184],
2	Agarwal	NNP	ORGANIZATION	Agarwal	nn	3	SENT_223	[p15l54t160r172b191],
3	V	NNP	ORGANIZATION	V	_	0	SENT_223	[p15l201t161r227b187],
4	,	,	O	,	_	0	SENT_223	[p15l201t161r227b187],
5	Kommaddi	NNP	ORGANIZATION	Kommaddi	nn	6	SENT_223	[p15l257t160r414b184],
6	RP	NNP	ORGANIZATION	RP	appos	3	SENT_223	[p15l443t161r485b187],
7	,	,	O	,	_	0	SENT_223	[p15l443t161r485b187],
8	Valli	NNP	PERSON	Valli	nn	9	SENT_223	[p15l515t160r581b184],
9	K	NNP	PERSON	K	appos	3	SENT_223	[p15l609t161r638b187],
10	,	,	O	,	_	0	SENT_223	[p15l609t161r638b187],
11	Ryder	NNP	O	Ryder	nn	12	SENT_223	[p15l668t160r752b191],
12	D	NNP	O	D	appos	3	SENT_223	[p15l779t161r808b187],
13	,	,	O	,	_	0	SENT_223	[p15l779t161r808b187],
14	Hyde	NNP	PERSON	Hyde	nn	15	SENT_223	[p15l838t160r913b191],
15	TM	NNP	O	TM	appos	3	SENT_223	[p15l942t161r998b187],
16	,	,	O	,	_	0	SENT_223	[p15l942t161r998b187],
17	Kleinman	NNP	PERSON	Kleinman	nn	18	SENT_223	[p15l55t196r193b220],
18	IE	NN	O	ie	appos	3	SENT_223	[p15l205t198r234b226],
19	at	IN	O	at	_	0	SENT_223	[p15l249t199r275b220],
20	a	DT	O	a	det	21	SENT_223	[p15l287t196r319b220],
21	]	NN	O	]	prep_at	18	SENT_223	[p15l287t196r319b220],
22	.	.	O	.	_	0	SENT_223	[p15l287t196r319b220],

1	Drug	NN	O	drug	nn	2	SENT_224	[p15l333t198r401b228],
2	metabolism	NN	O	metabolism	_	0	SENT_224	[p15l415t196r579b220],
3	in	IN	O	in	_	0	SENT_224	[p15l593t197r621b220],
4	human	JJ	O	human	amod	5	SENT_224	[p15l634t196r733b220],
5	brain	NN	O	brain	prep_in	2	SENT_224	[p15l745t196r826b220],
6	:	:	O	:	_	0	SENT_224	[p15l745t196r826b220],
7	high	JJ	O	high	amod	8	SENT_224	[p15l841t196r904b228],
8	levels	NNS	O	level	dep	2	SENT_224	[p15l918t196r998b220],
9	of	IN	O	of	_	0	SENT_224	[p15l55t233r83b257],
10	cytochrome	NN	O	cytochrome	nn	11	SENT_224	[p15l93t233r258b264],
11	P4503A43	NN	O	p4503a43	prep_of	8	SENT_224	[p15l270t234r414b257],
12	in	IN	O	in	_	0	SENT_224	[p15l427t234r455b256],
13	brain	NN	O	brain	prep_in	11	SENT_224	[p15l466t233r540b257],
14	and	CC	O	and	_	0	SENT_224	[p15l552t233r604b257],
15	metabolism	NN	O	metabolism	conj_and	13	SENT_224	[p15l615t233r780b257],
16	of	IN	O	of	_	0	SENT_224	[p15l792t233r820b257],
17	anti-anxiety	JJ	O	anti-anxiety	amod	19	SENT_224	[p15l830t234r999b264],
18	drug	NN	O	drug	nn	19	SENT_224	[p15l56t270r119b302],
19	alprazolarn	NN	O	alprazolarn	prep_of	8	SENT_224	[p15l130t270r287b302],
20	to	TO	O	to	_	0	SENT_224	[p15l297t274r323b294],
21	its	PRP$	O	its	poss	23	SENT_224	[p15l333t271r366b294],
22	active	JJ	O	active	amod	23	SENT_224	[p15l377t271r459b294],
23	metabolite	NN	O	metabolite	prep_to	19	SENT_224	[p15l470t270r626b294],
24	.	.	O	.	_	0	SENT_224	[p15l470t270r626b294],

1	PLOS	NNP	O	PLOS	_	0	SENT_225	[p15l637t271r710b294],
2	One	CD	NUMBER	one	num	1	SENT_225	[p15l721t271r777b294],
3	2008	CD	DATE	2008	num	5	SENT_225	[p15l788t274r862b298],
4	;	:	O	;	_	0	SENT_225	[p15l788t274r862b298],
5	3	CD	NUMBER	3	dep	1	SENT_225	[p15l874t274r896b294],
6	:	:	O	:	_	0	SENT_225	[p15l874t274r896b294],
7	e2337	NN	O	e2337	dep	1	SENT_225	[p15l908t274r998b294],
8	.	.	O	.	_	0	SENT_225	[p15l908t274r998b294],

1	Ghotbi	NNP	PERSON	Ghotbi	nn	2	SENT_226	[p15l6t307r100b331],
2	R	NNP	PERSON	R	_	0	SENT_226	[p15l110t309r137b335],
3	,	,	O	,	_	0	SENT_226	[p15l110t309r137b335],
4	Mannheimer	NNP	PERSON	Mannheimer	nn	5	SENT_226	[p15l147t307r330b331],
5	B	NNP	PERSON	B	appos	2	SENT_226	[p15l339t309r366b335],
6	,	,	O	,	_	0	SENT_226	[p15l339t309r366b335],
7	Aklillu	NNP	PERSON	Aklillu	nn	8	SENT_226	[p15l376t307r477b331],
8	E	NNP	PERSON	E	appos	2	SENT_226	[p15l486t309r512b335],
9	,	,	O	,	_	0	SENT_226	[p15l486t309r512b335],
10	Suda	NNP	PERSON	Suda	nn	11	SENT_226	[p15l524t307r595b331],
11	A	NNP	O	A	appos	2	SENT_226	[p15l603t309r634b335],
12	,	,	O	,	_	0	SENT_226	[p15l603t309r634b335],
13	Bertilsson	NNP	ORGANIZATION	Bertilsson	nn	14	SENT_226	[p15l645t307r787b331],
14	L	NNP	ORGANIZATION	L	appos	2	SENT_226	[p15l796t309r822b335],
15	,	,	O	,	_	0	SENT_226	[p15l796t309r822b335],
16	Eliasson	NNP	PERSON	Eliasson	nn	17	SENT_226	[p15l832t307r951b331],
17	E	NNP	O	E	appos	2	SENT_226	[p15l54t346r71b368],
18	et	FW	O	et	nn	19	SENT_226	[p15l97t347r122b368],
19	aI	FW	O	ai	dep	17	SENT_226	[p15l145t344r177b368],
20	.	.	O	.	_	0	SENT_226	[p15l145t344r177b368],

1	Carriers	NNS	O	carrier	nsubjpass	11	SENT_227	[p15l202t345r312b368],
2	of	IN	O	of	_	0	SENT_227	[p15l337t344r365b368],
3	the	DT	O	the	det	5	SENT_227	[p15l385t344r429b368],
4	UGT1A4	NN	O	ugt1a4	nn	5	SENT_227	[p15l453t345r577b368],
5	14ZT	NN	O	14zt	nn	9	SENT_227	[p15l603t345r725b368],
6	>	JJR	O	>	dep	7	SENT_227	[p15l603t345r725b368],
7	G	NN	O	g	amod	9	SENT_227	[p15l603t345r725b368],
8	gene	NN	O	gene	nn	9	SENT_227	[p15l747t353r812b376],
9	variant	NN	O	variant	prep_of	1	SENT_227	[p15l835t345r934b368],
10	are	VBP	O	be	auxpass	11	SENT_227	[p15l958t353r999b368],
11	predisposed	VBN	O	predispose	_	0	SENT_227	[p15l54t381r228b412],
12	to	TO	O	to	aux	14	SENT_227	[p15l242t384r268b405],
13	reduced	VBN	O	reduce	amod	14	SENT_227	[p15l282t381r397b405],
14	olanzapine	NN	O	olanzapine	xcomp	11	SENT_227	[p15l412t381r567b412],
15	exposure	NN	O	exposure	dobj	14	SENT_227	[p15l582t389r776b412],
16	—	CD	NUMBER	—	num	15	SENT_227	[p15l582t389r776b412],
17	an	DT	O	a	det	18	SENT_227	[p15l582t389r776b412],
18	impact	NN	O	impact	npadvmod	19	SENT_227	[p15l790t382r887b412],
19	similar	JJ	O	similar	amod	15	SENT_227	[p15l901t381r1000b405],
20	to	TO	O	to	_	0	SENT_227	[p15l54t421r80b442],
21	male	JJ	O	male	amod	22	SENT_227	[p15l94t418r162b442],
22	gender	NN	O	gender	prep_to	14	SENT_227	[p15l176t418r273b449],
23	or	CC	O	or	_	0	SENT_227	[p15l287t426r315b442],
24	smoking	NN	O	smoking	conj_or	22	SENT_227	[p15l329t418r448b449],
25	in	IN	O	in	_	0	SENT_227	[p15l462t419r490b441],
26	schizophrenic	JJ	O	schizophrenic	amod	27	SENT_227	[p15l505t418r705b449],
27	patients	NNS	O	patient	prep_in	22	SENT_227	[p15l720t419r839b449],
28	.	.	O	.	_	0	SENT_227	[p15l720t419r839b449],

1	Eur	NNP	MISC	Eur	nsubj	3	SENT_228	[p15l855t419r907b442],
2	I	PRP	O	I	dep	1	SENT_228	[p15l916t419r931b447],
3	Clin	VBP	O	clin	_	0	SENT_228	[p15l943t418r999b442],
4	Pharmacol	NNP	O	Pharmacol	dobj	3	SENT_228	[p15l54t454r209b478],
5	2010	CD	DATE	2010	num	4	SENT_228	[p15l221t457r294b482],
6	;	:	O	;	_	0	SENT_228	[p15l221t457r294b482],
7	66	CD	NUMBER	66	num	9	SENT_228	[p15l308t457r348b478],
8	:	:	O	:	_	0	SENT_228	[p15l308t457r348b478],
9	465-474	CD	NUMBER	465-474	dep	4	SENT_228	[p15l361t457r487b478],
10	.	.	O	.	_	0	SENT_228	[p15l361t457r487b478],

1	Davis	NNP	PERSON	Davis	nn	2	SENT_229	[p15l6t492r84b515],
2	J	NNP	PERSON	J	_	0	SENT_229	[p15l110t492r128b521],
3	,	,	O	,	_	0	SENT_229	[p15l110t492r128b521],
4	Chen	NNP	PERSON	Chen	nn	6	SENT_229	[p15l156t491r229b515],
5	N.	NNP	PERSON	N.	nn	6	SENT_229	[p15l255t492r285b515],
6	Dose	NNP	PERSON	Dose	appos	2	SENT_229	[p15l313t492r380b515],
7	response	NN	O	response	dep	6	SENT_229	[p15l407t499r532b522],
8	and	CC	O	and	_	0	SENT_229	[p15l559t491r611b515],
9	dose	NN	O	dose	appos	2	SENT_229	[p15l639t491r702b515],
10	equivalence	JJ	O	equivalence	amod	9	SENT_229	[p15l729t491r898b522],
11	of	IN	O	of	_	0	SENT_229	[p15l926t491r954b515],
12	antipsychotics	NNS	O	antipsychotic	prep_of	9	SENT_229	[p15l55t528r268b560],
13	.	.	O	.	_	0	SENT_229	[p15l55t528r268b560],

1	I	PRP	O	I	nsubj	2	SENT_230	[p15l280t530r295b558],
2	Clin	VBP	O	clin	_	0	SENT_230	[p15l304t528r360b552],
3	Psychopharmacol	JJ	O	psychopharmacol	amod	4	SENT_230	[p15l372t528r628b560],
4	2004	CD	DATE	2004	dobj	2	SENT_230	[p15l640t532r714b556],
5	;	:	O	;	_	0	SENT_230	[p15l640t532r714b556],
6	24	CD	NUMBER	24	num	8	SENT_230	[p15l727t532r767b552],
7	:	:	O	:	_	0	SENT_230	[p15l727t532r767b552],
8	192-208	CD	NUMBER	192-208	dep	4	SENT_230	[p15l782t532r906b552],
9	.	.	O	.	_	0	SENT_230	[p15l782t532r906b552],

1	21	CD	NUMBER	21	num	3	SENT_231	[p15l1077t163r1107b183],
2	Gardner	NNP	PERSON	Gardner	nn	3	SENT_231	[p15l1126t160r1241b184],
3	D	NNP	O	D	_	0	SENT_231	[p15l1251t161r1280b187],
4	,	,	O	,	_	0	SENT_231	[p15l1251t161r1280b187],
5	Murphy	NNP	PERSON	Murphy	nn	6	SENT_231	[p15l1291t160r1407b191],
6	A	NNP	O	A	appos	3	SENT_231	[p15l1417t161r1448b187],
7	,	,	O	,	_	0	SENT_231	[p15l1417t161r1448b187],
8	O’Donnell	NNP	O	O’Donnell	nn	9	SENT_231	[p15l1460t160r1605b184],
9	H	NNP	O	H	appos	3	SENT_231	[p15l1616t161r1647b187],
10	,	,	O	,	_	0	SENT_231	[p15l1616t161r1647b187],
11	Centorrino	NNP	O	Centorrino	nn	12	SENT_231	[p15l1659t161r1811b184],
12	F	NN	O	f	appos	3	SENT_231	[p15l1822t161r1844b187],
13	,	,	O	,	_	0	SENT_231	[p15l1822t161r1844b187],
14	Baldessarini	NNP	ORGANIZATION	Baldessarini	nn	18	SENT_231	[p15l1856t160r2031b184],
15	R.	NNP	ORGANIZATION	R.	nn	18	SENT_231	[p15l2042t161r2069b184],
16	International	NNP	ORGANIZATION	International	nn	18	SENT_231	[p15l1125t196r1309b220],
17	consensus	NN	O	consensus	nn	18	SENT_231	[p15l1332t204r1477b220],
18	study	NN	O	study	appos	3	SENT_231	[p15l1501t196r1579b228],
19	of	IN	O	of	_	0	SENT_231	[p15l1601t196r1630b220],
20	antipsychotic	JJ	O	antipsychotic	amod	21	SENT_231	[p15l1650t196r1841b228],
21	dosing	NN	O	dosing	prep_of	18	SENT_231	[p15l1865t196r1965b228],
22	.	.	O	.	_	0	SENT_231	[p15l1865t196r1965b228],

1	Am	VBP	O	be	cop	2	SENT_232	[p15l1988t198r2039b220],
2	]	CD	NUMBER	]	_	0	SENT_232	[p15l2059t198r2074b226],
3	Psychiatzy	JJ	O	psychiatzy	amod	2	SENT_232	[p15l1125t233r1277b264],
4	2010	CD	DATE	2010	tmod	3	SENT_232	[p15l1287t236r1360b260],
5	;	:	O	;	_	0	SENT_232	[p15l1287t236r1360b260],
6	167	CD	NUMBER	167	num	8	SENT_232	[p15l1374t236r1431b257],
7	:	:	O	:	_	0	SENT_232	[p15l1374t236r1431b257],
8	686-693	CD	NUMBER	686-693	dep	2	SENT_232	[p15l1445t236r1570b257],
9	.	.	O	.	_	0	SENT_232	[p15l1445t236r1570b257],

1	22	CD	NUMBER	22	num	3	SENT_233	[p15l1077t274r1107b294],
2	Mauri	NNP	O	Mauri	nn	3	SENT_233	[p15l1126t271r1211b294],
3	MC	NNP	O	MC	_	0	SENT_233	[p15l1222t271r1279b298],
4	,	,	O	,	_	0	SENT_233	[p15l1222t271r1279b298],
5	Steinhilber	NNP	ORGANIZATION	Steinhilber	nn	6	SENT_233	[p15l1292t270r1449b294],
6	CPC	NNP	ORGANIZATION	CPC	appos	3	SENT_233	[p15l1461t271r1527b298],
7	,	,	O	,	_	0	SENT_233	[p15l1461t271r1527b298],
8	Marino	NNP	PERSON	Marino	nn	9	SENT_233	[p15l1539t271r1641b294],
9	R	NNP	PERSON	R	appos	3	SENT_233	[p15l1653t272r1680b298],
10	,	,	O	,	_	0	SENT_233	[p15l1653t272r1680b298],
11	Invernizzi	NNP	PERSON	Invernizzi	nn	12	SENT_233	[p15l1692t271r1836b294],
12	E	NNP	PERSON	E	appos	3	SENT_233	[p15l1847t272r1873b298],
13	,	,	O	,	_	0	SENT_233	[p15l1847t272r1873b298],
14	Fiorentini	NNP	PERSON	Fiorentini	nn	15	SENT_233	[p15l1885t271r2027b294],
15	A	NNP	O	A	appos	3	SENT_233	[p15l2039t272r2070b298],
16	,	,	O	,	_	0	SENT_233	[p15l2039t272r2070b298],
17	19	CD	NUMBER	19	num	18	SENT_233	[p15l2082t273r2112b294],
18	Cerveri	NN	O	cerverus	appos	3	SENT_233	[p15l1077t308r1179b331],
19	G	NN	O	g	dep	18	SENT_233	[p15l1190t308r1212b331],
20	et	FW	O	et	nn	19	SENT_233	[p15l1223t310r1248b331],
21	a	FW	O	a	nn	19	SENT_233	[p15l1259t307r1291b331],
22	]	FW	O	]	dep	19	SENT_233	[p15l1259t307r1291b331],
23	.	.	O	.	_	0	SENT_233	[p15l1259t307r1291b331],

1	Clinical	JJ	O	clinical	amod	2	SENT_234	[p15l1303t307r1414b331],
2	outcome	NN	O	outcome	_	0	SENT_234	[p15l1426t311r1546b331],
3	and	CC	O	and	_	0	SENT_234	[p15l1558t307r1610b331],
4	olanzapine	NN	O	olanzapine	nn	6	SENT_234	[p15l1622t307r1777b339],
5	plasma	NN	O	plasma	nn	6	SENT_234	[p15l1789t307r1890b339],
6	levels	NNS	O	level	conj_and	2	SENT_234	[p15l1901t307r1982b331],
7	in	IN	O	in	_	0	SENT_234	[p15l1994t308r2022b331],
8	acute	JJ	O	acute	amod	9	SENT_234	[p15l1126t348r1200b368],
9	schizophrenia	NN	O	schizophrenia	prep_in	2	SENT_234	[p15l1213t344r1421b376],
10	.	.	O	.	_	0	SENT_234	[p15l1213t344r1421b376],

1	Eur	NNP	O	Eur	nn	2	SENT_235	[p15l1434t346r1486b368],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_235	[p15l1495t344r1647b376],
3	2005	CD	DATE	2005	num	2	SENT_235	[p15l1657t347r1730b372],
4	;	:	O	;	_	0	SENT_235	[p15l1657t347r1730b372],
5	20	CD	NUMBER	20	num	7	SENT_235	[p15l1744t347r1784b368],
6	:	:	O	:	_	0	SENT_235	[p15l1744t347r1784b368],
7	55-60	CD	NUMBER	55-60	dep	2	SENT_235	[p15l1798t347r1888b368],
8	.	.	O	.	_	0	SENT_235	[p15l1798t347r1888b368],

1	23	CD	NUMBER	23	_	0	SENT_236	[p15l1077t384r1107b405],
2	Mauri	NNP	O	Mauri	nn	3	SENT_236	[p15l1125t382r1210b405],
3	MC	NNP	O	MC	dep	1	SENT_236	[p15l1221t382r1278b408],
4	,	,	O	,	_	0	SENT_236	[p15l1221t382r1278b408],
5	Volonteri	NNP	O	Volonteri	nn	6	SENT_236	[p15l1290t381r1421b405],
6	LS	NN	O	l	appos	3	SENT_236	[p15l1432t382r1477b408],
7	,	,	O	,	_	0	SENT_236	[p15l1432t382r1477b408],
8	Colasanti	NNP	PERSON	Colasanti	nn	9	SENT_236	[p15l1489t381r1620b405],
9	A	NNP	O	A	appos	3	SENT_236	[p15l1632t382r1662b408],
10	,	,	O	,	_	0	SENT_236	[p15l1632t382r1662b408],
11	Fiorentini	NNP	PERSON	Fiorentini	nn	12	SENT_236	[p15l1674t382r1816b405],
12	A	NNP	O	A	appos	3	SENT_236	[p15l1827t382r1858b408],
13	,	,	O	,	_	0	SENT_236	[p15l1827t382r1858b408],
14	De	NNP	PERSON	De	nn	15	SENT_236	[p15l1870t382r1907b405],
15	Gaspari	NNP	PERSON	Gaspari	appos	3	SENT_236	[p15l1918t382r2025b412],
16	IF	IN	O	if	amod	15	SENT_236	[p15l2036t382r2069b408],
17	,	,	O	,	_	0	SENT_236	[p15l2036t382r2069b408],
18	Bareggi	NNP	O	Bareggi	nn	19	SENT_236	[p15l1126t419r1230b449],
19	SR.	NNP	O	SR.	appos	3	SENT_236	[p15l1243t419r1288b442],
20	.	.	O	.	_	0	SENT_236	[p15l1243t419r1288b442],

1	Clinical	JJ	O	clinical	amod	2	SENT_237	[p15l1302t418r1413b442],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_237	[p15l1426t418r1678b449],
3	of	IN	O	of	_	0	SENT_237	[p15l1692t418r1720b442],
4	atypical	JJ	O	atypical	amod	5	SENT_237	[p15l1730t418r1843b449],
5	antipsychotics	NNS	O	antipsychotic	prep_of	2	SENT_237	[p15l1856t418r2069b449],
6	:	:	O	:	_	0	SENT_237	[p15l1856t418r2069b449],
7	a	DT	O	a	det	9	SENT_237	[p15l1126t463r1140b478],
8	critical	JJ	O	critical	amod	9	SENT_237	[p15l1180t454r1278b478],
9	review	NN	O	review	dep	2	SENT_237	[p15l1317t455r1413b478],
10	of	IN	O	of	_	0	SENT_237	[p15l1453t454r1481b478],
11	the	DT	O	the	det	12	SENT_237	[p15l1517t454r1561b478],
12	relationship	NN	O	relationship	prep_of	9	SENT_237	[p15l1600t454r1771b486],
13	between	IN	O	between	_	0	SENT_237	[p15l1811t454r1930b478],
14	plasma	NN	O	plasma	nn	16	SENT_237	[p15l1969t454r2071b486],
15	20	CD	NUMBER	20	num	16	SENT_237	[p15l2084t457r2115b478],
16	concentrations	NNS	O	concentration	prep_between	12	SENT_237	[p15l1078t492r1286b515],
17	and	CC	O	and	_	0	SENT_237	[p15l1303t491r1355b515],
18	clinical	JJ	O	clinical	amod	19	SENT_237	[p15l1371t491r1476b515],
19	response	NN	O	response	prep_of	9	SENT_237	[p15l1492t499r1624b522],
20	.	.	O	.	_	0	SENT_237	[p15l1492t499r1624b522],

1	CI1	NN	O	ci1	_	0	SENT_238	[p15l1643t491r1699b515],
2	'n	CC	O	'n	_	0	SENT_238	[p15l1643t491r1699b515],
3	Pharmacokinet	NNP	O	Pharmacokinet	conj_'n	1	SENT_238	[p15l1715t491r1932b515],
4	2007	CD	DATE	2007	num	3	SENT_238	[p15l1947t494r2021b518],
5	;	:	O	;	_	0	SENT_238	[p15l1947t494r2021b518],
6	46	CD	NUMBER	46	num	8	SENT_238	[p15l1125t532r1166b552],
7	:	:	O	:	_	0	SENT_238	[p15l1125t532r1166b552],
8	359-388	CD	NUMBER	359-388	dep	1	SENT_238	[p15l1180t532r1305b552],
9	.	.	O	.	_	0	SENT_238	[p15l1180t532r1305b552],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_239	[p15l6t617r275b658],
2	Information	NNP	O	Information	dep	3	SENT_239	[p15l286t617r492b648],
3	accompanies	VBZ	O	accompany	_	0	SENT_239	[p15l503t619r728b658],
4	the	DT	O	the	det	5	SENT_239	[p15l739t617r793b648],
5	paper	NN	O	paper	dobj	3	SENT_239	[p15l805t628r904b658],
6	on	IN	O	on	_	0	SENT_239	[p15l916t628r959b648],
7	the	DT	O	the	det	10	SENT_239	[p15l969t617r1023b648],
8	Molecular	JJ	O	molecular	amod	10	SENT_239	[p15l1034t617r1213b648],
9	Psychiatry	NNP	O	Psychiatry	nn	10	SENT_239	[p15l1223t617r1406b658],
10	website	NN	O	website	prep_on	3	SENT_239	[p15l1416t617r1549b648],
11	(	CD	NUMBER	(	num	13	SENT_239	[p15l1562t617r2068b658],
12	http://www.nature.com/mp	NN	O	http://www.nature.com/mp	nn	13	SENT_239	[p15l1562t617r2068b658],
13	)	NN	O	)	nsubj	3	SENT_239	[p15l1562t617r2068b658],

